company_name,sector,funding,funding_citation,ai_enabled
23 century clinic,Biopharmaceutical,$40M,https://23cbio.com/,No
a2 biotherapeutics inc,Biotechnology,$80M Series C,https://www.businesswire.com/news/home/20250108230204/en/A2-Biotherapeutics-Closes-%2480-Million-Series-C-Financing-to-Advance-Clinical-Development-of-Its-Precision-Cell-Therapies-Using-Its-Proprietary-Tmod-Technology-Platform,No
apeiron biologics ag,Biotechnology,$100M,https://investor.ligand.com/news-and-events/press-releases/news-details/2024/Ligand-to-Acquire-APEIRON-Biologics-AG-for-100-Million/default.aspx,No
avrobio inc,Biotechnology,$60M,https://leadiq.com/c/avrobio/5a1dac332300005300a16398,No
abata therapeutics,Biotechnology,Corporate round,https://www.crunchbase.com/organization/abata-therapeutics,No
abelzeta inc,Biopharmaceutical,Series A - $120M,https://www.oncologypipeline.com/apexonco/cellular-biomedicine-draws-line-under-its-past,No
acer therapeutics inc,Pharmaceutical Manufacturing,$1.0M,https://www.linkedin.com/company/acer-therapeutics-inc,No
achilles therapeutics plc,Biotechnology,US$ 4.1M,https://uk.linkedin.com/company/achillestx.com,No
adaptimmune therapeutics plc,Biotechnology,$25.0M,https://www.linkedin.com/company/adaptimmune,No
aderans research institute,Regenerative Medicine,Incubator/Accelerator,https://www.cbinsights.com/company/aderans-research-institute,No
affyimmune therapeutics inc,Biotechnology,"Series A, $20M",https://www.linkedin.com/company/affyimmune,No
alaunos therapeutics inc,Healthcare,$50M,https://www.linkedin.com/company/alaunos,No
aleta biotherapeutics inc,Biotechnology,"Series A, $13.7M",https://www.linkedin.com/company/aletabio,No
allife medical science and technology co ltd,Biotechnology,Private,https://crisprmedicinenews.com/company/card/allife-medical-science-and-technology/,No
allocure inc. (inactive),Biotechnology,Series B - II,https://www.cbinsights.com/company/allocure,No
allovir inc,Healthcare,$100M,https://www.globenewswire.com/news-release/2025/03/18/3044996/0/en/Kalaris-Announces-Closing-of-Merger-with-AlloVir.html,No
alloplex biotherapeutics inc,Biotechnology,Angel Funded,https://www.massbio.org/members/alloplex-biotherapeutics-inc/,No
altheia science srl,Biotechnology,"Series A, $11.0M",https://www.crunchbase.com/organization/altheia-science,No
alzamend neuro inc,Biotechnology,$5M Private Placement,https://alzamend.com/,No
american gene technologies international inc,Biotechnology,Series D,https://www.crunchbase.com/organization/american-gene-technologies-international,No
amgen inc,Healthcare,$900M,https://finance.yahoo.com/news/amgen-amgn-announces-650m-puerto-063331605.html,No
amniotics ab,Biotechnology,SEK 60 million,https://www.biospace.com/stem-cell-therapy-company-amniotics-raises-sek-60-million-before-deduction-of-transaction-costs-in-first-north-ipo-to-advance-lead-candidate-pulmostem-into-clinic,No
amphera bv,Biotechnology,€12.5M,https://www.euroquity.com/en/company/amphera-bv,No
andalusian initiative for advanced therapies,Biotechnology,$96.88M,https://pmc.ncbi.nlm.nih.gov/articles/PMC3659837/,No
angiocrine bioscience inc,Biotechnology,$2.1M,https://www.linkedin.com/company/angiocrine-bioscience-inc-,No
anhui kedgene biotechnology co ltd,Biotechnology,Private,https://crisprmedicinenews.com/company/card/anhui-kedgene-biotechnology/,No
anika therapeutics inc,Healthcare,Post IPO equity,https://www.linkedin.com/company/anika-therapeutics,No
ann & robert h lurie children’s hospital of chicago,Healthcare,$3.7M,https://www.linkedin.com/company/ann-and-robert-h-lurie-children's-hospital-of-chicago,No
anocca ab,Biotechnology,SEK 440 million,https://www.contractpharma.com/breaking-news/anocca-raises-46m-to-advance-clinical-trial-targeting-pancreatic-cancer/,No
antria inc,Biotechnology,$1.4M,https://www.linkedin.com/company/antria-inc-,No
arcellx inc,Healthcare,$200M,https://www.linkedin.com/company/arcellx,No
astellas pharma inc,Pharmaceutical,"Grant Aug 22, 2020",https://www.linkedin.com/company/astellaspharmainc,No
athenex inc,Biopharmaceutical,$30M,https://www.linkedin.com/company/athenex,No
athersys inc,Biotechnology,$3.7M,https://www.linkedin.com/company/athersys,No
aurealis oy,Biotechnology,$40M Series B,https://fi.linkedin.com/company/aurealis-ltd,No
autolus therapeutics plc,Biotechnology,$350M,https://uk.linkedin.com/company/autolus-ltd-,No
avenge bio inc (inactive),Biotech,$45M Series A,https://www.decibio.com/insights/next-generation-therapeutics-newsletter-august-roundup-2024,No
avotres inc,Biotechnology,$4.0M,https://www.crunchbase.com/organization/avotres,No
azellon ltd (inactive),Healthcare,£1.622M,https://gtr.ukri.org/projects?ref=102164,No
base therapeutics,Gene Editing,Series A,https://www.biospace.com/press-releases/the-worlds-first-base-edited-nk-cell-therapy-receives-ind-approval-in-both-china-and-the-u-s,No
baylor college of medicine,Healthcare,$374M,https://www.topuniversities.com/universities/baylor-college-medicine,No
beijing immunochina pharmaceuticals co ltd,Biotechnology,Series D+,http://imunopharm.com/en/index.php/Home/gywm/gywm2.html,No
beijing you''an hospital,Healthcare,"$120,000",https://www.fordfoundation.org/work/our-grants/awarded-grants/grants-database/beijing-youan-hospital-106162/,No
beth israel deaconess medical center,Healthcare,$200M annually (biomedical research funding),https://en.wikipedia.org/wiki/Beth_Israel_Deaconess_Medical_Center,No
biocardia inc,Biotechnology,$6.0M,https://www.linkedin.com/company/biocardia,No
biorestorative therapies inc,Biotechnology,$7.8M,https://www.linkedin.com/company/biorestorative-therapies-inc-,No
biogencell ltd,Biotechnology,$16M,https://www.calcalistech.com/ctechnews/article/hki11xl2wa,No
bioncart gmbh,Biotechnology,Seven-figure sum,https://www.bm-t.de/en/2024-en/bioplanta-becomes-bioncart-bmt-tgfs-private-investors-and-founders-jointly-invest-a-seven-figure-sum-to-conduct-a-clinical-trial/,No
biotherapy services ltd,Biopharmaceutical,£3.0M,https://www.foresight.group/news/innovative-biopharmaceutical-company-biotherapy-services-ltd-secures-30-million-investment-from-foresight,No
bluerock therapeutics llc,Biotechnology,"Series A, $225M",https://www.linkedin.com/company/bluerocktx,No
bobcatbio inc,Biotechnology,$27.1M,https://www.fundz.net/fundings/sirpant-immunotherapeutics-funding-round-f50f9b,No
boryung vigencell inc,Biotechnology,KRW 7.9 billion,https://www.marketscreener.com/quote/stock/VIGENCELL-INC-126415396/news/Gaeun-Global-Co-Ltd-agreed-to-acquire-11-36-stake-in-ViGenCell-Inc-from-Boryung-Corporation-for-K-48640742/,No
bristar immunotech biotechnology co ltd,Biotechnology,B+ round financing,https://en.bristarimmunotech.com/about/,No
bristol-myers squibb co,Healthcare,$13.0B,https://www.linkedin.com/company/bristol-myers-squibb,No
carsgen therapeutics ltd,Biopharmaceutical,"RMB80,000,000",https://www.prnewswire.com/news-releases/carsgen-therapeutics-announces-2025-interim-results-302529973.html,No
cefo co ltd,Biotechnology,USD 5 ~ 10 million (Share: 10%),https://www.investkorea.org/ik-en/pgm/i-2804/mtchg/hope/front/detail.do?entp_sn=113,No
cabaletta bio inc,Biotechnology,$100M,https://www.linkedin.com/company/cabalettabio,No
calidi biotherapeutics inc,Biotechnology,$6.9M,https://www.calidibio.com/,No
cancer research uk,Non-profit,£10M,https://uk.linkedin.com/company/cancer-research-uk,No
carisma therapeutics inc,Biotechnology,"Series C, $30M",https://www.linkedin.com/company/carisma-therapeutics,No
cartesian bio llc,Biotechnology,$130M,https://www.biospace.com/employer/397218/cartesian-therapeutics,No
"cartesian bio, llc",Biotechnology,$130M,https://www.biospace.com/employer/397218/cartesian-therapeutics,No
casa sollievo della sofferenza hospital,Healthcare,€73M agreement with suppliers,https://operapadrepio.it/it/,No
castle creek biosciences inc,Biotechnology,$112.8M,https://paragonbiosci.com/2022/05/25/castle-creek-biosciences-raises-112-8-million-to-advance-novel-gene-therapies-and-expand-pipeline/,No
cell and gene therapy catapult,Biotechnology,US$ 1.5M,https://uk.linkedin.com/company/cgt-catapult,No
cellpoint bv,Biotechnology,Series A,https://www.prnewswire.com/news-releases/pregene-enters-into-innovative-partnership-with-cellpoint-to-develop-anti-bcma-car-t-cell-therapy-in-europe-and-the-us-301518944.html,No
cellprothera sas,Biotechnology,"€5,000,000","https://www.northdata.com/Cellprothera%20SAS,%20Mulhouse/Siren%20504305855",No
cellaion sa,Biotechnology,€5.5M,https://newtonbiocapital.com/en/news-article/cellaion-sa-announces-an-additional-closing-of-5-5m-euros-financing-on-june-13th-2023,No
cellatoz therapeutics inc,Biotechnology,$10M Series A,https://www.nature.com/articles/d43747-020-00921-8,No
cellcolabs clinical spv ltd,Biotechnology,"$8,667,846",https://se.linkedin.com/company/cellcolabs,No
cellectis sa,Biotechnology,$228M,https://en.wikipedia.org/wiki/Cellectis,No
cellular biomedicine group inc,Biopharmaceutical,$120M Series A,https://www.oncologypipeline.com/apexonco/cellular-biomedicine-draws-line-under-its-past,No
cellular biomedicine group ltd,Biopharmaceutical,$120M Series A,https://www.oncologypipeline.com/apexonco/cellular-biomedicine-draws-line-under-its-past,No
celularity inc,Biotechnology,$30.0M,https://www.linkedin.com/company/celularity,No
chengdu medgencell biotechnology co ltd,Biotechnology,Private,https://crisprmedicinenews.com/company/card/chengdu-medgencell/,No
children''s hospital of philadelphia,Healthcare,$1.0M,https://www.linkedin.com/company/the-childrens-hospital-of-philadelphia,No
children's hospital of philadelphia,Healthcare,$1.0M,https://www.linkedin.com/company/the-childrens-hospital-of-philadelphia,No
city of hope,Healthcare,$5.4M,https://www.linkedin.com/company/city-of-hope,No
cook group inc,Medical Technology,$875M,https://en.wikipedia.org/wiki/Cook_Group,No
cynata therapeutics ltd,Biotechnology,$1.0M,https://au.linkedin.com/company/cynata-therapeutics,No
dc prime bv,Biopharmaceutical,SEK 250 million,https://synapse.patsnap.com/organization/315d16d189f14690fc499e0fd3181fef,No
dendright pty ltd,Biotechnology,Seed Funding,https://www.uq.edu.au/news/article/2013/08/new-rheumatoid-arthritis-treatment-moves-step-closer-reality,No
department of science & technology,Science and Technology,$720M,https://en.wikipedia.org/wiki/Department_of_Science_and_Technology_(India),No
deverra therapeutics inc,Biotechnology,$6.94M,https://www.cbinsights.com/company/deverra-therapeutics,No
discgenics inc,Biopharmaceutical,"Series C, $50M",https://www.crunchbase.com/organization/discgenics,No
edigene inc,Biotechnology,"Series B, $61.6M",https://www.linkedin.com/company/edigene,No
editas medicine inc,Biotechnology,$57M upfront payment,https://finance.yahoo.com/news/editas-medicine-inc-edit-promising-075517711.html,No
elixirgen therapeutics inc,Biotechnology,$7.0M,https://www.linkedin.com/company/elixirgen-therapeutics-inc,No
estrella biopharma inc,Biopharmaceutical,$23.11M,https://www.winston.com/en/experience/estrella-biopharma-inc-closes-business-combination-with-tradeup-acquisition-corp-68701101,No
eureka therapeutics inc,Biotechnology,$10.6M,https://www.cirm.ca.gov/our-progress/institutions/eureka-therapeutics-inc/,No
eutilex co ltd,Biotechnology,$30M investment,https://synapse.patsnap.com/organization/57fa55b87956590baefba5e5e8c37d99,No
exo biologics sa,Biotechnology,EUR 16 million Series A,https://www.exobio.be/en/,No
famicordtx sa,Biotechnology,PLN 16 million (approximately EUR 3.5 million),https://www.nextcellpharma.com/press-releases/nextcell-invests-in-car-t-technology,No
fate therapeutics inc,Biotechnology,$7.9M,https://www.crunchbase.com/organization/fate-therapeutics,No
first affiliated hospital of guangdong pharmaceutical university,Healthcare,"$740,300",https://govt.chinadaily.com.cn/s/201905/08/WS5cd299fa498e079e6801fae9/the-first-affiliated-hospital-of-guangdong-pharmaceutical-university.html,No
fondazione telethon,Biomedical Research,€741M,https://www.fondazionetelethon.it/en/,No
foundation for health research and training in the region of murcia,Biomedical,Horizon Europe Grant Agreement No 101080156,https://www.nanemiar.eu/nanemiar/consortium.jsf,No
fundacio institut d''investigacio en ciencies de la salut germans trias i pujol,Biomedicine,2024 Gilead Sciences Grant,https://es.linkedin.com/company/igtp,No
fundacio sant joan de deu,Healthcare,€10M,https://www.irsjd.org/ca/,No
g. papanikolaou hospital,Healthcare,€254M,https://commission.europa.eu/projects/health-infrastructure-nhs-hospital-renovation-and-infrastructure-upgradethessaloniki-general_en,No
gid group inc,Biotechnology,$250K,https://www.linkedin.com/company/the-gid-group-inc.,No
gamida cell ltd,Biotechnology,$25M Post IPO Debt,https://www.linkedin.com/company/gamida-cell-ltd-,No
gansu provincial cancer hospital,Healthcare,"RMB 1,500 million",https://www.ndb.int/project/gansu-regional-medical-centre/,No
genentech inc,Biotechnology,"$725M cash upfront, with an additional $1 billion in milestone payments (Seragon acquisition, 2014)",https://en.wikipedia.org/wiki/Genentech,No
genentech usa inc,Biotechnology,"$725M cash upfront, with an additional $1 billion of payments dependent on successful development of products in Seragon's pipeline",https://en.wikipedia.org/wiki/Genentech,No
genoimmune therapeutics biotechnology co ltd,Biotechnology,Undisclosed (Seed Round),https://tracxn.com/d/companies/genoimmune-therapeutics/__jc5DYO66E54b7CJiNk5roriLecBdBmZYuq_WVcUeS5k,No
gracell biotechnologies inc,Biotechnology,$100M,https://www.linkedin.com/company/gracellbio,No
graphite bio inc,Biotechnology,$150.7M Series B,"https://www.linkedin.com/company/graphitebio#:~:text=Graphite%20Bio%20is%20a%20clinical,serious%20and%20life%2Dthreatening%20diseases.",No
guangzhou reforgene medicine co ltd,Biotechnology,Series Unknown,https://www.linkedin.com/company/reforgene,No
h. lee moffitt cancer center & research institute inc,Healthcare,$706M,https://en.wikipedia.org/wiki/H._Lee_Moffitt_Cancer_Center_%26_Research_Institute,No
h. lee moffitt cancer center and research institute hospital inc,Healthcare,$706M,https://en.wikipedia.org/wiki/H._Lee_Moffitt_Cancer_Center_%26_Research_Institute,No
hrain biotechnology co ltd,Biotechnology,Series C,https://www.crunchbase.com/organization/hrain-biotechnology,No
hadassah medical organization,Healthcare,$6.5M donation,https://hadassahinternational.org/who-we-are/hadassah-medical-center/,No
harvard apparatus regenerative technology inc,Biotechnology,$2.0M,https://www.linkedin.com/company/hregen-inc,No
hasumi international research foundation,Cancer Research,"$50,000",https://www.instrumentl.com/990-report/hasumi-international-research-foundation,No
heartseed inc,Biotechnology,$40MM Series B,https://www.bio.org/events/bio-investor-forum/sessions/717205,No
hebei senlang biotechnology co ltd,Biotechnology,$29.6M,https://tracxn.com/d/companies/hebei-senlang-biotechnology/__b_mXzB7MdWXyAGj950HMBCPcuvgZmuFmo7n2jk60AWE,No
herbert irving comprehensive cancer center,Healthcare,$700M,https://en.wikipedia.org/wiki/Herbert_Irving_Comprehensive_Cancer_Center,No
histocell sl,Regenerative Medicine,$53.8K,https://www.crunchbase.com/organization/histocell-sl,No
hong kong children''s hospital,Healthcare,$13B,https://en.wikipedia.org/wiki/Hong_Kong_Children%27s_Hospital,No
hopstem biotechnology inc,Biotechnology,"Series B, $40M",https://www.linkedin.com/company/hopstem,No
hopstem biotechnology llc,Biotechnology,Series B $40.0M,https://www.linkedin.com/company/hopstem,No
huadao shanghai biomedical co ltd,Biopharmaceuticals,CNY 50 million,https://sa.marketscreener.com/news/huadao-bio-pharmaceutical-co-ltd-announced-that-it-expects-to-receive-cny-50-million-in-funding-f-ce7d58dfdb8cf421,No
huaian first people''s hospital,Healthcare,$130M,https://www.sinophi.com/about-us/our-hospitals/,No
hyogo prefectural kobe children''s hospital,Healthcare,¥42M,https://www.hyogo-kodomo-hosp.com/,No
imv inc,Biotechnology,$25M,https://www.linkedin.com/company/imv-inc,No
icahn school of medicine at mount sinai,Healthcare,$489.8M,https://en.wikipedia.org/wiki/Icahn_School_of_Medicine_at_Mount_Sinai,No
immpact bio usa inc,Biotechnology,$111M,https://www.biospace.com/employer/2257824/immpact-bio-usa-inc,No
immunic inc,Healthcare,$65M,https://finance.yahoo.com/quote/IMUX/,No
immunitybio inc,Biotechnology,$80M,https://finance.yahoo.com/news/immunitybio-inc-ibrx-reports-strong-174542869.html,No
immunoact pvt ltd,Biotechnology,$18M,https://www.biospectrumasia.com/analysis/115/25375/startup-of-the-year-2024-immunoact.html,No
immunotech biopharm ltd,Biopharmaceutical,$142M,https://www.bioworld.com/keywords/18537-immunotech-biopharm-ltd,No
immunovative therapies ltd,Biotechnology,"$12,000,000",https://www.crunchbase.com/organization/immunovative-therapies,No
immusoft corp,Biotechnology,"$11,994,676",https://www.cirm.ca.gov/our-progress/institutions/immusoft-corporation/,No
imunopharm technology co ltd,Biotechnology,Series E,https://www.cbinsights.com/company/immunochina,No
inregen,Biotechnology,$62M,https://www.prnewswire.com/news-releases/prokidney-announces-62-million-acquisition-of-inregen-300777588.html,No
indian council of medical research,Biomedical Research,"₹3,900.69 crore (US$460 million) (2025–26)",https://www.indiascienceandtechnology.gov.in/organisations/ministry-and-departments/indian-council-medical-research-icmr,No
indiana university school of medicine,Healthcare,$546M,https://medicine.iu.edu/,No
ingenium pharmaceuticals gmbh,Biotechnology,Series unknown,https://www.linkedin.com/company/ingenium-pharmaceuticals-ag,No
inmune bio inc,Biotechnology,$19M,https://www.reddit.com/r/pennystocks/comments/1lm4b8r/inmune_bio_a_potential_alzheimers_gamechanger/,No
innovacell biotechnologie ag (inactive),Regenerative Medicine,€15M venture debt loan,https://www.eib.org/en/press/all/2022-170-eib-supports-innovacell-s-innovative-cell-therapy-for-treating-incontinence,No
innsbruck medical university,Medical Research,€260 million,https://en.wikipedia.org/wiki/Medical_University_of_Innsbruck,No
institute of post graduate medical education and research,Medical Research,"₹2,400 crore (US$280 million) (2025)",https://en.wikipedia.org/wiki/Postgraduate_Institute_of_Medical_Education_and_Research,No
instituto de investigacion sanitaria marques de valdecilla,Biomedical Research,€15M annual budget,https://es.wikipedia.org/wiki/Instituto_de_Investigaci%C3%B3n_Marqu%C3%A9s_de_Valdecilla,No
invios gmbh,Biotechnology,€8.2 million Series A,https://finance.yahoo.com/news/invios-raises-8-2-million-083000757.html,No
iovance biotherapeutics inc,Biotechnology,$211M,https://www.linkedin.com/company/iovance,No
ixaka ltd,Biotechnology,$54.0M,https://uk.linkedin.com/company/ixaka-limited,No
ixaka ltd (inactive),Biotechnology,$54.0M,https://uk.linkedin.com/company/ixaka-limited,No
jewish general hospital,Healthcare,$400M,https://jghfoundation.org/,No
juno therapeutics inc,Biotechnology,Series B $134M,https://www.linkedin.com/company/juno-therapeutics,No
kadimastem ltd,Biotechnology,$168K,https://www.linkedin.com/company/kadimastem/,No
kalaris therapeutics inc,Healthcare,$100M,https://www.ophthalmologytimes.com/view/kalaris-and-allovir-inc-complete-merger,No
kanglin biotech hangzhou co ltd,Biotechnology,$20M Series A,https://synapse.patsnap.com/article/kanglin-biotechnology-secures-20m-series-a-for-gene-therapy-development,No
kangstem biotech co ltd,Biotechnology,KRW 47.99962221 billion,https://www.marketscreener.com/quote/stock/KANGSTEM-BIOTECH-CO-LTD-27329670/,No
karolinska university hospital,Healthcare,Public hospital,https://en.wikipedia.org/wiki/Karolinska_University_Hospital,No
kite pharma inc,Biotechnology,$11.9 billion (Acquisition by Gilead Sciences),https://www.gilead.com/news/news-details/2017/gilead-sciences-to-acquire-kite-pharma-for-119-billion,No
kolon tissuegene inc,Biotechnology,$35M,https://www.linkedin.com/company/tissuegene-inc.,No
kousai bio co ltd,Biotechnology,$100M Series A,https://www.kousai.vip/en/2023/11/2338/,No
kuur therapeutics ltd,Biotechnology,$185M,https://www.ppf.eu/en/insights/biotech-market/may-2021-review-of-news-from-the-most-innovative-therapeutic-areas-and-the-busine/athenex-agreed-to-acquired-kuur-for-usd185-million-adding-car-nkt-platform,No
la paz university hospital,Healthcare,$1B,https://www.comunidad.madrid/hospital/lapaz/,No
legend biotech corp,Healthcare,$350M,https://www.linkedin.com/company/legendbiotechco.,No
leiden university medical center,Healthcare,€2.7M EU Horizon 2020 grant,https://en.wikipedia.org/wiki/Leiden_University_Medical_Center,No
life sciences institute,Life Sciences,$419M,https://lsi.ubc.ca/,No
lineage cell therapeutics inc,Biotechnology,$12.0M,https://www.linkedin.com/company/lineagecell,No
lion tcr pte ltd,Biotechnology,"Series B, $41.6M",https://www.crunchbase.com/organization/lion-tcr,No
lipogems international spa,Biotechnology,€12.5M,https://www.marketscreener.com/quote/stock/ABC-COMPANY-S-P-A-11156362/news/Lipogems-International-S-P-A-announced-that-it-has-received-128-12-5-million-in-funding-from-ABC-42625958/,No
longeveron inc,Biotechnology,$17.5M,https://finance.yahoo.com/news/longeveron-announces-17-5-million-172800184.html,No
lumos pharma inc,Biotechnology,$38M,https://www.pharmaceutical-technology.com/news/dpv-lumos-pharma-38m/,No
lyell immunopharma inc,Biotechnology,$50M,https://www.linkedin.com/company/lyell,No
magellan stem cells pty ltd,Biotechnology,$7M,https://biotechdispatch.com.au/news/magellan-stem-cells-welcomes-7-million-federal-government-grant,No
mana therapeutics inc,Biopharmaceutical,Series A and Venture Debt Facility - $7.5M,https://www.businesswire.com/news/home/20211130005364/en/MANA-Therapeutics-Announces-Final-Closing-of-Series-A-and-Closing-of-Venture-Debt-Facility,No
marino biotechnology co ltd,Biotechnology,"Capital increase after IPO - $1,273,038",https://at.linkedin.com/company/marinomed-biotech-ag,No
marker therapeutics inc,Biotechnology,$16.1M,https://www.linkedin.com/company/marker-therapeutics,No
massachusetts general hospital,Healthcare,$100M,https://www.bostonglobe.com/2025/10/01/business/mass-general-new-balance-foundation/,No
matilde tettamanti foundation,Healthcare,€5M,https://it.wikipedia.org/wiki/Fondazione_Tettamanti,No
medeor therapeutics inc,Biotechnology,$18.8M,https://www.crunchbase.com/organization/medeor-therapeutics,No
medical college of wisconsin,Healthcare,$1.64 billion endowment (2023),https://en.wikipedia.org/wiki/Medical_College_of_Wisconsin,No
medinno inc,Biotechnology,"Series C, $8.2M",https://www.linkedin.com/company/medinno,No
mesoblast ltd,Healthcare,$5.8M,https://en.wikipedia.org/wiki/Mesoblast,No
metcela inc,Biotechnology,"Series C, $13.7M",https://www.crunchbase.com/organization/metcela-inc,No
metrohealth medical center,Healthcare,$946M,https://en.wikipedia.org/wiki/The_MetroHealth_System,No
mink therapeutics inc,Healthcare,Grant,https://www.linkedin.com/company/minktherapeutics,No
"mink therapeutics, inc.",Healthcare,Grant,https://www.linkedin.com/company/minktherapeutics,No
microbot medical inc,Medical Robotics,$92.2M,https://www.tipranks.com/news/company-announcements/microbot-medical-announces-series-h-options-exercise,No
"ministry of research and technology, indonesia;national research and innovation agency of indonesia",Research and Innovation,$736.4M,https://en.wikipedia.org/wiki/National_Research_and_Innovation_Agency,No
ministry of science and technology of the people''s republic of china,Science and Technology,$51 billion,https://en.wikipedia.org/wiki/Ministry_of_Science_and_Technology_(China),No
minovia therapeutics ltd,Biotechnology,$180M SPAC deal,https://finance.yahoo.com/news/minovia-therapeutics-ltd-launch-one-123000200.html,No
mirror biologics inc,Biopharmaceutical,$14M,https://srfc.law/cmf-represents-mirror-biologics-inc-14-million-offering/,No
moorfields eye hospital nhs foundation trust,Healthcare,$352M,https://en.wikipedia.org/wiki/Moorfields_Eye_Hospital_NHS_Foundation_Trust,No
mustang bio inc,Biotechnology,$8.0M,https://www.linkedin.com/company/mustangbio,No
nkgen biotech inc,Healthcare,$2.0M,https://www.linkedin.com/company/nkgen-biotech-inc,No
nkmax co ltd,Biotechnology,KRW 23.2 billion,https://www.marketscreener.com/quote/stock/NKMAX-CO-LTD-26375900/,No
nkure therapeutics pvt ltd,Biotechnology,$745K Seed,https://tracxn.com/d/companies/nkure-theraputics/__VP1SinhCld7Yk640rsqGAJ43F6H9sZZuBkHotJA-FrA,No
nanjing bioheng biotech co ltd,Biotechnology,$80M Series B,https://www.bioheng.com/,No
nanjing legend biotech co ltd,Biotechnology,$350M,https://www.linkedin.com/company/legendbiotechco.,No
national cancer center hospital,Healthcare,"$792,000",https://nationalcancercenter.org/,No
national cancer institute us,Healthcare,$5 billion annually,https://en.wikipedia.org/wiki/National_Cancer_Institute,No
national center for research resources,Biomedical Research,"$10,878,016",https://taggs.hhs.gov/Detail/CFDADetail?arg_CFDA_NUM=93389,No
national science research and innovation fund,Research Services,$9.06B,https://www.nsf.gov/,No
netherlands organisation for health research and development,Health Research,€354 million (2021),https://www.glopid-r.org/members/netherlands-organisation-for-health-research-and-development-zonmw/,No
neuroplast bv,Biotechnology,"Series B, $11.3M",https://www.linkedin.com/company/neuroplast,No
new york university school of medicine,Healthcare,$450M,https://en.wikipedia.org/wiki/New_York_University_Grossman_School_of_Medicine,No
neximmune inc,Healthcare,$3.67M Registered Direct Offering,https://stockanalysis.com/quote/otc/NEXI/,No
nexcella inc,Biopharmaceutical,"$7,999,467",https://www.cirm.ca.gov/our-progress/institutions/nexcella-inc/,No
nighthawk biosciences inc,Biotechnology,$3.25M,https://nighthawkbio.chadbaucom.com/index.html,No
nino jesus university children''s hospital,Healthcare,€11.9M,https://beamerproject.eu/b-compass-pilot-site/foundation-for-biomedical-research-of-university-pediatric-hospital-nino-jesus-of-madrid/,No
nino jesus university children's hospital,Healthcare,€11.9M,https://beamerproject.eu/b-compass-pilot-site/foundation-for-biomedical-research-of-university-pediatric-hospital-nino-jesus-of-madrid/,No
novadip biosciences sa,Biotechnology,"Series B, $23.4M",https://be.linkedin.com/company/novadip-biosciences-s-a-,No
novartis ag,Healthcare,$1.4B,https://seekingalpha.com/article/4827673-novartis-superstars-entresto-and-kisqali-fuel-market-outperformance,No
novatim immune therapeutics (zhejiang) co ltd,Biotechnology,Completed First Round of Financing,http://en.novatim-zj.com/,No
ohsu knight cancer institute,Healthcare,$600M,https://en.wikipedia.org/wiki/Knight_Cancer_Institute,No
onechain immunotherapeutics,Biotechnology,$7.3M Seed,https://www.crunchbase.com/organization/onechain-immunotherapeutics,No
orbsen therapeutics ltd,Biotechnology,$1.3M,https://ie.linkedin.com/company/orbsen-therapeutics-limited,No
oregon health & science university,Health Sciences,$2 billion,https://www.oregonlive.com/health/2025/10/ohsu-researchers-create-human-eggs-from-skin-cells-pointing-to-new-frontier-in-fertility-treatment.html,No
organogenesis holdings inc,Healthcare,$130M,https://www.linkedin.com/company/organogenesis,No
orgenesis inc,Biotechnology,$1.6M,https://www.linkedin.com/company/orgenesis-inc-orgs-,No
oricell therapeutics (shanghai) co ltd,Cancer Immunotherapy,$45M Series B1,https://www.prnewswire.com/news-releases/oricell-closes-45m-series-b1-financing-to-expand-development-of-key-products-301758123.html,No
palisade bio inc,Biopharmaceutical,$138M,https://www.stocktitan.net/news/PALI/palisade-bio-announces-closing-of-upsized-138-million-public-4rnirkc1nrjh.html,No
"palisade bio, inc",Biopharmaceutical,$138M,https://www.stocktitan.net/news/PALI/palisade-bio-announces-closing-of-upsized-138-million-public-4rnirkc1nrjh.html,No
peking university shenzhen hospital,Healthcare,450 million RMB,https://www.eyeshenzhen.com/content/2016-08/01/content_16031760.htm,No
pepromene bio inc,Biotechnology,$11M,https://www.prnewswire.com/news-releases/pepromene-bio-inc-and-the-institute-for-follicular-lymphoma-innovation-ifli-announce-the-first-follicular-lymphoma-fl-patient-treated-with-baff-r-targeting-car-t-cells-pmb-ct01-achieves-a-complete-response-302460318.html,No
personalized stem cells inc,Biotechnology,$1.6M Seed,https://www.crunchbase.com/organization/personalized-stem-cells,No
pharmicell co ltd,Biotechnology,$7.6M,https://www.linkedin.com/company/pharmicell-co-ltd-,No
pluri inc,Biotechnology,$10M,https://finance.yahoo.com/quote/PLUR/,No
plus therapeutics inc,Biotechnology,$17.6M,https://en.wikipedia.org/wiki/Plus_Therapeutics,No
polarityte inc,Biotechnology,$22.5M,https://finance.yahoo.com/news/polarityte-secures-22-5-million-120000932.html,No
poseida therapeutics inc,Biotechnology,$50M,https://www.linkedin.com/company/poseida-therapeutics-inc-,No
precigen inc,Biotechnology,$125M,https://www.prnewswire.com/news-releases/precigen-announces-up-to-125-million-non-dilutive-financing-302544623.html,No
precision biosciences inc,Biotechnology,Series B $110M,https://en.wikipedia.org/wiki/Precision_BioSciences,No
prokidney corp,Biotechnology,$295M,https://finance.yahoo.com/news/prokidney-corp-prok-touts-reparencel-064330009.html,No
qilu cell therapy technology co ltd,Cell Therapy,$1M,http://yfswjt.com/en/m/show.php?id=49,No
quell therapeutics ltd,Biotechnology,Series B $156M,https://www.synconaltd.com/portfolio/clinical-companies/quell-therapeutics/,No
r-biopharm ag,Biotechnology,Private equity,https://www.linkedin.com/company/r-biopharm-ag,No
reneuron group plc,Biotechnology,US$ 106.1M,https://uk.linkedin.com/company/reneuron,No
recibio inc,Healthcare,$200K,https://www.cbinsights.com/company/recibio,No
red de terapia celular,Biotechnology,"€193,930",http://www.csic.es/es/investigacion/proyectos-de-investigacion/red-de-terapia-celular-tercel,No
regenetp inc,Biotechnology,$22.5M,https://www.marketscreener.com/quote/stock/REGENETP-INC-33339222/news/,No
regina margherita children''s hospital,Healthcare,"US$21,659 Childhood Cancer Grant + US$3,000 DCG + US$13,000 District Funds",https://lionmagazine.org/articles/enhancing-care-upgrading-the-pediatric-oncology-ward-at-regina-margherita-childrens-hospital/,No
renji hospital,Healthcare,271 million RMB,https://www.shsmu.edu.cn/english/info/1085/1232.htm,No
repertoire immune medicines inc,Biotechnology,"Series B, $189M",https://www.crunchbase.com/organization/repertoire-immune-medicines,No
reprogenix,Regenerative Medicine,27 - 41 million USD,https://convention.bio.org/program-1/reprogenix-bioscience,No
rigshospitalet,Healthcare,Government hospital,https://en.wikipedia.org/wiki/Rigshospitalet,No
rinri therapeutics ltd,Biotechnology,$15.7M,https://tracxn.com/d/companies/rinri-therapeutics/__Lyhw5tQnp7D9bp2ScDwd8kMKL1I1UgDQ0VYBUWQuCTw,No
rocket pharmaceuticals inc,Biotechnology,$150M public offering,https://www.globaldata.com/company-profile/inotek-pharmaceuticals-corp/,No
roger williams medical center,Healthcare,$165M,https://www.wpri.com/news/local-news/globe-ri-12-news/sale-of-fatima-roger-williams-hospitals-at-risk-of-falling-through/,No
rubius therapeutics inc,Biotechnology,$200M,https://www.linkedin.com/company/rubius-therapeutics,No
rush university medical center,Health Care,$581.8M endowment (2020),https://en.wikipedia.org/wiki/Rush_University_Medical_Center,No
scg cell therapy pte ltd,Biotechnology,"Series C, $8.1M",https://www.crunchbase.com/organization/scg-cell-therapy,No
san gerardo hospital,Healthcare,$200M,https://www.rcf.it/en/-/san-gerardo-hospital-monza-fake-/en/,No
sangamo therapeutics inc,Biotechnology,$50M upfront in licensing fees from Genentech,https://www.biospace.com/employer/248576/sangamo-therapeutics-inc,No
seattle children''s hospital,Healthcare,$400M,https://en.wikipedia.org/wiki/Seattle_Children%27s,No
seattle children's hospital,Healthcare,$400M,https://en.wikipedia.org/wiki/Seattle_Children%27s,No
secretome therapeutics,Biotechnology,$20.4M,https://www.businesswire.com/news/home/20241125920830/en/Secretome-Therapeutics-Closes-%2420.4-Million-Financing-Round-to-Advance-Cardiomyopathy-and-Heart-Failure-Therapies,No
seraxis inc,Regenerative Medicine,$40M Series C,https://news.biobuzz.io/2025/07/16/seraxis-announced-closing-of-40m-series-c-financing-round/,No
sernova biotherapeutics inc,Biotechnology,$4 Million Loan,https://www.globenewswire.com/search/organization/Sernova%2520Biotherapeutics%CE%B4%2520Inc%C2%A7,No
servier institute of international research,Pharmaceutical,"€50,000 grant for IDEAL-HFHo project",https://www.linkedin.com/company/l-institut-servier/,No
shanghai bendao gene technology co ltd,Gene Therapy,60 million yuan (A round),http://www.ennovationvc.com/en/index.php?m=content&c=index&a=show&catid=56&id=84,No
shanghai bioray laboratory inc,Biopharmaceutical,$217.7M,https://www.linkedin.com/company/bioraypharm,No
shanghai cell therapy group co,Healthcare,"$260.2M, Series E",https://www.cbinsights.com/company/shanghai-cell-therapy-group,No
shanghai grit biotechnology inc,Biotechnology,$75.3M,https://tracxn.com/d/companies/grit-biotechnology/__4Zmdeyuxbga-1qHDixbYlTEP5vp3EoEa-LUErfCcwRo,No
shanghai hexaell biotech co ltd,Biotechnology,$31M Series B+,https://www.cbinsights.com/company/hexaell-biotech,No
shanghai jiading central hospital,Healthcare,$309.68M,http://english.jiading.gov.cn/medicare.html,No
shanghai saibiman biotechnology co ltd,Biotechnology,Pre-A financing,https://www.symraybiopharma.com/en/About,No
shanghai yuesai biotechnology co ltd,Healthcare,CNY 200M (Pre-A Round),https://equalocean.com/briefing/20220314230128378,No
shenzhen hemogen gene biotechnology co ltd,Gene Therapy,$4.44M,https://www.globaldata.com/company-profile/bgi-genomics-co-ltd/deals/,No
shenzhen pregene biopharma co ltd,Biopharmaceutical,€20M upfront and near-term consideration,https://www.prnewswire.com/news-releases/pregene-enters-into-innovative-partnership-with-cellpoint-to-develop-anti-bcma-car-t-cell-therapy-in-europe-and-the-us-301518944.html,No
shenzhen second people''s hospital,Healthcare,$16M,https://med.szu.edu.cn/en/hospitals/content_803,No
shenzhen wingor biotechnology co ltd,Biotechnology,Tens of millions in CNY,https://www.prnewswire.com/news-releases/wingor-bio-lands-tens-of-millions-in-initial-funding-with-round-still-open-forges-ahead-on-stem-cell-drug-and-clinical-programs-302537579.html,No
sidney kimmel comprehensive cancer center,Healthcare,$125M,https://en.wikipedia.org/wiki/Sidney_Kimmel_Comprehensive_Cancer_Center,No
sonoma biotherapeutics inc,Biotechnology,$265M Series B,https://www.biospace.com/employer/2008694/sonoma-biotherapeutics,No
sorrento therapeutics inc (inactive),Biotechnology,$105M,https://financhill.com/blog/investing/will-sorrento-therapeutics-stock-recover,No
st. jude children’s research hospital inc,Healthcare,$1.5M,https://www.linkedin.com/company/st-jude-childrens-research-hospital,No
statens serum institut,Medical Research,100 million DKK,https://en.wikipedia.org/wiki/Statens_Serum_Institut,No
stem cell medicine ltd,Biotechnology,"$5,523,336",https://il.linkedin.com/company/stem-cell-medicine,No
stemcyte inc,Biotechnology,$6.3M,https://finance.yahoo.com/quote/4178.TWO/,No
steminent biotherapeutics inc,Biotechnology,Series B,https://www.crunchbase.com/organization/steminent-biotherapeutics,No
steno diabetes center copenhagen,Healthcare,DKK 2.95 billion (€395 million),https://steno.dk/centres/steno-diabetes-center-copenhagen/,No
suzhou regend therapeutics co ltd,Biotechnology,$15.8M,https://tracxn.com/d/companies/regend-therapeutics/__nawlUXEpCdru7oCTbv-cbo6_R08Tm36D7oHn4tv7eYs,No
suzhou science and technology town hospital,Healthcare,$5.7 billion,http://www.snd.gov.cn/hqenglish/Industrial/202007/d9fd77ab475f45f1892c34b211f6a0f2.shtml,No
synthekine inc,Biotechnology,"Series C, $100M",https://www.crunchbase.com/organization/synthekine,No
t-knife gmbh,Biotechnology,$110M Series B,https://www.mdc-berlin.de/news/press/berlin-start-t-knife-raises-110-million,No
tc biopharm ltd,Biotechnology,$250K,https://uk.linkedin.com/company/tc-biopharm-limited,No
tscan therapeutics inc,Healthcare,$30.0M,https://www.linkedin.com/company/tscan-therapeutics,No
tvax biomedical inc,Biotechnology,$2.0M,https://www.linkedin.com/company/tvax-biomedical-inc-,No
taiga biotechnologies inc (inactive),Biotechnology,$14.0M,https://www.linkedin.com/company/taiga-biotechnologies,No
talaris therapeutics inc,Biotechnology,$115M Series B,https://www.linkedin.com/company/talaris-therapeutics,No
targazyme inc,Biopharmaceutical,$70MM,https://www.targazyme.com/,No
tata memorial hospital,Healthcare,Rs 380 crore,https://www.devdiscourse.com/article/health/3653189-nses-landmark-csr-venture-transforming-cancer-care-at-tata-memorial,No
tengion inc (inactive),Biotechnology,$15M,https://www.biospace.com/tengion-inc-gets-last-minute-financing-to-stay-alive,No
tettamanti foundation m.de marchi onlus,Healthcare,€5M,https://it.wikipedia.org/wiki/Fondazione_Tettamanti,No
the cleveland clinic foundation,Healthcare,$3.1M,https://www.linkedin.com/company/cleveland-clinic,No
the prince charles hospital,Healthcare,$360M,https://en.wikipedia.org/wiki/The_Prince_Charles_Hospital,No
the scripps research institute,Biomedical Research,$310M,https://en.wikipedia.org/wiki/Scripps_Research,No
the university of texas md anderson cancer center (bay area),Healthcare,$7.06 billion (FY 2024),https://en.wikipedia.org/wiki/MD_Anderson_Cancer_Center,No
the university of texas md anderson cancer center.,Healthcare,$7.06 billion (FY 2024),https://en.wikipedia.org/wiki/MD_Anderson_Cancer_Center,No
theravitae co ltd,Biotechnology,"$3,000,000",https://www.biospace.com/stem-cell-company-theravitae-establishes-subsidiary-in-north-america,No
throne biotechnologies inc,Biotechnology,$150K,https://www.crunchbase.com/organization/throne-biotechnologies,No
tissue genesis inc,Regenerative Medicine,"$1,195,629",https://www.inknowvation.com/sbir/companies/tissue-genesis-inc,No
tmunity therapeutics inc,Biotechnology,Series B - $75M,https://www.biopharmadive.com/news/gilead-tmunity-car-t-acquisition-cell-therapy/639192/,No
tongji university school of medicine,Healthcare,200 million RMB annually,https://www.digiedupro.com/tongji-university-school-of-medicine/,No
tourmaline bio inc,Biotechnology,$172.5M,https://www.linkedin.com/company/tourmaline-bio,No
tr1x inc,Biotechnology,$75M Series A,https://www.biospace.com/employer/2812901/tr1x-bio/,No
u.s. stem cell inc,Biotechnology,$190K,https://www.linkedin.com/company/u.s.-stem-cell-inc,No
uab minority health and health equity research center,Research Services,$9.6M,https://www.onealcanceruab.org/news-and-events/news/9-3-million-grant-will-create-center-for-cancer-control-in-persistent-poverty-areas-through-the-uab-minority-health-health-equity-research-center-and-oneal-comprehensive-cancer-center/,No
uclas jonsson comprehensive cancer center,Healthcare,$16M,https://www.linkedin.com/company/jonsson-cancer-center,No
unc lineberger comprehensive cancer center,Healthcare,$50M annually,https://en.wikipedia.org/wiki/UNC_Lineberger_Comprehensive_Cancer_Center,No
utc therapeutics inc,Biotechnology,Series Unknown,https://www.linkedin.com/company/utc-therapeutics,No
university hospital la paz,Healthcare,€1 Billion,https://www.comunidad.madrid/hospital/lapaz/,No
university hospital of amiens,Healthcare,EUR 260 million,https://www.eib.org/en/projects/pipelines/all/20070445,No
university hospital of lyon,Healthcare,€1.8 billion annual budget,https://h2020qualitop.liris.cnrs.fr/wordpress/index.php/hospices-civils-de-lyon-hcl/,No
university hospitals cleveland medical center,Healthcare,$1 billion,https://en.wikipedia.org/wiki/University_Hospitals_Cleveland_Medical_Center,No
university of michigan comprehensive cancer center,Healthcare,$150M,https://en.wikipedia.org/wiki/University_of_Michigan_Rogel_Cancer_Center,No
university of minnesota medical school,Healthcare,$341M,https://en.wikipedia.org/wiki/University_of_Minnesota_Medical_School,No
university of rochester medical center,Healthcare,$500M,https://en.wikipedia.org/wiki/University_of_Rochester_Medical_Center,No
university of texas health science center at houston,Healthcare,$487.6M,https://en.wikipedia.org/wiki/University_of_Texas_Health_Science_Center_at_Houston,No
university of texas md anderson cancer center,Healthcare,$7.06 billion (FY 2024),https://en.wikipedia.org/wiki/MD_Anderson_Cancer_Center,No
vessl therapeutics ltd,Biotechnology,$16M,https://en.globes.co.il/en/article-israeli-co-vessl-therapeutics-raises-16m-1001368678,No
vaccinogen inc (inactive),Biotechnology,$80M,https://www.prnewswire.com/news-releases/vaccinogen-closes-second-tranche-of-80-million-financing-at-550-per-unit-300026886.html,No
vardhman mahavir medical college & safdarjung hospital,Healthcare,"₹2,179.58 crore (US$260 million) (2025–26)",https://en.wikipedia.org/wiki/Vardhman_Mahavir_Medical_College,No
vericel corp,Biotechnology,$74.8M,https://www.linkedin.com/company/vericel-corporation,No
verismo therapeutics,Biotechnology,$4.0M,https://www.crunchbase.com/organization/verismo-therapeutics,No
verismo therapeutics inc,Biotechnology,$4.0M Seed,https://www.crunchbase.com/organization/verismo-therapeutics,No
vertex pharmaceuticals inc,Biotechnology,$1.1M,https://www.linkedin.com/company/vertex-pharmaceuticals,No
"viacyte, inc.",Biotechnology,$80M Series D,https://www.baincapital.com/news/viacyte-secures-80-million-financing-advance-functional-cures-insulin-requiring-diabetes,No
wake forest university health sciences,Healthcare,"$2,555,548,246",https://taggs.hhs.gov/Detail/RecipDetail?arg_EntityId=nFxzWNGJgR2DIWiiG6mPLw%3D%3D,No
"wake forest university;national autonomous university of nicaragua;ministry of health, nicaragua",Global Health,"$179,234",https://fundraise.globalbrigades.org/chapters/university/wake-forest-university,No
wannan medical college first affiliated hospital,Healthcare,10 million yuan,https://www.intimestudyadvisors.com/wannan-medical-college/,No
wugen inc,Biotechnology,$115M,https://www.biopharmadive.com/news/wugen-funding-car-t-allogeneic-off-the-shelf/758726/,No
wuhan ruijian pharmaceutical technology co ltd,Regenerative Medicine,$40M Series B,https://tracxn.com/d/companies/wuhan-ruijian-pharmaceutical-technology/__Dx-SkvzVUGXwpPR4rPoSjEtAl8HtLVD1wOz9u3U5xg8,No
xenetic biosciences inc,Biotechnology,$488.8K,https://www.linkedin.com/company/xenetic-biosciences-inc-,No
xiangxue life sciences,Biotechnology,$15.39M,https://www.cbinsights.com/company/xiangxue-life-sciences,No
zephyrm biotechnologies co ltd,Biotechnology,$29.1M Series B,https://tracxn.com/d/companies/beijing-zephyrm-biotechnologies/__-7HCbW7PMX2O7x1yClmZ6J-ma4xvIPJNXitw74BUDYo,No
zhongsheng kangyuan biotechnology (beijing) co ltd,Biotechnology,Undisclosed Series A,https://tracxn.com/d/companies/zhongsheng-kangyuan-biotechnology/__4547VQDJQko1ZLKZwMFMMqrTjKA2yDeE3y7-E63AhvI/funding-and-investors,No
zhujiang hospital of southern medical university,Healthcare,3.7 million yuan,https://www.chinaorganharvest.org/hospitals/zhujiang-hospital-of-southern-medical-university/,No
bluebird bio inc,Biotechnology,Private equity $29M,https://www.fiercepharma.com/pharma/once-valued-10b-bluebird-bio-sells-private-equity-firms-29m,No
4d molecular therapeutics inc,Biotechnology,$300M,https://www.linkedin.com/company/4d-molecular-therapeutics-llc,No
aavantgarde bio srl,Biotechnology,"Series A, $65.3M",https://www.crunchbase.com/organization/aavantgarde-bio,No
asc therapeutics inc,Biotechnology,Private,https://crisprmedicinenews.com/company/card/asc-therapeutics/,No
accuredit therapeutics (suzhou) co ltd,Biotechnology,"Series A, $75M",https://www.linkedin.com/company/accuredit,No
actym therapeutics inc,Biotechnology,$59.5M Series A,https://www.prnewswire.com/news-releases/actym-closes-59-5-million-series-a-with-new-25-5-million-extension-301960330.html,No
adverum biotechnologies inc,Biotechnology,$127.5M,https://pitchbook.com/profiles/company/59995-99,No
alexion pharmaceuticals inc,Biotechnology,$5.8M,https://www.linkedin.com/company/alexion-pharmaceuticals,No
applied genetic technologies corp,Biotechnology,$23.5M upfront cash with potential future aggregate payments of up to $50M,https://www.biospace.com/syncona-to-acquire-applied-genetic-technologies-corporation,No
ascidian therapeutics inc,Biotechnology,"Series A, $40M",https://www.linkedin.com/company/ascidian-therapeutics,No
asklepios biopharmaceutical inc,Biotechnology,$2 billion upfront and up to $2 billion in milestone payments,https://www.bayer.com/media/en-us/bayer-acquires-asklepios-biopharmaceutical-to-broaden-innovation-base-in-cell-and-gene-therapy/,No
atsena therapeutics inc,Biotechnology,$150M Series C,https://www.globenewswire.com/news-release/2025/04/02/3054152/0/en/Atsena-Therapeutics-Announces-Oversubscribed-150-Million-Series-C-Financing-to-Further-Advance-Ocular-Gene-Therapy-Programs.html,No
aurealis therapeutics ag,Biotechnology,$40M Series B,https://fi.linkedin.com/company/aurealis-ltd,No
aviadobio ltd,Biotechnology,$20M,https://www.prnewswire.com/news-releases/astellas-and-aviadobio-announce-exclusive-option-and-license-agreement-for-gene-therapy-avb-101-targeting-frontotemporal-dementia-and-other-indications-302270158.html,No
axovia therapeutics ltd,Gene Therapy,Undisclosed,https://tracxn.com/d/companies/axovia-therapeutics/__7zgfbsW75qUxuevSNU72MbciV0tu2Wf0ZEQq9mxru-c,No
beacon therapeutics ltd,Biotechnology,$170M Series B,https://www.prnewswire.com/news-releases/beacon-therapeutics-raises-170-million-in-series-b-funding-to-advance-development-of-ophthalmic-gene-therapies-302188599.html,No
beam therapeutics inc,Biotechnology,$180M IPO,https://en.wikipedia.org/wiki/Beam_Therapeutics,No
beijing anlong biomedical co ltd,Biotechnology,Series A,https://www.crunchbase.com/organization/anlong-bio,No
belief biomed inc,Biotechnology,$120M,https://www.crunchbase.com/organization/belief-biomed,No
biomarin pharmaceutical inc,Biotechnology,$1.5M (Seed Investment),https://en.wikipedia.org/wiki/BioMarin_Pharmaceutical,No
cmax clinical research pty ltd,Pharmaceuticals,"$200M, Acquired",https://www.afr.com/street-talk/blackstone-agrees-200m-sale-of-cmax-clinical-research-to-pacify-accc-20250902-p5mrt9,No
capsida biotherapeutics inc,Biotechnology,"$140M, Seed",https://www.biospace.com/employer/2388561/capsida-biotherapeutics/,No
dimension therapeutics inc,Biotechnology,"$252M, Acquired",https://drug-dev.com/dimension-therapeutics-bayer-sign-252-million-deal/,No
eg 427,Biotechnology,"$21M, Series A",https://fr.linkedin.com/company/eg427,No
eiger biopharmaceuticals inc,Biotechnology,"$87M, Acquired",https://www.abladvisor.com/news/39318/ssg-advises-eiger-biopharmaceuticals-in-sale-of-lonafarnib-and-lambda-program-ass,No
elpida therapeutics,Biotechnology,"$3.9M, Not Found",https://blog.cirm.ca.gov/2024/10/15/elpida-therapeutics-cmt4j/,No
encoded therapeutics inc,Biotechnology,"$135M, Series D",https://www.crunchbase.com/organization/encoded-genomics,No
epicrispr biotechnologies inc,Biotechnology,"$68M, Series B",https://www.biopharmadive.com/news/epicrispr-fshd-series-b-financing-epigenetic-editing/743366/,No
excision biotherapeutics inc,Biotechnology,"$60M, Not Found",https://en.wikipedia.org/wiki/Excision_BioTherapeutics,No
exegenesis bio inc,Biotechnology,"$150M, Series B",https://www.linkedin.com/company/exegenesis,No
fkd therapies oy,Biotechnology,"$570M, Not Found",https://ferringusa.com/?press=ferring-and-blackstone-life-sciences-invest-over-570-million-usd-in-novel-gene-therapy-for-bladder-cancer-patients,No
ferring holding sa,Pharmaceuticals,"$570M, Not Found",https://en.wikipedia.org/wiki/Ferring_Pharmaceuticals,No
ferring international center sa,Pharmaceuticals,"$570M, Not Found",https://en.wikipedia.org/wiki/Ferring_Pharmaceuticals,No
flexion therapeutics inc,Biotechnology,"$30M, Post IPO debt",https://www.linkedin.com/company/flexion-therapeutics,No
flexion therapeutics inc (inactive),Biotechnology,"$450M, Acquired",https://www.pharmtech.com/view/pacira-biosciences-acquires-flexion-therapeutics-for-630-million,No
forge biologics inc,Biotechnology,"$90M, Series C",https://www.linkedin.com/company/forge-biologics,No
freeline therapeutics holdings plc,Biotechnology,"$15M, Convertible Debt Financing",https://www.synconaltd.com/news-insights/news/syncona-to-acquire-freeline-therapeutics/,No
gemma biotherapeutics inc,Biotechnology,"$34M, Seed",https://www.prnewswire.com/news-releases/gemmabio-secures-34-million-in-seed-funding-to-drive-gene-therapy-advancements-302338394.html,No
gensight biologics sa,Biotechnology,"$4.3M, Post IPO equity",https://www.linkedin.com/company/gensight-biologics-sa/,No
genvec llc,Biotechnology,"$7.00 per share, Acquired",https://www.prnewswire.com/news-releases/intrexon-to-acquire-genvec-to-expand-industry-leading-gene-delivery-platform-300395556.html,No
genascence corp,Biotechnology,"$11.6M, Grant",https://www.linkedin.com/company/genascence-corporation,No
grace science llc,Biotechnology,"$54M, Not Found",https://timmermanreport.com/2022/06/grace-science-turning-lemons-into-lemonade/,No
gyroscope therapeutics holdings ltd,Biotechnology,"$800M, Acquired",https://www.novartis.com/news/media-releases/novartis-acquire-gyroscope-therapeutics-adding-one-time-gene-therapy-could-transform-care-geographic-atrophy-leading-cause-blindness,No
gyroscope therapeutics holdings plc,Biotechnology,"$800M, Acquired",https://www.novartis.com/news/media-releases/novartis-acquire-gyroscope-therapeutics-adding-one-time-gene-therapy-could-transform-care-geographic-atrophy-leading-cause-blindness,No
homology medicines inc,Biotechnology,"$42M, Acquired",https://www.prnewswire.com/news-releases/q32-bio-announces-closing-of-merger-with-homology-medicines-and-concurrent-private-placement-of-42-million-302098557.html,No
ilya pharma ab,Biotechnology,"$10M, Grant",https://www.crunchbase.com/organization/ilya-pharma,No
innostellar biotherapeutics co ltd,Biotechnology,"$10M, Series A",https://www.legendcapital.com.cn/news_en/index_mob.aspx?nodeid=45&page=ContentPage&contentid=561,No
intellia therapeutics inc,Biotechnology,"$112.1M, IPO",https://en.wikipedia.org/wiki/Intellia_Therapeutics,No
interius biotherapeutics inc,Biotechnology,"$76M, Series A",https://www.baincapital.com/news/interius-biotherapeutics-raises-76m-series-financing-advance-breakthrough-cell-and-gene-therapy,No
jaguar gene therapy llc,Biotechnology,"$10M, Seed",https://deerfield.com/what-we-do/investment/portfolio/companies/jaguar-gene-therapy,No
juventas therapeutics inc,Biotechnology,"$107M, Series C",https://tracxn.com/d/companies/juventas-therapeutics/__5JZ4GHM003Q7TnAJOU-iTSocnI5n5B7Wo-j4LrTVZQM,No
kyorin pharmaceutical co ltd,Pharmaceuticals,"$10M, Not Found",https://www.globenewswire.com/news-release/2025/09/30/3159137/0/en/Hinge-Bio-Announces-License-and-Collaboration-with-Kyorin-Pharmaceutical-Co-Ltd-for-the-Development-and-Commercialization-of-HB2198-in-Japan-for-Autoimmune-Diseases.html,No
kelonia therapeutics inc,Biotechnology,"$50M, Series A",https://www.crunchbase.com/organization/kelonia-therapeutics,No
krystal biotech inc,Biotechnology,"$160M, Post IPO equity",https://www.linkedin.com/company/krystal-biotech-inc,No
lexeo therapeutics llc,Biotechnology,"$80M, Post IPO equity",https://www.linkedin.com/company/lexeo-therapeutics,No
lexeo therapeutics inc,Biotechnology,"$80M, Post IPO Equity",https://www.linkedin.com/company/lexeo-therapeutics,No
logicbio therapeutics inc,Biotechnology,"$2.07 per share, Acquired",https://www.astrazeneca-us.com/media/press-releases/2022/alexion-astrazeneca-rare-disease-completes-acquisition-of-logicbio-therapeutics.html,No
lysogene sas,Biotechnology,"$6.80M, IPO",https://live.euronext.com/en/ipo-showcase/lysogene,No
medytox inc,Biotechnology,"$57.8M, IPO",https://www.linkedin.com/company/medy-tox-inc./,No
neuexcell therapeutics inc,Biotechnology,"$12M, Pre-A",https://www.nature.com/articles/d43747-021-00136-5,No
neurocrine biosciences inc,Biotechnology,"$34.2M, IPO",https://en.wikipedia.org/wiki/Neurocrine_Biosciences,No
neurophth therapeutics inc,Biotechnology,"$60M, Series C",https://www.neurophth.com/en/index.html,No
novartis gene therapies,Biotechnology,"$8.7B, Acquired",https://en.wikipedia.org/wiki/Novartis_Gene_Therapies,No
ocugen inc,Biotechnology,"$20M, Post IPO equity",https://www.linkedin.com/company/ocugen,No
oncosec medical inc,Biotechnology,"$1.3M, Post IPO equity",https://www.linkedin.com/company/oncosec-medical-inc,No
opus genetics inc,Biotechnology,"$37M, Acquired",https://www.ncbiotech.org/news/opus-genetics-acquired-becomes-public-company-based-nc,No
opus genetics incorporation,Biotechnology,"$37M, Acquired",https://www.ncbiotech.org/news/opus-genetics-acquired-becomes-public-company-based-nc,No
ptc therapeutics inc,Pharmaceuticals,"$1.0B, Post IPO equity",https://www.linkedin.com/company/ptc-therapeutics,No
prevail therapeutics inc,Biotechnology,"$880M, Acquired",https://www.prnewswire.com/news-releases/lilly-announces-agreement-to-acquire-prevail-therapeutics-301192753.html,No
pulsesight therapeutics sas,Biotechnology,"$10M, Series A",https://sprim.net/pulsesight-therapeutics-announces-first-close-of-its-series-a-financing-to-fund-clinical-development-of-pst-611-in-dry-amd/,No
ray therapeutics inc,Biotechnology,"$8M, Grant",https://www.cirm.ca.gov/our-progress/institutions/ray-therapeutics-inc/,No
recode therapeutics inc,Biotechnology,"$15M, Series Unknown",https://www.crunchbase.com/organization/recode-therapeutics,No
regenxbio inc,Biotechnology,"$150M, Post IPO Debt",https://www.linkedin.com/company/regenx,No
ribox (shanghai) therapeutics co ltd,Biotechnology,"$110M, Not Found",https://synapse.patsnap.com/organization/ee9d476e4c53bda0b62fb060da3ea2d1,No
snipr biome aps,Biotechnology,"$40.8M, Series B",https://www.biospace.com/press-releases/snipr-biome-raises-eur-35-million-series-b-financing-to-advance-crispr-medicines-targeting-antimicrobial-resistance,No
selecta biosciences inc,Biotechnology,"$60.3M, Post IPO Equity",https://www.linkedin.com/company/selecta-bio,No
sichuan zhishan weixin biotechnology co ltd,Biotechnology,"$29.6M, Series A",https://tracxn.com/d/companies/sichuan-zhishanweixin-biotechnology/__qUjax0yjNT3NbYEAC2v90C86iqGcy3_FHAyI9gcIZIQ,No
sparingvision sas,Biotechnology,"$74.9M, Series B",https://www.crunchbase.com/organization/sparingvision,No
spark therapeutics inc,Biotechnology,"$161M, IPO",https://en.wikipedia.org/wiki/Spark_Therapeutics,No
spirovant sciences inc,Biotechnology,"$4.5M, Grant",https://www.linkedin.com/company/spirovant,No
splice bio sl,Biotechnology,"$135M, Series B",https://european-biotechnology.com/latest-news/splicebio-sl-secures-us135m-in-series-b-financing/,No
spur therapeutics ltd,Biotechnology,"$50M, Private Equity",https://www.synconaltd.com/news-insights/news/spur-therapeutics-formerly-freeline-announces-new-name-and-brand/,No
suzhou huayi liangjian biotechnology co ltd,Biotechnology,"$10M, Series A",https://tracxn.com/d/companies/suzhou-huayi-lejian-biotechnology/__8rcRT8U5H73UHhKHL4SosZhm1AGUeOdtkKd_OEoTJqU,No
swanbio therapeutics inc,Biotechnology,"$10M, Series Unknown",https://www.crunchbase.com/organization/swanbio-therapeutics,No
swanbio therapeutics ltd,Biotechnology,"$10M, Series Unknown",https://www.crunchbase.com/organization/swanbio-therapeutics,No
tenaya therapeutics inc,Biotechnology,"$52.5M, Post IPO equity",https://www.linkedin.com/company/tenaya-therapeutics,No
tern therapeutics llc,Biotechnology,"$15M, Seed",https://www.linkedin.com/company/terntx,No
the hospital for sick children,Biotechnology,"$1.5B, Not Found",Not Found,No
translate bio inc,Biotechnology,"$3.2B, Acquired",https://www.drugtargetreview.com/news/97380/sanofi-acquires-translate-bio-for-mrna-therapeutic-development/,No
ultragenyx pharmaceutical inc,Biotechnology,"$126M, IPO",https://en.wikipedia.org/wiki/Ultragenyx,No
uniqure biopharma bv,Biotechnology,"$345M, Post IPO equity",https://www.linkedin.com/company/uniqure,No
uniqure nv,Biotechnology,"$345M, Post IPO equity",https://www.linkedin.com/company/uniqure,No
urovant sciences inc,Pharmaceuticals,"$140M, IPO",https://www.ocbj.com/healthcare/urovant-being-folded-into-japanese-pharma-giant/,No
urovant sciences inc (inactive),Biotechnology,"$681M, Acquired",https://www.omm.com/news/press-releases/o-melveny-represents-urovant-in-its-sale-to-sumitovant/,No
verve therapeutics inc,Biotechnology,"$143.8M, Post IPO Equity",https://www.linkedin.com/company/verve-therapeutics-inc,No
vigeneron gmbh,Biotechnology,"$10M, Series A",https://www.bionity.com/en/companies/1035873/vigeneron-gmbh.html,No
vironexis biotherapeutics inc,Biotechnology,"$26M, Seed",https://www.biospace.com/press-releases/vironexis-biotherapeutics-launches-with-fda-clearance-of-ind-application-for-first-ever-clinical-trial-of-an-aav-delivered-cancer-immunotherapy,No
vivet therapeutics sas,Biotechnology,"$635.8M, Acquired",https://www.pfizer.com/news/press-release/press-release-detail/pfizer_secures_exclusive_option_to_acquire_gene_therapy_company_vivet_therapeutics,No
wuhan neophth biotechnology co ltd,Biotechnology,"$95M, Series C+",https://www.prnewswire.com/news-releases/neurophth-secures-nearly-95-million-usd-in-series-c-financing-for-gene-therapy-clinical-trials-301898549.html,No
wuhan neurophth biological technology ltd,Biotechnology,"$95M, Series C+",https://www.prnewswire.com/news-releases/neurophth-secures-nearly-95-million-usd-in-series-c-financing-for-gene-therapy-clinical-trials-301898549.html,No
xalud therapeutics inc,Biotechnology,"$30M, Series C",https://www.linkedin.com/company/xalud-therapeutics-inc.,No
xylocor therapeutics inc,Biotechnology,"$67.5M, Series B",https://www.businesswire.com/news/home/20250107904126/en/XyloCor-Therapeutics-Raises-%2467.5-Million-in-Series-B-Financing-to-Advance-Clinical-Development-of-Novel-Gene-Therapy-in-Cardiovascular-Disease,No
yap therapeutics inc,Biotechnology,"$30.06M, Series B",https://www.cbinsights.com/company/yap-therapeutics,No
zhongze therapeutics,Biotechnology,"$10M, Series Pre-A",https://www.zhongzetherapeutics.com/index.php/en,No
engene holdings inc,Biotechnology,"$43.2M, Post IPO Equity",https://www.linkedin.com/company/engene,No
engene inc,Biotechnology,"$43.2M, Post IPO equity",https://www.linkedin.com/company/engene,No
ethris gmbh,Biotechnology,"$5M, Grant",https://european-biotechnology.com/latest-news/ethris-gmbh-bags-us5m-from-cepi/,No
iecure,Biotechnology,"$65M, Series A",https://www.linkedin.com/company/iecure,No
iecure inc,Biotechnology,"$65M, Series A",https://www.linkedin.com/company/iecure,No
3sbio inc,Biotechnology,"$1.25B, Acquired",https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-licensing-agreement-3sbio,No
4sc ag,Biotechnology,"$17.5M, Series A",https://imux.com/immunic-acquires-4scs-immunology-portfolio/,No
4teen4 pharmaceuticals gmbh,Pharmaceuticals,"$10.5M, Series C",https://www.crunchbase.com/organization/sphingotec-gmbh,No
7 hills pharma llc,Pharmaceuticals,"$34M, Not Found",https://www.7hillspharma.com/,No
abl bio inc,Biotechnology,"$3M, Series Unknown",https://www.linkedin.com/company/ablbio/,No
adc therapeutics sa,Biotechnology,"$100M, Post IPO equity",https://www.linkedin.com/company/adc-therapeutics,No
adcendo aps,Biotechnology,"$135M, Series B",https://www.prnewswire.com/news-releases/adcendo-aps-completes-oversubscribed-135-million-series-b-financing-to-advance-first-in-class-adc-pipeline-302314835.html,No
aim immunotech inc,Biotechnology,"$8M, Post IPO equity",https://www.linkedin.com/company/aimimmuno,No
al-s pharma ag,Biotechnology,"$10M, Series A",https://tvm-capital.com/portfolio/al-s-pharma-ag/,No
ap biosciences inc,Biotechnology,"$38M, Series D",https://www.apbioinc.com/en/news-detail20.htm,No
ars pharmaceuticals inc,Pharmaceuticals,"$100M, Post IPO Debt",https://www.linkedin.com/company/arspharmaceuticals,No
aveo pharmaceuticals inc,Biotechnology,"$55.2M, Post IPO equity",https://www.linkedin.com/company/aveo-oncology,No
aadi bioscience inc,Biotechnology,"$100M, PIPE",https://www.prnewswire.com/news-releases/aadi-bioscience-announces-closing-of-100-million-pipe-financing-302392049.html,No
abalos therapeutics gmbh,Biotechnology,"$35.93M, Series A",https://www.crunchbase.com/organization/abalos-therapeutics,No
abbisko cayman limited,Biotechnology,"$10M, Not Found",Not Found,No
abcuro inc,Biotechnology,"$200M, Series C",https://www.businesswire.com/news/home/20250212455038/en/Abcuro-Announces-%24200-Million-Series-C-Financing-to-Advance-Its-First-In-Class-Medicine-in-Development-for-Inclusion-Body-Myositis,No
abdera therapeutics inc,Biotechnology,"$142M, Series B",https://www.crunchbase.com/organization/abdera-therapeutics,No
abivax sa,Biotechnology,"$747.5M, IPO",https://www.linkedin.com/company/abivax/,No
ablynx nv,Biotechnology,"$230M, IPO",https://be.linkedin.com/company/ablynx,No
aboleris pharma,Biotechnology,"$29.2M, Series A",https://www.crunchbase.com/organization/aboleris-pharma,No
aceragen inc,Biotechnology,"$51M, Acquired",https://news.biobuzz.io/2025/07/16/following-merger-with-idera-pharmaceuticals-aceragen-cuts-costs-slashes-80-of-headcount/,No
aclaris therapeutics inc,Biotechnology,"$80M, Post IPO equity",https://www.linkedin.com/company/aclaris-therapeutics-inc-,No
actinium pharmaceuticals inc,Biotechnology,"$25M, Post IPO equity",https://www.linkedin.com/company/actinium-pharmaceuticals-inc-,No
acumen pharmaceuticals inc,Biotechnology,"$50M, Post IPO Debt",https://www.linkedin.com/company/acumen-pharm,No
advaxis inc,Biotechnology,"$9.3M, IPO",https://www.iposcoop.com/ipo/advaxis-inc/,No
advenchen laboratories llc,Biotechnology,"$4.5M, Series Unknown",https://www.linkedin.com/company/advenchen-laboratories-llc,No
aethlon medical inc,Biotechnology,"$4.5M, Post IPO Equity",https://www.linkedin.com/company/aethlon-medical-inc-,No
aevi genomic medicine inc (inactive),Biotechnology,"$15.6M, Acquired",https://www.marketscreener.com/quote/stock/AEVI-GENOMIC-MEDICINE-INC-32526460/,No
affimed gmbh,Biotechnology,"$90M, IPO","https://www.crunchbase.com/organization/affimed-therapeutics#:~:text=Affimed%20Therapeutics%20is%20focused%20on,100%20www.affimed.com%2F",No
agalimmune ltd,Biotechnology,"$Not Found, Acquired",https://www.prnewswire.com/news-releases/biolinerx-announces-acquisition-of-agalimmune-ltd-to-accelerate-expansion-of-immuno-oncology-pipeline-616907734.html,No
agenus inc,Biotechnology,"$16M, Post IPO equity",https://www.linkedin.com/company/agenus,No
agomab therapeutics nv,Biotechnology,"$89M, Series D",https://www.businesswire.com/news/home/20241024624593/en/Agomab-Announces-%2489-Million-Series-D-Financing-to-Support-Broad-Fibrosis-Focused-Pipeline,No
akamis bio ltd,Biotechnology,"$60M, Series A",https://www.linkedin.com/company/akamisbio,No
alentis therapeutics ag,Biotechnology,"$181.4M, Series D",https://www.businesswire.com/news/home/20241112618033/en/Alentis-Therapeutics-Raises-%24181.4-Million-in-an-Oversubscribed-Series-D-Financing-to-Advance-the-Clinical-Development-of-Anti-Claudin-1-ADCs-in-Solid-Tumors,No
alethia biotherapeutics inc,Biotechnology,"$4.0M, Debt financing",https://ca.linkedin.com/company/alethia-biotherapeutics-inc-,No
"aliada therapeutics, inc",Biotechnology,"$1.4B, Acquired",https://www.fiercebiotech.com/biotech/abbvie-inks-14b-aliada-buyout-landing-ex-jj-alzheimers-drug-leap-blood-brain-barrier,No
alimera sciences inc,Pharmaceuticals,"$26.75M, Series A",https://en.wikipedia.org/wiki/Alimera_Sciences,No
alladapt immunotherapeutics inc,Biotechnology,"$119M, Institutional Financing",https://patientsquarecapital.com/alladapt-announces-completion-of-oversubscribed-119-million-institutional-financing/,No
allakos inc,Biotechnology,"$150M, Post IPO equity",https://www.linkedin.com/company/allakos-inc,No
allegheny-singer research institute,Biotechnology,"$2.17M, Not Found",https://taggs.hhs.gov/Detail/RecipDetail?arg_EntityId=jor7XaTzbgQ0dNvSwSwktQ%3D%3D,No
alnylam pharmaceuticals inc,Biotechnology,"$26M, IPO",https://en.wikipedia.org/wiki/Alnylam_Pharmaceuticals,No
alpha tau medical ltd,Biotechnology,"$36.9M, Not Found",https://www.lw.com/en/news/2025/04/latham-watkins-advises-alpha-tau-medical-in-us36-9-million-registered-direct-offering,No
altor bioscience llc,Biotechnology,"$100K, Grant",https://www.gatesfoundation.org/about/committed-grants/2008/10/opp52092,No
altrubio inc,Biotechnology,"$225M, Series B",https://www.biospace.com/employer/2388550/altrubio,No
alvotech sa,Biotechnology,"$78.3M, Post IPO equity",https://www.linkedin.com/company/alvotechpr,No
alvotech swiss ag,Biotechnology,"$78.3M, Post IPO equity",https://www.linkedin.com/company/alvotechpr,No
amal therapeutics sa,Biotechnology,"$32.6M, Series B",https://www.linkedin.com/company/amal-therapeutics/,No
ambrx biopharma inc,Biotechnology,"$75M, Post IPO equity",https://www.linkedin.com/company/ambrx,No
amphivena therapeutics inc,Biotechnology,"$128M, Series C",https://tracxn.com/d/companies/amphivena-therapeutics/__JvJVEZSnEc1RZwm53v5OHy6TLc5y9H9c98TqGFlrqWA,No
amplyx pharmaceuticals inc,Pharmaceuticals,"$11.39M, Series C",https://www.pfizer.com/news/press-release/press-release-detail/pfizer-acquires-amplyx-pharmaceuticals,No
ampo biotechnology inc,Biotechnology,"$5.56M, Phase II",https://www.sbir.gov/portfolio/1823905,No
amunix operating inc,Biotechnology,"$117M, Series B",https://www.baincapital.com/news/amunix-raises-117-million-series-b-financing-fund-its-oncology-pipeline,No
amunix pharmaceuticals inc,Biotechnology,"$117M, Series B",https://www.baincapital.com/news/amunix-raises-117-million-series-b-financing-fund-its-oncology-pipeline,No
anaptysbio inc,Biotechnology,"$100M, Post IPO equity",https://www.crunchbase.com/organization/anaptysbio,No
anaveon ag,Biotechnology,"$119.69M, Series B",https://ch.linkedin.com/company/anaveon-ag,No
anewpharma,Pharmaceuticals,"$370M, Acquired",http://www.bettapharma.com/en.php/Newdrug/partner,No
angiex inc,Biotechnology,"$25M, Series B",https://www.linkedin.com/company/angiex-inc,No
angitia biopharmaceuticals,Biotechnology,"$120M, Series C",https://www.globenewswire.com/news-release/2024/12/11/2995375/0/en/Angitia-Biopharmaceuticals-Announces-120-Million-Series-C-Financing.html,No
angitia biopharmaceuticals ltd,Biotechnology,"$120M, Series C",https://www.globenewswire.com/news-release/2024/12/11/2995375/0/en/Angitia-Biopharmaceuticals-Announces-120-Million-Series-C-Financing.html,No
annexon inc,Biotechnology,"$227M, IPO",https://www.tipranks.com/stocks/annx,No
anthos therapeutics inc,Biotechnology,"$3.1B, Acquired",https://www.blackstone.com/news/press/blackstone-life-sciences-and-anthos-therapeutics-announce-agreement-for-anthos-to-be-acquired-by-novartis-for-up-to-3-1-billion/,No
anwita biosciences inc,Biotechnology,"$18.5M, Series B",https://anwitabio.com/,No
apellis pharmaceuticals inc,Biotechnology,"$300M, Not Found",https://www.biospace.com/employer/400428/apellis-pharmaceuticals-inc,No
apexigen inc,Biotechnology,"$35M, Acquired",https://finance.yahoo.com/news/pyxis-oncology-successfully-completes-acquisition-123500387.html,No
apogee therapeutics inc,Biotechnology,"$300.05M, IPO",https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-apge/apogee-therapeutics,No
apollo therapeutics ltd,Biotechnology,"$400M, Series C",https://uk.linkedin.com/company/apollo-therapeutics,No
applied molecular transport inc,Biotechnology,"$120.8M, Post IPO Equity",https://www.linkedin.com/company/applied-molecular-transport,No
aprinoia therapeutics inc,Biotechnology,"$4.4M, Series Unknown",https://www.linkedin.com/company/aprinoia-therapeutics,No
aptevo therapeutics inc,Biotechnology,"$8M, Post IPO equity",https://www.linkedin.com/company/aptevo-therapeutics-inc,No
aqualung therapeutics corp,Biotechnology,"$1.5M, Series A",https://finance.yahoo.com/news/aqualung-therapeutics-receives-fda-clearance-213000316.html,No
aravive inc,Biotechnology,"$18M, Not Found",https://www.globenewswire.com/search/organization/Aravive%CE%B4%2520Inc%C2%A7,No
arbutus biopharma corp,Biotechnology,"$20M, Not Found",https://en.wikipedia.org/wiki/Arbutus_Biopharma,No
arch oncology inc,Biotechnology,"$105M, Series C",https://www.biostl.org/news-and-media/home/biogenerator-company-arch-oncology-closes-105m-series-c-financing,No
archigen biotech ltd (inactive),Biotechnology,"$126M, Not Found",https://www.centerforbiosimilars.com/view/samsung-biologics-and-astrazeneca-dissolve-rituximab-partnership,No
arcus biosciences inc,Biotechnology,"$150M, Post IPO equity",https://www.crunchbase.com/organization/arcus-biosciences,No
arialys therapeutics inc,Biotechnology,"$58M, Seed",https://www.biospace.com/arialys-therapeutics-launches-to-lead-the-development-of-new-precision-medicines-for-autoimmune-neuropsychiatric-diseases,No
ariceum therapeutics gmbh,Biotechnology,"$51.6M, Series A",https://tracxn.com/d/companies/ariceum-therapeutics/__3RmDyoVcPGt5Qvdmy_NC_yBI01vyFKkSqhHIraVQCtY,No
aridis pharmaceuticals inc,Biotechnology,"$6.5M, Asset Acquisition",https://www.stocktitan.net/news/ARDS/aridis-provides-corporate-mq8c1efkgdkc.html,No
arrys therapeutics inc,Biotechnology,"$39M, Acquired",https://www.marketscreener.com/quote/stock/IKENA-ONCOLOGY-INC-120405762/news/Ikena-Oncology-Inc-acquired-Arrys-Therapeutics-Inc-for-39-million-36432732/,No
artiva biotherapeutics inc,Biotechnology,"$167.04M, IPO",https://www.iposcoop.com/ipo/artiva-biotherapeutics-inc/,No
arxx therapeutics as,Biotechnology,"$13.2M, Seed",https://tracxn.com/d/companies/arxx-therapeutics/__y-FKJ4xejT7ExqzNwypGRIDhd2rwqHlfKyzBHY7QP3k,No
ascendis pharma as,Biotechnology,"$300M, Post IPO Equity",https://www.linkedin.com/company/ascendis-pharma-a-s,No
ascentage pharma group international,Biotechnology,"$50M, IPO",https://stockanalysis.com/stocks/aapg/,No
asher biotherapeutics inc,Biotechnology,"$218M, Series C",https://tracxn.com/d/companies/asher-biotherapeutics/__tUfwQphgotV2QUNLcSLWsnQ8rklOetceDiIDV2bq7-I,No
ashibio inc,Biotechnology,"$40M, Seed and Series A",https://www.biospace.com/ashibio-raises-40m-in-seed-and-series-a-financing-to-advance-therapies-for-bone-and-connective-tissue-disorders,No
askgene pharma inc,Pharmaceuticals,"$10M, Series A",https://www.linkedin.com/company/askgene-pharma,No
aston sci co ltd,Biotechnology,"$24.7M, Series C",https://www.linkedin.com/company/astonsci,No
astria therapeutics inc,Biotechnology,"$125M, Post IPO equity",https://www.linkedin.com/company/astria-therapeutics,No
athenex inc (inactive),Biotechnology,"$500M, IPO",https://buffalonews.com/news/local/business/athenex-to-close-newstead-plant-cut-92-jobs/article_6e7c0c3e-8628-11ed-9e23-f797253d306c.html,No
atreca inc,Biotechnology,"$125M, Post IPO equity",https://www.linkedin.com/company/atreca-inc,No
avalo therapeutics inc,Biotechnology,"$69.4M, Post IPO equity",https://www.linkedin.com/company/avalotx,No
avencell europe gmbh,Biotechnology,"$112M, Series B",https://www.linkedin.com/company/avencell,No
avencell therapeutics inc,Biotechnology,"$112M, Series B",https://www.prnewswire.com/news-releases/avencell-raises-112-million-in-series-b-funding-led-by-novo-holdings-302282924.html,No
avenzo therapeutics inc,Biotechnology,"$60M, Series B",https://www.linkedin.com/company/avenzotx,No
avid bioservices inc,Biotechnology,"$1.1B, Acquired",https://www.globenewswire.com/news-release/2024/11/06/2976216/0/en/Avid-Bioservices-to-be-Acquired-by-GHO-Capital-Partners-and-Ampersand-Capital-Partners-in-1-1-Billion-Transaction.html,No
avidity biosciences inc,Biotechnology,"$690M, IPO",https://www.linkedin.com/company/avidity-biosciences-llc,No
baili-bio (chengdu) pharmaceutical co ltd,Biotechnology,"$132M, IPO",https://systimmune.com/news-biokin,No
bailisi kang biomedicine (hangzhou) co ltd,Biotechnology,"$14M, Series A",https://www.moomoo.com/news/post/54883203/baolisi-kang-has-received-over-100-million-yuan-in-series,No
bambusa therapeutics inc,Biotechnology,"$90M, Series A",https://www.prnewswire.com/news-releases/bambusa-therapeutics-raises-approximately-90-million-in-series-a-financing-to-advance-next-generation-bispecific-antibodies-for-immunology--inflammation-diseases-302376866.html,No
basilea pharmaceutica ltd,Biotechnology,"$25M, Grant",https://ch.linkedin.com/company/basilea-pharmaceutica-ltd,No
bausch health companies inc,Pharmaceuticals,"$2.5B, Post IPO Debt",https://finance.yahoo.com/quote/BHC/,No
bavarian nordic as,Biotechnology,"$171.7M, Post IPO Equity",https://www.linkedin.com/company/bavariannordic,No
beone medicines ltd,Biotechnology,"$20M, Seed",https://en.wikipedia.org/wiki/BeOne_Medicines,No
beigene (suzhou) co ltd,Biotechnology,"$182M, IPO",https://en.wikipedia.org/wiki/BeOne_Medicines,No
beigene ltd,Biotechnology,"$182M, IPO",https://en.wikipedia.org/wiki/BeOne_Medicines,No
beijing anshi biotechnology co ltd,Biotechnology,"$200M, Series A",https://equalocean.com/briefing/20211210230102319,No
beijing kanova biopharmaceutical co ltd,Biotechnology,"$50M, Series B+",http://en.kanovabiopharma.com/,No
beijing kawin technology share-holding co ltd,Biotechnology,"$10M, IPO",https://www.kawin-bio.com/about/profile/,No
benaroya research institute at virginia mason,Biotechnology,"$70M, Not Found",https://en.wikipedia.org/wiki/Benaroya_Research_Institute,No
bergenbio asa,Biotechnology,"$12.3M, Rights Issue",https://www.oncoinvent.com/press-release/bergenbio-and-oncoinvent-a-rising-innovator-in-radiopharmaceutical-cancer-therapies-announce-proposed-merger-and-a-fully-underwritten-rights-issue/,No
betta pharmaceuticals co ltd,Pharmaceuticals,"$10M, Series B",https://www.linkedin.com/company/betta-pharmaceuticals-co-ltd/,No
bexion pharmaceuticals inc,Biotechnology,"$1.4M, Grant",https://www.crunchbase.com/organization/bexion-pharmaceuticals,No
bexion pharmaceuticals llc,Biotechnology,"$1.4M, Grant",https://www.linkedin.com/company/bexion-pharmaceuticals,No
bicara therapeutics inc,Biotechnology,"$165M, Series C",https://www.linkedin.com/company/bicara-therapeutics,No
bicycle therapeutics plc,Biotechnology,"$555M, Post IPO equity",https://www.linkedin.com/company/bicycle-therapeutics,No
bill & melinda gates medical research institute,Biotechnology,"$273M, Not Found",https://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Medical_Research_Institute,No
bio-thera solutions ltd,Biotechnology,"$21M, Not Found",https://www.bio-thera.com/plus/view.php?aid=1130,No
bioatla inc,Biotechnology,"$9.2M, Post IPO equity",https://www.linkedin.com/company/bioatla,No
biocryst pharmaceuticals inc,Biotechnology,"$450M, Post IPO Debt",https://www.linkedin.com/company/biocryst-pharmaceuticals,No
bioeclipse therapeutics inc,Biotechnology,"$8M, Not Found",https://www.cirm.ca.gov/our-progress/institutions/bioeclipse-therapeutics-inc/,No
biofactura inc,Biotechnology,"$78M, Not Found",https://sjpi.com/press-releases/biofactura-inc-expands-presence-at-riverside-tech-park-in-frederick-maryland-to-17520-square-feet,No
bioinvent international ab,Biotechnology,"$20M, Asset Disposal",https://www.globaldata.com/company-profile/bioinvent-international-ab/,No
biolinerx ltd,Biotechnology,"$10M, IPO",https://en.wikipedia.org/wiki/BioLineRx,No
biocon ltd,Biotechnology,"$10,000, Seed",https://en.wikipedia.org/wiki/Biocon,No
bioeq gmbh,Biotechnology,"$650M, Acquired",https://www.bigmoleculewatch.com/2022/05/13/formycon-ag-acquires-biosimilar-assets-ustekinumab-and-ranibuzumab/,No
bionomics ltd,Biotechnology,"$20.03M, IPO",https://www.iposcoop.com/ipo/bionomics-limited/,No
biora therapeutics inc,Biotechnology,"$10.25M, Post IPO Equity",https://www.globenewswire.com/news-release/2024/12/30/3002651/0/en/Biora-Therapeutics-Undertakes-Chapter-11-Sale-Process-to-Position-Business-for-Future-Growth.html,No
biothera pharmaceutical inc,Biotechnology,"$13.6M, Series Unknown",https://www.linkedin.com/company/biothera,No
biotheus inc,Biotechnology,"$800M, Acquired",https://finance.yahoo.com/news/biontech-buy-biotheus-gaining-control-064500109.html,No
bioverativ inc,Biotechnology,"$11.6B, Acquired",https://en.wikipedia.org/wiki/Bioverativ,No
bird rock bio inc,Biotechnology,"$17M, Acquired",https://ir.skyebioscience.com/news-releases/detail/173/skye-completes-17m-financing-and-acquires-novel-phase-2-ready-cb1-inhibiting-monoclonal-antibody,No
bluejay therapeutics inc,Biotechnology,"$182M, Series C",https://www.crunchbase.com/organization/bluejay-therapeutics,No
blueprint medicines corp,Biotechnology,"$9.5B, Acquired",https://www.investopedia.com/blueprint-medicines-stock-soars-as-biotech-agrees-to-over-9b-sanofi-takeover-11746204,No
bolt biotherapeutics inc,Biotechnology,"$15M, Post IPO equity",https://www.linkedin.com/company/bolt-biotherapeutics-inc,No
boston pharmaceuticals inc,Pharmaceuticals,"$1.2B, Acquired",https://www.linkedin.com/company/boston-pharmaceuticals,No
boundless bio inc,Biotechnology,"$100M, Series C",https://www.crunchbase.com/organization/boundless-bio,No
brii biosciences ltd,Biotechnology,"$289.9M, IPO",https://www.prnewswire.com/apac/news-releases/brii-biosciences-provides-corporate-updates-and-reports-2025-interim-financial-results-302535357.html,No
c4 therapeutics inc,Biotechnology,"$25M, Post IPO equity",https://www.linkedin.com/company/c4-therapeutics-inc.,No
cdr-life inc,Biotechnology,"$76M, Series A",https://www.swissbiotech.org/listing/cdr-life-announces-76-million-raised-in-series-a-funding/,No
cg oncology inc,Biotechnology,"$380M, IPO",https://www.biopharmadive.com/news/cg-oncology-cretostimogene-phase-3-data/715109/,No
chu de quebec universite laval research center,Biotechnology,"$90M, Not Found",https://www.renewcanada.net/the-chu-de-quebec-universite-laval-inaugurates-its-new-research-center/,No
corat therapeutics gmbh,Biotechnology,"$42M, Corporate Round",https://www.prnewswire.com/news-releases/corat-therapeutics-gmbh-announces-partnership-with-dermapharm-holding-se-as-strong-strategic-partner-for-the-further-development-of-cor-101-301328126.html,No
cti biopharma corp,Biotechnology,"$50M, Post IPO Debt",https://www.linkedin.com/company/cti-biopharma,No
caelum biosciences inc,Biotechnology,"$500M, Acquired",https://www.biospace.com/astrazeneca-exercises-option-to-buy-caelum-biosciences-in-500-million-deal,No
calithera biosciences inc,Biotechnology,"$4M, Series A",https://www.biospace.com/calithera-biosciences-announces-update-on-complete-liquidation-and-dissolution,No
calluna pharma inc,Biotechnology,"$81.43M, Series A",https://respiratory-therapy.com/disorders-diseases/chronic-pulmonary-disorders/asthma/calluna-pharma-launches-e75m-inflammatory-fibrotic-disease-therapies/,No
calypso biotech sa,Biotechnology,"$250M, Acquired",https://www.startupticker.ch/en/news/novartis-pays-250m-upfront-to-acquire-calypso-biotech,No
canadian cancer trials group,Biotechnology,"$1.5M, Not Found",https://www.ctg.queensu.ca/,No
cantargia ab,Biotechnology,"$2.6M, Post IPO Debt",https://www.linkedin.com/company/cantargia-ab/,No
capella bioscience ltd,Biotechnology,"$7M, Acquired",https://www.fiercebiotech.com,No
capella bioscience ltd (inactive),Biotechnology,"$15.5M, Series A",https://www.fiercebiotech.com/biotech/capella-bioscience-completes-series-a-financing-of-%C2%A311-million-15-5-million-to-progress,No
cassava sciences inc,Pharmaceuticals,"$1M, Seed",https://en.wikipedia.org/wiki/Cassava_Sciences,No
catalym gmbh,Biotechnology,"$150M, Series D",https://european-biotechnology.com/latest-news/catalym-raises-us150m/,No
catalyst biosciences inc,Biotechnology,"$20M, Post IPO equity",https://www.linkedin.com/company/catalyst-biosciences,No
celgene inc,Biotechnology,"$74B, Acquired",https://news.bms.com/news/details/2019/Bristol-Myers-Squibb-to-Acquire-Celgene-to-Create-a-Premier-Innovative-Biopharma-Company/default.aspx,No
cellcentric ltd,Biotechnology,"$120M, Series C",https://uk.linkedin.com/company/cellcentric,No
celltrion inc,Biotechnology,"$72.8M, Not Found",https://en.wikipedia.org/wiki/Celltrion,No
centessa pharmaceuticals plc,Biotechnology,"$225M, Post IPO equity",https://www.linkedin.com/company/centessa,No
ception therapeutics inc,Biotechnology,"$77.7M, Series C",https://tracxn.com/d/companies/ception-therapeutics/__B6h0NYgNYZs6R0_qW6p3mpIbrbsJhePDbZz56es42B8,No
cerium pharmaceuticals inc,Pharmaceuticals,"$13.08M, Series A",https://www.cbinsights.com/company/cerium-pharmaceuticals,No
cessation therapeutics inc,Biotechnology,"$14.8M, Not Found",https://www.businesswire.com/news/home/20231018223510/en/Cessation-Therapeutics-Awarded-%2414.8-Million-Grant-from-the-National-Institute-of-Drug-Abuse-to-Develop-Novel-Formulation-of-Anti-Fentanyl-Monoclonal-Antibody,No
changchun baike biotech co ltd,Biotechnology,"$31.2M, IPO",http://www.bchtpharm.com/en/,No
changchun bcht biotechnology co ltd,Biotechnology,"$130M, IPO",http://www.bchtpharm.com/en/,No
changchun beike biotechnology co ltd,Biotechnology,"$6M, Not Found",Not Found,No
checkpoint therapeutics inc,Pharmaceuticals,"$12M, Post IPO equity",https://www.linkedin.com/company/checkpoint-therapeutics-inc,No
chemocentryx inc,Biotechnology,"$3.7B, Acquired",https://www.prnewswire.com/news-releases/amgen-successfully-completes-acquisition-of-chemocentryx-301654916.html,No
chengdu baili dot biopharmaceutical co ltd,Pharmaceuticals,"$132M, IPO",https://systimmune.com/news-biokin,No
chengdu baiyu pharmaceutical co ltd,Pharmaceuticals,"$70M, Acquired",https://www.fiercebiotech.com/biotech/novartis-pays-baiyu-70m-upfront-11b-chaser-small-molecule-cancer-candidate,No
chengdu suncadia medicine co ltd,Pharmaceuticals,"$800,000, Not Found",https://www.tianfulifesciencepark.com/en/News/Detail?id=1010,No
chinook therapeutics inc,Biotechnology,"$3.2B, Acquired",https://www.novartis.com/news/media-releases/novartis-completes-acquisition-chinook-therapeutics,No
cidara therapeutics inc,Biotechnology,"$339M, Grant",https://www.biospace.com/press-releases/cidara-therapeutics-announces-barda-award-to-support-expanded-manufacturing-and-clinical-development-of-cd388-its-non-vaccine-influenza-preventative-therapeutic,No
citryll bv,Biotechnology,"$85M, Series B",https://www.globenewswire.com/news-release/2024/12/09/2993455/0/en/Citryll-Raises-EUR-85-Million-Series-B-to-Advance-Novel-NET-Targeting-Therapy-for-Immune-Mediated-Inflammatory-Disorders.html,No
clarametyx biosciences inc,Biotechnology,"$10M, Series A",https://www.businesswire.com/news/home/20250128564757/en/Clarametyx-Biosciences-Announces-Investment-by-Kineticos-AMR-Accelerator-Fund,No
clasp therapeutics inc,Biotechnology,"$150M, Series A",https://www.crunchbase.com/organization/clasp-therapeutics,No
clinvest inc,Pharmaceuticals,Acquired,https://headlandsresearch.com/news/headlands-research-acquires-clinvest-research-the-clinical-research-site-networks-third-addition-of-2023/,No
clovis oncology inc,Biotechnology,"$10M, Series Unknown",https://www.linkedin.com/company/clovis-oncology,No
coimmune inc,Biotechnology,"$45M, Series A",https://www.globenewswire.com/search/organization/CoIMMUNE,No
cogent biosciences inc,Biotechnology,"$230M, Post IPO equity",https://pitchbook.com/profiles/company/98678-08,No
coherent biopharma,Biotechnology,"$100M, Series B",https://www.crunchbase.com/funding_round/coherent-biopharma-series-b--3f1f2ffd,No
coherus biosciences inc,Biotechnology,"$50M, Post IPO equity",https://www.linkedin.com/company/coherus-oncology,No
coherus oncology inc,Biotechnology,"$50M, Post IPO equity",https://www.linkedin.com/company/coherus-oncology,No
compass therapeutics inc,Biotechnology,"$120M, IPO",https://www.globenewswire.com/news-release/2025/08/11/3130767/0/en/Compass-Therapeutics-Reports-2025-Second-Quarter-Financial-Results-and-Provides-Corporate-Update.html,No
conjupro biotherapeutics inc,Biotechnology,"$9.32M, Series A",https://tracxn.com/d/companies/conjupro-biotherapeutics/__eGQCOuM5x1Gx0sQ-G9g7jlgTmNk01TWxdXdfNnwqMZY,No
convergent therapeutics inc,Biotechnology,"$90M, Series A",https://www.prnewswire.com/news-releases/convergent-therapeutics-announces-90-million-series-a-financing-to-advance-the-clinical-development-of-radiopharmaceuticals-for-the-treatment-of-prostate-cancer-and-other-solid-tumors-301813685.html,No
corbus pharmaceuticals holdings inc,Biotechnology,"$94.5M, Post IPO equity",https://www.linkedin.com/company/corbus-pharmaceuticals,No
corixa corp,Biotechnology,"$300M, Acquired",https://www.seattletimes.com/business/glaxosmithkline-to-buy-corixa/,No
corvus pharmaceuticals inc,Biotechnology,"$30.6M, Post IPO Equity",https://www.linkedin.com/company/corvus-pharmaceuticals,No
crescendo biologics ltd,Biotechnology,"$32M, Not Found",https://www.anderapartners.com/en/crescendo-biologics-secures-32m-and-announces-expansion-of-cb307-phase-1b-trial-in-psma-solid-tumours/,No
crucell nv (inactive),Biotechnology,"$30M, Acquired",https://www.fiercebiotech.com/biotech/crucell-n-v-crxl-signs-exclusive-license-agreement-talecris-biotherapeutics-worth-up-to-30,No
cue biopharma inc,Biotechnology,"$20M, IPO",https://www.cuebiopharma.com/,No
cyteir therapeutics inc,Biotechnology,"$80M, Series C",https://www.linkedin.com/company/cyteir-therapeutics,No
cyteir therapeutics inc (inactive),Biotechnology,"$133M, IPO",https://neurodex.co/lexingtons-cyteir-therapeutics-to-close/,No
cytodyn inc,Biotechnology,"$1.89M, Not Found",https://www.globaldata.com/company-profile/cytodyn-inc/,No
cytomx therapeutics inc,Biotechnology,"$158.1M, Not Found",https://seekingalpha.com/article/4828073-cytomx-a-fresh-start-with-new-drugs-after-total-pipeline-failure,No
cytovation as,Biotechnology,"$6M, Not Found",https://www.linkedin.com/company/cytovation-asa/,No
d3 bio inc,Biotechnology,"$62M, Series A+",https://www.biospace.com/d3-bio-completes-series-a-round-to-advance-innovative-oncology-pipeline,No
dartsbio pharmaceutical (guangdong) co ltd,Pharmaceuticals,"$10M, Series B",https://www.cbinsights.com/company/darts-bio,No
deciphera pharmaceuticals inc,Biotechnology,"$125M, Post IPO equity",https://www.linkedin.com/company/deciphera-pharmaceuticals,No
defence therapeutics inc,Biotechnology,"$2M, Not Found",https://www.newsfilecorp.com/company/8000/Defence-Therapeutics-Inc.,No
deka biosciences inc,Biotechnology,"$60M, Not Found",https://synapse.patsnap.com/organization/b381a109fe3a779358c43c382839a4e6,No
delcath systems inc,Pharmaceuticals,"$16.3M, Post IPO equity",https://www.linkedin.com/company/delcath-systems-inc,No
dianthus therapeutics inc,Biotechnology,"$288M, IPO",https://finance.yahoo.com/news/dianthus-therapeutics-inc-announces-pricing-023500033.html,No
disc medicine inc,Biotechnology,"$225.5M, Post IPO equity",https://www.globaldata.com/company-profile/disc-medicine-inc/,No
dizal (jiangsu) pharmaceutical co ltd,Biotechnology,"$246.2M, IPO",https://www.linkedin.com/company/dizal-pharma,No
dizal pharmaceutical co,Biotechnology,"$246.2M, Post IPO equity",https://www.crunchbase.com/organization/dizal-pharma,No
dizal pharmaceutical co ltd,Biotechnology,"$246.2M, Post IPO equity","https://www.linkedin.com/company/dizal-pharma#:~:text=Dizal%20Pharmaceutical%20Co.%2C%20Ltd%20(,of%20cancer%20and%20immunological%20diseases.",No
dracen pharmaceuticals inc,Biotechnology,"$2.3M, Debt Financing",https://www.linkedin.com/company/dracen-pharmaceuticals-inc,No
dragonfly therapeutics inc,Biotechnology,"$475M, Not Found",https://www.biospace.com/employer/2082881/dragonfly-therapeutics,No
dren bio inc,Biotechnology,"$25M, Corporate Round",https://www.crunchbase.com/organization/dren-bio,No
duality biologics (shanghai) co ltd,Biotechnology,"$90M, Series B",https://www.linkedin.com/company/duality-biologics-shanghai-co-ltd/,No
enb therapeutics llc,Biotechnology,"$10M, Series A",https://www.avestria.vc/enb-therapeutics,No
eqrx inc,Pharmaceuticals,"$1.8B, IPO",https://www.baincapital.com/news/eqrx-accelerate-growth-18-billion-raise-through-proposed-combination-cm-life-sciences-iii,No
eusa pharma (uk) ltd,Pharmaceuticals,"$130M, Acquired",https://www.jaba-recordati.pt/pt/noticias/recordati-to-acquire-eusa-pharma-uk-ltd,No
eden biologics inc,Biotechnology,"$50M, Acquired",https://bora-corp.com/bora-pharmaceuticals-acquires-eden-biologics-cdmo-assets-bora-establishes-a-leadership-position-in-taiwans-cdmo-sector-as-it-continues-to-expand-into-the-global-cdmo-market/,No
edesa biotech inc,Biotechnology,"$15M, Post IPO equity",https://ca.linkedin.com/company/edesa-biotech,No
eisbach bio gmbh,Biotechnology,"$4.75M, Grant",https://www.biospace.com/press-releases/eisbach-bio-secures-cprit-grant-to-advance-novel-cancer-therapeutic,No
eledon pharmaceuticals inc,Biotechnology,"$85M, Post IPO equity",https://www.linkedin.com/company/eledon-pharma,No
elevar therapeutics inc,Pharmaceuticals,"$20M, Series Unknown",https://www.linkedin.com/company/elevartherapeutics,No
elevation oncology inc,Biotechnology,"$93.2M, Acquired",https://www.prnewswire.com/news-releases/elevation-oncology-enters-into-agreement-to-be-acquired-by-concentra-biosciences-for-0-36-in-cash-per-share-plus-a-contingent-value-right-302475956.html,No
eli lilly and co,Pharmaceuticals,"$1B, Not Found",Not Found,No
elusys therapeutics inc,Biotechnology,"$450M, Acquired",https://elusys.com/,No
engeneic ltd,Biotechnology,"$100M, Not Found",https://www.forbes.com.au/covers/entrepreneurs/inside-engeneics-100-million-push-to-transform-cancer-treatment/,No
enliven therapeutics inc,Biotechnology,"$230M, Post IPO equity",https://finance.yahoo.com/news/enliven-therapeutics-inc-elvn-backed-173336114.html,No
epicentrx inc,Biotechnology,"$100M, Not Found",https://www.epicentrx.com/blog/on-the-origin-of-rrx-001/,No
epimab biotherapeutics inc,Biotechnology,"$120M, Series C",https://www.linkedin.com/company/epimab-biotherapeutics/,No
epizyme inc,Biotechnology,"$195M, Acquired",https://www.ipsen.com/press-releases/ipsen-to-acquire-epizyme-expanding-its-portfolio-in-oncology/,No
epsilogen ltd,Biotechnology,"$16.3M, Series B",https://european-biotechnology.com/latest-news/epsilogen-ltd-completes-12-5m-series-b-expansion/,No
equillium inc,Biotechnology,"$50M, Post IPO equity",https://www.equilliumbio.com/investors/press-releases/news-details/2025/Equillium-Announces-Up-to-50-Million-Financing-to-Advance-EQ504-a-Novel-Aryl-Hydrocarbon-Receptor-Modulator-into-the-Clinic/default.aspx,No
eradivir inc,Biotechnology,"$10.25M, Series A",https://www.purdue.edu/newsroom/2024/Q3/biotech-company-eradivir-closes-10-25m-series-a-funding-round-to-complete-phase-2a-study-of-influenza-therapeutic,No
erasca inc,Biotechnology,"$184M, IPO",https://www.linkedin.com/company/erasca,No
eurofarma laboratorios sa,Pharmaceuticals,"$99.6M, Debt Financing",https://www.linkedin.com/company/eurofarma,No
evelo biosciences inc,Biotechnology,"$25.5M, Not Found",https://www.biopharmadive.com/news/evelo-close-layoffs-shut-flagship-microbiome/700618/,No
everimmune sa,Biotechnology,"$3.7M, Debt Financing",https://www.crunchbase.com/organization/everimmune,No
evopoint bioscience co ltd,Biotechnology,"$130M, Not Found","https://newsroom.astellas.us/2025-05-29-Astellas-Enters-Exclusive-License-Agreement-with-Evopoint-Biosciences-for-XNW27011,-a-Novel-Clinical-stage-Antibody-Drug-Conjugate-Targeting-CLDN18-2",No
exelixis inc,Biotechnology,"$118M, IPO",https://en.wikipedia.org/wiki/Exelixis,No
eyebiotech ltd,Biotechnology,"$65M, Series A",https://www.linkedin.com/company/eyebio,No
f-star therapeutics inc,Biotechnology,"$161M, Acquired",https://www.businesswire.com/news/home/20230308005755/en/invoX-Pharma-Completes-Acquisition-of-F-star-Therapeutics-Inc.,No
fbd biologics ltd,Biotechnology,"$10M, Seed",https://www.pharmaindustrial-india.com/news/henlius-hanchorbio-partner-to-develop-novel-sirp-fc-fusion-for-tumour-immunotherapy,No
ff pharmaceuticals bv,Pharmaceuticals,"$5.3M, Series A",https://tracxn.com/d/companies/ff-pharma/__a6TGBgqCT3jTAeGToWGrEYvsFPWf2_6KfKe4FT78st0,No
"facet solutions, inc. (inactive)",Biotechnology,"$2.1M, Debt Financing",https://www.linkedin.com/company/facet-solutions-inc.,No
faron pharmaceuticals oy,Biotechnology,"$12.46M, IPO",https://fi.linkedin.com/company/faron,No
fibrogen inc,Biotechnology,"$220M, Post IPO Debt",https://en.wikipedia.org/wiki/FibroGen,No
five prime therapeutics inc,Biotechnology,"$1.9B, Acquired",https://www.amgen.com/newsroom/press-releases/2021/03/amgen-to-acquire-five-prime-therapeutics-for-$1-9-billion-in-cash,No
flamingo therapeutics nv,Biotechnology,"$1.9M, Grant",https://www.crunchbase.com/organization/flamingo-therapeutics,No
forbius,Biotechnology,"$2.5M, Series C",https://www.linkedin.com/company/forbius,No
forma therapeutics inc,Biotechnology,"$100M, Series D",https://www.linkedin.com/company/forma-therapeutics,No
forte biosciences inc,Biotechnology,"$75M, IPO",https://www.fortebiorx.com/investor-relations/news/news-details/2025/Forte-Biosciences-Announces-Pricing-of-75-Million-Public-Offering/default.aspx,No
fortis therapeutics inc,Biotechnology,"$58M, Series A",https://www.cbinsights.com/company/fortis-therapeutics,No
fred hutchinson cancer research center,Biotechnology,"$654.62M, Not Found",https://en.wikipedia.org/wiki/Fred_Hutchinson_Cancer_Center,No
fusion pharmaceuticals inc,Biotechnology,"$60M, Post IPO equity",https://www.linkedin.com/company/fusion-pharmaceuticals,No
g1 therapeutics inc,Biotechnology,"$405M, Acquired",https://finance.yahoo.com/news/pharmacosmos-group-g1-therapeutics-announce-125400333.html,No
gi innovation co ltd,Biotechnology,"$230M, IPO",https://convention.bio.org/program-1/gi-innovation,No
galderma sa,Pharmaceuticals,"$10.2B, Acquired",https://en.wikipedia.org/wiki/Galderma,No
galectin therapeutics inc,Biotechnology,"$10M, Post IPO Debt",https://www.linkedin.com/company/galectin-therapeutics,No
galecto inc,Biotechnology,"$64M, Series D",https://www.linkedin.com/company/galecto-biotech/,No
galvanize therapeutics inc,Biotechnology,"$100M, Series C",https://www.prnewswire.com/news-releases/galvanize-therapeutics-raises-100-million-in-oversubscribed-series-c-financing-to-transform-the-treatment-of-cancer-and-chronic-lung-disease-302544329.html,No
gamamabs pharma sa,Biotechnology,"$5M, Acquired",https://www.eurobiomed.org/en/actualites/article-adherent/exelixis-expands-its-biotherapeutics-portfolio-with-acquisition-of-gamamabs-pharmas-first-in-class-humanized-antibody-program-against-a-novel-oncology-target/,No
ganymed pharmaceuticals gmbh,Biotechnology,"$1.4B, Acquired",https://www.astellas.com/en/news/7896,No
geneuro sa,Biotechnology,"$5.4M, Post IPO equity",https://www.linkedin.com/company/geneuro-sa/,No
genfleet therapeutics (shanghai) inc,Biotechnology,"$184M, IPO",https://synapse.patsnap.com/organization/40bf01d212e70db17bb7757f99a2a68f,No
genequantum healthcare suzhou co ltd,Biotechnology,"$13B, Series C",https://convention.bio.org/program-1/genequantum-healthcare,No
genelux corp,Biotechnology,"$27.97M, IPO",https://finance.yahoo.com/quote/GNLX/,No
genenta science spa,Biotechnology,"$22.7M, Strategic Financing",https://genenta.gcs-web.com/news-events/news-releases,No
geneos therapeutics inc,Biotechnology,"$5M, Series A",https://www.geneostx.com/,No
genmab as,Biotechnology,"$8B, Acquired",https://finance.yahoo.com/quote/GMAB/,No
genome & co,Biotechnology,"$10M, Series C",http://genomecom.co.kr/eng/about/,No
genome &,Biotechnology,"$10M, Series C",http://genomecom.co.kr/eng/about/,No
genor biopharma co ltd,Biotechnology,"$160M, Series B",https://dealstreetasia.com,No
genta incorporated (inactive),Biotechnology,"$480M, Not Found",https://en.wikipedia.org/wiki/Genta_(company),No
genzyme corp,Biotechnology,"$20.1B, Acquired",https://www.statnews.com/2022/02/03/sanofi-genzyme-boston-name/,No
georgiamune inc,Biotechnology,"$75M, Series A",https://www.prnewswire.com/news-releases/georgiamune-inc-achieves-us-fda-clearance-for-investigational-new-drug-ind-application-and-secures-75-million-in-series-a-financing-301896408.html,No
global blood therapeutics inc,Biotechnology,"$5.4B, Acquired",https://www.pfizer.com/news/press-release/press-release-detail/pfizer-acquire-global-blood-therapeutics-54-billion-enhance,No
glycotope gmbh,Biotechnology,"$132.5M, Acquired",https://daiichisankyo.us/press-releases/-/article/daiichi-sankyo-acquires-intellectual-property-rights-for-anti-ta-muc1-antibody-in-ds-3939-from-glycotope-gmbh,No
gmax biopharm llc,Biotechnology,"$78M, Not Found",https://www.gmaxbiopharm.com/wap_indexen.html,No
gossamer bio inc,Biotechnology,"$212M, Post IPO equity",https://www.linkedin.com/company/gossamer-bio,No
granite bio ag,Biotechnology,"$100M, Series B",https://forbion.com/news-insights/news/forbion-co-leads-100-million-series-b-financing-of-granite-bio/,No
groteks llc,Pharmaceuticals,"$9.5B, Not Found",https://tadviser.com/index.php/Company:Grotex_(Solopharm),No
hanchorbio inc,Biotechnology,"$80M, IPO",https://finance.yahoo.com/news/tpex-listed-hanchorbio-advances-global-130000806.html,No
hangzhou jiuyuan gene engineering co ltd,Biotechnology,"$1.6M, Series A",https://www.linkedin.com/company/hangzhou-jiuyuan-gene-engineering-co-ltd-/,No
hangzhou sumgen biotech co ltd,Biotechnology,"$30M, Series B",https://www.sumgenbio.com/en/,No
hansa biopharma ab,Biotechnology,"$71M, IPO",https://www.hansabiopharma.com/,No
hansoh pharmaceutical group co ltd,Pharmaceuticals,"$1.2B, IPO",https://en.wikipedia.org/wiki/Hansoh_Pharmaceutical,No
harpoon therapeutics inc,Biotechnology,"$680M, Acquired",https://www.biopharmadive.com/news/merck-harpoon-acquire-deal-bispecific-lung-cancer/703880/,No
heidelberg pharma ag,Biotechnology,"$70M, Not Found",https://www.linkedin.com/company/heidelberg-pharma-ag/,No
helix biopharma corp,Biotechnology,"$2.1M, Post IPO Equity",https://ca.linkedin.com/company/helix-biopharma-corp,No
hemab aps,Biotechnology,"$135M, Series B",https://www.prnewswire.com/news-releases/hemab-therapeutics-announces-135m-series-b-financing-to-advance-first-prophylactic-treatments-for-underserved-bleeding-and-thrombotic-disorders-301750293.html,No
highlight therapeutics sl,Biotechnology,"$15M, Series Unknown",https://www.linkedin.com/company/highlight-therapeutics?trk=ppro_cprof,No
hikma pharmaceuticals plc,Pharmaceuticals,"$250M, Post IPO Debt",https://www.linkedin.com/company/hikma-pharmaceuticals,No
hisun biopharmaceutical co ltd,Pharmaceuticals,"$295M, Not Found",https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_hisun_announce_launch_of_hisun_pfizer_pharmaceuticals_co_ltd,No
hongyun huaning (hangzhou) biopharmaceutical co ltd,Biotechnology,"$155M, Series B",https://www.bioworld.com/articles/509777-hongyun-closes-155m-series-b-to-develop-new-generation-egfr-inhibitor,No
hookipa pharma inc,Biotechnology,"$10M, Acquired",https://finance.yahoo.com/news/hookipa-pharma-announces-intention-voluntarily-200500019.html,No
horizon therapeutics plc,Pharmaceuticals,"$963.5M, Post IPO equity",https://www.linkedin.com/company/horizontherapeutics,No
humabs biomed sa,Biotechnology,"$Not Found, Acquired",https://www.usi.ch/en/innovation/innovate/usi-transfer/about/success-stories/humabs,No
human genome sciences inc,Biotechnology,"$3.6B, Acquired",https://www.gsk.com/en-gb/media/press-releases/gsk-to-acquire-human-genome-sciences-for-us-1425-per-share-in-cash/,No
human immunology biosciences inc,Biotechnology,"$1.15B, Acquired",https://www.goodwinlaw.com/en/news-and-events/news/2024/05/announcements-lifesciences-hi-bio-acquired-by-biogen,No
hutchison medipharma ltd,Biotechnology,"$608M, Not Found",https://www.hutch-med.com/news/news-press-releases/,No
hutchmed china ltd,Biotechnology,"$100M, Post IPO equity",https://www.linkedin.com/company/hutchmed,No
i-mab,Biotechnology,"$65M, Post IPO Equity",https://www.linkedin.com/company/i-mab,No
imbiologics corp,Biotechnology,"$20M, Series B",http://imbiologics.com/about/company.php,No
io biotech inc,Biotechnology,"$60M, Post IPO Debt",https://www.linkedin.com/company/io-biotech/,No
isa pharmaceuticals bv,Biotechnology,"$30.6M, Series Unknown",https://www.crunchbase.com/organization/isa-pharmaceuticals,No
itb-med ab,Biotechnology,"$6.7M, Not Found",https://nordic9.com/news/itb-med-ab-announces-an-equity-investment-in-a-67m-financing-deal-news8035767673/,No
itabmed co ltd,Biotechnology,"$20M, Series A",https://itabmed.us/,No
iveric bio inc,Biotechnology,"$300M, Post IPO equity",https://www.linkedin.com/company/ivericbio,No
ichnos glenmark innovation,Biotechnology,"$700M, Acquired","https://news.abbvie.com/2025-07-10-AbbVie-and-Ichnos-Glenmark-Innovation-IGI-Announce-Exclusive-Global-Licensing-Agreement-for-ISB-2001,-a-First-in-Class-CD38xBCMAxCD3-Trispecific-Antibody",No
idera pharmaceuticals inc,Biotechnology,"$3.5M, Not Found",https://finance.yahoo.com/news/idera-pharmaceuticals-announces-name-change-130000783.html,No
idorsia pharmaceutical ltd,Pharmaceuticals,"$947.7M, Post IPO Debt",https://www.linkedin.com/company/idorsia,No
ikena oncology inc,Biotechnology,"$40M, Post IPO equity",https://www.linkedin.com/company/ikenaoncology,No
iksuda therapeutics ltd,Biotechnology,"$47M, Series A",https://www.crunchbase.com/organization/glythera,No
imcheck therapeutics sas,Biotechnology,"$20M, Not Found",https://www.boehringer-ingelheim-venture.com/portfolio/imcheck,No
imaginab inc,Biotechnology,"$13M, Growth Funding",https://www.auntminnie.com/resources/vendors/radiopharmaceuticals/radiopharmeceuticals-nuclear-medicine/company/15554088/imaginab-inc,No
immorna biotherapeutics inc,Biotechnology,"$3.8M, Grant",https://www.gatesfoundation.org/about/committed-grants/2024/08/inv-070028,No
immune biosolutions inc,Biotechnology,"$22.94M, Not Found",https://www.biospace.com/immune-biosolutions-a-step-closer-to-the-first-inhaled-antibody-treatment-for-covid-19,No
immune onc therapeutics inc,Biotechnology,"$25M, Series B",https://www.crunchbase.com/organization/immune-onc-therapeutics,No
immune pharmaceuticals inc,Biotechnology,"$18M, Post IPO equity",https://www.crunchbase.com/organization/immune-pharmaceuticals,No
immuneoncia therapeutics inc,Biotechnology,"$24M, IPO",https://www.bioworld.com/articles/720353-cancer-drug-specialist-immuneoncia-raises-24m-in-kosdaq-listing,No
immunesensor therapeutics inc,Biotechnology,"$10M, Series A",https://www.crunchbase.com/organization/immunesensor-therapeutics,No
immunewalk therapeutics inc,Biotechnology,"$7M, Seed",https://www.globenewswire.com/news-release/2025/05/07/3076269/0/en/ImmuneWalk-Therapeutics-Announces-7-Million-Seed-Financing-and-Upcoming-Presentations-of-Positive-Clinical-Results-at-Upcoming-Medical-and-Industry-Conferences.html,No
immunicom inc,Biotechnology,"$2M, Grant",https://www.linkedin.com/company/immunicom,No
immunogen inc,Biotechnology,"$10.1B, Acquired","https://news.abbvie.com/2023-11-30-AbbVie-to-Acquire-ImmunoGen,-including-its-Flagship-Cancer-Therapy-ELAHERE-R-mirvetuximab-soravtansine-gynx-,-Expanding-Solid-Tumor-Portfolio",No
immunomedics inc,Biotechnology,"$21B, Acquired",https://www.gilead.com/news/news-details/2020/gilead-sciences-to-acquire-immunomedics,No
immunos therapeutics ag,Biotechnology,"$11M, Series C",https://www.globenewswire.com/news-release/2024/09/17/2947186/0/en/ImmunOs-Therapeutics-AG-Raises-11-Million-and-Further-Strengthens-Investor-Base.html,No
immutep ltd,Biotechnology,"$59.5M, Post IPO equity",https://au.linkedin.com/company/immutep-ltd,No
immvira co ltd,Biotechnology,"$10M, Series C",https://hk.linkedin.com/company/immvira,No
imunon inc,Biotechnology,"$3.3M, Post IPO equity",https://www.linkedin.com/company/imunon,No
incepta pharmaceuticals ltd,Pharmaceuticals,"$6.87M, Not Found",https://www.gatesfoundation.org/about/committed-grants/2021/11/inv032563,No
indapta therapeutics inc,Biotechnology,"$22.5M, Series A",https://www.businesswire.com/news/home/20241217242473/en/Indapta-Therapeutics-Secures-%2422.5-Million-to-Advance-Clinical-Trials-of-Innovative-Cancer-and-Autoimmune-Treatments,No
indaptus therapeutics inc,Biotechnology,"$5.7M, Post IPO Debt",https://www.linkedin.com/company/indaptus-therapeutics-inc,No
infinity pharmaceuticals inc,Biotechnology,"$92M, IPO",https://www.linkedin.com/company/ipi,No
inhalon biopharma inc,Biotechnology,"$2M, Grant",https://www.linkedin.com/company/inhalon-biopharma,No
inhibrx biosciences inc,Biotechnology,"$1.7B, Acquired",https://www.sanofi.com/en/media-room/press-releases/2024/2024-05-30-13-01-38-2890833,No
inhibrx inc,Biotechnology,"$1.7B, Acquired",https://www.sanofi.com/en/media-room/press-releases/2024/2024-01-23-06-30-00-2813696,No
innate pharma sa,Biotechnology,"$17M, Post IPO equity",https://pitchbook.com/profiles/company/13465-09,No
inovio pharmaceuticals inc,Biotechnology,"$25M, Post IPO equity",https://www.linkedin.com/company/inovio-pharmaceuticals,No
inspirna inc,Biotechnology,"$55.1M, Series D",https://www.crunchbase.com/organization/rgenix,No
instil bio inc,Biotechnology,"$85M, Series C",https://www.linkedin.com/company/instil-bio,No
institute for developing science & health initiatives,Biotechnology,"$1.03M, Not Found",https://www.gatesfoundation.org/about/committed-grants/2023/08/inv-059440,No
intensity therapeutics inc,Biotechnology,"$11.3M, IPO",https://www.prnewswire.com/news-releases/intensity-therapeutics-reports-second-quarter-2025-financial-results-and-provides-corporate-update-302524797.html,No
intervexion therapeutics llc,Biotechnology,"$14.5M, Not Found",https://news.uams.edu/tag/intervexion-therapeutics/,No
istari oncology inc,Biotechnology,"$43.4M, Series Unknown",https://www.linkedin.com/company/istari-oncology,No
izana bioscience ltd,Biotechnology,"$1.8M, Grant",https://uk.linkedin.com/company/izana-bioscience,No
jacobio pharmaceuticals group co ltd,Biotechnology,"$27M, Series C",https://www.linkedin.com/company/jacobio-pharma,No
jade biosciences inc,Biotechnology,"$300M, Post IPO Equity",https://www.biopharmadive.com/news/jade-aerovate-reverse-merger-paragon-april-igan/731597/,No
jasper therapeutics inc,Biotechnology,"$30M, Post IPO equity","https://finance.yahoo.com/quote/JSPR/#:~:text=Jasper%20Therapeutics%2C%20Inc.%2C%20a,hematopoietic%20stem%20cell%20driven%20diseases.",No
jiangsu qyuns therapeutics co ltd,Biotechnology,"$10M, IPO",https://www.qyuns.net/en/,No
jiangsu aidea pharmaceutical co ltd,Pharmaceuticals,"$Not Found, IPO",https://www.linkedin.com/company/aideapharma,No
jiangxi jemincare group co ltd,Pharmaceuticals,"$35M, Not Found",https://www.sidley.com/en/newslanding/newsannouncements/2025/01/sidley-represents-rapt-therapeutics-in-exclusive-license-agreement,No
jiangxi jemincare pharmaceutical co ltd,Pharmaceuticals,"$60M, Not Found",https://www.prnewswire.com/news-releases/jemincare-announces-exclusive-license-agreement-with-genentech-to-develop-and-commercialize-novel-oral-androgen-receptor-degrader-301608317.html,No
jinan central hospital,Healthcare,"$182.19M, Not Found",https://govt.chinadaily.com.cn/s/201906/10/WS5cfdc4dc498e079e68022739/jinan-central-hospital.html,No
jounce therapeutics inc,Biotechnology,"$56.3M, Post IPO Equity",https://www.linkedin.com/company/jounce-therapeutics,No
kalivir immunotherapeutics inc,Biotechnology,"$10M, Series A",https://www.crunchbase.com/organization/kalivir-immunotherapeutics,No
kalvista pharmaceuticals inc,Pharmaceuticals,"$110M, Convertible Notes Offering",https://www.cnbc.com/quotes/KALV,No
kashiv biosciences llc,Biotechnology,"$150M, Debt Financing",https://www.businesswire.com/news/home/20250403907363/en/Kashiv-BioSciences-Secures-%24150-Million-Debt-Financing-from-GoldenTree-Asset-Management,No
kazia therapeutics ltd,Biotechnology,"$1.3M, Post IPO equity",https://au.linkedin.com/company/kaziatx,No
keymed biosciences inc,Biotechnology,"$180M, Series A","https://finance.yahoo.com/quote/2162.HK/#:~:text=Keymed%20Biosciences%20Inc.%2C%20a%20biotechnology,in%20Mainland%20China%20and%20internationally.",No
kineta inc,Biotechnology,"$12.5M, Acquired",https://www.prnewswire.com/news-releases/tuhura-biosciences-completes-acquisition-of-kineta-302494115.html,No
kiniksa pharmaceuticals international plc,Biotechnology,"$80M, Post IPO equity",https://www.linkedin.com/company/kiniksa-pharmaceuticals,No
kiniksa pharmaceuticals ltd,Biotechnology,"$80M, Post IPO equity",https://www.linkedin.com/company/kiniksa-pharmaceuticals,No
kumquat biosciences inc,Biotechnology,"$70M, Corporate Round",https://www.crunchbase.com/organization/kumquat-biosciences,No
kymab ltd,Biotechnology,"$220M, Acquired",https://www.devex.com/organizations/kymab-limited-56547,No
lava therapeutics nv,Biotechnology,"$83M, Series C",https://www.linkedin.com/company/lavatherapeutics,No
lanova medicines ltd,Biotechnology,"$42M, Series C",https://www.lanovamedicines.com/en,No
laekna inc,Biotechnology,"$61M, Series D",https://www.linkedin.com/company/laekna?trk=ppro_cprof,No
laekna therapeutics shanghai co ltd,Biotechnology,"$61M, Series D",https://www.linkedin.com/company/laekna?trk=ppro_cprof,No
lassen therapeutics 1 inc,Biotechnology,"$85M, Series B",https://www.linkedin.com/company/lassen-therapeutics,No
leap therapeutics inc,Biotechnology,"$58.88M, PIPE",https://www.prnewswire.com/news-releases/leap-therapeutics-announces-58-88-million-private-placement-in-cash-commitments-led-by-winklevoss-capital-to-initiate-a-digital-asset-treasury-strategy-302575729.html,No
legochem biosciences inc,Biotechnology,"$416.5M, Post IPO Equity",https://www.linkedin.com/company/legochem-biosciences-inc-/,No
leyden laboratories bv,Biotechnology,"$70M, Series B",https://www.businesswire.com/news/home/20250109992744/en/Leyden-Labs-Raises-%2470M-to-Advance-its-Intranasal-Antibody-Programs-to-Protect-against-Influenza-and-other-Viruses,No
ligachem biosciences inc,Biotechnology,"$416.5M, Post IPO equity",https://www.linkedin.com/company/legochem-biosciences-inc-/,No
light chain bioscience,Biotechnology,"$29.8M, Series C",https://www.linkedin.com/company/novimmune/,No
linnaeus therapeutics inc,Biotechnology,"$8.3M, Not Found",https://www.prnewswire.com/news-releases/linnaeus-therapeutics-awarded-its-fourth-competitive-sbir-award-by-the-national-cancer-institute-bringing-total-sbir-funding-to-8-3-million-302412016.html,No
lipomedix pharmaceutical inc,Pharmaceuticals,"$10M, Horizon 2020 SME-Instrument",https://www.lipomedix.com/,No
lixte biotechnology holdings inc,Biotechnology,"$1.5M, Post IPO equity",https://www.linkedin.com/company/lixte-biotechnology-holdings-inc-,No
loxo oncology inc,Biotechnology,"$70M, Acquired",https://www.prnewswire.com/news-releases/lilly-announces-agreement-to-acquire-loxo-oncology-300773673.html,No
ludwig institute for cancer research ltd,Biotechnology,"$3.6B, Not Found",https://en.wikipedia.org/wiki/Ludwig_Cancer_Research,No
lumen bioscience inc,Biotechnology,"$150M, Not Found",https://www.lumen.bio/,No
lutris pharma,Biotechnology,"$30M, Series Unknown",https://www.prnewswire.com/news-releases/lutris-pharma-secures-30-million-financing-to-advance-the-development-of-biopharmaceutical-to-improve-anti-cancer-drug-effectiveness-302361244.html,No
lycera corp (inactive),Biotechnology,"$17.5M, Acquired",https://www.prnewswire.com/news-releases/lycera-announces-celgene-has-exercised-its-option-to-license-portfolio-of-ex-vivo-rorgamma-agonist-compounds-under-global-strategic-collaboration-300201777.html,No
lytix biopharma as,Biotechnology,"$10.14M, IPO",https://www.crunchbase.com/organization/lytix-biopharma,No
lyvgen biopharma ltd,Biotechnology,"$30M, Series C",https://tracxn.com/d/companies/lyvgen-biopharma/__eMIU6NJj9itggbFZ9q5B7udw5Qg9_kIFkYaejo19KG8,No
maia biotechnology inc,Biotechnology,"$10M, Seed",https://en.wikipedia.org/wiki/Maia_Biotechnology,No
mbrace therapeutics inc,Biotechnology,"$85M, Series B",https://www.linkedin.com/company/mbrace-therapeutics,No
mei pharma inc,Pharmaceuticals,"$100M, PIPE",https://finance.yahoo.com/news/mei-pharma-meip-becomes-first-043527392.html,No
mabion sa,Biotechnology,"$15M, Loan Agreement",https://www.mabion.eu/,No
mabspace international ltd,Biotechnology,"$15M, Series A",https://www.lavfund.com/blog/mabspace-biosciences-secures-15-million-in-series-a-financing-from-lilly,No
macrogenics inc,Biotechnology,"$110M, Post IPO equity",https://www.linkedin.com/company/macrogenics,No
mage biologics inc,Biotechnology,"$900M, Not Found",https://tvm-capital.com/portfolio/mage-biologics-inc/,No
marengo therapeutics inc,Biotechnology,"$80M, Series B",https://pitchbook.com/profiles/company/168960-79,No
mary crowley cancer research center,Biotechnology,"$500,000, Not Found",https://www.crystalcharityball.org/get-involved/underwriting?id=140,No
maverick therapeutics inc,Biotechnology,"$125M, Acquired",https://www.takeda.com/newsroom/newsreleases/2021/takeda-to-acquire-maverick-therapeutics-to-advance-t-cell-engager-therapies-for-solid-tumors-and-expand-novel-immuno-oncology-portfolio/,No
medannex ltd,Biotechnology,"$402.4K, Grant",https://www.crunchbase.com/organization/medannex-ltd,No
medimmune llc (inactive),Biotechnology,"$15.6B, Acquired",https://www.nytimes.com/2007/04/24/business/24drug-web.html,No
mediar therapeutics inc,Biotechnology,"$85M, Series A",https://www.linkedin.com/company/mediar-therapeutics,No
medivir ab,Biotechnology,"$2.84M, Loan after IPO",https://se.linkedin.com/company/medivir,No
memo therapeutics ag,Biotechnology,"$22.02M, Series C",https://ch.linkedin.com/company/memo-therapeutics-ag,No
merrimack pharmaceuticals inc,Pharmaceuticals,"$1B, Acquired",https://en.wikipedia.org/wiki/Merrimack_Pharmaceuticals,No
merrimack pharmaceuticals inc (inactive),Pharmaceuticals,"$1B, Acquired",https://en.wikipedia.org/wiki/Merrimack_Pharmaceuticals,No
mersana therapeutics inc,Biotechnology,"$100M, Post IPO Debt",https://www.linkedin.com/company/mersana-therapeutics,No
merus nv,Biotechnology,"$8B, Acquired",https://ir.genmab.com/news-releases/news-release-details/genmab-acquire-merus-expanding-late-stage-pipeline-and,No
millennium pharmaceuticals inc,Pharmaceuticals,"$8.8B, Acquired",https://www.fiercebiotech.com/biotech/takeda-to-acquire-millennium-for-us-25-00-per-share-an-all-cash-tender-offer-valued-at-8-8,No
mina therapeutics ltd,Biotechnology,"$15M, Corporate Round",https://uk.linkedin.com/company/mina-therapeutics,No
mingsight pharmaceuticals inc,Pharmaceuticals,"$10M, Series A",https://www.businesswire.com/news/home/20211112005302/en/MingSight-Completes-a-New-Round-of-Financing-to-Accelerate-Clinical-Development-in-Chronic-Lymphocytic-Leukemia-and-Diabetic-Macular-Edema,No
minghui pharmaceutical (shanghai) co ltd,Pharmaceuticals,"$131M, Pre-IPO",https://www.prnewswire.com/news-releases/minghui-pharmaceutical-announces-usd-131-million-pre-ipo-financing-to-advance-late-stage-pipeline-and-global-expansion-302524051.html,No
mirati therapeutics inc,Biotechnology,"$345M, Post IPO Equity",https://www.linkedin.com/company/mirati-therapeutics,No
mitsubishi tanabe pharma corp,Pharmaceuticals,"$3.4B, Acquired",https://www.baincapital.com/news/bain-capital-acquire-mitsubishi-tanabe-pharma-corporation,No
molecular partners ag,Biotechnology,"$20M, Post IPO equity",https://www.linkedin.com/company/molecular-partners-ag-zurich-switzerland,No
momenta pharmaceuticals inc,Biotechnology,"$6.5B, Acquired",https://www.jnj.com/media-center/press-releases/johnson-johnson-to-acquire-momenta-pharmaceuticals-inc-expanding-janssens-leadership-in-novel-treatments-for-autoimmune-diseases,No
monopar therapeutics inc,Biotechnology,"$135M, Post IPO equity",https://finance.yahoo.com/news/why-monopar-therapeutics-inc-mnpr-002249060.html,No
monopteros therapeutics inc,Biotechnology,"$20M, Series A",https://www.biospace.com/monopteros-therapeutics-initiates-clinical-trial-to-reprogram-regulatory-t-cells-in-solid-tumors,No
moonbiotech,Biotechnology,"$41.3M, Series C+",https://www.echemi.com/cms/1958758.html,No
moonlake immunotherapeutics,Biotechnology,"$75M, Post IPO Debt",https://www.linkedin.com/company/moonlake-immunotherapeutics-ag/,No
morphosys ag,Biotechnology,"$239M, IPO",https://en.wikipedia.org/wiki/MorphoSys,No
morphotek inc,Biotechnology,"$325M, Acquired",https://www.flagshippioneering.com/companies/morphotek,No
mozart therapeutics inc,Biotechnology,"$25M, Series A",https://www.crunchbase.com/organization/mozart-therapeutics,No
multitude therapeutics inc,Biotechnology,"$1B, Not Found",https://www.prnewswire.com/news-releases/adcendo-aps-and-multitude-therapeutics-inc-announce-global-development-and-commercialization-agreement-on-first-in-class-adc-drug-candidate-targeting-tissue-factor-302225429.html,No
multitude therapeutics inc (inactive),Biotechnology,"$1B, Not Found",https://adcendo.com/adcendo-aps-and-multitude-therapeutics-inc-announce-global-development-and-commercialization-agreement-on-first-in-class-adc-drug-candidate-targeting-tissue-factor/,No
mural oncology inc,Biotechnology,"$275M, Corporate round",https://www.crunchbase.com/organization/mural-oncology,No
mycenax biotech inc,Biotechnology,"$56M, IPO",https://www.linkedin.com/company/mycenax,No
myeloproliferative disorders-research consortium,Biotechnology,"$20M, Not Found",https://reports.mountsinai.org/article/tisch2024-03-mpn-consortium,No
mythic therapeutics inc,Biotechnology,"$103M, Series B",https://pitchbook.com/profiles/company/343417-51,No
nbe-therapeutics ag,Biotechnology,"$22M, Series C",https://ch.linkedin.com/company/nbe-therapeutics-ag,No
ngm biopharmaceuticals inc,Biotechnology,"$122M, Series A",https://www.linkedin.com/company/ngm-biopharmaceuticals,No
nanocarrier co ltd,Biotechnology,"$25.7M, Post IPO Debt",https://www.linkedin.com/company/nanocarrier-ltd-,No
nanobiotix sa,Biotechnology,"$18M, IPO",https://en.wikipedia.org/wiki/Nanobiotix,No
nantcell inc,Biotechnology,"$Not Found, Acquired",https://cdek.pharmacy.purdue.edu/org/3196/,No
nascent biotech inc,Biotechnology,"$750K, Grant",https://www.linkedin.com/company/nascent-biotech,No
navifus corp,Biotechnology,"$10M, Seed",https://is.linkedin.com/company/navifus-corporation,No
nectin therapeutics ltd,Biotechnology,"$10M, Series Unknown",https://www.crunchbase.com/organization/nectin-therapeutics,No
neotx therapeutics ltd,Biotechnology,"$45M, Series C",https://www.linkedin.com/company/neotx-therapeutics-ltd/,No
neonc technologies inc,Biotechnology,"$50M, Not Found",https://finance.yahoo.com/news/neonc-technologies-quazar-investment-set-130000126.html,No
nerviano medical sciences srl,Biotechnology,"$21M, Not Found",https://www.novaquest.com/news/nerviano-medical-sciences-srl-announces-rozlytrek-entrectinib-royalty-agreement/,No
neutec pharma ltd,Pharmaceuticals,"$569M, Acquired",https://www.neutecpharma.com/,No
nextcure inc,Biotechnology,"$2M, Post IPO Equity",https://www.linkedin.com/company/nextcure-inc,No
nikang therapeutics inc,Biotechnology,"$200M, Series C",https://www.linkedin.com/company/nikang-therapeutics-inc,No
nkarta inc,Biotechnology,"$100M, IPO",https://www.biopharmadive.com/news/nkarta-layoffs-restructuring-autoimmune-cell-therapy/743693/,No
nordic nanovector asa,Biotechnology,"$25M, Private Placement",https://www.inderes.dk/en/releases/nordic-nanovector-asa-key-information-regarding-potential-subsequent-offering,No
northern biologics inc,Biotechnology,"$45M, Series A",https://www.versantventures.com/portfolio/northern-biologics,No
nouscom ag,Biotechnology,"$7.6M, Series C",https://www.crunchbase.com/organization/nouscom,No
novarock biotherapeutics ltd,Biotechnology,"$7.5M, Not Found",https://www.prnewswire.com/news-releases/novarock-biotherapeutics-announces-exclusive-license-agreement-and-strategic-partnership-with-flame-biosciences-301363104.html,No
novelmed therapeutics inc,Biotechnology,"$20.19M, Not Found",https://www.sbir.gov/portfolio/252531,No
novimmune sa,Biotechnology,"$29.8M, Series C",https://www.linkedin.com/company/novimmune/,No
novo holdings as,Biotechnology,"$205M, Series A",https://www.linkedin.com/company/novo-a-s/,No
numab therapeutics ag,Biotechnology,"$180M, Series C",https://www.bakermckenzie.com/en/newsroom/2025/01/numab-therapeutics-in-series-c-financing-round,No
oric pharmaceuticals inc,Biotechnology,"$125M, Not Found",https://seekingalpha.com/symbol/ORIC,No
ose immunotherapeutics sa,Biotechnology,"$1.5M, Grant",https://www.linkedin.com/company/ose-immunotherapeutics/,No
ology bioservices inc,Biotechnology,"$8.4M, Grant",https://www.crunchbase.com/organization/ology-bioservices,No
omega therapeutics inc,Biotechnology,"$126M, IPO",https://www.biopharmadive.com/news/omega-therapeutics-bankruptcy-flagship-genetic-medicines/739175/,No
omeros corp,Biotechnology,"$22M, Registered Direct Offering",https://finance.yahoo.com/news/omeros-corporation-announces-pricing-22-120000222.html,No
omni active health technologies pvt ltd,Pharmaceuticals,"$10M, Series Unknown",https://www.crunchbase.com/organization/omniactive-health-technologies,No
oncusp therapeutics inc,Biotechnology,"$100M, Series A",https://www.prnewswire.com/news-releases/oncusp-therapeutics-raises-oversubscribed-100-million-series-a-financing-to-advance-portfolio-of-assets-for-cancer-patients-302026328.html,No
onkure inc,Pharmaceuticals,"$54M, Series C",https://www.colorado.edu/venturepartners/startup-portfolio/onkure-therapeutics-inc-okur,No
onkure therapeutics inc,Pharmaceuticals,"$54M, Series C",https://www.colorado.edu/venturepartners/startup-portfolio/onkure-therapeutics-inc-okur,No
oncoimmune inc,Biotechnology,"$425M, Acquired",https://www.merck.com/news/merck-to-acquire-oncoimmune/,No
onconano medicine inc,Biotechnology,"$18.4M, Series B",https://www.crunchbase.com/organization/onconano-medicine,No
oncoquest inc,Biotechnology,"$50M, Acquired",https://www.newswire.ca/news/oncoquest-inc./,No
oncoresponse inc,Biotechnology,"$27M, Not Found",https://www.prnewswire.com/news-releases/oncoresponse-awarded-13-million-in-funding-from-cprit-and-raises-14-million-in-added-funds-from-investors-to-advance-cancer-immunotherapy-301828055.html,No
oncosynergy inc,Biotechnology,"$3.3M, Series Unknown",https://www.linkedin.com/company/oncosynergy,No
oncosynergy inc (inactive),Biotechnology,"$26.7M, Series A",https://tracxn.com/d/companies/oncosynergy/__iPxgl2MRCgrHMzL1bAz4Y5V2bU5DLSn1ZKJaGKtJfCs,No
oncoverity inc (inactive),Biotechnology,"$30M, Series A",https://www.pharmaceutical-technology.com/news/oncoverity-eyes-cusatuzumab-development-in-aml-after-licensing-rights/,No
oncoinvent as,Biotechnology,"$12.9M, Rights Issue",https://www.linkedin.com/company/oncoinvent-as/,No
oncomatryx biopharma sl,Biotechnology,"$12.5M, Not Found",https://www.biospace.com/press-releases/oncomatryx-biopharma-awarded-12-5-million-eic-accelerator-funding-to-advance-groundbreaking-adcs,No
oncorus inc,Biotechnology,"$79.5M, Series B",https://www.biospace.com/employer/546432/oncorus,No
oncternal therapeutics,Biotechnology,"$86.2M, Post IPO equity","https://www.linkedin.com/company/oncternal-therapeutics#:~:text=Oncternal%20Therapeutics%20is%20a%20clinical,pathways%20implicated%20in%20cancer%20progression.",No
oncternal therapeutics inc,Biotechnology,"$86.2M, Post IPO equity",https://www.linkedin.com/company/oncternal-therapeutics,No
opsidio llc,Biotechnology,"$500K, Series Unknown",https://www.linkedin.com/company/opsidio-llc,No
opsona therapeutics ltd (inactive),Biotechnology,"$18M, Not Found",https://en.wikipedia.org/wiki/Opsona_Therapeutics,No
opthea ltd,Biotechnology,"$113.3M, Post IPO equity",https://finance.yahoo.com/quote/OPT.AX/,No
orfan-bio,Biotechnology,"$10M, Seed",https://o2h.com/ventures/orfan-biotech-a-company-dedicated-to-developing-small-molecules-for-the-treatment-of-primary-hyperoxaluria/,No
orient europharma co ltd,Pharmaceuticals,"$11.2M, Not Found",https://www.reuters.com/markets/companies/4120.TWO/,No
otsuka holdings co ltd,Pharmaceuticals,"$2.4B, IPO",https://en.wikipedia.org/wiki/Otsuka_Pharmaceutical,No
outlook therapeutics inc,Biotechnology,"$13M, Post IPO equity",https://www.linkedin.com/company/outlook-therapeutics,No
pdc line pharma sas,Biotechnology,"$13.3M, Series B",https://www.crunchbase.com/organization/pdc-line-pharma,No
pdl biopharma inc,Biotechnology,"$400M, Acquired",https://en.wikipedia.org/wiki/PDL_BioPharma,No
pibd-net,Biotechnology,"$10M, Horizon 2020",https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/pibd-net-inception-cohort-and-safety-registry/,No
palleon pharmaceuticals inc,Biotechnology,"$100M, Series B",https://www.linkedin.com/company/palleon-pharmaceuticals,No
panbela therapeutics inc,Pharmaceuticals,"$12M, Not Found",https://www.stocktitan.net/news/PBLA/,No
pancreatic cancer research team,Biotechnology,"$10M, Series A",https://www.aacr.org/professionals/research-funding/funded-research/independent-research-grants/pancreatic-cancer-collective/,No
peel therapeutics inc,Biotechnology,"$10M, Series A",https://www.linkedin.com/company/peel-therapeutics,No
pelican therapeutics inc,Biotechnology,"$15.2M, Acquired",https://ir.scorpiusbiologics.com/news-events/press-releases/detail/562/heat-biologics-announces-completion-of-acquisition-of-pelican-therapeutics,No
perseus proteomics inc,Biotechnology,"$1.3M, Series Unknown",https://www.linkedin.com/company/perseus-proteomics-inc-,No
perspective therapeutics inc,Pharmaceuticals,"$80M, Post IPO equity",https://pitchbook.com/profiles/company/41963-05,No
pharmabcine inc,Biotechnology,"$10M, Seed",https://www.nature.com/articles/d43747-020-00769-y,No
pharmaessentia corp,Biotechnology,"$462.7M, IPO",https://www.businesswire.com/news/home/20230421005053/en/PharmaEssentia-Corporation-Announces-Closing-of-Global-Depositary-Receipt-Offering-Generating-US%24462.7M-to-Support-Growth-Plans-and-Pipeline-Development,No
pharmacyclics llc,Biotechnology,"$21B, Acquired",https://en.wikipedia.org/wiki/Pharmacyclics,No
phasebio pharmaceuticals inc,Biotechnology,"$120M, Not Found",https://www.cov.com/en/news-and-insights/insights/2023/01/phasebio-a-drug-development-financing-almost-tested-in-bankruptcy,No
pheast therapeutics inc,Biotechnology,"$76M, Series A",https://www.crunchbase.com/organization/pheast-therapeutics,No
pheon therapeutics inc,Biotechnology,"$120M, Series B",https://www.crunchbase.com/organization/pheon-therapeutics,No
philogen spa,Biotechnology,"$69.5M, Series Unknown",https://cy.linkedin.com/company/philogen?trk=ppro_cprof,No
pieris pharmaceuticals inc,Biotechnology,"$5M, Post IPO equity",https://www.linkedin.com/company/pieris-pharma,No
pionyr immunotherapeutics inc,Biotechnology,"$78M, Series D",https://www.gilead.com/news/news-details/2020/gilead-sciences-secures-exclusive-option-to-acquire-pionyr-immunotherapeutics,No
pliant therapeutics inc,Biotechnology,"$287.5M, IPO",https://www.crunchbase.com/organization/pliant-therapeutics,No
poltreg sa,Biotechnology,"$1.7M, Not Found",https://synapse.patsnap.com/organization/a96ddad8f30fa9bd5fc967f4537a5531,No
portage biotech inc,Biotechnology,"$38.2M, Post IPO equity",https://www.linkedin.com/company/portage-biotech-inc,No
precirix nv,Biotechnology,"$117M, Series B",https://www.biopharmadive.com,No
profoundbio us co,Biotechnology,"$112M, Series B",https://www.prnewswire.com/news-releases/profoundbio-raises-112-million-in-oversubscribed-series-b-equity-financing-to-advance-its-clinical-stage-antibody-drug-conjugate-adc-pipeline-302060191.html,No
prometheus biosciences inc,Biotechnology,"$10.8B, Acquired",https://www.merck.com/news/merck-completes-acquisition-of-prometheus-biosciences-inc/,No
prothena corp plc,Biotechnology,"$172.4M, Post IPO equity",https://www.linkedin.com/company/prothena_biosciences_inc,No
provectus biopharmaceuticals inc,Biotechnology,"$10M, Seed",https://finance.yahoo.com/quote/PVCT/,No
provention bio inc,Biotechnology,"$2.9B, Acquired",https://www.sanofi.com/en/media-room/press-releases/2023/2023-03-13-06-00-00-2625367,No
psioxus therapeutics ltd,Biotechnology,"$60M, Series A",https://www.linkedin.com/company/akamisbio,No
puma biotechnology inc,Biotechnology,"$10M, Post IPO equity",https://www.linkedin.com/company/puma-biotechnology-ltd,No
pure biologics sa,Biotechnology,"$1.06M, Not Found",https://www.linkedin.com/company/pure-biologics/,No
purinomia biotech inc,Biotechnology,"$7.83M, Seed",https://tracxn.com/d/companies/purinomia-biotech/__2qLjYKDu8BEUuFdZ6WGTByXgw__O8nF_kja7D4CRWGo,No
purple biotech ltd,Biotechnology,"$18M, IPO",https://finance.yahoo.com/news/purple-biotech-announces-closing-18-200000564.html,No
pyxis oncology inc,Biotechnology,"$50M, Post IPO equity",https://www.linkedin.com/company/pyxis-oncology,No
quanta therapeutics inc,Biotechnology,"$50.7M, Series D",https://www.crunchbase.com/organization/quanta-therapeutics,No
qurebio ltd,Biotechnology,"$14M, Series C1",https://www.prnewswire.com/news-releases/qurebio-ltd-completes-nearly-cny-100-million-series-c1-financing-led-by-efung-capital-accelerating-clinical-progress-in-global-competition-for-core-pipelines-302473108.html,No
qurient co ltd,Biotechnology,"$7.2M, Post IPO Equity",https://kr.linkedin.com/company/quro-science-inc.,No
r-pharm,Pharmaceuticals,"$200M, Not Found",https://en.wikipedia.org/wiki/R-Pharm,No
rapt therapeutics inc,Biotechnology,"$150M, Post IPO equity",https://www.linkedin.com/company/rapt,No
radiopharm theranostics ltd,Biotechnology,"$5M, Post IPO equity",https://au.linkedin.com/company/radiopharm-theranostics,No
rallybio corp,Biotechnology,"$25M, Not Found",https://www.stocktitan.net/news/RLYB/,No
rani therapeutics llc,Biotechnology,"$3M, Post IPO Equity",https://www.crunchbase.com/organization/rani-therapeutics,No
rayzebio inc,Biotechnology,"$160M, Series D",https://www.linkedin.com/company/rayzebio,No
redx pharma limited,Biotechnology,"$43.6M, Post IPO equity",https://uk.linkedin.com/company/redx-pharma,No
redx pharma plc,Biotechnology,"$43.6M, Post IPO equity",https://uk.linkedin.com/company/redx-pharma,No
remegen co ltd,Biotechnology,"$2.6B, Not Found",https://www.remegen.com/,No
repertoire genesis inc,Biotechnology,"$7.4M, Corporate Round",https://www.linkedin.com/company/repertoire-genesis-%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE,No
replimune ltd,Biotechnology,"$55M, Series B",https://www.foresitecapital.com/portfolio/replimune-group/,No
revolution medicines inc,Biotechnology,"$238M, IPO",https://www.biospace.com/employer/401009/revolution-medicines,No
rezolute inc,Biotechnology,"$96.9M, Post IPO equity",https://www.linkedin.com/company/rezolute,No
ribon therapeutics inc,Biotechnology,"$65M, Series Unknown",https://www.biospace.com/business/big-pharma-backed-ribon-therapeutics-shuts-down-business-operations,No
rimo therapeutics inc,Biotechnology,"Undisclosed, Angel",https://tracxn.com/d/companies/rimo-therapeutics/__T37D__ple0Vg3gj-HQ5np-2U2gOXlSFnzR4OBk75PkI,No
rin institute inc,Biotechnology,"$1.93M, Seed",https://tracxn.com/d/companies/rin-institute/__q0FDM8NQojBvBmePGdZT8JJV7AxPYP7FdA-3wk1F5oA,No
river vision development corp (inactive),Biotechnology,"$145M, Acquired",https://www.fiercebiotech.com/biotech/horizon-pharma-145m-river-vision-buy-and-its-fast-tracked-eye-med,No
rocky mountain ms research group llc,Biotechnology,"$2M, Not Found",Not Found,No
rznomics inc,Biotechnology,"$60.9M, Series A, Series B, Series C",https://kr.linkedin.com/company/rznomics,No
sab bio,Biotechnology,"$175M, Post IPO equity",https://www.linkedin.com/company/sab-biotherapeutics,No
sellas life sciences group inc,Biotechnology,"$23.6M, Not Found",https://sellaslifesciences.com/,No
sfj pharmaceuticals inc,Pharmaceuticals,"$30M, Series Unknown",https://www.linkedin.com/company/sfj-pharmaceuticals-inc.,No
sl vaxigen inc,Biotechnology,"$10M, Unattributed VC",https://www.cbinsights.com/company/sl-vaxigen,No
sotio biotech as,Biotechnology,"$280M, Not Found",https://www.ppf.eu/en/our-companies/sotio,No
sqz biotechnologies co,Biotechnology,"$71M, IPO",https://www.lifescienceleader.com/doc/where-are-they-now-sqz-biotech-0001,No
sqz biotechnologies co (inactive),Biotechnology,"$71M, IPO",https://www.lifescienceleader.com/doc/where-are-they-now-sqz-biotech-0001,No
synimmune gmbh,Biotechnology,"$6.4M, Not Found",https://tracxn.com/d/companies/synimmune/__9b-nLHxhfGJFiezVvIEI0v_KqkxSBY2G35MPawW-eb4,No
Synimmune GmbH (inactive),Biotechnology,"€6.4M, Grants",https://tracxn.com/d/companies/synimmune/__9b-nLHxhfGJFiezVvIEI0v_KqkxSBY2G35MPawW-eb4,No
sairopa bv,Biotechnology,"$35M, Not Found",https://www.biospace.com/press-releases/sairopa-reports-research-milestones-achieved-in-partnership-with-exelixis-totalling-35-million-from-consecutive-clinical-milestone-payments-in-2024,No
salubris biotherapeutics inc,Biotechnology,"$35M, Not Found",https://www.biospace.com/salubris-biotherapeutics-announces-35-million-in-financing-and-provides-pipeline-progress-update,No
samsung biologics co ltd,Biotechnology,"$1.2B, Not Found",https://en.wikipedia.org/wiki/Samsung_Biologics,No
sapience therapeutics inc,Biotechnology,"$41M, Series B",https://www.prnewswire.com/news-releases/sapience-therapeutics-announces-41-million-series-b-financing-to-advance-pipeline-of-peptide-therapeutics-targeting-protein-protein-interactions-301557720.html,No
scancell holdings plc,Biotechnology,"$14.4M, Post IPO equity",https://uk.linkedin.com/company/scancell-limited,No
scirhom gmbh,Biotechnology,"$68M, Series A",https://www.bio-m.org/en/news/news-detail/scirhom-secures-eur-63-million-in-series-a-financing-round-for-antibody-therapy-against-autoimmune-d.html,No
seagen inc,Biotechnology,"$1.0B, Post IPO equity",https://www.linkedin.com/company/seagen,No
secura bio inc,Pharmaceuticals,"$90M, Debt financing",https://www.linkedin.com/company/securabio,No
selecxine inc,Biotechnology,"$27M, Series B",http://www.selecxine.com/eng/about.php,No
sensei biotherapeutics inc,Biotechnology,"$30M, Series B",https://pitchbook.com/profiles/company/149156-20,No
seven and eight biopharmaceuticals corp,Biotechnology,"$106M, Series C",https://tracxn.com/d/companies/seven-and-eight-biopharmaceuticals/__a9OdNFmns11m73ysl4o38Wi72R0vJYtfttFaZEm13YU,No
shanghai allink biotherapeutics co ltd,Biotechnology,"$42M, Series A",https://www.prnewswire.com/news-releases/allink-biotherapeutics-raises-42m-series-a-financing-to-accelerate-global-development-of-bispecific-antibody-and-adc-pipeline-302318081.html,No
shanghai allist pharmaceuticals co ltd,Pharmaceuticals,"$240M, IPO",https://www.allist.com.cn/en/aboutus.html,No
shanghai bao pharmaceuticals co ltd,Biotechnology,"$213M, IPO",https://synapse.patsnap.com/organization/fa4ea06b77a79bf57b972d289c2c21cd,No
shanghai biotroy biotechnology co ltd,Biotechnology,"$21M, Series A+",https://www.biotroy.com/News-m.html?article_id=97,No
shanghai haihe biopharma co ltd,Biotechnology,"$136.6M, Series A",https://www.haihepharma.com/en,No
shanghai hansoh biomedical co ltd,Pharmaceuticals,"$1.01B, IPO",https://en.wikipedia.org/wiki/Hansoh_Pharmaceutical,No
shanghai jiatan pharmaceutical technology co ltd,Pharmaceuticals,"$145,000, Seed",https://www.marketscreener.com/quote/stock/CISEN-PHARMACEUTICAL-CO-L-42613318/news/Cisen-Pharmaceutical-Co-Ltd-acquired-1-stake-in-Shanghai-Jiatan-Pharmaceutical-Technology-Co-L-34743155/,No
shanghai kangabio co ltd,Biotechnology,"$13.82M, Seed",https://www.cbinsights.com/company/kangabio,No
shanghai mabgeek biotechnology co ltd,Biotechnology,"$10M, IPO",https://www.mabge.com/en/,No
"shanghai mabgeek biotechnology co., ltd",Biotechnology,"$10M, IPO",https://www.mabge.com/en/,No
shanghai meiji biotechnology co ltd,Biotechnology,"$10M, IPO",https://www.mabge.com/en/,No
shanghai novamab biopharmaceuticals co ltd,Biotechnology,"$24.4M, Series B",https://www.crunchbase.com/organization/novamab,No
shanghai united cell biotechnology co ltd,Biotechnology,"$61.15M, Not Found",https://www.echemi.com/drugs-manufacturer/ep2505161617.html,No
shanghai xinshi biological medicine co ltd,Biotechnology,"$Not Found, Not Found",Not Found,No
shenzhen oculgen biomedical technology co ltd,Biotechnology,"$20M, Series A",https://www.linkedin.com/posts/jack-chen-2104204a_shenzhen-oculgen-biomedical-technology-co-activity-7268659467674619904-1HlL,No
shionogi & co ltd,Pharmaceuticals,"$375M, Grant",https://www.linkedin.com/company/shionogi-&-co.-ltd/,No
sichuan baili pharmaceutical co ltd,Pharmaceuticals,"$132M, IPO",https://systimmune.com/news-biokin,No
sichuan biokin pharmaceutical co ltd,Pharmaceuticals,"$132M, IPO",https://systimmune.com/news-biokin,No
sichuan huiyu pharmaceutical co ltd,Pharmaceuticals,"$1.5M, Series A",https://www.linkedin.com/company/sichuan-huiyu-pharmaceutical-company,No
sichuan kelun biotech biopharmaceutical co ltd,Biotechnology,"$250M, Not Found",https://www.prnewswire.com/news-releases/kelun-biotech-announces-approximately-us250-million-placement-302475045.html,No
sichuan kelun botai biomedical co ltd,Biotechnology,"$200M, Series B",https://www.globaldata.com/company-profile/sichuan-kelun-pharmaceutical-co-ltd/deals/,No
signalrx pharmaceuticals inc,Pharmaceuticals,"$250K, Seed",https://tracxn.com/d/companies/signalrx-pharmaceuticals/__GOdH1wUipa6B4X0JKcKIBJ0ddWOpsZ8v6z2vAVea2o4,No
sihuan pharmaceutical holdings group ltd,Pharmaceuticals,"$10M, Not Found",Not Found,No
sillajen biotherapeutics,Biotechnology,"$12M, Series Unknown",https://www.crunchbase.com/organization/sillajen,No
silverback therapeutics inc,Biotechnology,"$126M, IPO",https://www.marketbeat.com/stocks/NASDAQ/SBTX/,No
spectrum pharmaceuticals inc,Pharmaceuticals,"$30M, Post IPO Debt",https://www.linkedin.com/company/spectrum-pharmaceuticals,No
spikimm sas,Biotechnology,"$15M, Not Found",https://www.pasteur.fr/en/spikimm-receives-major-funding-accelerate-clinical-and-industrial-development-its-monoclonal,No
spyre therapeutics inc,Biotechnology,"$200M, Post IPO equity",https://www.linkedin.com/company/spyre-therapeutics,No
starpharma holdings ltd,Biotechnology,"$5.5M, Collaboration Agreement",https://au.linkedin.com/company/starpharma,No
staten biotechnology bv,Biotechnology,"$430M, Series A",https://european-biotechnology.com/latest-news/staten-biotechnology-in-430m-deal-with-novo-nordisk/,No
storm therapeutics ltd,Biotechnology,"$42M, Series B",https://pitchbook.com/profiles/company/160539-58,No
surface oncology inc,Biotechnology,Acquired,https://www.bigmoleculewatch.com/2023/06/22/coherus-to-acquire-surface-oncology/,No
sutro biopharma inc,Biotechnology,"$170M, Not Found",https://en.wikipedia.org/wiki/Sutro_Biopharma,No
suzhou connect biopharmaceuticals ltd,Biotechnology,"$267.7M, IPO",https://www.globenewswire.com/news-release/2023/04/11/2644919/0/en/Connect-Biopharma-Reports-Full-Year-2022-Financial-Results-and-Provides-Business-Update.html,No
suzhou corning jerry biotechnology co ltd,Biotechnology,"$422M, Not Found",https://en.gcbiotek.com/news_1/1840685565374570496.html,No
suzhou medilink therapeutics ltd,Biotechnology,"$50M, Not Found",https://www.prnewswire.com/news-releases/medilink-therapeutics-announces-worldwide-collaboration-and-license-agreement-with-roche-to-develop-next-generation-antibody-drug-conjugate-in-oncology-302024162.html,No
suzhou xinkanghe biomedical technology co ltd,Biotechnology,"$50M, Series B+",http://en.kanovabiopharma.com/,No
synlogic inc,Biotechnology,"$21M, Post IPO Equity",https://www.linkedin.com/company/synlogic-therapeutics,No
synthorx inc,Biotechnology,"$2.5B, Acquired",https://www.sanofi.com/en/media-room/press-releases/2020/2020-01-23-13-52-33-1974331,No
t3 pharmaceuticals ag,Biotechnology,"$450M, Acquired",https://baselarea.swiss/blog-post/boehringer-ingelheim-acquires-t3-pharma/,No
t7 therapeutics inc,Biotechnology,"$25M, Seed",https://www.bioworld.com/articles/694125-tvm-invests-25m-in-new-ige-directed-antibody-allergy-play,No
tilt biotherapeutics ltd,Biotechnology,"$25.6M, Series B",https://www.globenewswire.com/news-release/2025/05/13/3079780/0/en/TILT-Biotherapeutics-Announces-Closing-of-USD-25-Million-Series-B-Financing.html,No
tagworks pharmaceuticals bv,Pharmaceuticals,"$65M, Series A",https://www.prnewswire.com/news-releases/tagworks-pharmaceuticals-announces-65-million-in-series-a-financing-to-advance-click-to-release-therapeutics-301857548.html,No
tallac therapeutics inc,Biotechnology,"$5M, Debt Financing",https://www.crunchbase.com/organization/tallac-therapeutics,No
tango therapeutics inc,Biotechnology,"$55M, Series A",https://www.linkedin.com/company/tango-therapeutics,No
tasly biopharmaceuticals co ltd,Biotechnology,"$40M, Not Found",https://www.sutrobio.com/sutro-biopharma-and-tasly-biopharmaceuticals-enter-into-exclusive-license-agreement-for-stro-002-in-greater-china/,No
tavotek biotherapeutics,Biotechnology,"$35M, Series B",https://www.crunchbase.com/organization/tavotek-biotherapeutics,No
teclison ltd,Biotechnology,"$5.9M, Not Found",https://www.biospace.com/teclison-completes-5-9-million-capital-raise,No
tempest therapeutics inc,Biotechnology,"$4.6M, Post IPO equity",https://www.nasdaq.com/articles/tempest-therapeutics-inc-announces-46-million-registered-direct-offering-common-stock,No
tesaro inc,Pharmaceuticals,"$5.1B, Acquired",https://www.gsk.com/en-gb/investors/corporate-actions/agreement-to-acquire-tesaro/,No
tessa therapeutics ltd,Biotechnology,"$74.2K, Grant",https://www.crunchbase.com/organization/tessa-therapeutics,No
the lundquist institute,Biotechnology,"$90M, Not Found",https://ctsi.ucla.edu/lundquist-institute-for-biomedical-innovation-at-harbor,No
the walter and eliza hall institute of medical research,Biotechnology,"$500K, Grant",https://au.linkedin.com/company/wehi_research,No
theras inc,Biotechnology,"$200M, Not Found",https://www.biopharmadive.com/news/bridge-bio-oncology-launch-kras-cancer-drug-theras/714885/,No
theratechnologies inc,Biotechnology,"$75M, Post IPO Debt",https://ca.linkedin.com/company/theratechnologies-inc,No
therini bio inc,Biotechnology,"$75M, Series A",https://www.globenewswire.com/news-release/2025/05/14/3081286/0/en/Therini-Bio-Raises-Additional-39M-Series-A-Financing-to-Advance-Clinical-Development-of-Neurodegenerative-Disease-Pipeline.html,No
third arc bio inc,Biotechnology,"$165M, Series A",https://www.prnewswire.com/news-releases/third-arc-bio-launches-with-oversubscribed-165-million-series-a-financing-to-deliver-superior-biologics-for-solid-tumors-and-inflammatory--immunology-ii-diseases-302201952.html,No
thor medical asa,Biotechnology,"$8.5M, Private Placement",https://no.linkedin.com/company/thor-medical-asa,No
tiumbio co ltd,Biotechnology,"$15.4M, Post IPO equity",https://www.crunchbase.com/organization/tiumbio,No
tizona therapeutics inc,Biotechnology,"$300M, Corporate Round",https://www.gilead.com/news/news-details/2020/gilead-sciences-secures-exclusive-option-to-acquire-tizona-therapeutics-for-300-million,No
tonghua dongbao pharmaceutical co ltd,Pharmaceuticals,"$14.6M, Strategic Investment",http://www.thdb.com/en,No
toragen inc,Biotechnology,"$12M, Convertible Note Financing",https://finance.yahoo.com/news/toragen-inc-announces-12-million-232000640.html,No
toscana life sciences foundation,Biotechnology,"$415M, Not Found",https://www.toscanalifesciences.org/en/,No
transcenta holding ltd,Biotechnology,"$Not Found, Not Found",Not Found,No
treadwell therapeutics inc,Biotechnology,"$91M, Series B",https://www.crunchbase.com/organization/treadwell-therapeutics,No
trellis bioscience llc (inactive),Biotechnology,"$3.2M, Seed",https://carb-x.org/carb-x-news/carb-x-funds-trellis-bioscience-to-support-the-development-of-a-monoclonal-antibody-designed-to-strip-off-superbugs-protective-coating-so-that-antibiotics-can-kill-them/,No
tubulis gmbh,Biotechnology,"$139.3M, Series B",https://www.crunchbase.com/organization/tubulis-technologies,No
turning point therapeutics inc,Biotechnology,"$460M, IPO",https://www.linkedin.com/company/tp-therapeutics,No
turnstone biologics inc,Biotechnology,"$80M, Series D",https://www.linkedin.com/company/turnstone-biologics,No
tvardi therapeutics inc,Biotechnology,"$72.4M, Series B",https://www.linkedin.com/company/tvardi,No
tvardi therapeutics inc.,Biotechnology,"$72.4M, Series B",https://www.linkedin.com/company/tvardi,No
ultimovacs as,Biotechnology,"$32.3M, Post IPO equity",https://www.linkedin.com/company/ultimovacs-as/,No
ultimovacs asa,Biotechnology,"$32.3M, Post IPO equity",https://www.linkedin.com/company/ultimovacs-as/,No
uniquity bio inc,Biotechnology,"$300M, Series A",https://www.blackstone.com/news/press/blackstone-life-sciences-launches-uniquity-bio-to-develop-novel-medicines-in-immunology-inflammation/,No
upstream bio inc,Biotechnology,"$200M, Series B",https://www.linkedin.com/company/upstreambio,No
urogen pharma ltd,Biotechnology,"$107.5M, Post IPO equity",https://www.linkedin.com/company/urogenpharma,No
vaccitech plc,Biotechnology,"$168M, IPO",https://en.wikipedia.org/wiki/Barinthus_Biotherapeutics,No
valo therapeutics oy,Biotechnology,"$20.6M, Series Unknown",https://pitchbook.com/profiles/company/231324-94,No
vedanta biosciences inc,Biotechnology,"$106.5M, Series D",https://puretechhealth.com/programs/details/vedanta,No
vega therapeutics inc,Biotechnology,"$40M, Not Found",https://star-therapeutics.com/vega-therapeutics-launches-and-unveils-its-first-in-class-antibody-therapy-for-von-willebrand-disease-at-ash-annual-meeting/,No
velosbio inc,Biotechnology,"$137M, Series B",https://www.businesswire.com/news/home/20200708005049/en/VelosBio-Raises-%24137-Million-in-Series-B-Financing-to-Advance-Development-of-ROR1-Directed-Therapeutics-in-Oncology,No
veloxis pharmaceuticals as,Pharmaceuticals,"$60M, Post IPO Debt",https://www.linkedin.com/company/veloxis-pharmaceuticals,No
veloxis pharmaceuticals inc,Pharmaceuticals,"$60M, Post IPO Debt",https://www.linkedin.com/company/veloxis-pharmaceuticals,No
verastem inc,Biotechnology,"$16M, Series A",https://en.wikipedia.org/wiki/Verastem_Oncology,No
viela bio inc,Biotechnology,"$169M, IPO",https://www.linkedin.com/company/viela-bio,No
vifor pharma ag,Pharmaceuticals,"$11.7B, Acquired",https://en.wikipedia.org/wiki/CSL_Vifor,No
vigil neuroscience inc,Biotechnology,"$40M, Post IPO Equity",https://www.linkedin.com/company/vigil-neuroscience,No
vir biotechnology inc,Biotechnology,"$50M, Grant",https://www.linkedin.com/company/vir-biotechnology-inc.,No
viralytics pty ltd,Biotechnology,"$394M, Acquired",https://www.merck.com/news/merck-and-viralytics-announce-acquisition-agreement-expanding-mercks-leading-immuno-oncology-pipeline/,No
viralytics pty ltd (inactive),Biotechnology,"$394M, Acquired",https://www.merck.com/news/merck-and-viralytics-announce-acquisition-agreement-expanding-mercks-leading-immuno-oncology-pipeline/,No
viridian therapeutics inc,Biotechnology,"$225M, Post IPO equity",https://www.linkedin.com/company/viridiantx,No
virogin biotech ltd,Biotechnology,"$120M, Series D",https://ca.linkedin.com/company/viroginbiotech,No
vitaeris inc,Biotechnology,"$15M, Acquired",https://www.biospace.com/csl-behring-buys-vitaeris-picks-up-transplant-rejection-therapeutic,No
vivace therapeutics inc,Biotechnology,"$35M, Series D",https://www.prnewswire.com/news-releases/vivace-therapeutics-raises-35-million-in-series-d-financing-to-support-clinical-development-of-first-in-class-cancer-drug-targeting-the-hippo-pathway-302397707.html,No
vividion therapeutics inc,Biotechnology,"$135M, Series C",https://www.crunchbase.com/organization/vividion-therapeutics,No
vyriad inc,Biotechnology,"$29.5M, Series B",https://www.crunchbase.com/organization/vyriad,No
walden biosciences inc,Biotechnology,"$51M, Series B",https://www.linkedin.com/company/waldenbiosciences,No
wellmarker bio co ltd,Biotechnology,"$11.8M, Series C",https://www.linkedin.com/company/wellmarkerbio/,No
x4 pharmaceuticals inc,Biotechnology,"$85M, Post IPO equity",https://www.linkedin.com/company/x4-pharmaceuticals,No
xbiotech inc,Biotechnology,"$750M, Acquired",https://en.wikipedia.org/wiki/XBiotech,No
xoma corp,Biotechnology,"$140M, Non-Dilutive Financing",https://xoma.com/,No
xbrane biopharma ab,Biotechnology,"$22M, IPO",https://xbrane.com/en/,No
xencor inc,Biotechnology,"$110.5M, IPO",https://www.globaldata.com/company-profile/xencor-inc/,No
xilio therapeutics inc,Biotechnology,"$50M, Post IPO equity",https://www.linkedin.com/company/xilio-tx,No
xuanzhu biopharmaceutical ltd,Pharmaceuticals,"$11.60M, IPO",https://www.bloomberg.com/quote/2593041D:HK,No
xynomic pharmaceuticals holdings inc,Pharmaceuticals,"$10M, Series B",https://www.linkedin.com/company/xynomic-pharma,No
y-mabs therapeutics inc,Biotechnology,"$115M, Post IPO equity",https://www.linkedin.com/company/y-mabs-therapeutics-inc-,No
zai lab ltd,Biotechnology,"$230M, Post IPO equity",https://www.linkedin.com/company/zai-lab,No
zelluna asa,Biotechnology,"$5M, Private Placement",https://www.euronext.com/en/about/media/euronext-press-releases/zelluna-lists-euronext,No
zenas biopharma (usa) llc,Biotechnology,"$300M, Post IPO equity",https://www.linkedin.com/company/zenas-biopharma,No
zenas biopharma inc,Biotechnology,"$120M, Post IPO equity",https://finance.yahoo.com/news/zenas-biopharma-zbio-32-5-161631854.html,No
zentalis pharmaceuticals inc,Biotechnology,"$235.5M, Post IPO equity",https://www.linkedin.com/company/zentalis-pharmaceuticals,No
zentera therapeutics inc,Biotechnology,"$75M, Series B",https://www.globenewswire.com/news-release/2021/08/02/2272699/0/en/Zentera-Therapeutics-Announces-Closing-of-75-Million-Series-B-Financing.html,No
zhejiang borui biopharmaceutical co ltd,Biotechnology,"$77.1M, Equity Offering",https://www.globaldata.com/company-profile/zhejiang-hisun-pharmaceutical-co-ltd/deals/,No
zhejiang xinkanghe biomedical technology co ltd,Biotechnology,"$10M, Series A",http://en.kanovabiopharma.com/,No
zion pharma co ltd,Biotechnology,"$70M, Acquired",https://www.pharmaceutical-technology.com/news/roche-zion-pharmas-zn-a-1041/,No
zumutor biologics inc,Biotechnology,"$6.2M, Series A",https://www.linkedin.com/company/zumutor,No
zura bio ltd,Biotechnology,"$112.5M, IPO",https://www.stocktitan.net/news/ZURA/,No
zymeworks inc,Biotechnology,"$59M, IPO",https://en.wikipedia.org/wiki/Zymeworks,No
effector therapeutics inc,Biotechnology,"$325M, IPO",https://www.sfgate.com/tech/article/effector-therapeutics-biotech-shut-down-19539918.php,No
iomx therapeutics ag,Biotechnology,"$75.37M, Series B",https://de.linkedin.com/company/iomx-therapeutics,No
ionctura sa,Biotechnology,"$80M, Series B",https://www.cancerresearchhorizons.com/news-and-events/our-news/ionctura-announces-eu80m-series-b-financing-progress-pipeline-through,No
iteos therapeutics inc,Biotechnology,"$120M, Post IPO equity","https://www.linkedin.com/company/iteos-therapeutics-sa#:~:text=iTeos%20Therapeutics%20is%20a%20clinical,immuno%2Doncology%20therapeutics%20for%20patients.",No
iteos therapeutics sa,Biotechnology,"$156.5M, Not Found",https://www.biopharmadive.com/news/iteos-operations-wind-down-biotech-shareholders/749137/,No
anrs research center,Biotechnology,"$51M, Not Found",https://www.glopid-r.org/members/institut-national-de-la-sante-et-de-la-recherche-medicale-inserm/,No
artus therapeutics inc,Pharmaceuticals,"$501K, Grant",https://tracxn.com/d/companies/artus-therapeutics/__b4LNkelDTcfWjJJK-BZciCU045k1EE1AltNvwnpUi_s,No
cr2o bv,Pharmaceuticals,"$25.9M, Not Found",https://www.cr2o.nl/,No
cansino biologics inc,Biotechnology,"$750M, IPO",https://en.wikipedia.org/wiki/CanSino_Biologics,No
canadian immunization research network,Biotechnology,"$15M, Not Found",https://research.mcmaster.ca/funding/cihr-canadian-immunization-research-network-cirn/,No
curevac nv,Biotechnology,"$213M, IPO",https://en.wikipedia.org/wiki/CureVac,No
geovax labs inc,Biotechnology,"$12.8M, IPO",https://en.wikipedia.org/wiki/GeoVax,No
hdt bio corp,Biotechnology,"$1M, Grant",https://www.crunchbase.com/organization/hdt-bio,No
institut pasteur de tunis,Biotechnology,"$596,970, Not Found",https://www.gatesfoundation.org/about/committed-grants/2023/08/inv-059607,No
lemonex inc,Biotechnology,"$4.6M, Not Found",https://cepi.net/cepi-partners-lemonex-advance-mrna-vaccine-delivery-against-future-pandemic-threats,No
neovac ltd,Biotechnology,"$1.49M, Seed",https://www.cbinsights.com/company/neovac,No
novavax inc,Biotechnology,"$1.6B, Operation Warp Speed",https://en.wikipedia.org/wiki/Novavax,No
pt bio farma,Pharmaceuticals,"$45.76M, Not Found",https://www.gatesfoundation.org/about/committed-grants/2020/02/inv004075,No
pharmajet inc,Biotechnology,"$10M, Corporate round",https://www.linkedin.com/company/pharmajet-inc,No
providence therapeutics inc,Biotechnology,"$2.1M, Grant",https://www.crunchbase.com/organization/providence-therapeutics,No
rvac medicines pte ltd,Biotechnology,"$140M, Series B",https://www.linkedin.com/company/rvac-medicines,No
recovac consortium,Biotechnology,"$10M, Not Found",https://www.pandemicpact.org/grants/P29519,No
replicate bioscience inc,Biotechnology,"$40M, Series A",https://www.crunchbase.com/organization/replicate-bioscience,No
shanghai rnacure biopharma co ltd,Biotechnology,"$10M, Series A",https://www.cbinsights.com/company/rnacure,No
vaxart inc,Biotechnology,"$40M, Post IPO equity",https://www.linkedin.com/company/vaxart,No
adarx pharmaceuticals inc,Biotechnology,"$200M, Series C",https://www.baincapital.com/news/adarx-pharmaceuticals-leader-next-generation-rna-therapeutics-announces-oversubscribed-200,No
arthex biotech sl,Biotechnology,"$87M, Series B",https://es.linkedin.com/company/arthex-pharma,No
achieve life sciences inc,Biotechnology,"$45M, Post IPO equity",https://www.linkedin.com/company/achieve-life-sciences,No
agios pharmaceuticals inc,Pharmaceuticals,"$250M, IPO",https://en.wikipedia.org/wiki/Agios_Pharmaceuticals,No
akcea therapeutics inc,Biotechnology,"$175M, Acquired",https://www.prnewswire.com/news-releases/ionis-pharmaceuticals-completes-acquisition-of-akcea-therapeutics-301150205.html,No
aldena therapeutics inc,Biotechnology,"$30M, Series B",https://tracxn.com/d/companies/aldena-therapeutics/__twfqDsLf6lyCVrSZ5iRZqpTw1bbRUJItC50X0TsDKKY,No
aligos therapeutics inc,Biotechnology,"$105M, Post IPO equity",https://be.linkedin.com/company/aligos-therapeutics,No
amylyx pharmaceuticals inc,Pharmaceuticals,"$175M, IPO",https://finance.yahoo.com/quote/AMLX/,No
antios therapeutics inc,Biotechnology,"$75M, Series B",https://www.crunchbase.com/organization/antios-therapeutics,No
arnatar therapeutics inc,Biotechnology,"$52M, Series A",https://globalgenes.org/raredaily/arnatar-therapeutics-emerges-from-stealth-with-52-million-and-an-rpdd-for-alagille-syndrome-therapy/,No
aro biotherapeutics co,Biotechnology,"$415M, Series B",https://jnjinnovation.com/news/press-releases/aro-biotherapeutics-secures-415m-series-b-financing,No
arrowhead pharmaceuticals inc,Biotechnology,"$200M, Collaboration Agreement",https://finance.yahoo.com/quote/ARWR/,No
assembly biosciences inc,Biotechnology,"$175M, Post IPO equity",https://www.biospace.com/press-releases/assembly-biosciences-announces-pricing-of-175-million-in-equity-financings,No
ausper biopharma co ltd,Biotechnology,"$50M, Series B+",https://www.prnewswire.com/news-releases/ausperbio-raises-50-million-in-series-b-to-advance-functional-cure-for-chronic-hepatitis-b-302467345.html,No
basking biosciences inc,Biotechnology,"$55M, Series A",https://oied.osu.edu/basking-biosciences-announces-close-55-million-financing-accelerate-clinical-development-first,No
camp4 therapeutics corp,Biotechnology,"$100M, Private Placement",https://www.linkedin.com/company/camp4-therapeutics,No
cardior pharmaceuticals gmbh,Pharmaceuticals,"$75.3M, Series B",https://www.crunchbase.com/organization/cardior-pharmaceuticals,No
causeway therapeutics ltd,Biotechnology,"$10.5M, Series Unknown",https://www.crunchbase.com/organization/causeway-therapeutics,No
codiak biosciences inc,Biotechnology,"$20M, IPO",https://www.biospace.com/employer/1935177/codiak-biosciences#:~:text=Codiak%20Biosciences%20filed%20for%20bankruptcy%20in%202023.,No
dicerna pharmaceuticals inc,Biotechnology,"$200M, Post IPO Equity",https://www.linkedin.com/company/dicerna-pharmaceuticals-inc.,No
dynacure sas,Biotechnology,"$5M, Seed",https://www.biopharmadive.com/news/dynacure-secures-rights-to-ionis-rare-disease-drug/510600/,No
entrada therapeutics inc,Biotechnology,"$100M, Post IPO Equity",https://www.linkedin.com/company/entradatx,No
glaukos corp,Pharmaceuticals,"$30M, Series F",https://www.linkedin.com/company/glaukos-corporation,No
hybridon inc,Biotechnology,"$15M, Acquired",https://www.pharmaceuticalonline.com/doc/avecia-acquires-hybridons-dna-manufacturing-b-0002,No
index pharmaceuticals holding ab,Pharmaceuticals,"$48M, Not Found",Not Found,No
interna technologies bv,Biotechnology,"$10.25M, Not Found",https://interna.bio/,No
ionis pharmaceuticals inc,Biotechnology,"$5M, Seed",https://en.wikipedia.org/wiki/Ionis_Pharmaceuticals,No
lipigon pharmaceuticals ab,Pharmaceuticals,"$91M, Not Found",https://www.ubi.se/case/stefan-nilsson-lipigon-ab/,No
pyc therapeutics ltd,Biotechnology,"$26.3M, Post IPO equity",https://au.linkedin.com/company/pyc-tx,No
phio pharmaceuticals corp,Biotechnology,"$9.2M, Post IPO equity",https://www.linkedin.com/company/phio-pharmaceuticals-corp,No
phoenicis therapeutics inc,Biotechnology,"$2.99M, Grant",https://tracxn.com/d/companies/phoenicis/__NGlqPWDN-KpVtkniBepTsmPfS-pmdQfUmfY53Hzu6c0,No
praxis precision medicines inc,Biotechnology,"$200M, Post IPO equity",https://www.linkedin.com/company/praxis-precision-medicines-inc,No
proqr therapeutics nv,Biotechnology,"$75M, Post IPO equity",https://www.linkedin.com/company/proqr-therapeutics,No
pulmotect inc,Biotechnology,"$5.9M, Series C",https://ktla.com/business/press-releases/ein-presswire/744190129/pulmotect-raises-5-9m-series-c-round-led-by-fannin-partners,No
quark pharmaceuticals inc,Pharmaceuticals,"$37M, Series E",https://tracxn.com/d/companies/quark-pharmaceuticals/__eii6Lk-FEx9MpoqM-cCIk1lrT_lG4-jI15NEmgpTPwE,No
quark pharmaceuticals inc (inactive),Pharmaceuticals,"$37M, Series E",https://tracxn.com/d/companies/quark-pharmaceuticals/__eii6Lk-FEx9MpoqM-cCIk1lrT_lG4-jI15NEmgpTPwE,No
quralis corporation,Biotechnology,"$88M, Series B",https://www.prnewswire.com/news-releases/quralis-closes-88-million-series-b-financing-to-advance-precision-medicines-for-neurodegenerative-diseases-301765435.html,No
ractigen therapeutics inc,Biotechnology,"$47M, Series A+",https://www.ractigen.com/,No
regulus therapeutics inc,Biotechnology,"$1.7B, Acquired",https://www.prnewswire.com/news-releases/regulus-therapeutics-reports-first-quarter-2025-financial-results-and-recent-updates-302449287.html,No
rigerna therapeutics ltd,Biotechnology,"$30M, Seed",https://www.biospace.com/press-releases/sirna-biotech-rigerna-bio-secured-over-usd-30m-initial-financing-with-aspirations-to-create-therapies-for-kidney-patients,No
rnatics gmbh,Biotechnology,"$7M, Not Found",https://www.munich-startup.de/en/startups/rnatics-gmbh/,No
rona therapeutics inc,Biotechnology,"$25M, Series B",https://www.linkedin.com/company/ronatherapeutics/,No
shanghai argo pharmaceutical co ltd,Biotechnology,"$41M, Series A",https://www.linkedin.com/company/shanghai-argo-biopharmaceutical-co-ltd,No
silenseed ltd,Biotechnology,"$18M, Not Found",https://en.tgt.co.il/project-35/silenseed/,No
silexion therapeutics corp,Biotechnology,"$6M, IPO",https://il.linkedin.com/company/silexion-therapeutics-ltd,No
sirius therapeutics inc,Biotechnology,"$150M, Not Found",https://www.linkedin.com/company/sirius-therapeutics-inc,No
sirnaomics ltd,Biotechnology,"$7.6M, IPO",https://www.marketscreener.com/quote/stock/SIRNAOMICS-LTD-131014685/company/,No
stoke therapeutics inc,Biotechnology,"$125M, Post IPO Equity",https://www.linkedin.com/company/stoke-therapeutics,No
suzhou ribo life sciences co ltd,Biotechnology,"$2B, Agreement",https://www.biospace.com/article/siRNA-on-the-precipice-as-candidates-reach-beyond-the-liver/,No
syntara ltd,Biotechnology,"$3.6M, Not Found",https://au.linkedin.com/company/syntara-tx,No
the medicines co,Pharmaceuticals,"$400M, Post IPO Debt",https://www.linkedin.com/company/the-medicines-company,No
transcode therapeutics inc,Biotechnology,"$10M, IPO",https://www.prnewswire.com/news-releases/transcode-therapeutics-inc-announces-registered-direct-offering-priced-at-the-market-under-nasdaq-rules-302408720.html,No
vico therapeutics bv,Biotechnology,"$60M, Series B",https://www.prnewswire.com/news-releases/vico-therapeutics-announces-positive-interim-phase-12a-clinical-data-of-vo659-in-treatment-of-huntingtons-disease-302247239.html,No
visirna therapeutics hk ltd,Biotechnology,"$60M, Seed",https://globalgenes.org/raredaily/arrowhead-and-vivo-capital-launch-joint-venture-in-china-to-develop-rnai-based-therapies/,No
sirnagen therapeutics corp,Biotechnology,"$10M, Series A",https://www.decibio.com/insights/the-broadening-use-of-sirna-in-the-clinic-decibios-q-a-with-june-park-ceo-of-sirnagen-therapeutics,No
9 meters biopharma inc (inactive),Biotechnology,"$31.5M, Not Found",https://www.rttnews.com/3182826/here-s-why-9-meters-biopharma-stock-is-rising.aspx,No
apim therapeutics as,Biotechnology,"$3M, Series Unknown",https://www.crunchbase.com/organization/apim-therapeutics,No
abvance therapeutics inc,Biotechnology,"$3.9M, Seed",https://synapse.patsnap.com/organization/d4b316292573cd23deb619269d294467,No
acadia pharmaceuticals inc,Biotechnology,"$287.5M, Post IPO equity",https://www.linkedin.com/company/acadia-pharmaceuticals,No
adocia sas,Biotechnology,"$10.2M, Post IPO equity",https://www.crunchbase.com/organization/adocia,No
advanced accelerator applications sa,Pharmaceuticals,"$3.9B, Acquired",https://en.wikipedia.org/wiki/Advanced_Accelerator_Applications,No
aileron therapeutics inc,Biotechnology,"$21M, Post IPO equity",https://www.linkedin.com/company/rein-therapeutics,No
akums drugs & pharmaceuticals ltd,Pharmaceuticals,"$60M, Not Found",Not Found,No
amolyt pharma,Biotechnology,"$138.6M, Series C",https://www.linkedin.com/company/amolytpharma,No
antev ltd,Biotechnology,"$2.97M, Acquired",https://finance.yahoo.com/news/medicus-pharma-ltd-completes-acquisition-113000757.html,No
apeptico research and development ltd,Biotechnology,"$3.4M, Not Found",https://www.lifesciencesdirectory.at/detail/apeptico-forschung-und-entwicklung-gmbh,No
artery therapeutics inc,Biotechnology,"$52M, Pre-Series A",https://www.nia.nih.gov/research/sbir/nia-small-business-showcase/artery-therapeutics-inc,No
atox bio ltd,Biotechnology,"$30M, Series C",https://www.integra-holdings.com/news/atox-bio-closes-30-million-investment/,No
attenuon llc,Biotechnology,"$665,960, Phase I",https://www.sbir.gov/portfolio/100878,No
brim biotechnology inc,Biotechnology,"$45.8M, IPO",https://synapse.patsnap.com/organization/771ef147054b849ce990a0d2355975db,No
biolingus ag,Biotechnology,"$47M, IPO",https://www.swissbiotech.org/listing/biolingus-files-for-usd-47-million-ipo-at-nasdaq/,No
bioniz therapeutics inc,Biotechnology,"$10M, Seed",https://synapse.patsnap.com/organization/0aa07e3953e6f8ea631534cd1e3d5ee5,No
bioxodes sa,Biotechnology,"$15M, Series A",https://www.biospace.com/press-releases/bioxodes-secures-new-funds-to-reach-early-2025-milestones-and-pursue-series-b-financing,No
botanix pharmaceuticals ltd,Pharmaceuticals,"$20.2M, Post IPO Debt",https://www.linkedin.com/company/botanix-pharmaceuticals,No
ck regeon inc,Biotechnology,"$12.19M, Series B",https://www.crunchbase.com/organization/ck-regeon,No
cara therapeutics inc,Biotechnology,"$28M, Acquired",https://www.globenewswire.com/news-release/2025/04/15/3062122/0/en/Tvardi-Therapeutics-Announces-Closing-of-Merger-with-Cara-Therapeutics.html,No
carmot therapeutics inc,Biotechnology,"$150M, Series E",https://www.linkedin.com/company/carmot-therapeutics-inc,No
cephalon inc (inactive),Biotechnology,"$6.8B, Acquired",https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2011/Teva-Completes-Acquisition-of-Cephalon/default.aspx,No
chiasma inc,Biotechnology,"$176.3M, Acquired",https://www.globenewswire.com/news-release/2021/05/05/2223243/0/en/Amryt-Pharma-to-Acquire-Chiasma-Inc-to-Further-Strengthen-Global-Leadership-in-Rare-and-Orphan-Diseases.html,No
clarity pharmaceuticals ltd,Biotechnology,"$203M, Post IPO equity",https://www.claritypharmaceuticals.com,No
cohbar inc,Biotechnology,"$15M, PIPE Financing",https://www.biospace.com/cohbar-inc-and-morphogenesis-inc-enter-into-definitive-merger-agreement-to-advance-an-innovative-late-stage-clinical-immuno-oncology-pipeline-of-therapies-to-overcome-resistance-to-cancer-immunotherapy,No
cosette pharmaceuticals inc,Pharmaceuticals,"$430M, Acquired",https://www.ncbiotech.org/news/cosette-pharmaceuticals-acquire-mayne-pharma-430m,No
digestome therapeutics inc,Biotechnology,"$10M, Seed",https://www.viagetx.com/,No
e-star biotech llc,Biotechnology,"$36M, Seed",https://www.biospace.com/press-releases/e-star-biotech-announces-dosing-of-first-patient-in-phase-2-clinical-trials-of-manp-in-resistant-hypertension,No
eiger biopharmaceuticals inc (inactive),Biotechnology,"$87M, Acquired",https://www.sfnet.com/home/industry-data-publications/the-secured-lender/tsl-express-daily-articles-news/tsl-express-daily-articles-news/2024/09/16/ssg-advises-eiger-biopharmaceuticals-inc-in-the-sale-of-lonafarnib-and-lambda-program-assets-to-eiger-innotherapeutics-inc,No
endevica bio,Biotechnology,"$10M, Series B",https://www.linkedin.com/company/endevicabio,No
endevica bio inc,Biotechnology,"$10M, Series B",https://www.crunchbase.com/organization/tci-peptide-therapeutics,No
find therapeutics inc,Biotechnology,"$8.1M, Convertible Note",https://www.prnewswire.com/news-releases/find-therapeutics-announces-the-closing-of-a-convertible-note-financing-with-investissement-quebec-302247899.html,No
follicum ab,Biotechnology,"$3.54M, Acquired",https://www.marketscreener.com/quote/stock/FOLLICUM-AB-PUBL-120972169/,No
foresee pharmaceuticals co ltd,Pharmaceuticals,"$42.2M, Post IPO equity",https://www.crunchbase.com/organization/foresee-pharma,No
foresee pharmaceuticals llc,Pharmaceuticals,"$42.2M, Post IPO equity",https://www.linkedin.com/company/foreseepharma,No
forest laboratories llc (inactive),Pharmaceuticals,"$2.9B, Acquired",https://en.wikipedia.org/wiki/Forest_Laboratories,No
g2e co ltd,Biotechnology,"$4.72M, Series B",https://tracxn.com/d/companies/g2e/__dtogbIT10uaK9_ZX8d_V9ZvsMkJlzLuEaAB2ANHMLXM,No
galmed pharmaceuticals ltd,Biotechnology,"$6.5M, Not Found",https://www.prnewswire.com/news-releases/galmed-pharmaceuticals-reports-first-quarter-2025-financial-results-and-provides-business-update-302463065.html,No
hec pharma co ltd,Pharmaceuticals,"$400M, Post IPO equity",https://www.linkedin.com/company/hec-group,No
haemostatix ltd,Biotechnology,"$8M, Acquired",https://ergomedgroup.com/news/proposed-acquisition-of-haemostatix-limited-conditional-placing-of-6433350-initial-placing-shares-at-140-pence-each-conditional-placing-of-up-to-2875000-option-shares-at-140-pence-each-and-notice/,No
hightide biopharma pty ltd,Pharmaceuticals,"$107M, Series C",https://www.linkedin.com/company/hightide-therapeutics,No
hysensbio corp,Biotechnology,"$7.74M, Series B",https://www.cbinsights.com/company/hysensbio,No
idp discovery pharma sl,Biotechnology,"$1.6M, Seed",https://www.linkedin.com/company/idp-pharma,No
immupharma plc,Biotechnology,"$2.91M, Not Found",https://www.immupharma.co.uk/,No
intarcia therapeutics inc,Biotechnology,"$1B, Not Found",Not Found,No
invex therapeutics ltd,Pharmaceuticals,"$6M, Not Found",https://convention.bio.org/exhibitors/invex-therapeutics-limited,No
ironwood pharmaceuticals inc,Pharmaceuticals,"$281M, IPO",https://en.wikipedia.org/wiki/Ironwood_Pharmaceuticals,No
jiangsu protelight pharmaceutical & biotechnology co ltd,Biotechnology,"$8.2M, Series E",https://finance.yahoo.com/news/dr-yuxin-chen-president-ceo-013000411.html,No
jiangsu protelight pharmaceutical and biotechnology co ltd,Biotechnology,"$8.2M, Series E",https://finance.yahoo.com/news/dr-yuxin-chen-president-ceo-013000411.html,No
kailera therapeutics inc,Biotechnology,"$400M, Series A",https://www.globenewswire.com/news-release/2024/10/01/2955962/0/en/Kailera-Therapeutics-Launches-with-400-Million-Series-A-Financing-to-Advance-Portfolio-of-Next-Generation-Therapies-for-Obesity-and-Related-Conditions.html,No
kedrion spa,Pharmaceuticals,"$10M, Private Equity",https://it.linkedin.com/company/kedrion-biopharma,No
kissei pharmaceutical co ltd,Pharmaceuticals,"$70M, Acquired",https://finance.yahoo.com/quote/4547.T/,No
kuros biosciences ag,Biotechnology,"$6.2M, Post IPO equity",https://www.linkedin.com/company/kurosbiosciences,No
la jolla pharmaceutical company,Biotechnology,"$149M, Acquired",https://www.fiercepharma.com/pharma/innoviva-snaps-la-jolla-and-its-two-fda-approved-drugs-149-million,No
lung therapeutics inc,Pharmaceuticals,"$36M, Series C",https://www.linkedin.com/company/lung-therapeutics-inc-,No
mbx biosciences inc,Biotechnology,"$63.5M, Series C",https://www.linkedin.com/company/mbx-biosciences-inc,No
myr gmbh,Biotechnology,"$10M, Series A",https://www.htgf.de/en/portfolio/htgffamily/myr-2/,No
mannkind corp,Biotechnology,"$75M, Post IPO Debt",https://www.linkedin.com/company/mannkind-corporation,No
mapi pharma ltd,Pharmaceuticals,"$20M, Corporate Round",https://il.linkedin.com/company/mapi-pharma,No
molecular targeting technologies inc,Pharmaceuticals,"$1.5M, Not Found",https://taggs.hhs.gov/Detail/RecipDetail?arg_EntityId=O22NPTyEhuPy%2B0W8xMN%2FVQ%3D%3D,No
montreal clinical research institute,Biotechnology,"$3.6M, Not Found",https://leadiq.com/c/institut-de-recherches-cliniques-de-montr%C3%A9al-ircm--montreal-clinical-research-institute/5a1d981d2300005a0086bffc,No
nrx pharmaceuticals inc,Biotechnology,"$8.8M, Post IPO equity",https://www.linkedin.com/company/nrx-pharma,No
nanjing hang seng pharmaceutical co ltd,Pharmaceuticals,"$105M, Acquired",https://thebambooworks.com/brief-baiyunshan-invests-105-million-for-11-of-nanjing-pharma/,No
nano intelligent biomedical engineering corp,Biotechnology,"$435M, Not Found",https://www.bioworld.com/keywords/60541-nano-intelligent-biomedical-engineering-corp,No
national centre for nuclear research radioisotope centre polatom,Pharmaceuticals,"$3.63M, Not Found",https://www.polatom.pl/our-projects/in-progress/secure/,No
neuraly inc,Pharmaceuticals,"$36M, Series A",https://www.linkedin.com/company/neuraly-inc,No
neurobo pharmaceuticals inc,Biotechnology,"$70M, Not Found",https://www.prnewswire.com/news-releases/neurobo-pharmaceuticals-announces-strategic-realignment-ahead-of-important-clinical-milestones-with-name-change-to-metavia---reflecting-the-companys-focus-on-cardiometabolic-diseases-302308180.html,No
neurodegenerative disease research inc,Biotechnology,"$12.5M, Not Found",https://www.feinberg.northwestern.edu/giving/stories/_stories/2021/ndr-als-gift.html,No
nordic bioscience as,Biotechnology,"$100M, Private Equity",https://www.linkedin.com/company/nordicbioscience/,No
nutrinia ltd (inactive),Biotechnology,"$30M, Series D",https://www.finsmes.com/2016/08/nutrinia-closes-30m-series-d-financing.html,No
okyo pharma ltd,Biotechnology,"$1.9M, Grant",https://www.cnn.com/markets/stocks/OKYO,No
onl therapeutics inc,Biotechnology,"$65M, Series D",https://onltherapeutics.com/2024/09/13/onl-therapeutics-closes-65-million-in-oversubscribed-series-d-financing/,No
ocelot bio inc,Biotechnology,"$3M, Debt Financing",https://www.linkedin.com/company/ocelot-bio,No
organon & co,Pharmaceuticals,"$1.0B, Post IPO Debt",https://www.linkedin.com/company/organon,No
pmd device solutions ab,Biotechnology,"$11M, Acquired",https://www.irishexaminer.com/business/companies/arid-41545816.html,No
point biopharma global inc,Biotechnology,"$125M, Post IPO equity",https://www.linkedin.com/company/point-biopharma,No
palatin technologies inc,Biotechnology,"$1.1M, IPO",https://www.prnewswire.com/news-releases/palatin-technologies-announces-closing-of-reduced-public-offering-302450802.html,No
pentixapharm gmbh,Biotechnology,"$16.5M, Series A",https://www.crunchbase.com/organization/pentixapharm,No
pentixapharm holding ag,Biotechnology,"$19.89M, IPO",https://www.deutsche-boerse-cash-market.com/dbcm-en/instruments-statistics/statistics/primary-market-statistics/Pentixapharm-Holding-AG-4120852,No
peptomyc sl,Biotechnology,"$4.3M, Not Found",https://vhio.net/2023/12/20/the-spin-off-peptomyc-and-vhio-awarded-e4-million-from-the-spanish-ministry-of-science-and-innovation-to-advance-the-clinical-development-of-the-first-myc-oncogene-inhibitor/,No
pharma holdings as,Biotechnology,"$1.86M, Not Found",https://www.linkedin.com/company/pharma-holdings-as/,No
pharmain corp,Biotechnology,"$19.1M, Not Found",https://www.sbir.gov/portfolio/269126,No
pharmathen international sa,Pharmaceuticals,"$1.6B, Acquired",https://www.partnersgroup.com/news-and-views/press-releases/investment-news/detail?news_id=39bd39f0-69cc-4c16-8e95-6fe12d23d619,No
pharmazz inc,Biotechnology,"$15M, Strategic Equity Investment",https://finance.yahoo.com/news/pharmazz-inc-sun-pharma-entered-110000385.html,No
promore pharma ab,Biotechnology,"$2.4M, Private Placement",https://www.biospace.com/promore-pharma-ab-intends-to-carry-out-a-reverse-acquisition-of-pmd-device-solutions-ab,No
protagonist therapeutics inc,Biotechnology,"$132.2M, Post IPO equity",https://www.linkedin.com/company/protagonist-therapeutics,No
protelight pharmaceuticals australia pty ltd,Pharmaceuticals,"$7.69M, Series D",https://www.cbinsights.com/company/protelight-pharma,No
quadmedicine,Pharmaceuticals,"$11.7M, Series C",https://www.linkedin.com/company/quadmedicine,No
rs research,Biotechnology,"$108,734, Series B",https://tr.linkedin.com/company/rs-research,No
radiomedix inc,Biotechnology,"$100M, Acquired",https://www.sanofi.com/en/media-room/press-releases/2024/2024-09-12-05-00-00-2944919,No
radius health inc,Pharmaceuticals,"$175M, Post IPO Debt",https://www.linkedin.com/company/radius-health-inc,No
realta life sciences inc,Biotechnology,"$3.2M, Grant",https://www.crunchbase.com/organization/realta-life-sciences,No
red queen therapeutics inc,Biotechnology,"$55M, Series A",https://www.prnewswire.com/news-releases/apple-tree-partners-launches-red-queen-therapeutics-to-bring-potentially-lifesaving-treatments-to-people-at-greatest-risk-from-viral-infections-302214934.html,No
resother pharma aps,Biotechnology,"$2.67M, Grant",https://tracxn.com/d/companies/resother-pharma/__a4VsdF_gcx0EsPl_Pg8KoXLURPMVi-9LfRHY9mTqgf8,No
rhythm pharmaceuticals inc,Biotechnology,"$175M, Post IPO equity",https://www.linkedin.com/company/rhythm-pharmaceuticals-inc-,No
river 2 renal corp,Pharmaceuticals,"$40M, Series A",https://www.baincapital.com/news/narrow-river-management-announces-formation-and-financing-two-new-companies-developing,No
salix pharmaceuticals inc,Pharmaceuticals,"$750M, Post IPO equity",https://www.linkedin.com/company/salix-pharmaceuticals,No
scarless laboratories inc,Biotechnology,"$13.36M, Not Found",https://www.sbir.gov/portfolio/297908,No
sciclone pharmaceuticals holdings ltd,Pharmaceuticals,"$134.0M, Series Unknown",https://www.linkedin.com/company/sciclone-pharmaceuticals,No
sciwind biosciences co ltd,Biotechnology,"$70M, Not Found",https://www.contractpharma.com/breaking-news/sciwind-biosciences-and-verdiva-bio-enter-global-licensing-agreement/,No
shire-nps pharmaceuticals inc,Biotechnology,"$5.2B, Acquired",https://www.prnewswire.com/news-releases/plshire-to-acquire-nps-pharma-as-further-step-in-building-a-leading-biotech-288188461.html,No
soligenix inc,Biotechnology,"$7.5M, Post IPO equity",https://www.linkedin.com/company/soligenix-inc-,No
spine biopharma inc,Biotechnology,"$13.5M, Not Found",https://www.linkedin.com/company/spine-biopharma,No
spine biopharma llc,Biotechnology,"$3M, Convertible Note",https://www.healio.com/news/orthopedics/20210423/spine-biopharma-announces-3-million-investment-by-pacira-biosciences,No
spyryx biosciences inc (inactive),Biotechnology,"$28.98M, Debt - III",https://www.cbinsights.com/company/spyryx-biosciences,No
stealth biotherapeutics corp,Biotechnology,"$8.5M, Post IPO equity",https://www.linkedin.com/company/stealth-biotherapeutics,No
stealth biotherapeutics inc,Biotechnology,"$8.5M, Post IPO equity",https://www.linkedin.com/company/stealth-biotherapeutics,No
stealth biotherapeutics inc.,Biotechnology,"$8.5M, Post IPO equity",https://www.linkedin.com/company/stealth-biotherapeutics,No
stelis biopharma ltd,Biotechnology,"$95M, Pre-Listing",https://au.linkedin.com/company/stelisbiosource,No
suzhou thery pharmaceutical co ltd,Pharmaceuticals,"$38M, Series C",https://www.geneonline.com/first-generic-drug-tasigna-approved-china/,No
teitur trophics aps,Biotechnology,"$28M, Series A",https://www.teiturtrophics.com/,No
thallion pharmaceuticals inc. (inactive),Biotechnology,"$8.85M, Not Found",https://www.biospace.com/thallion-pharmaceuticals-inc-announces-completion-of-8-85-million-non-dilutive-capital-transaction,No
the lunenfeld-tanenbaum research institute,Biotechnology,"$91M, Not Found",Not Found,No
tiburio therapeutics inc (inactive),Biotechnology,"$31M, Series A",https://tracxn.com/d/companies/tiburio-therapeutics/__EcQoPkW8Tgb8zep1iCYwLqb8HguHiMqKjHBDBf6DnmM,No
topas therapeutics gmbh,Biotechnology,"$70M, Series D",https://www.evotec.com/news/evotec-spins-off-auto-immune-disease-company-as-topas-therapeutics-gmbh,No
torrent pharmaceuticals ltd,Pharmaceuticals,"$367M, Post IPO secondary",https://in.linkedin.com/company/torrent-pharmaceuticals-ltd,No
trevena inc,Biotechnology,"$2M, Post IPO Debt",https://www.linkedin.com/company/trevena-inc,No
visen pharmaceuticals,Pharmaceuticals,"$101M, IPO",https://www.cooley.com/news/coverage/2025/2025-03-21-visen-pharmaceuticals-announces-hk$783-million-ipo,No
vectivbio holding ag,Biotechnology,"$125M, IPO",https://www.globenewswire.com/search/organization/VectivBio%2520AG,No
verrica pharmaceuticals inc,Biotechnology,"$10M, IPO",https://www.globenewswire.com/news-release/2025/10/07/3162943/0/en/Verrica-Pharmaceuticals-to-Present-New-Data-on-VP-315-from-its-Phase-2-Trial-in-Basal-Cell-Carcinoma-BCC-at-the-40th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html,No
veru inc,Biotechnology,"$33M, Post IPO equity",https://www.linkedin.com/company/veru-pharma,No
viewpoint molecular targeting llc,Pharmaceuticals,"$13M, Series A",https://uirf.research.uiowa.edu/news/2021/05/viewpoint-molecular-targetingtm-announces-closing-its-series-financing-proceeds-13,No
vifor pharma management ltd,Pharmaceuticals,"$11.7B, Acquired",https://en.wikipedia.org/wiki/CSL_Vifor,No
vigeo therapeutics inc,Biotechnology,"$7.5M, Debt Financing",https://www.crunchbase.com/organization/vigeo-therapeutics,No
vivani medical inc,Biotechnology,"$10M, Equity Financing",https://finance.yahoo.com/quote/VANI/,No
windtree therapeutics inc,Biotechnology,"$520M, Not Found",https://www.stocktitan.net/news/WINT/,No
xeris biopharma holdings inc,Pharmaceuticals,"$200M, Post IPO Debt",https://www.linkedin.com/company/xeris-pharmaceuticals,No
xinnate ab,Pharmaceuticals,"$2.9M, Seed",https://xinnate.com/,No
yicheng kangtai (xiamen) biotechnology co ltd,Biotechnology,"$4.2M, Pre-A",https://www.xiamenbiotime.com/about-us_d1,No
yuyu pharma inc,Pharmaceuticals,"$834,174, Not Found","https://www.linkedin.com/company/yuyu-pharma#:~:text=Yuyu%20Pharma%20(KRX%20000220)%20was,South%20Korea%20and%20Southeast%20Asia.",No
zealand pharma as,Biotechnology,"$4.1M, Post IPO equity",https://www.linkedin.com/company/zealand-pharma,No
zhejiang boyiao biopharmaceutical co ltd,Biotechnology,"$33.2M, IPO",https://www.reuters.com/markets/companies/300294.SZ/,No
zhejiang sundoc pharmaceutical science and tech co ltd,Pharmaceuticals,"$10M, Not Found",Not Found,No
zhejiang xianju pharmaceutical co ltd,Pharmaceuticals,"$241.7K, Not Found",https://www.linkedin.com/company/zhejiang-xianju-pharmaceutical-co-ltd-/,No
zhongshan laboruichen biopharmaceutical co ltd,Pharmaceuticals,"$8.7M, Series A",http://www.zs.gov.cn/ywb/economy/content/post_2083408.html,No
zucara therapeutics inc,Biotechnology,"$25M, Series B",https://www.prnewswire.com/news-releases/zucara-therapeutics-announces-second-and-final-closing-of-us25-million-series-b-financing-302441949.html,No
amcure gmbh,Biotechnology,"$2.1M, Grant",https://www.linkedin.com/company/amcure-gmbh,No
35pharma inc,Biotechnology,"$53M, Series C",https://www.globenewswire.com/news-release/2024/11/26/2987436/0/en/35Pharma-Closes-Series-C-Financing-to-Advance-Clinical-Pipeline-of-Activin-Inhibitors-for-Pulmonary-Hypertension-Cardiometabolic-Disease-and-Obesity.html,No
89bio inc,Biotechnology,"$3.5B, Acquired",https://www.biospace.com/press-releases/89bio-inc-announces-agreement-to-be-acquired-by-roche,No
ab2 bio ltd,Biotechnology,"$36M, Not Found",https://www.biospace.com/press-releases/ab2-bio-signs-u-s-option-and-licensing-agreement-with-nippon-shinyaku-for-tadekinig-alfa-for-an-ultra-rare-autoimmune-disease,No
abionyx pharma sa,Biotechnology,"$8.7M, Not Found",https://www.linkedin.com/company/abionyx/,No
aeon biopharma inc,Pharmaceuticals,"$20M, Post IPO equity",https://www.linkedin.com/company/aeon-biopharma-inc,No
amag pharmaceuticals inc,Pharmaceuticals,"$300M, Post IPO Debt",https://www.linkedin.com/company/amag-pharmaceuticals,No
arca biopharma inc,Biotechnology,"$275M, Private Placement",https://www.biospace.com/press-releases/oruka-therapeutics-announces-closing-of-merger-with-arca-biopharma-and-previously-announced-private-placement-of-275-million,No
acceleron pharma inc,Biotechnology,"$10B, Acquired",https://www.merck.com/news/merck-completes-acquisition-of-acceleron-pharma-inc/,No
acelyrin inc,Biotechnology,"$300M, Series C",https://www.linkedin.com/company/acelyrin-inc,No
adalta ltd,Biotechnology,"$8.1M, Not Found",https://www.bio.org/events/bio-investor-forum/sessions/675482,No
adamed pharma sa,Pharmaceuticals,"$60M, Acquired",https://synapse.patsnap.com/organization/9bd6dda1b9d302dd9b182cfd6dff0f24,No
aeglea biotherapeutics inc,Biotechnology,"$210M, Post IPO Equity",https://www.linkedin.com/company/aeglea-biotherapeutics,No
airway therapeutics inc,Biotechnology,"$15.5M, Series C",https://www.linkedin.com/company/airway-therapeutics,No
akero therapeutics inc,Biotechnology,"$366.9M, Post IPO equity",https://www.linkedin.com/company/akerotx,No
albireo pharma inc,Biotechnology,"$952M, Acquired",https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/,No
allievex corp,Biotechnology,"$10M, Series A",https://www.linkedin.com/company/allievex,No
alopexx oncology llc (inactive),Biotechnology,"$8M, Not Found",https://www.prnewswire.com/news-releases/provenance-biopharmaceuticals-corp-announces-8m-financing-arrangement-136096363.html,No
alpine immune sciences inc,Biotechnology,"$150M, Post IPO equity",https://www.linkedin.com/company/alpine-immune-sciences,No
alteogen inc,Biotechnology,"$10M, Series A",https://www.linkedin.com/company/alteogen/,No
"alvine pharmaceuticals, inc. (inactive)",Biotechnology,"$70M, Acquired",https://www.biospace.com/alvine-pharmaceuticals-inc-lands-70-million-from-abbvie-for-celiac-disease-drug,No
amryt pharma plc,Pharmaceuticals,"$1.48B, Acquired",https://www.raglancapital.ie/amryt-pharma,No
ankasa regenerative therapeutics inc,Biotechnology,"$17M, Series A",https://www.odtmag.com/breaking-news/ankasa-regenerative-therapeutics-receives-85-million-in-financing/,No
annexin pharmaceuticals ab,Biotechnology,"$673.8K, Post IPO equity",https://www.linkedin.com/company/annexin-pharmaceuticals/,No
anokion sa,Biotechnology,"$35M, Not Found",https://www.businesswire.com/news/home/20221018005257/en/Anokion-Announces-%2435-Million-Equity-Investment-from-Pfizer,No
ansun biopharma inc,Biotechnology,"$85M, Series A",https://www.biospace.com/employer/399220/ansun-biopharma-inc,No
anthera pharmaceuticals inc (inactive),Biotechnology,"$36M, Venture Financing",https://www.pappas-capital.com/anthera-pharmaceuticals-secures-36m-venture-financing-initiate-clinical-programs/,No
apcintex ltd,Biotechnology,"$250M, Series A",https://www.ipgroupplc.com/news-and-events/ip-group-news/2021/2021-02-17,No
"apex bioscience, inc. (inactive)",Biotechnology,"$33M, Series C",https://wraltechwire.com/2002/06/14/apex-bioscience-parent-to-merge-with-fellow-german-drug-company/,No
apogenix ag,Biotechnology,"$72.3M, Series B",https://tracxn.com/d/companies/apogenix/__0ezzFeODe4ra_YzjlxjNr6MjYPfXy99D9aQfIca4X14,No
arecor therapeutics plc,Biotechnology,"$11M, IPO",https://arecor.com/news/,No
armagen inc,Biotechnology,"$10M, Series Unknown",https://www.linkedin.com/company/armagen,No
aronora inc,Biotechnology,"$39.1M, Seed",https://www.sbir.gov/portfolio/401980,No
attovia therapeutics inc,Biotechnology,"$90M, Series C",https://www.globenewswire.com/news-release/2025/04/15/3061599/0/en/Attovia-Therapeutics-Announces-90-Million-Series-C-Financing-to-Advance-ATTOBODY-based-Programs-through-Clinical-Proof-of-Concept.html,No
attralus inc,Biotechnology,"$56M, Series B",https://www.biospace.com/attralus-closes-56-million-financing,No
aura biosciences inc,Biotechnology,"$75M, IPO",https://www.annualreports.com/Company/aura-biosciences-inc,No
avecho biotechnology ltd,Biotechnology,"$19M, Licensing Agreement",https://au.linkedin.com/company/avecholtd,No
bioaegis therapeutics inc,Biotechnology,"$50M, Not Found",https://www.bioaegistherapeutics.com/,No
biogenerix ag (inactive),Biotechnology,"$43M, Acquired",https://www.biospace.com/neose-technologies-inc-announces-closing-of-asset-sales-to-novo-nordisk-a-s-and-biogenerix-ag-first-step-in-plan-of-liquidation,No
biocon biologics ltd,Biotechnology,"$150M, Corporate round",https://in.linkedin.com/company/bioconbiologics,No
biogenomics llc,Biotechnology,"$24.6M, Seed",https://tracxn.com/d/companies/biogenomics/__fduITjhjFdFQz3kvxCVo5M5nAWy3DHWQOwMLG3k3keI,No
biosimilar solutions llc,Biotechnology,"$50M, Not Found",https://biosimilarsolutions.com/,No
biosintez,Pharmaceuticals,"$24M, Acquired",https://www.pharmanow.live/latest-news/sun-pharma-acquires-jsc-biosintez-stake,No
biotest ag,Pharmaceuticals,"$2B, Acquired",https://www.grifols.com/en/view-news/-/news/grifols-completes-the-acquisition-of-biotest-a-strategic-and-transformational-transaction-to-accelerate-growth-and-innovation,No
bioverativ therapeutics inc,Biotechnology,"$11.6B, Acquired",https://en.wikipedia.org/wiki/Bioverativ,No
bone biologics corp,Biotechnology,"$5M, Post IPO equity",https://www.linkedin.com/company/bone-biologics,No
bright peak therapeutics ag,Biotechnology,"$90M, Series C",https://www.crunchbase.com/organization/bright-peak-therapeutics,No
canbridge life sciences ltd,Biotechnology,"$Not Found, Not Found",Not Found,No
cel-sci corp,Biotechnology,"$10M, IPO",https://finance.yahoo.com/quote/CVM/,No
cellusion inc,Biotechnology,"$20.3M, Series C",https://www.linkedin.com/company/cellusion/,No
celtic biotech iowa inc,Biotechnology,"$2.7M, Grant",https://ie.linkedin.com/company/celticbiotech,No
celtic biotech iowa inc (inactive),Biotechnology,"$2.5M, Not Found",https://en.wikipedia.org/wiki/Spotlight_Innovation,No
centergene pharmaceuticals co ltd,Pharmaceuticals,"$12M, Not Found",https://www.organon.com/news/organon-enters-into-licensing-agreement-with-bao-pharmaceutical-and-its-wholly-owned-subsidiary-centergene-pharmaceuticals-for-innovative-investigational-asset-in-assisted-reproductive-technology-art/,No
chengdu jinkai biotechnology co ltd,Biotechnology,"$46M, Acquired",https://www.legal-monitor.com/news/dacheng-advises-suzhou-genemen-and-chengdu-jinkai-financing-deals-szse-listed-salubris,No
china biologic products holdings inc,Biotechnology,"$4.6B, Acquired",https://en.wikipedia.org/wiki/China_Biologic_Products,No
china resources pharmaceutical group ltd,Pharmaceuticals,"$192M, IPO",https://dcfmodeling.com/blogs/history/3320hk-history-mission-ownership?srsltid=AfmBOorlKqPBpB6txQ5lOvud0W5V-KyDeueqHHIR-zX0ouyEmBIE9VgA,No
chongqing kerun biopharm r &,Biotechnology,"$10M, Series A",https://www.globaldata.com/company-profile/chongqing-zhifei-biological-products-co-ltd/deals/,No
chongqing yuyan pharmaceutical co ltd,Pharmaceuticals,"$41M, Not Found",https://www.marketscreener.com/quote/stock/HUADONG-MEDICINE-CO-LTD-6497912/news/Chongqing-Yuyan-Pharmaceutical-Co-Ltd-announced-that-it-has-received-CNY-300-million-in-funding-f-45365741/,No
claris biotherapeutics inc,Biotechnology,"$57M, Series A",https://www.globenewswire.com/news-release/2024/01/04/2803976/0/en/Claris-Bio-Emerges-From-Stealth-With-a-New-Investor-and-Prepares-for-Next-Development-Stage-With-Late-Stage-Data-Expected-in-1H24.html,No
connext co ltd,Biotechnology,"$5M, Series B",https://connext.co.kr/index_eng.php,No
contrafect corp,Biotechnology,"$7M, Post IPO Equity",https://www.linkedin.com/company/contrafect-corp,No
cour pharmaceuticals development co inc,Biotechnology,"$84M, Series B",https://www.globenewswire.com/news-release/2024/12/03/2990410/0/en/COUR-Pharmaceuticals-Enters-Collaboration-and-Licensing-Agreement-with-Genentech-to-Develop-and-Commercialize-Tolerogenic-Therapy-for-the-Treatment-of-an-Autoimmune-Disease.html,No
crossbow therapeutics inc,Biotechnology,"$80M, Series A",https://www.crunchbase.com/organization/crossbow-therapeutics,No
cugene inc,Biotechnology,"$48.5M, Not Found",https://news.abbvie.com/2022-05-16-AbbVie-and-Cugene-Announce-Collaboration-in-Autoimmune-Diseases,No
curateq biologics gmbh (inactive),Biotechnology,"$36M, Not Found",https://www.bioprocessintl.com/global-markets/aurobindo-eyes-wuxi-moment-to-kickstart-indian-bio-cdmo-sector,No
curemark llc,Biotechnology,"$1.5M, Series Unknown",https://www.linkedin.com/company/curemark-llc,No
cytoki pharma aps,Biotechnology,"$45M, Series A",https://www.crunchbase.com/organization/cytoki-pharma,No
cytonics corp,Biotechnology,"$30M, Regulation A+",https://www.linkedin.com/company/cytonics-corporation,No
diamedica therapeutics inc,Biotechnology,"$30.1M, Post IPO equity",https://www.linkedin.com/company/diamedica,No
diakonos oncology corp,Biotechnology,"$20M, Series A",https://www.prnewswire.com/news-releases/diakonos-oncology-closes-20-million-financing-to-accelerate-phase-2-glioblastoma-clinical-development-program-and-expand-use-of-innovative-dendritic-cell-platform-for-studies-in-other-indications-302468995.html,No
erytech pharma sa,Biotechnology,"$17.68M, IPO",https://live.euronext.com/en/ipo-showcase/erytech-pharma,No
edimer pharmaceuticals inc,Biotechnology,"$Not Found, Not Found",Not Found,No
eleva gmbh,Biotechnology,"$74M, Series Unknown",https://www.crunchbase.com/organization/eleva,No
elgan pharma ltd,Biotechnology,"$2.5M, Grant",https://synapse.patsnap.com/organization/6f5ce46f7316df7543bc1e77a94fa66b,No
entero therapeutics inc,Pharmaceuticals,"$3M, Post IPO equity",https://www.linkedin.com/company/enterothera,No
enthera srl,Biotechnology,"$8.5M, Series A",https://www.linkedin.com/company/enthera-pharmaceuticals/,No
eris lifesciences ltd,Pharmaceuticals,"$141.4M, IPO",https://in.linkedin.com/company/eris-lifesciences,No
esperare foundation,Biotechnology,"$1M, Seed",https://ch.linkedin.com/company/esperare-foundation,No
eubiologics co ltd,Pharmaceuticals,"$4.2M, Not Found",https://kr.linkedin.com/company/eubiologics-official,No
evolus inc,Pharmaceuticals,"$150M, Post IPO Debt",https://www.linkedin.com/company/evolusaesthetic,No
evommune inc,Biotechnology,"$115M, Series C",https://wewillcure.com/insights/investment/funding-and-models/evommune-usd115m-series-c-funding-fuels-innovation-in-chronic-inflammation,No
fab’entech sa,Biotechnology,"$21.2M, Not Found",https://european-biotechnology.com/latest-news/e20m-loan-for-pandemic-preparedness/,No
ferring bv,Pharmaceuticals,"$570M, Not Found",https://en.wikipedia.org/wiki/Ferring_Pharmaceuticals,No
ferring pharmaceuticals co ltd,Pharmaceuticals,"$530.88M, Not Found",https://ch.linkedin.com/company/ferring-pharmaceuticals,No
first wave biopharma inc,Biotechnology,"$1.1M, Not Found",https://finance.yahoo.com/news/first-wave-biopharma-inc-raise-115500185.html,No
fortunerock (china) ltd,Biotechnology,"$24M, Series B",https://tracxn.com/d/companies/fortune-rock/__VfXjCtXmCNbvZmuRGShPuubgJFmjBmbk6pa-mkuD-_c,No
gammacan international inc (inactive),Biotechnology,"$1.2M, Not Found",https://www.biospace.com/gammacan-international-inc-closes-additional-1-2-million-investment,No
gemini therapeutics inc,Biotechnology,"$175M, Acquired",https://www.discmedicine.com/news/gemini-therapeutics-and-disc-medicine-announce-merger-agreement/,No
genera research ltd,Biotechnology,"$4.67M, Not Found",https://genera-research.com/,No
gliknik inc,Biotechnology,"$25M, Acquired",https://www.pfizer.com/news/press-release/press-release-detail/gliknik-enters-licensing-agreement-pfizer-drug-candidate,No
guizhou taibang biological products co ltd,Biotechnology,"$62.1M, Acquired",https://www.prnewswire.com/news-releases/china-biologic-acquires-full-ownership-of-guizhou-taibang-300351498.html,No
hcw biologics inc,Biotechnology,"$5M, Post IPO Equity",https://www.linkedin.com/company/hcw-biologics,No
hanbio therapeutics ltd,Biotechnology,"$40M, Series A",https://www.prnewswire.com/news-releases/hanbio-therapeutics-announces-the-completion-of-a-us40-million-series-a-financing-led-by-orbimed-and-hankang-capital-301471066.html,No
hasten biopharmaceutic co ltd,Pharmaceuticals,"$315M, Not Found",https://www.reuters.com/business/healthcare-pharmaceuticals/singapores-cbc-abu-dhabis-mubadala-raise-315-mln-hasten-biopharmaceutic-2023-04-20/,No
hospira inc,Pharmaceuticals,"$17B, Acquired",https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-hospira,No
immunimed inc,Biotechnology,"$100,000, Seed",https://www.gatesfoundation.org/about/committed-grants/2017/05/inv-006740,No
immunoforge co ltd,Pharmaceuticals,"$10M, Series C",https://finance.yahoo.com/news/immunoforge-receives-ind-approval-phase-130000187.html,No
immunogenx llc,Biotechnology,"$5.43M, Acquired",https://www.sbir.gov/portfolio/410518,No
immunogenics llc,Biotechnology,"$5.43M, Not Found",Not Found,No
inozyme pharma inc,Biotechnology,"$60M, Post IPO equity",https://www.linkedin.com/company/inozyme,No
jhm biopharmaceutical (hangzhou) co ltd,Biotechnology,"$27.4M, Series B+",https://www.marketscreener.com/quote/stock/TONGHUA-DONGBAO-PHARMACEU-6497997/news/JHM-Biopharmaceutical-Co-Ltd-announced-that-it-expects-to-receive-CNY-100-million-in-funding-from-46730491/,No
janux therapeutics inc,Biotechnology,"$350M, Post IPO equity",https://www.linkedin.com/company/janux-therapeutics,No
jiangsu zhongxin medicine co ltd,Pharmaceuticals,"$37M, Acquired",https://www.marketscreener.com/quote/stock/JIANGSU-KANION-PHARMACEUT-9059402/news/Jiangsu-Kanion-Pharmaceutical-Co-Ltd-agreed-to-acquire-Jiangsu-Zhongxin-Medicine-Co-Ltd-from-Jia-48309878/,No
junhemeng biopharmaceutical (tonghua) co ltd,Biotechnology,"$14M, Series B",https://www.linkedin.com/pulse/newsletter-chinas-life-science-industry-may-oiqjc,No
kadmon holdings inc,Biotechnology,"$50M, Private Financing",https://en.wikipedia.org/wiki/Kadmon_Corporation,No
kamada pharmaceuticals,Pharmaceuticals,"$60M, IPO",https://il.linkedin.com/company/kamada,No
kanyos bio inc,Biotechnology,"$40M, Series B",https://www.vischer.com/en/knowledge/deals-cases/anokion-acquires-kanyos-bio-and-raises-usd-40m-37940/,No
keros therapeutics inc,Biotechnology,"$140M, IPO",https://www.linkedin.com/company/keros-therapeutics,No
laboratorio reig jofre sa,Pharmaceuticals,"$13M, Not Found","https://reigjofre.com/en/#:~:text=Founded%20in%201929%20in%20Barcelona,pharmaceutical%20products%20and%20food%20supplements.",No
lannett co inc,Pharmaceuticals,"$350M, Post IPO Debt",https://www.linkedin.com/company/lannett-company,No
lanzhou lansheng blood products co ltd,Pharmaceuticals,"$89.85M, Acquired",https://synapse.patsnap.com/organization/60e599c239918514ac93feb5d2ab9694,No
lekko pharmaceutical company,Pharmaceuticals,"$100M, Acquired",https://pharmstd.com/archivedetails_64_2667.html,No
levicept ltd,Biotechnology,"$3.9M, Grant",https://uk.linkedin.com/company/levicept-ltd,No
liminal biosciences inc,Biotechnology,"$1.8M, Post IPO equity",https://ca.linkedin.com/company/liminal-biosciences-inc,No
med discovery sa,Biotechnology,"$72.5K, Debt financing",https://www.linkedin.com/company/med-discovery-sa,No
medexus pharmaceuticals inc,Pharmaceuticals,"$30M, Post IPO equity",https://www.linkedin.com/company/medexuspharma,No
mediwound ltd,Biotechnology,"$30M, IPO",https://www.cnbc.com/quotes/MDWD,No
medikine inc,Biotechnology,"$242K, Grant",https://tracxn.com/d/companies/medikine/__bel3Q5KjQ0Ic4D6wjMd6z0_DDb3ow8feADhREiy1gJg,No
megalabs sa,Pharmaceuticals,"$70M, Not Found",https://idbinvest.org/en/projects/megalabs,No
memgen inc,Biotechnology,"$950K, Not Found",https://www.linkedin.com/company/memgen-inc,No
meridian bioscience inc,Biotechnology,"$1.53B, Acquired",https://www.prnewswire.com/news-releases/meridian-bioscience-inc-enters-into-agreement-to-be-acquired-by-sd-biosensor-and-sjl-partners-in-1-53-billion-all-cash-transaction-301582257.html,No
merz pharma gmbh & co kgaa,Pharmaceuticals,"$20M, Not Found",Not Found,No
merz pharmaceuticals gmbh,Pharmaceuticals,"$20M, Not Found",Not Found,No
nammi therapeutics inc,Biotechnology,"$30M, Series B",https://themmrf.org/mmrf-press-releases/nammi-therapeutics-inc-completes-series-b-round-with-investment-from-mmrfs-myeloma-investment-fund-advances-clinical-development-of-lead-program-qxl138am/,No
neumedicines inc,Biotechnology,"$64M, Grant",https://tracxn.com/d/companies/neumedicines/__b2NQ31Rl-SK1o7MZryAKmDtp0vM6pw-Fh75yOkZkDrU,No
neutrolis inc,Biotechnology,"$23.1M, Series A",https://www.crunchbase.com/organization/neutrolis,No
noveome biotherapeutics inc,Biotechnology,"$51M, Series E",https://www.cbs42.com/business/press-releases/ein-presswire/805640318/noveome-biotherapeutics-inc-completes-51-million-series-e-financing-to-support-clinical-trials-in-nec,No
nuvig therapeutics inc,Biotechnology,"$161M, Series B",https://www.businesswire.com/news/home/20241205877164/en/Nuvig-Therapeutics-Announces-%24161-Million-Series-B-Financing-and-Progression-to-Phase-2-Development-with-Novel-Second-Generation-Immunomodulator,No
obctcd24 ltd,Biotechnology,"$10M, Seed",https://www.ivc-online.com/Google-Card?id=c02d7cdd-4a83-ec11-b80d-00505695cd29,No
oncolix inc (inactive),Biotechnology,"$8.46M, Series A",https://tracxn.com/d/companies/oncolix/__GtDJeCaIJQyHTWFyn7xUm7jRacR4sdmpS-rwEj-ns64,No
oramed pharmaceuticals inc,Biotechnology,"$36.9M, Not Found",https://finance.yahoo.com/quote/ORMP/,No
orphan technologies ltd,Biotechnology,"$90M, Acquired",https://tracxn.com/d/companies/orphan-technologies/__dMSsDu0dOb37AhVYxPTzxhCsv1KXniXiTKHKy0M4On0,No
provirex genome editing therapies gmbh,Biotechnology,"$1.7M, Not Found",https://www.linkedin.com/company/provirex,No
pt daewoong infion,Biotechnology,"$38M, Series A",https://gosset.ai/companies/daewoong-infion/,No
panolos bioscience,Biotechnology,"$18M, Series A",https://www.linkedin.com/company/panolos-bioscience/,No
partner therapeutics inc,Biotechnology,"$60M, Series A",https://www.prnewswire.com/news-releases/partner-therapeutics-inc-ptx-closes-60-million-financing-300591618.html,No
phoenix tissue repair inc,Biotechnology,"$20M, Not Found",Not Found,No
pneumagen ltd,Biotechnology,"$10M, Series Unknown",https://uk.linkedin.com/company/pneumagen-limited,No
proda biotech llc,Biotechnology,"$2M, Seed",https://news.gsu.edu/2018/12/04/georgia-state-spinoff-gets-2-million-to-advance-new-cancer-drug/,No
propanc biopharma inc,Biotechnology,"$4M, IPO",https://www.quiverquant.com/news/Propanc+Biopharma+Reports+Fiscal+Year-End+Update+and+Strategic+Developments+Following+Nasdaq+Uplisting,No
protalix biotherapeutics inc,Biotechnology,"$5.3M, Series C",https://en.wikipedia.org/wiki/Protalix_BioTherapeutics,No
prothya biosolutions belgium bv,Pharmaceuticals,Acquired,https://www.prnewswire.com/news-releases/intas--accord-signs-agreement-to-acquire-prothya-biosolutions-302526475.html,No
proviva therapeutics inc,Biotechnology,"$18M, Series A",https://tracxn.com/d/companies/proviva-therapeutics/__tfMv7ihWNX7CE-WzMiPXDJCIX-mlUl7QGXPQws6TcsA,No
q-med ab,Pharmaceuticals,"$970M, Acquired",https://www.biospace.com/q-med-ab-agrees-to-be-acquired-by-galderma-pharma-s-a-for-970-million,No
remegen co ltd,Biotechnology,"$2.6B, Not Found",https://www.remegen.com/,No
resolve therapeutics llc (inactive),Biotechnology,"$5.8M, Not Found",https://www.fiercebiotech.com/biotech/resolve-therapeutics-raises-5-8-million-private-financing,No
revance therapeutics inc,Biotechnology,"$924M, Acquired",https://www.prnewswire.com/news-releases/crown-laboratories-announces-completion-of-acquisition-of-revance-therapeutics-302370202.html,No
rise therapeutics llc,Biotechnology,"$10M, Grant",https://www.linkedin.com/company/rise-therapeutics,No
sab biotherapeutics inc,Biotechnology,"$175M, Post IPO equity",https://www.linkedin.com/company/sab-biotherapeutics,No
serda therapeutics bv,Biotechnology,"$15M, Series A",https://nl.linkedin.com/company/serda-therapeutics,No
sk plasma co ltd,Pharmaceuticals,"$49.8M, Series Unknown",https://www.linkedin.com/company/skplasma/,No
sarkana pharma inc,Biotechnology,"$1.58M, Unattributed VC",https://www.cbinsights.com/company/sarkana-pharma,No
savara inc,Pharmaceuticals,"$30M, Post IPO Debt",https://synapse.patsnap.com/organization/95a8adb4046070ad668c2b78cda3576c,No
"savient pharmaceuticals, inc. (inactive)",Pharmaceuticals,"$120M, Acquired",https://njbiz.com/savient-acquired-by-crealta-pharmaceuticals-in-120m-bankruptcy-auction/,No
silver creek pharmaceuticals inc,Biotechnology,"$9.2M, Series Unknown",https://www.crunchbase.com/organization/silver-creek-pharmaceuticals,No
synageva biopharma corp,Biotechnology,"$308M, Post IPO equity",https://www.linkedin.com/company/synageva-biopharma-corp.,No
synairgen plc,Biotechnology,"$18M, Not Found",https://uk.linkedin.com/company/synairgen,No
synklino aps,Biotechnology,"$31.9M, Series A",https://eirventures.eu/eir-ventures-first-seedling-synklino-aps-completes-oversubscribed-dkk-106-million-series-a-round/,No
tafalgie therapeutics,Biotechnology,"$12M, Series A",https://www.eu-startups.com/2025/09/french-biotech-startup-tafalgie-therapeutics-locks-in-e12-million-to-tackle-the-opioid-crisis-with-non-opioid-drugs/,No
targed biopharmaceuticals bv,Biotechnology,"$13.5M, Not Found",https://nl.linkedin.com/company/targedbiopharmaceuticals,No
tectonic therapeutic inc,Biotechnology,"$185M, IPO",https://www.linkedin.com/company/tectonictx,No
thrombolytic science international llc,Biotechnology,"$8M, Not Found",https://en.wikipedia.org/wiki/Thrombolytic_Science_International,No
travere therapeutics inc,Biotechnology,"$125M, Post IPO equity",https://www.linkedin.com/company/travererare,No
trefoil therapeutics llc,Biotechnology,"$28M, Series A",https://www.exsightventures.com/blog/trefoil-moves-closer-to-a-clinical-trial-announcing-our-follow-on-investment,No
trigenesis life sciences pvt ltd,Pharmaceuticals,"$666K, Seed",https://tracxn.com/d/companies/trigenesis-lifesciences/__ZMljb92cpnn1C9sXHs1jpZoAj99oxpw3QtMRFvi8TdI,No
suzhou jinmeng biotechnology co ltd,Biotechnology,"$10M, Series B",https://be.linkedin.com/company/cellprobio-biotech,No
uro-1 inc,Biotechnology,"$8M, Series A",https://www.ncbiotech.org/news/uro-1-prepares-commercial-launch-prostate-biopsy-platform,No
vensica therapeutics,Biotechnology,"$11M, Series B",https://www.calcalistech.com/ctechnews/article/hjeuyr0lye,No
vera therapeutics inc,Biotechnology,"$500M, Refinancing",https://finance.yahoo.com/news/vera-therapeutics-announces-refinancing-existing-oxford-debt-facility-500-million-term-loans-123456789.html,No
wockhardt bio ag,Pharmaceuticals,"$250M, Secure Term Loan",https://www.marketscreener.com/quote/stock/WOCKHARDT-BIO-AG-23454514/,No
wockhardt ltd,Pharmaceuticals,"$11.7M, Post IPO Debt",https://in.linkedin.com/company/wockhardt,No
wuhan heyuan biotechnology co ltd,Biotechnology,"$480M, IPO",https://www.yicaiglobal.com/star50news/2023_11_216626210501485395980,No
xiamen tebao biological engineering co ltd,Biotechnology,"$2.04M, Not Found",https://www.yicaiglobal.com/bulletin/253000000303241476,No
zz biotech llc,Biotechnology,"$30M, Grant",https://synapse.patsnap.com/organization/7ea4c3481c5ec156dcfd40e31fd5e706,No
180 life sciences corp,Biotechnology,"$425M, PIPE",https://www.prnewswire.com/news-releases/180-life-sciences-closes-425-million-private-placement-to-advance-its-ethereum-treasury-strategy-302521381.html,No
5med gmbh,Pharmaceuticals,"$547,643, Not Found","https://www.northdata.de/5med%20GmbH,%20Freiburg%20i%C2%B7%20Breisgau/Amtsgericht%20Freiburg%20HRB%20732038",No
60 degrees pharmaceuticals llc,Pharmaceuticals,"$10M, IPO",https://finance.yahoo.com/news/60-degrees-pharmaceuticals-announces-closing-200100524.html,No
7tm pharma a/s (inactive),Biotechnology,"$15M, Not Found",https://sciencebusiness.net/news/69758/7TM-closes-%2415M-round-and-sells-rights-to-OSI,No
858 therapeutics inc,Biotechnology,"$50M, Series B",https://www.businesswire.com/news/home/20240926331123/en/858-Therapeutics-Announces-%2450-Million-Series-B-Financing,No
ab science sa,Pharmaceuticals,"$3.0M, Post IPO equity",https://www.linkedin.com/company/ab-science/,No
ab-biotics sa,Biotechnology,"$59K, Grant",https://www.crunchbase.com/organization/ab-biotics,No
abm therapeutics corp,Biotechnology,"$30M, Series B",https://www.vivabiotech.com/new/568.html,No
abm therapeutics inc,Biotechnology,"$30M, Series B",https://www.vivabiotech.com/new/568.html,No
acea biosciences inc,Biotechnology,"$20M, Acquired",https://www.linkedin.com/company/acea-biosciences,No
aco hud ab,Pharmaceuticals,"$330M, Acquired",https://www.ainvest.com/news/kkr-acquires-aco-hud-nordic-ab-dermacosmetics-assets-330m-2507/,No
act biotech inc,Biotechnology,"$12M, Acquired",https://www.cbinsights.com/company/act-biotech,No
advantage therapeutics inc,Biotechnology,"$2.5M, Grant",https://finance.yahoo.com/news/advantage-therapeutics-awarded-2-5-124300733.html,No
aft pharmaceuticals ltd,Pharmaceuticals,"$21.5K, Grant",https://nz.linkedin.com/company/aft-pharmaceuticals,No
agi therapeutics research ltd,Pharmaceuticals,"$6.6M, Acquired",https://www.irishtimes.com/business/health-pharma/agi-therapeutics-being-sold-for-6-6m-1.442154,No
akl research and development ltd,Pharmaceuticals,"$881.5K, Grant",https://www.crunchbase.com/organization/akl-research-development,No
alsi pharmaceuticals inc,Pharmaceuticals,"$100M, Seed",https://www.linkedin.com/company/alys-pharmaceuticals,No
amo pharma ltd,Pharmaceuticals,"$10M, Series A",https://www.linkedin.com/company/amo-pharma-ltd,No
an2 therapeutics inc,Biotechnology,"$10M, Grant",https://www.linkedin.com/company/an2-therapeutics-inc,No
aortica group,Biotechnology,"$10M, Acquired",https://evtoday.com/news/terumo-acquires-aortica-corporation-to-further-bolster-its-vascular-graft-portfolio,No
"apt pharmaceuticals, inc. (inactive)",Pharmaceuticals,"$22M, Series A-2",https://www.biospace.com/apt-pharmaceutical-llc-closes-new-22-million-funding-round,No
armgo pharma inc,Biotechnology,"$1M, Not Found",https://www.mda.org/press-releases/armgo-pharma-receives-1-million-mda-award-to-continue-development-of-novel-dmd-treatment,No
artbio inc,Biotechnology,"$132M, Series B",https://www.prnewswire.com/news-releases/artbio-announces-132-million-series-b-financing-to-advance-pipeline-of-alpha-radioligand-therapies-and-expand-manufacturing-and-supply-chain-infrastructure-302515362.html,No
atlas molecular pharma sl,Biotechnology,"$3.2M, Seed",https://biotech-spain.com/en/articles/atlas-molecular-pharma-closes-a-eur-3-million-round-of-funding-to-advance-clinical-development-of-a-drug-to-treat-congenital-erythropoietic-porphyria/,No
abbott healthcare pvt ltd,Pharmaceuticals,"$100K, Post IPO Debt",https://www.linkedin.com/company/abbott-,No
ability pharmaceuticals sl,Biotechnology,"$7M, Not Found",https://synapse.patsnap.com/organization/7b0412b5dff7c0e6d08d4f1880d98eaf,No
acacia pharma group ltd,Pharmaceuticals,"$30M, Debt Financing",https://www.linkedin.com/company/acaciapharmainc,No
acacia pharma group plc,Pharmaceuticals,"$30M, Debt Financing",https://www.linkedin.com/company/acaciapharmainc,No
acacia pharma ltd,Pharmaceuticals,"$30M, Debt Financing",https://www.linkedin.com/company/acaciapharmainc,No
academpharm,Pharmaceuticals,"$1M, Not Found",https://academpharm.by/en,No
accent therapeutics inc,Biotechnology,"$75M, Series C",https://www.crunchbase.com/organization/accent-therapeutics,No
acelrx pharmaceuticals inc,Pharmaceuticals,"$17M, Post IPO equity",https://www.linkedin.com/company/acelrx-pharmaceuticals,No
achaogen inc (inactive),Biotechnology,"$15M, IPO",https://www.nature.com/articles/s41599-024-03452-0,No
achillion pharmaceuticals inc (inactive),Biotechnology,"$930M, Acquired",https://www.fiercebiotech.com/biotech/alexion-inks-deal-to-acquire-achillion-for-930m-upfront,No
acurx pharmaceuticals inc,Biotechnology,"$12M, Equity Line of Credit",https://www.prnewswire.com/news-releases/acurx-pharmaceuticals-inc-reports-second-quarter-results-and-provides-business-update-302520712.html,No
adamas pharmaceuticals inc,Pharmaceuticals,"$59.2M, Post IPO equity",https://www.linkedin.com/company/adamas-pharmaceuticals-inc.,No
adams clinical trials llc,Biotechnology,"$10M, Private equity",https://www.linkedin.com/company/adams-clinical,No
addex therapeutics ltd,Biotechnology,"$2.1M, IPO",https://ch.linkedin.com/company/addex-therapeutics,No
addinex technologies inc,Pharmaceuticals,"$260K, Grant",https://www.globenewswire.com/news-release/2022/09/07/2511454/0/en/Addinex-Technologies-Awarded-260K-Grant-by-the-CDC-to-Improve-Addiction-Medication-Dispensing.html,No
adiso therapeutics inc,Biotechnology,"$60M, Series A",https://www.linkedin.com/company/adisotx,No
adium pharma sa,Pharmaceuticals,"$120M, Not Found",https://www.cbinsights.com/company/adium-pharma,No
adjutec pharma as,Pharmaceuticals,"$2.2M, Not Found",https://beam-alliance.eu/adjutec-pharma-will-lead-a-eurostars-project-of-e2-2mill/,No
adjuvance technologies inc,Biotechnology,"$13.4M, Series A",https://tracxn.com/d/companies/adjuvance-technologies/__1gvjW1MY6JQPnm1DA91vbeMJmp-Yja4wXMW2UlKvf0s,No
advanced biodesign,Biotechnology,"$30M, Not Found",https://fr.linkedin.com/company/advanced-biodesign,No
advaxis,Biotechnology,"$9.3M, IPO",https://www.iposcoop.com/ipo/advaxis-inc/,No
advicenne sa,Pharmaceuticals,"$3.0M, Post IPO equity",https://www.linkedin.com/company/advicenne-pharma-sa/,No
aeovian pharmaceuticals inc,Biotechnology,"$50M, Not Found",https://www.prnewswire.com/news-releases/aeovian-pharmaceuticals-doses-first-participants-in-phase-1-clinical-trial-strengthens-leadership-team-and-raises-additional-50-million-financing-302101427.html,No
aer therapeutics inc,Biotechnology,"$36M, Series A",https://www.biospace.com/article/aer-therapeutics-raises-36m-for-novel-approach-to-copd/,No
aer therapeutics inc (inactive),Biotechnology,"$36M, Series A",https://innovation.ucsf.edu/news/aer-therapeutics-closes-36-million-series-advance-development-aer-01-innovative-mucolytic,No
aerie pharmaceuticals inc,Pharmaceuticals,"$770M, Acquired",https://en.wikipedia.org/wiki/Aerie_Pharmaceuticals,No
aerorx therapeutics inc,Biotechnology,"$21M, Series A",https://vcnewsdaily.com/aerorx-therapeutics/venture-capital-funding/qlxjqqgtxb,No
aerorx therapeutics llc (inactive),Biotechnology,"$21M, Series A",https://finance.yahoo.com/news/aerorx-therapeutics-announces-21-million-110000368.html,No
aerovate therapeutics inc,Biotechnology,"$69.6M, Acquired",https://www.prnewswire.com/news-releases/aerovate-therapeutics-stockholders-approve-proposed-merger-with-jade-biosciences-and-all-related-proposals-302433012.html,No
aerpio pharmaceuticals inc (inactive),Pharmaceuticals,"$155M, Acquired",https://www.aadibio.com/aadi-bioscience-announces-closing-of-merger-with-aerpio-pharmaceuticals-and-155m-private-placement/,No
afasci inc,Biotechnology,"$30M, Series A",https://convention.bio.org/exhibitors/afasci-research-laboratories,No
afferent pharmaceuticals inc,Pharmaceuticals,"$80M, Acquired",https://www.genengnews.com/news/merck-co-to-acquire-afferent-pharmaceuticals-for-up-to-1-25b/,No
african institute of biomedical science and technology,Biotechnology,"$1.5M, Seed",https://www.gatesfoundation.org/about/committed-grants/2021/10/inv036801,No
agenebio inc,Pharmaceuticals,"$3.4M, Grant",https://www.linkedin.com/company/agenebio-inc-,No
agile therapeutics inc,Pharmaceuticals,"$45M, Acquired",https://njbiz.com/agile-therapeutics-acquired-for-45m/,No
aglowmed pharmaceuticals ltd,Pharmaceuticals,"$20M, Not Found",Not Found,No
ahammune biosciences pvt ltd,Biotechnology,"$8.02M, Series A",https://tracxn.com/d/companies/ahammune-biosciences/__ayBsd26wzTEOgW4bSYhfddUNrY3qY1tz5ZOlO-d1X78,No
aicuris anti-infective cures ag,Biotechnology,"$74.8M, Series B",https://www.linkedin.com/company/aicuris,No
akebia therapeutics inc,Biotechnology,"$37M, Post IPO Debt",https://www.linkedin.com/company/akebia-therapeutics,No
akorn operating company llc,Pharmaceuticals,"$4.3B, Acquired",https://en.wikipedia.org/wiki/Akorn,No
aktis oncology inc,Biotechnology,"$175M, Series B",https://www.crunchbase.com/organization/aktis-oncology,No
akums drugs &,Pharmaceuticals,"$50M, Not Found",Not Found,No
alar pharmaceuticals inc,Pharmaceuticals,"$15M, Not Found",https://www.indivior.com/en/media/press-releases/Indivior-Enters-an-Exclusive-Licensing-Agreement-with-Alar-Pharmaceuticals,No
albireo ab,Biotechnology,"$952M, Acquired",https://www.ipsen.com/press-releases/ipsen-to-acquire-albireo-accelerating-growth-in-rare-disease-with-treatments-for-several-pediatric-liver-diseases/,No
alchemia oncology pty ltd,Biotechnology,"$70M, Acquired",https://www.globenewswire.com/news-release/2015/07/01/1238245/0/en/Panther-Biotechnology-Announces-the-Acquisition-of-Alchemia-Oncology-Pty-Limited.html,No
alessa therapeutics inc,Biotechnology,"$15M, Seed",https://innovation.ucsf.edu/news/alessa-therapeutics-announces-closing-15m-seed-financing,No
alexza pharmaceuticals inc,Pharmaceuticals,"$5M, Post IPO Equity",https://www.linkedin.com/company/alexza-pharmaceuticals,No
alfasigma spa,Pharmaceuticals,"$176.3M, Debt Financing",https://www.linkedin.com/company/alfasigma/,No
algernon pharmaceuticals inc,Pharmaceuticals,"$4M, Not Found",https://www.algernonpharmaceuticals.com/,No
"algorx pharmaceuticals, inc. (inactive)",Pharmaceuticals,"$65M, Acquired",https://www.privateequityinternational.com/advent-closes-life-sciences-fund-on-125m/,No
alios biopharma inc,Biotechnology,"$1.75B, Acquired",https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-agreement-to-acquire-alios-biopharma,No
allvascular pty ltd.,Biotechnology,"$5M, IPO",https://www.afr.com/street-talk/medical-devices-start-up-allvascular-raises-5m-ipo-next-year-20211209-p59gdk,No
allay therapeutics inc,Biotechnology,"$57.5M, Series D",https://www.businesswire.com/news/home/20250605811033/en/Allay-Therapeutics-Announces-%2457.5M-Series-D-Financing-and-Venture-Debt-Line-to-Advance-ATX101-and-its-Ultra-Sustained-Pain-Platform-for-Post-Surgical-Pain-Management,No
allecra therapeutics gmbh,Biotechnology,"$24.8M, Series B",https://www.linkedin.com/company/allecra-therapeutics,No
allergan inc (inactive),Pharmaceuticals,"$60B, Acquired",https://news.abbvie.com/2020-05-08-AbbVie-Completes-Transformative-Acquisition-of-Allergan,No
allergy therapeutics plc,Pharmaceuticals,"$30M, Post IPO equity",https://uk.linkedin.com/company/allergy-therapeutics,No
alliance pharma plc,Pharmaceuticals,"$295M, Acquired",https://www.globaldata.com/company-profile/alliance-pharma-plc/,No
allist shanghai pharmaceutical technology co ltd,Pharmaceuticals,"$28M, Series A/A+",https://www.allist.com.cn/en/aboutus.html,No
allyx therapeutics inc,Biotechnology,"$7.6M, Series A",https://www.nia.nih.gov/research/sbir/nia-small-business-showcase/allyx-therapeutics-inc,No
alpheus medical inc,Biotechnology,"$52M, Series B",https://tcbmag.com/alpheus-medical-lands-52m-for-novel-brain-cancer-treatment/,No
altasciences co inc,Pharmaceuticals,"$716,876, Not Found",https://www.gatesfoundation.org/about/committed-grants/2017/11/inv-008970,No
alterity therapeutics ltd,Biotechnology,"$20M, Not Found",https://finance.yahoo.com/quote/ATHE/,No
alucent biomedical inc,Biotechnology,"$35M, Series B",https://www.stradlinglaw.com/experience/alucent-biomedical-closes-series-b-financing.html,No
alveron pharma,Pharmaceuticals,"$5.3M, Seed",https://www.crunchbase.com/organization/alveron-pharma,No
alvogen korea co ltd,Pharmaceuticals,"$669M, Debt Financing",https://www.linkedin.com/company/alvogenpr,No
alyra biotech pty ltd,Biotechnology,"$10M, Seed",https://www.drsusanevans.com.au/innovation/,No
alyssum therapeutics inc,Biotechnology,"$26M, Series A",https://www.crunchbase.com/organization/alyssum-therapeutics,No
alzecure pharma ab,Biotechnology,"$720.7K, Post IPO equity",https://www.crunchbase.com/organization/alzecure-pharma-ab,No
amarin corp plc,Pharmaceuticals,"$52.8M, Post IPO equity",https://www.linkedin.com/company/amarin-corporation,No
amazentis sa,Biotechnology,"$10M, Series A",https://www.nestlehealthscience.com/newsroom/press-releases/nestle-health-science-invests-in-global-strategic-partnership-with-amazentis-to-develop-its-new-cellular-nutrient-urolithinamazentis-to-develop-its-new-cellular-nutrient-urolithin,No
amicogen inc,Biotechnology,"$231M, Post IPO Equity",https://www.linkedin.com/company/amicogen-inc/,No
aminex therapeutics inc,Biotechnology,"$6.3M, Series Unknown",https://www.linkedin.com/company/aminex-therapeutics,No
amneal pharmaceuticals inc,Pharmaceuticals,"$2.4B, Post IPO Debt",https://www.linkedin.com/company/amneal-pharmaceuticals,No
amplia therapeutics ltd,Pharmaceuticals,"$27.5M, Not Found",https://au.linkedin.com/company/amplia-therapeutics,No
anheart therapeutics inc,Biotechnology,"$61M, Series B",https://www.linkedin.com/company/anheart-therapeutics-official,No
anacardio ab,Biotechnology,"$40M, Series A",https://se.linkedin.com/company/anacardio,No
ananda scientific inc,Biotechnology,"$2.35M, Series A",https://tracxn.com/d/companies/ananda-scientific/__LqNO5wEFIKOHYss9RrDZevB1WPv8GD6VIIy5RgwEMEE,No
ancora bio inc,Biotechnology,"$60M, Series A",https://www.cbinsights.com/company/ancora-biotech,No
anebulo pharmaceuticals inc,Pharmaceuticals,"$994,300, Grant",https://www.nasdaq.com/press-release/anebulo-pharmaceuticals-reports-fourth-quarter-and-fiscal-year-2025-financial-results,No
"anesiva, inc.",Biotechnology,"$2M, Post IPO Debt",https://www.linkedin.com/company/anesiva,No
angany inc,Biotechnology,"$20M, Not Found",https://nextmune.com/vet/blog-news/nextmune-angany,No
"anhui anke hengyi pharmaceutical co., ltd.",Pharmaceuticals,"$10M, Series A",https://www.linkedin.com/company/anhui-anke-biotechnology-group-co-ltd-/,No
anhui biochem united pharmaceutical co ltd,Pharmaceuticals,"$74.3M, Not Found",Not Found,No
anhui biomec biopharmaceutical co ltd,Biotechnology,"$13.7M, Series A",https://en.lcywhx.com/,No
anji pharma (us) llc,Pharmaceuticals,"$70M, Series B",https://www.crunchbase.com/organization/anji-pharmaceuticals,No
anji pharmaceuticals inc,Pharmaceuticals,"$70M, Series B",https://www.businesswire.com/news/home/20210928005198/en/Anji-Pharma-Secures-%2470-Million-to-Deploy-Dynamic-Equity-and-Further-Build-a-Global-Medicines-Company,No
annovis bio inc,Biotechnology,"$6M, Post IPO Equity",https://www.globenewswire.com/news-release/2025/10/10/3164858/0/en/Annovis-Announces-6-Million-Registered-Direct-Offering-of-Common-Stock.html,No
anqing echo bi pharmaceutical co ltd,Pharmaceuticals,"$10M, Not Found",Not Found,No
antabio sas,Biotechnology,"$27M, Series B",https://www.crunchbase.com/organization/antabio,No
antares pharma inc,Pharmaceuticals,"$960M, Acquired",https://www.prnewswire.com/news-releases/halozyme-to-acquire-antares-pharma-to-create-a-specialty-product-and-drug-delivery-leader-301524604.html,No
antibe therapeutics inc,Pharmaceuticals,"$100M, Licensing Deal",https://en.wikipedia.org/wiki/Antibe_Therapeutics,No
antios therapeutics inc (inactive),Biotechnology,"$96M, Series B",https://finance.yahoo.com/news/antios-therapeutics-raises-96-million-113000816.html,No
aptissen sa,Biotechnology,"$10M, Seed",https://www.crunchbase.com/organization/aptissen,No
aptose biosciences inc,Biotechnology,"$11.9M, Post IPO Debt",https://www.linkedin.com/company/aptose-biosciences,No
aragon pharmaceuticals inc,Pharmaceuticals,"$1B, Acquired",https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-aragon-pharmaceuticals-inc,No
arbor pharmaceuticals llc,Pharmaceuticals,"$Not Found, Acquired",https://www.linkedin.com/company/arbor-pharmaceuticals,No
arctic therapeutics ehf,Biotechnology,"$27.6M, Series A",https://globalgenes.org/raredaily/arctic-therapeutics-announces-27-6-million-financing/,No
arctic vision shanghai biotechnology co ltd,Biotechnology,"$100M, Series B",https://www.crunchbase.com/organization/arctic-vision,No
arcutis biotherapeutics inc,Biotechnology,"$150M, Post IPO equity",https://finance.yahoo.com/quote/ARQT/,No
ardelyx inc,Biotechnology,"$20M, Post IPO Debt",https://www.linkedin.com/company/ardelyx-inc-,No
arena pharmaceuticals inc,Pharmaceuticals,"$56M, Post IPO equity",https://www.linkedin.com/company/arena-pharmaceuticals,No
aresus pharma gmbh,Pharmaceuticals,"$765,655, Seed",https://www.companisto.com/en/investment/aresus-pharma-spv,No
areteia therapeutics inc,Biotechnology,"$425M, Series A",https://www.baincapital.com/news/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage,No
aribio,Biotechnology,"$90M upfront, up to $770M total, Corporate round",https://www.pharmaceutical-technology.com/news/aribio-licenses-alzheimers-pill-in-china-for-up-to-770m/,No
ariad pharmaceuticals inc,Biotechnology,"$5.2B, Acquired",https://www.takeda.com/newsroom/newsreleases/2017/takeda-to-acquire-ariad-pharmaceuticals-inc/,No
aristea therapeutics inc,Biotechnology,"$63M, Series B",https://www.biospace.com/article/pfizer-cuts-mid-stage-candidates-amid-declining-revenues/,No
aristea therapeutics inc (inactive),Biotechnology,"$63M, Series B",https://www.biopharmadive.com/news/an-astrazeneca-spinout-scores-a-buyout-option-from-arena/604014/,No
array biopharma inc,Pharmaceuticals,"$225M, Post IPO Equity",https://www.linkedin.com/company/array-biopharma,No
arrevus inc,Biotechnology,"$1.45M, Seed",https://tracxn.com/d/companies/arrevus/__Iq55l7zSe_6cVHSs9t_n3GgmDQaMHT18VcyN76U-gdg,No
arrevus inc (inactive),Biotechnology,"$800K, Grants",https://wraltechwire.com/2021/11/03/biopharma-deal-novaquest-backed-aceragen-buys-arrevus/,No
arrien pharmaceuticals llc,Pharmaceuticals,"$2.0M, Series A",https://www.biospace.com/arrien-pharmaceuticals-llc-founder-closes-2-0-million-series-a-financing,No
arrivent biopharma inc,Biotechnology,"$75M, IPO",https://finance.yahoo.com/quote/AVBP/,No
artax biopharma inc,Biotechnology,"$8M, Convertible Debt Financing",https://www.prnewswire.com/news-releases/artax-biopharma-raises-8-million-ahead-of-phase-2a-data-expected-in-q4-2024-302214540.html,No
artelo biosciences inc,Pharmaceuticals,"$2.0M, Post IPO equity",https://www.linkedin.com/company/artelo-biosciences-inc,No
arthrosi therapeutics inc,Biotechnology,"$153M, Series E",https://www.prnewswire.com/news-releases/arthrosi-secures-153-million-in-series-e-financing-to-complete-pivotal-development-of-pozdeutinurad-for-the-treatment-of-gout-and-tophaceous-gout-302578248.html,No
artios pharma ltd,Biotechnology,"$152.7M, Series C",https://www.crunchbase.com/organization/artios-pharma,No
arvinas inc,Biotechnology,"$704.1M, IPO",https://www.linkedin.com/company/arvinas,No
asarina pharma ab,Biotechnology,"$3M, Acquired",https://www.relmada.com/for-investors/news/detail/308/relmada-therapeutics-acquires-potential-therapy-for,No
ascelia pharma ab,Biotechnology,"$3.2M, Post IPO Equity",https://www.linkedin.com/company/asceliapharma,No
asceneuron sa,Biotechnology,"$100M, Series C",https://eqtgroup.com/news/eqt-life-sciences-invests-in-asceneuron-a-neurodegeneration-therapeutics-company-as-part-of-usd-100-million-series-c-financing-round-2024-07-16,No
ascentage pharma group inc,Biotechnology,"$192.3M, Post IPO equity",https://www.linkedin.com/company/ascentage-pharma-group-corporation,No
ascentawits pharmaceuticals ltd,Pharmaceuticals,"$10M, Seed",https://www.prnewswire.com/news-releases/sangel-capital-founder-receives-title-of-chinas-top-early-stage-investor-from-chinaventure-awards-301620123.html,No
ashvattha therapeutics llc,Biotechnology,"$50M, Series B",https://www.linkedin.com/company/ashvattha-therapeutics-inc,No
asociacion europea y latinoamericana selnet para la investigacion en sarcomas,Biotechnology,"$567,270.06, Not Found",https://cordis.europa.eu/project/id/825806,No
aspargo laboratories inc,Pharmaceuticals,"$60M, Private Equity",https://www.crunchbase.com/organization/aspargo-laboratories,No
atacama therapeutics inc,Biotechnology,"$830K, Unattributed",https://www.cbinsights.com/company/atacama-therapeutics,No
atea pharmaceuticals inc,Pharmaceuticals,"$215M, Series D",https://www.baincapital.com/news/atea-pharmaceuticals-announces-ind-clearance-527-covid-19-and-215-million-financing,No
athira pharma inc,Biotechnology,"$307.5M, IPO",https://www.biopharmadive.com/news/athira-strategic-alternatives-earnings-alzheimers-neuroscience/732405/,No
atrin pharmaceuticals llc,Pharmaceuticals,"$76M, Acquired",https://www.globenewswire.com/news-release/2022/05/16/2444027/0/en/Aprea-Therapeutics-Announces-Acquisition-of-Atrin-Pharmaceuticals-Inc-and-Reports-First-Quarter-2022-Financial-Results.html,No
atriva therapeutics gmbh,Biotechnology,"$24M, Debt Financing",https://www.eib.org/en/press/all/2020-280-germany-eib-backs-atriva-therapeutics-with-eur24-million-for-the-development-of-a-potential-covid-19-treatment,No
atrogi ab,Biotechnology,"$25M, Not Found",https://www.biospace.com/atrogi-announces-publication-on-advancements-in-combatting-obesity-and-metabolic-complications,No
attgeno ab,Biotechnology,"$2M, Seed",https://hadeanventures.com/2022/07/attgeno-ab-announces-fully-subscribed-share-issue-to-complete-clinical-phase-ii-study-in-acute-pulmonary-hypertension/,No
audiocure pharma gmbh,Pharmaceuticals,"$9.58M, Series A",https://www.crunchbase.com/organization/audiocure-pharma,No
auspex pharmaceuticals inc,Pharmaceuticals,"$3.5B, Acquired",https://www.reuters.com/article/business/healthcare-pharmaceuticals/teva-to-buy-us-drug-developer-auspex-pharma-for-35-billion-idUSKBN0MQ12I/,No
australasian myeloma research consortium,Biotechnology,"$1.5M, Not Found",https://clinicaltrialsalliance.org.au/latest-news/amarc-frail-m/,No
autifony therapeutics ltd,Biotechnology,"$10M, Seed",https://www.uclb.com/portfolio/our-spinouts/autifony-therapeutics-ltd/,No
autobahn therapeutics inc,Biotechnology,"$100M, Series C",https://www.biopharmadive.com/news/autobahn-therapeutics-cns-depression-bipolar-series-c/722214/,No
avalyn pharma inc,Biotechnology,"$100M, Series D",https://www.globenewswire.com/news-release/2025/07/22/3119277/0/en/Avalyn-Completes-Oversubscribed-100-Million-Series-D-Financing-to-Further-Advance-Clinical-Development-of-Novel-Inhaled-Therapies-for-Pulmonary-Fibrosis.html,No
avanir pharmaceuticals inc,Pharmaceuticals,"$95M, Acquired",https://www.otsuka-us.com/news/avanir-pharmaceuticals-inc-business-will-be-integrated-otsuka-america-pharmaceutical-inc,No
avelos therapeutics inc,Biotechnology,"$21.7M, Series B",https://www.prnewswire.com/news-releases/avelos-therapeutics-announces-krw-17-billion-series-b-funding-round-surpassing-krw-30-billion-total-raised-302157710.html,No
avenue therapeutics inc,Pharmaceuticals,"$5M, Post IPO equity",https://www.linkedin.com/company/avenue-therapeutics,No
avicanna inc,Biotechnology,"$727.6K, Post IPO Equity",https://www.crunchbase.com/organization/avicanna-inc,No
avior bio inc,Pharmaceuticals,"$1.4M, Seed",https://www.linkedin.com/company/avior-bio-inc,No
aviron pharma llc,Pharmaceuticals,"$8M, Private Funding",https://tracxn.com/d/companies/aviron/__ZaXfW_QF5UtDHmvfa8xTx76ZVJgyJyqg928uvAZMjkg,No
avistone biotechnology co ltd,Biotechnology,"$140.7M, Series B",https://www.linkedin.com/company/avistone-biotechnology-co-inc,No
axcella health inc,Biotechnology,"$34.2M, Post IPO equity",https://www.linkedin.com/company/axcella-tx,No
axial therapeutics inc,Biotechnology,"$37.3M, Series C",https://www.linkedin.com/company/axial-biotherapeutics-inc,No
ayuvis research inc,Biotechnology,"$5M, Seed",https://www.bio.org/events/bio-international-convention/sessions/2451091,No
azafaros bv,Biotechnology,"$146.69M, Series B",https://european-biotechnology.com/latest-news/azafaros-bv-bags-e132m-series-b-financing/,No
azora therapeutics inc,Biotechnology,"$581.4K, Series Unknown",https://www.crunchbase.com/organization/azora-therapeutics,No
azura ophthalmics pty ltd,Biotechnology,"$32M, Series B",https://www.crunchbase.com/organization/azura-ophthalmics,No
bellus health inc,Biotechnology,"$200M, Acquired",https://ca.linkedin.com/company/bellus-health,No
bhi therapeutic sciences,Biotechnology,"$1.2M, Seed",https://bhisciences.com/,No
bit pharma gmbh,Pharmaceuticals,"$10M, Seed",https://www.bit-pharma.com/,No
bacainn therapeutics inc,Biotechnology,"$25M, Not Found",https://www.biospace.com/bacainn-therapeutics-reports-positive-topline-results-from-phase-1-study-of-bt051-a-novel-therapeutic-approach-to-treat-inflammatory-diseases-such-as-ulcerative-colitis,No
balance therapeutics inc,Pharmaceuticals,"$21.16M, Series B",https://www.linkedin.com/company/balance-therapeutics-inc-,No
banner life sciences llc,Pharmaceuticals,Acquired,https://www.businesswire.com/news/home/20250113852731/en/Cycle-Pharma-Acquires-Banner-Life-Sciences-LLC,No
bantam pharmaceutical llc,Pharmaceuticals,"$25M, Seed",https://www.linkedin.com/company/bantam-pharmaceutical-llc,No
baoyuan biopharmaceuticals technology hangzhou co ltd,Biotechnology,"$15M, Series A",https://www.prnewswire.com/news-releases/preclincal-results-of-baoyuans-next-generation-ros1ntrk-inhibitor-ab-106-published-in-nature-communications-300925036.html,No
beijing beilu pharmaceutical co ltd,Pharmaceuticals,"$70.42M, IPO",https://en.wikipedia.org/wiki/Beilu_Pharmaceutical,No
beijing hope pharmaceutical co ltd,Pharmaceuticals,"$6.3M, IPO",https://www.linkedin.com/company/beijing-hope-international-pharmaceutical-co.-ltd.-bhip-/,No
beijing jialin pharmaceutical co ltd,Pharmaceuticals,"$600M, Acquired",https://www.asianscientist.com/2014/09/pharma/luye-acquires-jialin-us600-million-2014/,No
beijing joekai biotechnology co ltd,Biotechnology,"$7.82M, Series B",https://www.cbinsights.com/company/joekai-biotechnology,No
beijing minkang baicao pharmaceutical technology co ltd,Pharmaceuticals,"$5.5M, Series A",https://www.marketscreener.com/quote/stock/TONGHUA-GOLDEN-HORSE-PHAR-20701676/news/Beijing-Minkang-Baicao-Pharmaceutical-Technology-Co-Ltd-announced-that-it-expects-to-receive-CNY-34677684/,No
beijing nuobot biotechnology co ltd,Biotechnology,"$8.6M, Equity Round",https://www.marketscreener.com/quote/stock/IMEIK-TECHNOLOGY-DEVELOPM-119082514/news/Beijing-Nuobote-Biotech-Co-Ltd-announced-that-it-expects-to-receive-CNY-56-million-in-funding-fro-40217213/,No
beijing nuokangda pharmaceutical technology co ltd,Pharmaceuticals,"$23M, Unattributed VC",https://www.cbinsights.com/company/nuokangda-pharmaceutical-technology,No
beijing pearl biotechnology llc,Biotechnology,"$200M, Acquired",https://www.bioworld.com/articles/514271-avistone-raises-200m-acquires-pearl-biotech,No
beijing silian pharmaceutical co ltd,Pharmaceuticals,"$20M, Not Found",Not Found,No
beijing wehand-bio pharmaceutical co ltd,Pharmaceuticals,"$20.5M, Series A",http://www.wehandbio.com/,No
beijing zhidao biotechnology co ltd,Biotechnology,"$29.3M, Series C",https://tracxn.com/d/companies/beijing-zhidao-biotechnology/__7Cp9olmAziqRYUWeA8PMUoI384stUq5zdRjHZiHBA10,No
belite bio inc,Biotechnology,"$125M, Post IPO equity",https://www.linkedin.com/company/belitebio,No
betagenon ab,Biotechnology,"$26M, Acquired",https://www.biospace.com/amplifier-launches-to-bring-first-ampk-activator-for-obesity-to-clinic,No
bharat biotech ltd,Biotechnology,"$19.95M, Not Found",https://www.gatesfoundation.org/about/committed-grants/2019/11/inv003491,No
bial - portela & ca sa,Pharmaceuticals,"$45M, Not Found",https://en.wikipedia.org/wiki/Bial,No
bio blast pharma ltd,Biotechnology,"$6.7M, IPO",https://www.sec.gov/Archives/edgar/data/1596812/000114420414006928/v367497_f1.htm,No
bio-images drug delivery ltd,Pharmaceuticals,"$2.5M, Series Unknown",https://www.crunchbase.com/organization/bdd,No
biochemics inc (inactive),Biotechnology,"$9M, Not Found",https://www.forkeylaw.com/blog/biochemics_inc_john_masiz_craig_medoff_and_gregory_kroning_-_boca_raton_florida_securities_and_inves/,No
biodelivery sciences international inc,Pharmaceuticals,"$604M, Acquired",https://www.goodwinlaw.com/en/news-and-events/news/2022/02/02_14-biodelivery-sciences-international,No
biodonostia health research institute,Biotechnology,"$2M, Not Found",https://innovation-radar.ec.europa.eu/innovator/972652078,No
bioelectron technology corp,Biotechnology,"$10M, Acquired",https://www.fiercebiotech.com/biotech/pct-therapeutics-elevates-biotech-buyout-ceo-to-chief-development-officer,No
biokier inc,Biotechnology,"$5.16M, Not Found",https://www.sbir.gov/portfolio/690762,No
bionova pharmaceuticals ltd,Biotechnology,"$25M, Series B",https://lu.linkedin.com/company/bionova-pharmaceutical-ltd,No
bioregen biomedical (changzhou) co ltd,Biotechnology,"$9.93M, Series D",https://www.cbinsights.com/company/bioregen,No
bioshin ltd,Pharmaceuticals,"$60M, Series A",https://www.prnewswire.com/news-releases/bioshin-biohavens-asia-pacific-subsidiary-raises-60m-in-series-a-funding-to-advance-neuroscience-pipeline-in-asia-pacific-region-301138697.html,No
biotheryx inc,Biotechnology,"$6M, Corporate Round",https://www.crunchbase.com/organization/biotheryx,No
biocomposites ltd.,Pharmaceuticals,"$10M, Private Equity",https://www.ta.com/portfolio/investments/biocomposites/,No
biodol therapeutics sas,Biotechnology,"$7.6M, Not Found",https://www.crunchbase.com/organization/biodol-therapeutics,No
biomedica foscama group spa,Pharmaceuticals,"$22.6M, Not Found",https://www.linkedin.com/company/biomedicafoscama,No
biomedical advanced research and development authority,Biotechnology,"$1.6B, Not Found",https://en.wikipedia.org/wiki/Biomedical_Advanced_Research_and_Development_Authority,No
biomimetix jv llc,Biotechnology,"$2M, Seed",https://www.linkedin.com/company/biomimetix,No
biopharm spa,Pharmaceuticals,"$49M, IPO",https://www.sgbv.dz/?page=details_societe&id_soc=43&lang=eng,No
biotie therapies ltd,Biotechnology,"$363M, Acquired",https://www.fiercebiotech.com/biotech/acorda-to-acquire-biotie-therapies,No
biotyx medical (shenzhen) co ltd,Biotechnology,"$27.4M, Series B",https://www.prnewswire.com/apac/news-releases/lifetech-scientific-corporation-announced-2023-annual-results-international-business-achieved-a-robust-growth-innovation-at-the-core-to-drive-the-solid-development-302105910.html,No
bioversys ag,Pharmaceuticals,"$76.7M, IPO",https://ch.linkedin.com/company/bioversys-ag,No
birchbiomed inc,Biotechnology,"$5.3M, Series Unknown",https://ca.linkedin.com/company/birchbiomed-inc,No
black diamond therapeutics inc,Biotechnology,"$75M, Post IPO equity",https://www.linkedin.com/company/black-diamond-therapeutics,No
blade therapeutics inc,Biotechnology,"$254.3M, Not Found",https://www.biospace.com/employer/400420/blade-therapeutics,No
blossomhill therapeutics inc,Biotechnology,"$100M, Series B",https://www.crunchbase.com/organization/blossomhill-therapeutics,No
blueberry therapeutics ltd,Biotechnology,"$23.8M, Series B",https://tracxn.com/d/companies/blueberry-therapeutics/__Woij0NynWWQYpvMfZgORLuvNNuUtSGKdGbjTJZvN21M,No
bnh research,Biotechnology,"$13.5M, Series B",https://www.biospectator.com/news/view/20877,No
bod science ltd,Pharmaceuticals,"$2M, Not Found",https://nextinvestors.com,No
bol pharma,Pharmaceuticals,"$30M, Convertible Note",https://www.linkedin.com/company/bol-pharma/,No
bold therapeutics inc,Biotechnology,"$796.6K, Grant",https://www.crunchbase.com/organization/bold-therapeutics,No
bond biosciences (inactive),Biotechnology,"$6.8M, Series B",https://www.businesswire.com/news/home/20220125005090/en/Bond-Biosciences-Announces-the-Closing-of-a-Series-B-Financing,No
bonesupport ab,Biotechnology,"$39.3M, IPO",https://www.linkedin.com/company/bonesupport-ab,No
botanic healthcare pvt ltd,Biotechnology,"$30M, Series A",https://www.entrepreneur.com/en-in/news-and-trends/botanic-healthcare-secures-inr-250-crore-investment-for/485135,No
brain trust bio,Biotechnology,"$400K, Convertible Note",https://www.cbinsights.com/company/brain-trust-bio,No
braintree laboratories inc,Pharmaceuticals,"$Not Found, Acquired",https://www.wilmerhale.com/en/insights/news/20180510-wilmerhale-counsels-braintree-laboratories-in-acquisition-by-sebela-pharmaceuticals,No
braxia scientific corp,Biotechnology,"$15M, Not Found",https://www.bcsc.bc.ca/industry/issuer-regulation/reporting-issuers/reporting-issuers-list/s7s1s6s0s7s6s7sds6s3s7s1,No
breye therapeutics aps,Pharmaceuticals,"$10M, Series A",https://www.linkedin.com/company/breye-therapeutics-aps,No
bright minds biosciences inc,Biotechnology,"$100M, IPO",https://finance.yahoo.com/quote/DRUG.CN/profile/,No
brio bliss life science pvt ltd,Pharmaceuticals,"$2.49M, Angel",https://tracxn.com/d/companies/brio-bliss-life-science/__dWta51bITLEev43ip2NmQnSOM2bW5BngVV4O_GwSBaI,No
bto pharm co ltd,Pharmaceuticals,"$7.6M, Acquired",https://www.marketscreener.com/quote/stock/CG-INVITES-CO-LTD-120962288/news/CrystalGenomics-Inc-and-Hwail-Pharm-Co-Ltd-agreed-to-acquire-BTO-Bio-Pharmaceuticals-Co-Ltd-f-38147388/,No
bugworks research india pvt ltd,Biotechnology,"$42.9M, Series B",https://tracxn.com/d/companies/bugworks-research/__ZnDLP4i8MhjGMBE1k2uW8jzRiaxXfOW8Pvq_ufLt8sY,No
burnet institute,Biotechnology,"$175,481, Not Found",https://www.gatesfoundation.org/about/committed-grants/2017/11/inv-010292,No
cage bio inc,Biotechnology,"$7.2M, Series A",https://www.linkedin.com/company/cage-bio-inc,No
cargo therapeutics inc,Biotechnology,"$110M, Post IPO Equity",https://cargo-tx.com/cargo-therapeutics-announces-110-0-million-private-placement-equity-financing/,No
cba pharma inc,Pharmaceuticals,"$100K, Series Unknown",https://www.linkedin.com/company/cba-pharma-inc-,No
ceres brain therapeutics,Pharmaceuticals,"$12M, Not Found",https://www.linkedin.com/company/ceres-brain-therapeutics/,No
cero therapeutics inc,Biotechnology,"$8M, Post IPO equity",https://www.linkedin.com/company/cero-therapeutics,No
cf pharmtech inc,Pharmaceuticals,"$50.9M, Series F",https://www.linkedin.com/company/cf-pharmtech-inc-/,No
cmp pharma inc,Pharmaceuticals,"$10M, Private Equity",https://www.linkedin.com/company/cmp-pharma-inc.,No
cns pharmaceuticals inc,Biotechnology,"$5M, Post IPO Equity",https://www.linkedin.com/company/cnspharma,No
cost-bry pty ltd,Biotechnology,"$2.1M, Not Found",https://statedevelopment.sa.gov.au/news/sa-business-success,No
cv6 therapeutics (ni) ltd,Pharmaceuticals,"$9.2M, Seed",https://synapse.patsnap.com/organization/d2076182a634c04966a62bedd98043f9,No
cvie therapeutics company ltd,Biotechnology,"$39M, Acquired",https://www.biospace.com/windtree-therapeutics-and-cvie-therapeutics-announce-merger-to-create-a-global-acute-care-company-targeting-cardiovascular-and-respiratory-diseases,No
calcimedica subsidiary inc,Biotechnology,"$10.3M, Private Placement",https://www.globenewswire.com/news-release/2023/03/20/2630834/0/en/CalciMedica-Announces-Closing-of-Merger-with-Graybug-Vision-and-Concurrent-Private-Placement.html,No
calimmune inc,Biotechnology,"$15.9M, Series B",https://www.linkedin.com/company/calimmune-inc,No
calliditas therapeutics france sas,Pharmaceuticals,"$90M, IPO",https://www.calliditas.se/en/about-us/,No
callisto pharmaceuticals inc (inactive),Biotechnology,"$3M, Private Placement",https://www.eleconomista.es/empresas-finanzas/noticias/667261/07/08/Callisto-Pharmaceuticals-Announces-30-Million-Financing-by-Its-Synergy-Pharmaceuticals-Subsidiary-and-Related-Transactions-Leaving-Callisto-with-a-68-Stake-in-Synergy.html,No
camino pharma llc,Biotechnology,"$1.97M, Grant",https://www.prnewswire.com/news-releases/camino-pharma-receives-1-97m-small-business-innovation-research-sbir-grant-from-the-national-institute-of-alcohol-abuse-and-alcoholism-302008086.html,No
can-fite biopharma ltd,Biotechnology,"$175M, Not Found",https://finance.yahoo.com/quote/CANF/,No
canadian cancer trials group,Biotechnology,"$1.5M, Not Found",https://www.ctg.queensu.ca/,No
canary foundation for health research,Biotechnology,"$30M, Not Found",https://www.handsonbayarea.org/organization/0016000000ikWtoAAE,No
cancer prevention pharmaceuticals inc,Biotechnology,"$60M, Acquired",https://www.globenewswire.com/news-release/2022/02/22/2389291/37414/en/Panbela-Therapeutics-Inc-to-Acquire-Cancer-Prevention-Pharmaceuticals-Inc.html,No
cancer targeted technology llc,Biotechnology,"$13.34M, Grant",https://taggs.hhs.gov/Detail/RecipDetail?arg_EntityId=JVDRz%2FBcf0kGBNQvp%2BUENw%3D%3D,No
cann group ltd,Biotechnology,"$2M, Not Found",https://www.canngrouplimited.com/,No
cannabibs sp. z o.o.,Pharmaceuticals,"$180K, Seed",https://cannabibs.eu/,No
cannamore biotechs ltd,Biotechnology,"$2.1M, Seed",https://www.ivc-online.com/Google-Card?id=878d0eeb-5bd4-e911-8106-0050569a1018,No
captor therapeutics sa,Biotechnology,"$17M, Grant",https://ch.linkedin.com/company/captortherapeutics,No
cardeas pharma corp,Pharmaceuticals,"$49.02M, Series B",https://www.cbinsights.com/company/cardeas-pharma,No
cardurion pharmaceuticals inc,Biotechnology,"$260M, Series B",https://www.biopharmadive.com/news/cardurion-series-b-pde9-inhibitors-heart-drug-venture/721462/,No
cardurion pharmaceuticals llc,Biotechnology,"$260M, Series B",https://www.businesswire.com/news/home/20240716908637/en/Cardurion-Pharmaceuticals-Announces-%24260-Million-Series-B-Financing-to-Advance-Its-Pipeline-of-Innovative-Medicines-for-Cardiovascular-Diseases,No
caribou biosciences inc,Biotechnology,"$125M, Post IPO equity",https://pitchbook.com/profiles/company/97981-03,No
carna biosciences inc,Biotechnology,"$20M, Not Found",https://www.gilead.com/news/news-details/2019/gilead-and-carna-biosciences-announce-research-and-development-collaboration-to-develop-novel-immuno-oncology-therapies,No
carrick therapeutics ltd,Biotechnology,"$60M, Series C",https://www.cancerresearchhorizons.com/news-and-events/our-news/carrick-therapeutics-raises-60-million-through-series-c-and-pfizer,No
carthera sas,Biotechnology,"$45M, Series B",https://www.bioworld.com/keywords/19524-carthera-sa,No
cascadian therapeutics inc,Biotechnology,"$10M, Acquired",https://www.biospace.com/seattle-genetics-completes-acquisition-of-cascadian-therapeutics,No
cascadian therapeutics inc (inactive),Biotechnology,"$614M, Acquired",https://www.goodwinlaw.com/en/news-and-events/news/2018/01/01_31_18-cascadian-therapeutics-to-be-acquired,No
cassiopea spa,Pharmaceuticals,"$45M, Acquired",https://www.prnewswire.com/news-releases/sun-pharma-and-cassiopea-spa-announce-signing-of-license-and-supply-agreements-for-winlevi-clascoterone-cream-1-in-us-and-canada-301340816.html,No
catalyst pharmaceuticals inc,Biotechnology,"$375M, IPO",https://en.wikipedia.org/wiki/Catalyst_Pharmaceuticals,No
cebiotex sl,Biotechnology,"$10M, Seed",https://www.f6s.com/company/cebiotex,No
celcuity inc,Biotechnology,"$500M, Post IPO Debt",https://www.linkedin.com/company/celcuity,No
celecor therapeutics inc,Biotechnology,"$45.5M, Series Unknown",https://www.crunchbase.com/organization/celecor-therapeutics,No
"cell genesys, inc. (inactive)",Biotechnology,"$38M, Acquired",https://www.genengnews.com/news/biosante-to-take-over-cell-genesys-in-a-38m-all-stock-deal/,No
cellectar biosciences inc,Biotechnology,"$5.8M, Post IPO equity",https://www.cellectar.com/,No
cellestia biotech ag,Biotechnology,"$20M, Series B",https://www.startupticker.ch/en/company/cellestia-biotech,No
celonova biosciences inc,Biotechnology,"$20.8M, Series B",https://tracxn.com/d/companies/celonova-biosciences/__RE-zjn_lDjJyf4lnadTIUA3hbA-CTQFuFB2ABU6Aq1A,No
celtaxsys inc (inactive),Pharmaceuticals,"$53.1M, Series E",https://tracxn.com/d/companies/celtaxsys/__HEE_7cB6hzyAsEqcpEF6kwLcgmP7y-KWHRicgKnoYPA,No
censa pharmaceuticals inc,Biotechnology,"$1.5M, Series Unknown",https://www.linkedin.com/company/censa-pharmaceuticals-inc,No
centaur pharmaceuticals pvt ltd,Pharmaceuticals,"$7.5M, Seed",https://in.linkedin.com/company/centaur-pharmaceuticals-pvt.-ltd.,No
center for study of stem cells,Biotechnology,"$1.1M, Not Found",https://stemcell.nd.edu/,No
central drug research institute,Pharmaceuticals,"$83M, Not Found",https://en.wikipedia.org/wiki/Central_Drug_Research_Institute,No
centrexion therapeutics corp,Biotechnology,"$40.5M, Series Unknown",https://www.linkedin.com/company/centrexion-therapeutics-corp-,No
cephalon inc,Pharmaceuticals,"$6.8B, Acquired",https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2011/Teva-Completes-Acquisition-of-Cephalon/default.aspx,No
ceptaris therapeutics inc,Pharmaceuticals,"$10M, Acquired",https://www.thirdpointventures.com/companies/ceptaris/,No
cerrx inc,Biotechnology,"$2.13M, Series A",https://tracxn.com/d/companies/cerrx/__8QlLACR-200kEV0Q8WHGSfIJgRgq8SexA7khxegeVTc,No
cerebral therapeutics inc,Pharmaceuticals,"$40M, Series C",https://www.biospace.com/cerebral-therapeutics-inc-secures-40-million-series-c-financing,No
cerecin pte ltd,Biotechnology,"$255M, Series C",https://tracxn.com/d/companies/cerecin/__zOVHQjDhjqn1XDW8-_cUlPokGPki7soxYMBXw5nDOtM,No
cerevel therapeutics holdings inc,Biotechnology,"$445M, IPO",https://en.wikipedia.org/wiki/Cerevel_Therapeutics,No
cerevel therapeutics llc,Biotechnology,"$445M, IPO",https://en.wikipedia.org/wiki/Cerevel_Therapeutics,No
certa therapeutics pty ltd,Biotechnology,"$30M, Series B",https://www.globenewswire.com/news-release/2024/12/19/2999579/0/en/Certa-Therapeutics-Expands-GPR68-Platform-through-Acquisition-of-OccuRx.html,No
cervomed inc,Biotechnology,"$149.4M, Post IPO Debt",https://www.linkedin.com/company/cervomed,No
cessatech a/s,Pharmaceuticals,"$732.7K, Post IPO Debt",https://www.linkedin.com/company/cessatech/,No
charleston laboratories inc,Pharmaceuticals,"$7.4M, Series Unknown",https://www.linkedin.com/company/charleston-laboratories-inc-,No
chase therapeutics corp,Pharmaceuticals,"$30.9M, Series B",https://tracxn.com/d/companies/chase-therapeutics/__NxLpj_4Jgga63S7KbxYEWqki7YL06q0UZa1Suiu0bSw,No
chelsea therapeutics ltd,Biotechnology,"$658M, Acquired",https://www.pharmaceutical-technology.com/news/newslundbeck-to-acquire-chelsea-therapeutics-for-658m-4263311/,No
chelsea therapeutics international ltd,Biotechnology,"$14.52M, Acquired",https://www.cbinsights.com/company/chelsea-therapeutics-international,No
chemo/liconsa,Pharmaceuticals,"$1.18M, Not Found",https://www.chemopharmaceuticals.com/en/sede/rd-azuqueca-de-henares/,No
chengdu hengrui pharmaceutical co ltd,Pharmaceuticals,"$500M, Not Found",https://www.gsk.com/en-gb/media/press-releases/gsk-and-hengrui-pharma-enter-agreements/,No
chengdu kelingyuan pharmaceutical technology co ltd,Pharmaceuticals,"$6.85M, Series A",https://www.tianfulifesciencepark.com/en/News/Detail?id=1033,No
chengdu list pharmaceutical co ltd,Pharmaceuticals,"$736.29M, Acquired",https://en.avancpharma.com/%E8%BE%BD%E5%AE%81%E7%9C%81%E5%A7%94%E5%B8%B8%E5%A7%94%E3%80%81%E5%89%AF%E7%9C%81%E9%95%BF%E9%99%88%E5%90%91%E7%BE%A4%E4%B8%80%E8%A1%8C%E8%8E%85%E4%B8%B4%E5%A5%A5%E9%B8%BF%E8%8D%AF%E4%B8%9A%E8%A7%86-2/,No
chengdu shengdi medical company co ltd,Pharmaceuticals,"$12.3M, Series A",https://www.marketscreener.com/quote/stock/JIANGSU-HENGRUI-MEDICINE--6497440/news/Chengdu-Shengdi-Medical-Co-Ltd-announced-that-it-expects-to-receive-CNY-90-million-in-funding-fro-39107792/,No
chengdu shuode pharmaceutical co ltd,Pharmaceuticals,"$70M, Equity Round",https://www.marketscreener.com/quote/stock/CHENGDU-EASTON-BIOPHARMAC-119082746/news/Chengdu-Shuode-Pharmaceutical-Co-Ltd-announced-that-it-expects-to-receive-CNY-510-45-million-in-f-33687808/,No
chenxin pharmaceutical co ltd,Pharmaceuticals,"$50M, Acquired",https://www.kingdomway.com/EN/EnHolding/Index/bb75fbe3-46fb-4994-bd48-7c162ad87e63.html,No
chimerix inc,Biotechnology,"$935M, Acquired",https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-acquire-chimerix-further-diversifying-oncology-portfolio-302393029.html,No
chongqing derunsheng pharmaceutical co ltd,Pharmaceuticals,"$60M, Not Found",https://www.marketscreener.com/quote/stock/TIANSHENG-PHARMACEUTICAL--36818700/news/Chongqing-Pharmaceutical-CO-LTD-completed-the-acquisition-of-51-stake-in-Chongqing-Changsheng-Me-33417794/,No
chongqing yuyang pharmaceutical co ltd,Pharmaceuticals,"$41M, Equity Round",https://www.marketscreener.com/quote/stock/HUADONG-MEDICINE-CO-LTD-6497912/news/Chongqing-Yuyan-Pharmaceutical-Co-Ltd-announced-that-it-has-received-CNY-300-million-in-funding-f-45365741/,No
chordia therapeutics inc,Biotechnology,"$26.9M, Series B",https://www.linkedin.com/company/chordia-therapeutics-inc/,No
chr. hansen holding as,Biotechnology,"$711.3M, IPO",https://www.crunchbase.com/organization/chr-hansen-holding-a-s,No
chrono therapeutics inc,Pharmaceuticals,"$82.2M, Series B",https://tracxn.com/d/companies/chrono-therapeutics/__UdWwTR7_VHIhbaafVAK_LID0DcUsb-F05cgVrk8_UkE,No
cincor pharma inc,Biotechnology,"$1.8B, Acquired",https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-acquire-cincor-for-cardiorenal-asset.html,No
cindome pharma llc,Pharmaceuticals,"$40M, Series B",https://cinrx.com/cindome-pharma-announces-40-million-series-b-extension/,No
cinrx pharma llc,Pharmaceuticals,"$73M, Not Found",https://www.businesswire.com/news/home/20240530932802/en/CinRx-Pharma-Announces-Additional-%2473-Million-Financing,No
forsight vision5 inc,Biotechnology,"$11.8M, Debt Financing",https://www.linkedin.com/company/forsight-vision5,No
fore biotherapeutics inc,Biotechnology,"$38M, Series D",https://www.businesswire.com/news/home/20250522968382/en/FORE-Biotherapeutics-Raises-%2438-Million-in-Series-D-2-Financing-for-the-Continued-Advancement-of-Plixorafenib,No
formerly pharmaceutical profiles ltd,Pharmaceuticals,"$25M, Acquired",https://www.nottingham.ac.uk/news/pressreleases/2013/september/spin-out-company-molecular-profiles-purchased-by-us-based-columbia-laboratories-.aspx,No
formosa pharmaceuticals inc,Biotechnology,"$21.2M, Series C",https://is.linkedin.com/company/formosa-pharmaceuticals,No
forward pharma as,Biotechnology,"$1.25B, Acquired",https://www.annualreports.com/Company/forward-pharma-as,No
forward therapeutics inc,Biotechnology,"$50M, Series A",https://www.prnewswire.com/news-releases/forward-therapeutics-announces-50-million-series-a-financing-to-advance-next-generation-small-molecule-immune-therapies-301980905.html,No
foundation for research and biomedical innovation of the infanta leonor university hospital,Biotechnology,"$11.9M, Not Found",https://beamerproject.eu/b-compass-pilot-site/foundation-for-biomedical-research-and-innovation-in-primary-care-of-madrid/,No
foundation of biomedical research of university hospital of asturias,Biotechnology,"$8.6M, Not Found",https://www.ersnet.org/respire/fundacion-para-la-investigacion-e-innovacion-biosanitaria-en-el-principado-de-asturias-finba/,No
fred hutchinson cancer research center,Biotechnology,"$314M, Not Found",https://en.wikipedia.org/wiki/Fred_Hutchinson_Cancer_Center,No
frontage (shanghai) co ltd,Pharmaceuticals,"$22M, IPO",https://www.cbinsights.com/company/frontage-laboratories,No
fuan pharmaceutical group ningbo tianheng pharmaceutical co ltd,Pharmaceuticals,"$570M, Acquired",https://www.marketscreener.com/quote/stock/FUAN-PHARMACEUTICAL-GROUP-11367190/news/Fuan-Pharmaceutical-Co-Ltd-agreed-to-acquire-Ningbo-Tianheng-Pharmaceutical-Co-Ltd-from-Wang-T-38560864/,No
fuan pharmaceutical group ningbo tianheng pharmaceutical company limited,Pharmaceuticals,"$570M, Acquired",https://www.marketscreener.com/quote/stock/FUAN-PHARMACEUTICAL-GROUP-11367190/news/Fuan-Pharmaceutical-Co-Ltd-agreed-to-acquire-Ningbo-Tianheng-Pharmaceutical-Co-Ltd-from-Wang-T-38560864/,No
fuan pharmaceutical group yantai zhichu pharmaceutical co ltd,Pharmaceuticals,"$1.5B, Acquired",https://www.marketscreener.com/quote/stock/FUAN-PHARMACEUTICAL-GROUP-11367190/news/Fuan-Pharmaceutical-Co-Ltd-agreed-to-acquire-Yantai-Justaware-Pharmaceutical-Co-Ltd-from-Shand-38144891/,No
fulcrum therapeutics inc,Biotechnology,"$125M, Post IPO equity",https://www.linkedin.com/company/fulcrum-therapeutics,No
fusogen pharmaceuticals inc,Biotechnology,"$60M, Post IPO equity",https://www.linkedin.com/company/fusion-pharmaceuticals,No
g.st antivirals gmbh,Biotechnology,"$6.7M, Series A",https://www.linkedin.com/company/g-st-antivirals/,No
g2gbio inc,Biotechnology,"$37.7M, IPO","https://www.ipox.com/ipo-calendar/g2gbio#:~:text=G2GBIO%20Inc%20(Ticker%3A%20456160%20KS,2025%2C%20offering%20900%2C000%20new%20shares.",No
gaba international ag,Pharmaceuticals,"$841M, Acquired",https://en.wikipedia.org/wiki/Elmex,No
gaba therapeutics inc,Biotechnology,"$22M, Series A",https://tracxn.com/d/companies/gaba-therapeutics/__jCdYVmUDxyKDI0hMHirVphznk_5xp1zlvmvSoK9TqhY,No
gh research plc,Biotechnology,"$150M, IPO",https://www.linkedin.com/company/ghresearch,No
gie medical inc,Biotechnology,"$5M, Corporate Round",https://www.linkedin.com/company/gie-medical,No
gri bio inc,Biotechnology,"$5M, IPO",https://finance.yahoo.com/quote/GRI/,No
gt medical technologies inc,Biotechnology,"$53M, Series D",https://www.prnewswire.com/news-releases/gt-medical-technologies-completes-final-close-of-companys-oversubscribed-53-million-series-d-equity-financing-to-advance-commercial-treatment-for-patients-with-operable-brain-tumors-302504853.html,No
gw pharmaceuticals ltd,Pharmaceuticals,"$7.2B, Acquired",https://investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-completes-acquisition-gw-pharmaceuticals,No
galera therapeutics inc,Biotechnology,"$30M, IPO",https://www.linkedin.com/company/galera-therapeutics-inc-,No
galleon pharmaceuticals inc,Pharmaceuticals,"$16.5M, Series B",https://www.cbinsights.com/company/galleon-pharmaceuticals,No
gamaleya federal research center of epidemiology and microbiology,Biotechnology,"$10M, Not Found",Not Found,No
gem pharmaceuticals llc,Pharmaceuticals,"$4.5M, Phase II",https://drug-dev.com/gem-pharmaceuticals-announces-4-5-million-financing-for-phase-ii-trial/,No
gemin x pharmaceuticals,Pharmaceuticals,"$225M, Acquired",https://www.biospace.com/cephalon-inc-to-acquire-gemin-x-pharmaceuticals-inc-for-225-million-up-to-300-million-in-milestones,No
genkyotex sa,Biotechnology,"$5.4M, Post IPO Equity",https://www.linkedin.com/company/genkyotex-s.a/,No
"Genaissance Pharmaceuticals, Inc. (inactive)",Biotechnology,"$11M, Acquired",https://www.courant.com/2005/06/22/biotech-buyout/,No
general oncology inc,Biotechnology,"$7.2M, Series Unknown",https://www.linkedin.com/company/general-oncology,No
genfit sa,Biotechnology,"$29.8M, Post IPO equity",https://www.linkedin.com/company/genfit,No
george medicines pty ltd,Pharmaceuticals,"$1M, Series Unknown",https://uk.linkedin.com/company/george-medicines-pty-limited,No
gesynta pharma ab,Pharmaceuticals,"$27M, Series B",https://www.forbes.com/sites/jenniferkitepowell/2025/02/13/gesynta-pharma-receives-27-m-for-endometriosis-novel-therapy-drug/,No
ginkgo tree pharmaceutical (suzhou) co ltd,Biotechnology,"$20M, Series B",https://pitchhub.36kr.com/project/1679796954452743,No
glubio therapeutics inc,Biotechnology,"$72M, Series A",https://tracxn.com/d/companies/glubio-therapeutics/__CnrmBJ6Dk1doO-eEyukaLONnnwfsTih_vPF5bNZkqU4,No
goldfinch bio inc,Biotechnology,"$100M, Series B",https://www.biopharmadive.com/news/karuna-goldfinch-deal-brain-drugs-psychiatry/641863/,No
goldfinch bio inc (inactive),Biotechnology,"$214M, Series A",https://www.startupnetworks.co.uk/topic/434-why-goldfinch-bios-214m-mission-to-revolutionize-kidney-disease-fell-short/,No
grace therapeutics inc,Biotechnology,"$10.5M, Post IPO equity",https://ca.linkedin.com/company/grace-tx,No
graegis pharmaceuticals ltd,Pharmaceuticals,"$10.5M, Series A",https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/latest-pharmaceutical-manufacturing-news/new-startup-graegis-pharmaceuticals-to-prevent-side-effects-/,No
graviton bioscience corp,Biotechnology,"$64.8M, Series C",https://tracxn.com/d/companies/graviton-bioscience/__FOI_UtusoseB10DVQduwxVd0Y1UQRXoo3C_WHBUa8gY,No
green3bio inc,Pharmaceuticals,"$10M, Series A",https://pacylex.reportablenews.com/pr/pacylex-pharmaceuticals-closes-series-a-funding-to-advance-oncology-program-into-the-clinic,No
guangzhou bebetter medicine technology co ltd,Biotechnology,"$28.05M, Series A",https://www.marketscreener.com/quote/stock/GUANGZHOU-YUEXIU-CAPITAL--6497848/news/Guangzhou-Bebetter-Medicine-Technology-Co-Ltd-announced-that-it-has-received-28-05-million-in-fu-33855420/,No
guangzhou egg biotechnology co ltd,Biotechnology,"$2.74M, Not Found",https://www.newtbdrugs.org/content/guangzhou-egg-biotechnology-co-ltd,No
guangzhou institute of dermatology,Pharmaceuticals,"$7.3M, Not Found",Not Found,No
guangzhou magpie pharmaceutical co ltd,Pharmaceuticals,"$29.1M, Series B",https://tracxn.com/d/companies/guangzhou-magpie-pharmaceuticals/__n0ID18FEYXuqtUxoMTzDlbvVhMoOAT-J7eK738OCIuA,No
guangzhou yinming biomedical technology co ltd,Biotechnology,"$50M, Series A",https://bouncewatch.com/explore/startup/-2311,No
guizhou inochini technology co ltd,Pharmaceuticals,"$10M, Phase 1",https://synapse.patsnap.com/organization/c4f94b17cc5ade2cda218d80c6d73860,No
gut-brain axis therapeutics llc,Biotechnology,"$1.42M, Seed",https://tracxn.com/d/companies/gut-brain-axis-therapeutics/__BTbkK1bKAScZPLZ4IVIMrjx529AHNlvkD-Du7uyck_g,No
h3 biomedicine inc,Biotechnology,"$200M, Acquired",https://www.bionity.com/en/companies/1040474/h3-biomedicine-inc.html,No
hll lifecare ltd,Pharmaceuticals,"$100K, Not Found",https://www.gatesfoundation.org/about/committed-grants/2014/04/opp1108136,No
hangzhou chance pharmaceuticals,Biotechnology,"$10M, Series A",https://synapse.patsnap.com/organization/1993ca9f51daf14bbec67e3275b91c49,No
hangzhou minsheng pharmaceutical group co ltd,Pharmaceuticals,"$10M, IPO",https://www.hzmsjk.com/en/about.html,No
hangzhou synrx therapeutics co ltd,Biotechnology,"$14.2M, Seed",https://tracxn.com/d/companies/synrx-therapeutics/__H9cn8AaYZUk_YwoCjimSBM1f4el2W19nEEu8aBh5lto,No
harbor therapeutics inc,Biotechnology,"$105M, Not Found",https://www.prnewswire.com/news-releases/harbour-biomed-enters-into-global-strategic-collaboration-with-astrazeneca-to-discover-and-develop-next-generation-therapeutic-antibodies-302407924.html,No
harmony bioscience inc,Pharmaceuticals,"$248M, Post IPO Secondary",https://www.linkedin.com/company/harmonybiosciences,No
harmony biosciences holdings inc,Pharmaceuticals,"$248M, Post IPO Secondary",https://www.linkedin.com/company/harmonybiosciences,No
harmony biosciences llc.,Pharmaceuticals,"$248M, Post IPO secondary",https://www.linkedin.com/company/harmonybiosciences,No
harrow inc,Pharmaceuticals,"$250M, Post IPO Debt",https://finance.yahoo.com/quote/HROW/,No
haudongchun co ltd,Pharmaceuticals,"$2.6M, Acquired",https://www.marketscreener.com/quote/stock/HA-U-DONG-CHUN-CO-LTD-120972999/,No
heparegenix gmbh,Biotechnology,"$21.5M, Series C",https://www.globenewswire.com/news-release/2025/04/15/3061487/0/en/HepaRegeniX-completes-21-5-million-financing-to-support-clinical-advancement-of-HRX-215-for-liver-regeneration.html,No
heronova pharmaceuticals,Biotechnology,"$135M, Series A",https://www.mobihealthnews.com/news/womens-health-company-heranova-lifesciences-launches-135m,No
housey pharmaceutical research laboratories llc,Pharmaceuticals,"$635K, Series Unknown",https://www.linkedin.com/company/housey-pharmaceutical-research-laboratories-llc,No
hua medicine shanghai ltd,Pharmaceuticals,"$Not Found, Not Found",Not Found,No
hubei mon yan pharmaceutical co ltd,Pharmaceuticals,"$10M, Series B",https://en.monyan.cn/lists/55.html,No
humanetics corp,Pharmaceuticals,"$5M, Not Found",https://www.linkedin.com/company/humanetics-corporation,No
hutchison healthcare limited,Pharmaceuticals,"$0.6M, Acquired",https://www.investegate.co.uk/announcement/rns/hutchmed-china-limited--hcm/acquires-100-of-hutchison-he/2278794,No
hutchison whampoa guangzhou baiyunshan chinese medicine co ltd,Pharmaceuticals,"$169M, Acquired",https://www.hutch-med.com/closing-of-divestment-of-non-core-otc-joint-venture/,No
hyloris pharmaceuticals sa,Pharmaceuticals,"$1.1M, Grant",https://be.linkedin.com/company/hyloris-pharmaceuticals,No
iama therapeutics srl,Pharmaceuticals,"$17.1M, Series B",https://www.crunchbase.com/organization/iama-therapeutics,No
iliad biotechnologies llc,Biotechnology,"$42.8M, Series D",https://www.crunchbase.com/organization/iliad-biotechnologies,No
imgt co ltd,Biotechnology,"$10.7M, Not Found",Not Found,No
impact therapeutics inc,Biotechnology,"$34.6M, Series D",https://www.linkedin.com/company/impact-therapeutics-inc-/,No
ir scientific inc,Biotechnology,"$371.4K, Grant",https://ca.linkedin.com/company/ir-scientific,No
irlab therapeutics ab,Biotechnology,"$4M, Not Found",https://se.linkedin.com/company/irlab-therapeutics-ab,No
icon bioscience inc,Pharmaceuticals,"$5.3M, Convertible Note",https://rocketreach.co/icon-bioscience-inc-profile_b54623b4f6a2169f,No
idorsia pharmaceuticals ltd,Pharmaceuticals,"$466M, IPO",https://www.globenewswire.com/news-release/2025/10/09/3164383/0/en/Idorsia-launches-an-offering-of-registered-shares-to-fund-the-company-to-overall-profitability.html,No
impact biotech limited,Biotechnology,"$11.99M, Unknown Series",https://www.crunchbase.com/organization/impact-biotech,No
imago biosciences inc,Biotechnology,"$134.4M, IPO",https://www.iposcoop.com/ipo/imago-biosciences-inc/,No
imara inc,Biotechnology,"$85M, IPO",https://dcfmodeling.com/blogs/history/imra-history-mission-ownership?srsltid=AfmBOoquTQZfbaoq84GIz3mkejQHjQ4Bt_LDYTtoifXGsmn8D94yXk9D,No
imbria pharmaceuticals inc,Biotechnology,"$57.5M, Series B",https://www.globenewswire.com/news-release/2025/04/10/3059176/0/en/Imbria-Pharmaceuticals-Raises-57-5M-Series-B-Financing-Round-and-Appoints-Alvin-Shih-MD-as-CEO.html,No
immunoflex therapeutics inc,Biotechnology,"$500K, Seed",https://tracxn.com/d/companies/immunoflex/__phnEhSH8-qL-RzBlnmVn821gTmWhWzwXBv9G3qkapiU,No
immunomic therapeutics inc,Biotechnology,"$6.5M, Series Unknown",https://www.linkedin.com/company/immunomic-therapeutics-inc-,No
impax laboratories inc,Pharmaceuticals,"$1.45B, Acquired",https://en.wikipedia.org/wiki/Amneal_Pharmaceuticals,No
impax laboratories inc (inactive),Pharmaceuticals,"$33M, Acquired",https://www.impaxsecuritiessettlement.com/,No
incarda therapeutics inc,Biotechnology,"$30M, Series C",https://www.crunchbase.com/organization/incarda-therapeutics,No
inmed pharmaceuticals inc,Pharmaceuticals,"$5M, Private Placement",https://www.stocktitan.net/news/INM/,No
incannex healthcare ltd,Pharmaceuticals,"$12.5M, Post IPO equity",https://au.linkedin.com/company/impressionhealthcarelimited,No
incyclix bio llc,Biotechnology,"$11.25M, Series B",https://finance.yahoo.com/news/incyclix-bio-secures-11-25-110000925.html,No
indiana nanotech llc,Biotechnology,"$1.04M, Not Found",https://www.sbir.gov/portfolio/189604,No
indiana university research & technology corp,Biotechnology,"$10M, Seed",https://iuventures.com/introducing-iu-ventures-the-future-of-iu-innovation/,No
indivior inc,Pharmaceuticals,"$400M, Post IPO Debt",https://www.linkedin.com/company/indivior,No
inhibikase therapeutics inc,Pharmaceuticals,"$110M, IPO",https://www.linkedin.com/company/inhibikase-therapeutics,No
inhibitex llc,Biotechnology,"$2.5B, Acquired",https://drug-dev.com/inhibitex-to-be-acquired-by-bristol-myers-squibb-for-2-5-billion/,No
iniciativa andaluza en terapias avanzadas,Biotechnology,"$96.88M, Not Found",https://pmc.ncbi.nlm.nih.gov/articles/PMC3659837/,No
initiator pharma as,Biotechnology,"$2.1M, Secondary Market",https://www.linkedin.com/company/initiatorpharma.com,No
innovagyn inc,Pharmaceuticals,"$682,403, Not Found",https://www.sbir.gov/portfolio/820315,No
innovative molecules gmbh,Biotechnology,"$21.2M, Series A",https://www.innovativemolecules.com/,No
intekrin therapeutics inc,Biotechnology,"$65.2M, Series C",https://tracxn.com/d/companies/intekrin-therapeutics/__r3-MIoFC6xdY9zkaE2NWMpvRP8sbgrVy3O3grSYrIHw,No
intech biopharm ltd,Pharmaceuticals,"$10M, IPO",https://www.linkedin.com/company/intech-biopharm/,No
international partnership for microbicides,Pharmaceuticals,"$60M, Grant",https://www.gatesfoundation.org/about/committed-grants/2003/06/opp20988,No
intersect ent inc,Biotechnology,"$30M, Series D",https://en.wikipedia.org/wiki/Intersect_ENT,No
intezyne inc,Biotechnology,"$10M, Series A",https://www.crunchbase.com/organization/intezyne-technologies,No
intra-cellular therapies inc,Pharmaceuticals,"$14.6B, Acquired",https://www.reuters.com/markets/deals/jj-buy-intra-cellular-therapies-146-billion-2025-01-13/,No
intragel therapeutics ltd,Pharmaceuticals,"$20M, Seed",https://www.cbinsights.com/company/intragel-therapeutics,No
inventia healthcare ltd,Pharmaceuticals,"$13.4M, Acquired",https://www.platinumequity.com/news/platinum-equity-acquires-controlling-stake-in-inventia-healthcare/,No
inventiva sa,Biotechnology,"$10M, Post IPO equity",https://www.linkedin.com/company/inventiva-pharma,No
invenux llc,Pharmaceuticals,"$224,731, Seed",https://www.sbir.gov/awards/163290,No
inversago pharma inc,Biotechnology,"$35M, Series B; $70M, Series C",https://forbion.com/news-insights/news/forbion-portfolio-company-inversago-pharma-to-be-acquired-by-novo-nordisk/,No
invirsa inc,Pharmaceuticals,"$7.7M, Series B",https://www.businesswire.com/news/home/20230614023662/en/Invirsa-Completes-%247.7M-Series-B-Financing,No
ironshore pharmaceuticals and development inc,Pharmaceuticals,"$343M, Acquired",https://www.cbinsights.com/company/ironshore-pharmaceuticals-development,No
ironshore therapeutics inc,Pharmaceuticals,"$525M, Acquired",https://businessnc.com/north-carolina-pharma-company-being-sold-for-525-million/,No
island pharmaceuticals ltd,Biotechnology,"$2.4M, Post IPO equity",https://au.linkedin.com/company/island-pharmaceuticals,No
iterion therapeutics inc,Biotechnology,"$17M, Series B",https://www.linkedin.com/company/iterion-therapeutics,No
iterum therapeutics plc,Pharmaceuticals,"$2.2M, Post IPO equity",https://www.linkedin.com/company/iterum-therapeutics,No
ixchelsis ltd,Biotechnology,"$26M, Series B",https://www.cbinsights.com/company/ixchelsis,No
jixing pharmaceuticals (shanghai) co ltd,Pharmaceuticals,"$100M, Series D",https://www.bayer.com/media/en-us/bayer-and-rtw-investments-lead-series-d-financing-in-chinese-biotech-ji-xing-pharmaceuticals/,No
jade pharmaceuticals inc,Biotechnology,"$135M, PIPE",https://finance.yahoo.com/news/jade-biosciences-announces-135-million-110000547.html,No
jaguar health inc,Pharmaceuticals,"$250K, Grant",https://www.linkedin.com/company/jaguar-health,No
jenivision inc,Pharmaceuticals,"$10M, Series A",https://www.f6s.com/jenivisioninc,No
ji xing pharmaceuticals ltd,Biotechnology,"$167M, Series D",https://www.cbinsights.com/company/ji-xing-pharmaceuticals,No
jiangsu aidea pharmaceutical co ltd,Pharmaceuticals,"$10M, IPO",https://www.linkedin.com/company/aideapharma,No
jiangsu haosen pharmaceutical co ltd,Pharmaceuticals,"$1.01B, IPO",https://en.wikipedia.org/wiki/Hansoh_Pharmaceutical,No
jiangsu haosen pharmaceutical group co ltd,Pharmaceuticals,"$1B, IPO",https://en.wikipedia.org/wiki/Hansoh_Pharmaceutical,No
jiangsu huatai chenguang pharmaceutical co ltd,Pharmaceuticals,"$8.92M, Series C",https://tracxn.com/d/companies/jiangsu-huatai-chenguang-pharmaceutical/__SvsA4HWKmnNsFbXju51B8grB4rhjosgHU9qVXcTFF14,No
jiangxi institute of biological products inc,Pharmaceuticals,"$12.5M, IPO",https://thebambooworks.com/anti-toxin-provider-jiangxi-institute-joins-biopharma-ipo-rush/,No
jilin sihuan pharmaceutical co ltd,Pharmaceuticals,"$70M, Series A",https://www.bioworld.com/keywords/9283-sihuan-pharmaceutical-holdings-group-ltd,No
jinzhou ahon pharmaceutical co ltd,Pharmaceuticals,"$219M, Acquired",https://www.biospace.com/fosun-pharma-buys-70-percent-of-b-jinzhou-ahon-pharma-b-for-219-million,No
jixing pharmaceutical technology (shanghai) co ltd,Pharmaceuticals,"$162M, Series D",https://www.marketscreener.com/quote/stock/BAYER-AG-436063/news/Jixing-Pharmaceutical-Technology-Co-Ltd-announced-that-it-has-received-162-million-in-funding-fr-45696321/,No
jubilant pharmova ltd,Pharmaceuticals,"$132M, Not Found",https://markets.ft.com/data/announce/detail?dockey=600-202510100952PR_NEWS_USPRX____SF95167-1,No
Juniper Pharmaceuticals Inc (inactive),Pharmaceuticals,"$139.6M, Acquired",https://www.prnewswire.com/news-releases/juniper-pharmaceuticals-signs-definitive-agreement-to-be-acquired-by-catalent-inc-for-11-50-per-share-in-cash-300675731.html,No
jupiter neurosciences inc,Biotechnology,"$55.733M, IPO",https://finance.yahoo.com/quote/JUNS/,No
jupiter wellness inc,Pharmaceuticals,"$30M, Post IPO equity",https://www.linkedin.com/company/jupiterwellness,No
kbp biosciences co ltd,Biotechnology,"$76M, Series A",https://www.crunchbase.com/organization/kbp-biosciences,No
kandy therapeutics ltd,Biotechnology,"$34M, Series C",https://adventls.com/portfolio/kandy-therapeutics-2020/,No
kaerus bioscience ltd,Biotechnology,"$450M, Acquired",https://www.linkedin.com/company/kaerusbio,No
kairos pharma ltd,Biotechnology,"$3.5M, Post IPO equity",https://www.linkedin.com/company/kairospharmaltd,No
kaizen bioscience co,Biotechnology,"$10M, Seed",https://www.crunchbase.com/organization/kaizen-bioscience,No
kamau therapeutics inc,Biotechnology,"$5M, Early Venture Capital",https://www.crunchbase.com/organization/kamau-therapeutics,No
kangpu biopharmaceuticals ltd,Biotechnology,"$13.7M, Series B",https://www.linkedin.com/company/kangpu,No
karuna therapeutics inc,Biotechnology,"$80M, Series B",https://karuna-pharmaceuticals.squarespace.com/,No
keranetics llc,Biotechnology,"$3.4M, Series Unknown",https://www.crunchbase.com/organization/keranetics,No
keryx biopharmaceuticals inc,Biotechnology,"$165M, Acquired",https://www.biopharmadive.com/news/akebia-keryx-to-merge-creating-1b-kidney-disease-company/526761/,No
keryx biopharmaceuticals inc (inactive),Biotechnology,"$10M, Acquired",https://biopharmguy.com/links/company-by-name-defunct.php,No
keybioscience ag,Biotechnology,"$1.4B, Not Found",Not Found,No
kezar life sciences inc,Biotechnology,"$12.2M, Post IPO equity",https://www.linkedin.com/company/kezarlifesciences,No
kiadis pharma nv,Biotechnology,"$308M, Acquired",https://www.sanofi.com/en/media-room/press-releases/2020/2020-11-02-06-00-00-2118110,No
kinarus ag,Pharmaceuticals,"$4.36M, Acquired",https://www.startupticker.ch/en/news/curatis-enters-six-swiss-exchange-following-the-acquisition-of-kinarus,No
kinaset therapeutics inc,Pharmaceuticals,"$40M, Series A",https://www.crunchbase.com/organization/kinaset-therapeutics,No
kinoxis therapeutics pty ltd,Biotechnology,"$9.5M, Series B",https://www.crunchbase.com/organization/kinoxis-therapeutics,No
kiora pharmaceuticals inc,Biotechnology,"$15M, IPO",https://at.linkedin.com/company/kiorapharma,No
knopp biosciences llc,Biotechnology,"$350M, Series A",https://www.baincapital.com/news/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage,No
kobiolabs inc,Biotechnology,"$8.3M, Series Unknown",https://www.crunchbase.com/organization/kobiolabs,No
korea global pharm co ltd,Pharmaceuticals,"$16.8M, Acquired",https://www.marketscreener.com/quote/stock/KEEPS-BIOPHARMA-INC-42693138/news/KPS-Corporation-completed-the-acquisition-of-96-44-stake-in-Korea-Global-Pharm-Co-Ltd-from-a-gro-48891976/,No
kriya therapeutics inc,Biotechnology,"$320M, Series D",https://www.labiotech.eu/trends-news/kriya-therapeutics-900-million-gene-therapy/,No
kronos bio inc,Biotechnology,"$0.57 per share, Acquired",https://www.globenewswire.com/news-release/2025/05/01/3072392/0/en/Kronos-Bio-Enters-into-Agreement-to-Be-Acquired-by-Concentra-Biosciences-for-0-57-in-Cash-per-Share-Plus-a-Contingent-Value-Right.html,No
kubota vision inc,Biotechnology,"$450M, IPO",https://www.nbr.org/people/ryo-kubota/,No
kukjeon pharmaceutical co ltd,Pharmaceuticals,"$3M, Not Found",https://www.marketscreener.com/quote/stock/KUKJEON-PHARMACEUTICAL-CO-124598767/company/,No
kura oncology inc,Biotechnology,"$150M, Post IPO equity",https://finance.yahoo.com/quote/KURA/profile/,No
kymera therapeutics inc,Biotechnology,"$750M, Not Found",https://www.gilead.com/news/news-details/2025/gilead-sciences-and-kymera-therapeutics-enter-into-exclusive-option-and-license-agreement-to-develop-novel-oral-molecular-glue-cdk2-degraders,No
kynos therapeutics ltd,Biotechnology,"$8.5M, Seed",https://uk.linkedin.com/company/kynos-therapeutics-ltd,No
kyoto drug discovery & development co ltd,Biotechnology,"$10M, Seed",https://www.kyoto-unicap.co.jp/en/embark/kyoto-drug/,No
kyverna therapeutics inc,Biotechnology,"$60M, Series B",https://www.linkedin.com/company/kyverna,No
lb pharmaceuticals inc,Biotechnology,"$285M, IPO",https://finance.yahoo.com/quote/LBRX/#:~:text=LB%20Pharmaceuticals%20raises%20$285%20million%20in%20US%20IPO,No
leo pharma ab,Pharmaceuticals,"$36M, Acquired",https://en.wikipedia.org/wiki/Leo_Pharma,No
llc veropharm,Pharmaceuticals,"$395M, Acquired",https://www.drugdiscoverytrends.com/abbott-to-acquire-russian-pharma-co-veropharm/,No
lts lohmann therapie-systeme ag,Pharmaceuticals,"$4.3M, Grant",https://www.gatesfoundation.org/about/committed-grants/2023/10/inv-062686,No
la renon healthcare pvt ltd,Pharmaceuticals,"$10M, Series C",https://tracxn.com/d/legal-entities/india/la-renon-healthcare-private-limited/__isrV5yBtBoSCBI-72TQLTLJiLBZHq7m7cbC08dd-pLE,No
laboratoires delbert,Pharmaceuticals,"$47.48M, Private Equity - II",https://www.cbinsights.com/company/laboratoires-delbert/financials,No
laboratories ojer pharma sl,Pharmaceuticals,"$2.5M, Private Equity",https://www.linkedin.com/company/laboratorios-ojer-pharma/,No
laboratorio italiano biochimico farmaceutico lisapharma spa,Pharmaceuticals,"$87,649, Grant",https://it.linkedin.com/company/lisapharma-s.p.a.,No
lakewood-amedex inc,Pharmaceuticals,"$36.2M, Series C",https://tracxn.com/d/companies/lakewood-amedex/__4Adm_U1QHcfALAhh7AYvxIcPzlFNaBpB4Om46SSdNPI,No
lamassu bio inc,Biotechnology,"$4.2M, Series A",https://www.biospace.com/lamassu-bio-announces-new-venture-for-cancer-therapeutics/,No
lambda therapeutic research ltd,Pharmaceuticals,"$24.5M, Not Found",Not Found,No
landos biopharma inc,Biotechnology,"$10M, Series A",https://nimml.org/news/detail/landos-biopharma-raises-10-million-to-develop-new-therapeutics-for-autoimmu,No
latigo biotherapeutics inc,Biotechnology,"$150M, Series B",https://www.biopharmadive.com/news/latigo-series-b-pain-non-opioid-nav/742635/,No
laurent pharmaceuticals inc,Biotechnology,"$2M, Debt Financing",https://ca.linkedin.com/company/laurent-pharmaceuticals,No
lek pharmaceuticals dd,Pharmaceuticals,"$400M, Not Found",https://www.pharmaceutical-technology.com/projects/lek-pharmaceuticals-biosimilar-production-facility-lendava-slovenia/,No
lek dd,Pharmaceuticals,"$400M, Not Found",https://www.pharmaindustrial-india.com,No
lenz therapeutics llc,Pharmaceuticals,"$80M, Stock Sale",https://www.cnbc.com/quotes/LENZ,No
leonard-meron biosciences inc,Pharmaceuticals,"$100M, Acquired",https://www.prnewswire.com/news-releases/citius-pharmaceuticals-completes-acquisition-of-leonard-meron-biosciences-300245041.html,No
lexaria bioscience corp,Biotechnology,"$2.9M, Post IPO equity",https://ca.linkedin.com/company/lexaria-bioscience,No
lexicon pharmaceuticals inc,Biotechnology,"$250M, Post IPO equity",https://www.linkedin.com/company/lexicon-pharmaceuticals,No
lianbio,Biotechnology,"$310M, Series A",https://www.linkedin.com/company/lianbio,No
liaoning biomedical materials r&d center co ltd,Biotechnology,"$6.51M, Seed",https://www.dlyinyi.com/english/About_Us/History/,No
lifecare innovations pvt ltd,Pharmaceuticals,"Undisclosed, Grant",https://tracxn.com/d/companies/lifecare-innovations/__HEJeZlDqRcguy-o9uE4bwasVq-vNg-eYh-M02BOKwzE,No
lifetech scientific (shenzhen) co ltd,Biotechnology,"$10M, Post IPO equity",https://in.linkedin.com/company/lifetech-scientific-inc-,No
ligand pharmaceuticals inc,Biotechnology,"$44M, IPO",https://en.wikipedia.org/wiki/Ligand_Pharmaceuticals,No
light sciences oncology inc (inactive),Biotechnology,"$67M, Late-Stage Development",https://www.biospace.com/light-sciences-oncology-inc-completes-second-closing-in-67-million-financing-for-late-stage-development-of-litx-tm,No
lin bioscience inc,Biotechnology,"$30M, Rights Issue",https://www.linbioscience.com/,No
lipella pharmaceuticals inc,Pharmaceuticals,"$3.8M, Post IPO Equity",https://finance.yahoo.com/quote/LIPO/profile/,No
lipocine inc,Biotechnology,"$28.7M, Post IPO equity",https://www.linkedin.com/company/lipocine-inc-,No
liquidia corp,Biotechnology,"$50M, Not Found","https://www.linkedin.com/company/liquidia-corporation#:~:text=Liquidia%20Corporation%20is%20a%20biopharmaceutical,of%20its%20PRINT%C2%AE%20Technology.",No
liquidia technologies inc,Biotechnology,"$50M, Not Found",https://www.linkedin.com/company/liquidia-corporation,No
lixa pty ltd,Biotechnology,"$5M, Series A",https://biotechdispatch.com.au/news/clinical-trial-success-kicks-off-5m-fund-raising-round-for-was-lixa,No
lobe sciences ltd,Biotechnology,"$6M, Seed",https://www.biospace.com/press-releases/lobe-sciences-moves-forward-with-development-of-conjugated-psilocintm-following-april-14-agreement-to-spin-out-compound-to-cynaptec-pharmaceuticals,No
lohocla research corp,Biotechnology,"$32.45M, Grant",https://taggs.hhs.gov/Detail/RecipDetail?arg_EntityId=zRVnfLu%2BbcO%2F8bvDgV3sLg%3D%3D,No
longboard pharmaceuticals inc,Biotechnology,"$2.6B, Acquired",https://www.lundbeck.com/us/newsroom/2024/lundbeck-to-acquire-longboard-pharmaceuticals-in-a-strategic-deal,No
lophora aps,Biotechnology,"$3M, Seed",https://www.lophora.com/,No
love health industry co ltd,Pharmaceuticals,"$50M, IPO",https://www.renaissancecapital.com/Profile/LLLLU/Love-&-Health/IPO,No
luoxin pharmacy group co ltd,Pharmaceuticals,"$100M, IPO",https://luoxinpharma.en.made-in-china.com/,No
lygenesis inc,Biotechnology,"$19M, Series A",https://www.crunchbase.com/organization/lygenesis,No
lyka labs ltd,Pharmaceuticals,"$13.1M, Post IPO secondary",https://in.linkedin.com/company/lyka-labs-limited,No
lykos therapeutics,Biotechnology,"$50M, Series B",https://www.linkedin.com/company/lykos-therapeutics,No
lyndra therapeutics inc.,Biotechnology,"$101M, Series E",https://www.crunchbase.com/organization/lyndra-inc,No
lynk pharmaceuticals co ltd,Pharmaceuticals,"$44.1M, Series C",https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-completes-series-c2-financing-round-with-total-c-round-funding-of-322-million-rmb-301933690.html,No
lyra therapeutics inc,Biotechnology,"$15M, IPO",https://lyratherapeutics.com/,No
lyric pharmaceuticals inc (inactive),Pharmaceuticals,"$20.4M, Series A",https://www.fiercebiotech.com/biotech/lyric-pharmaceuticals-announces-20-4m-series-a-funding-round,No
maxvax biotechnology llc,Biotechnology,"$84.8M, Series C",https://tracxn.com/d/companies/maxvax-biotechnology/__C1qeMTLeUnW_YxYPRe28fQOIH1cHgRbYUCdTZj6QoWM,No
magenta therapeutics inc,Biotechnology,"$86.4M, Post IPO Equity",https://www.linkedin.com/company/magenta-therapeutics,No
maggie''s pearl llc,Biotechnology,"$2M, Direct-to-Phase 2",https://www.maggiespearl.com/,No
maggie's pearl llc,Biotechnology,"$1.8M, Phase II",https://www.inknowvation.com/sbir/companies/maggies-pearl-llc,No
malaghan institute of medical research,Biotechnology,"$15M, Series A1",https://nz.linkedin.com/company/malaghan-institute-of-medical-research,No
maplight therapeutics inc,Biotechnology,"$372.5M, Series D",https://www.linkedin.com/company/maplight-therapeutics-inc,No
mapreg sas,Biotechnology,"$3M, Seed",https://sciencebusiness.net/news/71059/Paris%3A-Investors-sought-for-Mapreg%E2%80%99s-nerve-repair,No
march biosciences,Biotechnology,"$28.4M, Series A",https://www.globenewswire.com/news-release/2024/10/23/2967726/0/en/March-Biosciences-Closes-Oversubscribed-28-4-Million-Series-A-Financing.html,No
marinomed biotech ag,Biotechnology,"$1.27M, IPO",https://at.linkedin.com/company/marinomed-biotech-ag,No
marinus pharmaceuticals inc,Pharmaceuticals,"$40.3M, IPO",https://www.baincapital.com/news/marinus-pharmaceuticals-announces-closing-public-offering-common-stock-and-full-exercise,No
martin pharmaceuticals inc,Pharmaceuticals,"$10M, Seed",https://www.linkedin.com/company/martinpharma,No
matinas biopharma holdings inc,Biotechnology,"$3.3M, Post IPO equity",https://www.linkedin.com/company/matinas-biopharma,No
mayne pharma group ltd,Pharmaceuticals,"$16M, Not Found",Not Found,No
maze therapeutics inc,Biotechnology,"$150M, Private Placement",https://www.linkedin.com/company/mazetx,No
medalliance llc,Biotechnology,"$50M, Private Equity",https://www.linkedin.com/company/medalliance-swiss-medical-technology,No
meda ab,Pharmaceuticals,"$7.2B, Acquired",https://investor.mylan.com/news-releases/news-release-details/mylan-acquire-meda,No
medesis pharma sa,Biotechnology,"$7.35M, IPO",https://www.medesispharma.com/investors/,No
mediprint ophthalmics inc,Pharmaceuticals,"$10M, Series A",https://mediprintlens.com/,No
medica korea corp,Pharmaceuticals,"$16.1M, Acquired",https://www.marketscreener.com/quote/stock/SYNERGY-INNOVATION-CO-LTD-6497193/news/Synergy-Innovation-Co-Ltd-agreed-to-acquire-additional-27-78-stake-in-Medica-Korea-Co-Ltd-for-K-46331322/,No
medical developments international ltd,Pharmaceuticals,"$6.5M, Post IPO equity",https://au.linkedin.com/company/medical-developments-international,No
medicinova inc,Biotechnology,"$22M, NIH Grant",https://www.linkedin.com/company/medicinova-inc.,No
medicines360,Pharmaceuticals,"$82.2M, Not Found",Not Found,No
medicure inc,Pharmaceuticals,"$60M, Post IPO Debt",https://www.linkedin.com/company/medicure,No
medincell sa,Pharmaceuticals,"$44.8M, Post IPO Equity",https://www.linkedin.com/company/medincell/,No
medivation inc (inactive),Biotechnology,"$14B, Acquired",https://www.pfizer.com/news/press-release/press-release-detail/pfizer-acquire-medivation,No
melinta therapeutics inc,Pharmaceuticals,"$123.2M, Post IPO equity",https://www.crunchbase.com/organization/melinta,No
melt pharmaceuticals inc,Pharmaceuticals,"$24M, Series B",https://www.meltpharma.com/news-releases/news-release-details/melt-pharmaceuticals-closes-24-million-series-b-preferred-stock,No
merlion pharmaceuticals pte ltd,Pharmaceuticals,"$30M, Not Found",https://www.biospace.com/merlion-pharmaceuticals-pte-ltd-announces-the-completion-of-merger-with-combinature-biopharm-ag-and-athelas-sa-closure-of-us-30-million-financing-ro,No
mercator medsystems inc,Biotechnology,"$14.3M, Series D",https://www.linkedin.com/company/mercator-medsystems-inc,No
meryx inc,Biotechnology,"$4.65M, Series A",https://tracxn.com/d/companies/meryx-pharma/__DZFd9ssOTwooGfI_bbyFEfnVOjV9bsZPHj3rQ-LKZg0,No
metabolic pharmaceuticals pty ltd,Pharmaceuticals,"$10M, IPO",https://www.investogain.com.au/company/metabolic-pharmaceuticals-limited/,No
metacrine inc,Biotechnology,"$50M, Debt financing",https://www.linkedin.com/company/metacrine-inc.,No
metagen therapeutics inc,Biotechnology,"$15M, Series B",https://www.linkedin.com/company/metagentx/,No
metriopharm ag,Biotechnology,"$27.5M, Not Found",https://www.swissbiotech.org/listing/metriopharm-ag-strengthens-equity-by-chf-27-5-m/,No
metro international biotech llc,Biotechnology,"$10.75M, Not Found",https://www.alzdiscovery.org/research-and-grants/portfolio-details/22305397,No
mezzion pharma co ltd,Pharmaceuticals,"$40M, Series Unknown",https://www.prnewswire.com/news-releases/mezzion-pharma-raises-nearly-40m-to-advance-a-first-to-market-treatment-option-for-fontan-patients-301807071.html,No
micell technologies inc,Biotechnology,"$61.8M, Series Unknown",https://www.linkedin.com/company/micell-technologies,No
microbion corp,Pharmaceuticals,"$22M, Not Found",https://microbioncorp.com/,No
midatech pharma plc,Biotechnology,"$10M, Not Found",https://finance.yahoo.com/news/bioaf-merger-midatech-pharma-150700246.html,No
mikrobiomik healthcare company sl,Biotechnology,"$500K, Seed",https://capitalcell.com/en/campaign/mikrobiomik/,No
milestone pharmaceuticals inc,Biotechnology,"$38.3M, Post IPO equity",https://finance.yahoo.com/quote/MIST/,No
mimivax llc,Biotechnology,"$4M, Not Found",https://www.linkedin.com/company/mimivax,No
mineralys therapeutics inc,Biotechnology,"$287.5M, IPO",https://www.linkedin.com/company/mineralys-therapeutics-inc,No
minerva biotechnologies corp,Biotechnology,"$4.5M, Series Unknown",https://www.crunchbase.com/organization/minerva-biotechnologies,No
minerva neurosciences inc,Biotechnology,"$88K, Post IPO equity",https://www.linkedin.com/company/minerva-neurosciences,No
minervax aps,Biotechnology,"$54M, Not Found",https://www.wacker.com/cms/en-us/press-and-media/press/press-releases/2024/detail-240193.html,No
minoryx therapeutics sl,Biotechnology,"$26.9M, Not Found",https://www.minoryx.com/,No
miralogx llc,Biotechnology,"$3M, Not Found",https://www.nasdaq.com/articles/mira-pharma-partners-with-miralogx-for-licensing-agreement-for-ketamir-2,No
mirum pharmaceuticals inc,Pharmaceuticals,"$275M, Post IPO equity",https://www.linkedin.com/company/mirum-pharmaceuticals,No
mission therapeutics ltd,Biotechnology,"$60M, Series C",https://uk.linkedin.com/company/mission-therapeutics,No
mithra pharmaceuticals sa,Pharmaceuticals,"$12.5M, IPO",https://live.euronext.com/en/ipo-showcase/mithra-pharmaceuticals,No
mitobridge inc,Biotechnology,"$45M, Series A",https://www.biospace.com/article/ocusciences-welcomes-michael-patane-phd-to-its-board-of-directors/,No
pellepharm inc,Biotechnology,"$760M, Acquired",https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/,No
peloton therapeutics inc,Biotechnology,"$150M, Acquired",https://www.foresitecapital.com/portfolio/peloton-therapeutics/,No
peplin inc (inactive),Biotechnology,"$287M, Acquired",https://www.biospace.com/peplin-inc-files-to-withdraw-ipo-plans,No
perception neuroscience llc,Pharmaceuticals,"$20M, Acquired",https://www.otsuka.co.jp/en/company/newsreleases/2021/20210316_1.html,No
perfuse therapeutics inc,Biotechnology,"$9M, Series A",https://www.linkedin.com/company/perfusetherapeutics,No
perha pharmaceuticals sas,Biotechnology,"$Not Found, Seed",https://www.crunchbase.com/organization/perha-pharmaceuticals,No
perosphere pharmaceuticals inc (inactive),Pharmaceuticals,"$6.21M, Not Found",https://tracxn.com/d/companies/perosphere-pharmaceuticals/__NGnZm__Rf4ydVPARMA56qAgeFVsbXqz4L2IvCEWR9jc,No
petra pharma corp,Biotechnology,"$48M, Series A",https://www.acceleratorlsp.com/companies/petra-pharma/,No
pharmakea therapeutics inc,Pharmaceuticals,"$45M, Seed",https://www.sandiegouniontribune.com/business/biotech/story/2020-01-07/san-diego-biotech-pharmakea-to-shut-down-local-office-merging-with-denmark-drugmaker/,No
pharmeste srl,Biotechnology,"$10M, Series B",https://www.mp-healthcare.com/portfolio,No
pharmactive,Biotechnology,"$10M, Private Equity",https://www.crunchbase.com/organization/pharmactive,No
"pharmasset, inc (inactive)",Pharmaceuticals,"$34M, Post IPO equity",https://www.linkedin.com/company/pharmasset-inc-,No
pharmatrophix inc,Biotechnology,"$250,000, Seed",https://www.alzdiscovery.org/research-and-grants/portfolio-details/2283,No
pharmstandard,Pharmaceuticals,"$880M, IPO",https://en.wikipedia.org/wiki/Pharmstandard,No
pharnext sa,Biotechnology,"$98.7M, Post IPO equity",https://www.linkedin.com/company/pharnext/,No
pharvaris nv,Pharmaceuticals,"$201.2M, IPO",https://www.linkedin.com/company/pharvaris,No
pherin pharmaceuticals inc,Pharmaceuticals,"$12.4M, Acquired",https://www.healio.com/news/psychiatry/20230203/vistagen-completes-acquisition-of-pherin-pharmaceuticals,No
phoenicia biosciences inc,Biotechnology,"$3.92M, Not Found",https://www.sbir.gov/portfolio/412482,No
phoenix molecular designs,Biotechnology,"$4.7M, Series A",https://pitchbook.com/profiles/company/187693-30,No
phoenix solutions as,Biotechnology,"$10M, Series B",https://exact-tx.com/news-page/2017-04,No
phost''in sas,Biotechnology,"$3.4M, Not Found",https://www.phostin.com/,No
pikralida sp zoo,Biotechnology,"$18M, Not Found",Not Found,No
pimera inc,Biotechnology,"$491K, Grant",https://tracxn.com/d/companies/pimera-therapeutics/__6iZN3rFFhHD4PU5LwYKZ4Pj0OzQqaeE56DxjOJO5Nxs,No
pinotbio inc,Biotechnology,"$9.5M, Series Unknown",https://www.linkedin.com/company/bionetix-inc/,No
pleopharma inc,Pharmaceuticals,"$6.2M, Series Unknown",https://www.linkedin.com/company/pleopharma,No
plethora solutions holdings plc,Pharmaceuticals,"$4M, Acquired",https://www.endurancerp.com/template?series=201,No
"point therapeutics, inc. (inactive)",Biotechnology,"$1.4B, Acquired",https://www.statnews.com/2023/10/03/lilly-bolts-another-one-on-acquiring-point-therapeutics-for-1-4-billion/,No
polichem sa,Pharmaceuticals,"$10M, Acquired",https://www.cbinsights.com/company/polichem-sa,No
polyactiva pty ltd,Biotechnology,"$25.7M, Series C",https://au.linkedin.com/company/polyactiva,No
polypid ltd,Pharmaceuticals,"$26.7M, IPO",https://il.linkedin.com/company/polypid,No
poniard pharmaceuticals inc (inactive),Pharmaceuticals,"$3.93M, Acquired",https://www.inknowvation.com/sbir/companies/poniard-pharmaceuticals-inc,No
portola pharmaceuticals llc,Pharmaceuticals,"$258.8M, Post IPO equity",https://www.linkedin.com/company/portola-pharmaceuticals,No
poxel sa,Biotechnology,"$50M, Post IPO Debt",https://www.linkedin.com/company/poxel,No
pozlab sp zoo,Pharmaceuticals,Acquired,https://www.biospace.com/selvita-completes-acquisition-of-pozlab-and-significantly-expands-its-drug-development-capabilities,No
pozen inc (inactive),Pharmaceuticals,"$300M, Acquired",https://www.biospace.com/departing-pozen-execs-receive-big-pay-day-as-company-looks-to-merger-with-tribute,No
preglem sa,Biotechnology,"$32.2M, Series B",https://www.linkedin.com/company/preglem-sa,No
prilenia therapeutics development ltd,Biotechnology,"$43M, Series B",https://www.linkedin.com/company/prilenia,No
primmune therapeutics inc,Biotechnology,"$8.4M, Series A",https://www.linkedin.com/company/primmune-therapeutics,No
principia biopharma inc,Biotechnology,"$3.68B, Acquired",https://www.sanofi.com/en/media-room/press-releases/2020/2020-08-17-05-00-00-2078993,No
priothera ltd,Pharmaceuticals,"$19.7M, Venture Debt",https://www.eib.org/en/projects/pipelines/all/20210189,No
privo technologies inc,Biotechnology,"$2.5M, Grant",https://www.linkedin.com/company/privo-technologies,No
processa pharmaceuticals inc,Pharmaceuticals,"$5-10M, Licensing Agreement",https://www.reddit.com/r/pennystocks/comments/1o0isfz/pcsalow_float_biotech_waking_up_ahead_of_a/,No
progenics pharmaceuticals inc,Biotechnology,"$75M, IPO",https://www.linkedin.com/company/progenics-pharmaceuticals,No
prolacta bioscience inc,Biotechnology,"$8.9M, Series Unknown",https://www.linkedin.com/company/prolacta-bioscience,No
proniras corp,Biotechnology,"$4.65M, Series B",https://www.biospace.com/proniras-corporation-secures-new-series-b-financing-and-names-new-board-members-to-support-phase-1-study-of-novel-treatment-for-opiate-withdrawal,No
pronova biopharma norway as (inactive),Pharmaceuticals,"$844M, Acquired",https://en.wikipedia.org/wiki/Pronova_BioPharma,No
propella therapeutics inc (inactive),Biotechnology,"$175M, Acquired",https://www.tracxn.com/d/companies/propella-therapeutics/__Z9JfFBybEa_rghuSCwoo7nAFpNzhmYz_rS-I3eGHf6g,No
protego biopharma inc,Biotechnology,"$51M, Series A",https://www.biospace.com/protego-biopharma-raises-51-million-series-a-financing-to-advance-the-treatment-of-protein-misfolding-diseases,No
proteus digital health inc,Pharmaceuticals,"$500M, Series A",https://www.cnbc.com/2020/06/15/proteus-digital-health-once-worth-1point5-billion-files-for-chapter-11.html,No
proteus digital health inc (inactive),Biotechnology,"$500M, Series A",https://www.cnbc.com/2020/06/15/proteus-digital-health-once-worth-1point5-billion-files-for-chapter-11.html,No
psyadon pharmaceuticals inc,Pharmaceuticals,"$250M, Series D",https://endpts.com/a-chicago-biotech-skips-the-ipo-in-favor-of-late-stage-series-d-for-a-phiii-tourette-drug,No
pulmocide ltd,Biotechnology,"$147.5M, Series C",https://www.ipgroupplc.com/news-and-events/portfolio-news/2022/2022-12-06,No
pulmovant inc,Biotechnology,"$14M, Not Found",https://www.biocentury.com/article/653496/deals-report-roivant-sets-up-pulmovant-to-advance-hypertension-therapy,No
pyrotech (beijing) biotechnology co ltd,Biotechnology,"$97M, Series A",https://www.biocentury.com/article/648738/china-venture-quick-takes-pyrotech-raises-97m-series-a,No
qingdao guohai biological pharmaceutical co ltd,Pharmaceuticals,"$68.5M, Not Found",Not Found,No
qingdao sino-cell biomedicine co ltd,Biotechnology,"$10M, Series A",https://www.cbinsights.com/company/sino-cell-biomed,No
qpex biopharma inc,Biotechnology,"$10M, Not Found",https://www.shionogi.com/global/en/news/2024/05/E_20240531_1.html,No
quadram institute bioscience,Biotechnology,"$2.5M, Grant",https://uk.linkedin.com/company/quadram-institute,No
que oncology inc,Pharmaceuticals,"$10M, Series A",https://pitchbook.com/profiles/company/173226-70,No
quince therapeutics inc,Biotechnology,"$22M, Private Placement",https://finance.yahoo.com/quote/QNCX/,No
rednvia co ltd,Biotechnology,"$150M, IPO",https://www.cbinsights.com/company/rednvia,No
reva medical inc,Biotechnology,"$45M, Series B",https://www.crunchbase.com/organization/reva-medical,No
rk pharma inc,Pharmaceuticals,"$200M, Acquired",https://www.contractpharma.com/breaking-news/rk-pharma-to-receive-200m-investment-from-pag/,No
reata pharmaceuticals inc,Pharmaceuticals,"$6.5B, Acquired",https://www.reuters.com/markets/deals/biogen-buy-reata-65-bln-bulk-up-rare-disease-portfolio-2023-07-28/,No
receptor life sciences inc,Pharmaceuticals,"$9.7M, Not Found",https://www.neuro-central.com/receptor-life-sciences-secures-9-7-million-financing-to-advance-rls103-inhaled-dry-powder-cbd-into-clinical-trials/,No
reconnect labs ag,Biotechnology,"$11M, Grant",https://www.linkedin.com/company/reconnect-labs,No
redhill biopharma ltd,Pharmaceuticals,"$10M, Not Found",Not Found,No
rediscovery life sciences,Biotechnology,"$4.5M, Series B",https://www.biospace.com/rediscovery-life-sciences-completes-4-5m-series-b-financing,No
rege nephro co ltd,Biotechnology,"$15.2M, Series B",https://www.crunchbase.com/organization/rege-nephro,No
regenacy pharmaceuticals llc,Biotechnology,"$9.3M, Series B",https://www.businesswire.com/news/home/20220824005201/en/Regenacy-Pharmaceuticals-Announces-Completion-of-Enrollment-for-Phase-2-Study-in-Diabetic-Peripheral-Neuropathy-%249.3-Million-Series-B-Financing,No
reneo pharmaceuticals inc,Pharmaceuticals,"$65M, IPO",https://www.jonesday.com/en/practices/experience/2024/05/reneo-pharmaceuticals-announces-reverse-merger-with-onkure,No
renibus therapeutics inc,Biotechnology,"$25M, Series B",https://www.crunchbase.com/organization/renibus-therapeutics,No
renovion inc,Pharmaceuticals,"$8.1M, Seed",https://grantengine.com/company-spotlight/renovion/,No
respirion pharmaceuticals pty ltd,Biotechnology,"$24M, Grant",https://www.cbinsights.com/company/respirion-pharmaceuticals,No
rest therapeutics sas,Biotechnology,"$2.49M, Grant",https://cordis.europa.eu/project/id/101144958,No
reunion neuroscience inc,Biotechnology,"$133M, Series A",https://www.linkedin.com/company/reunionneuro,No
revalesio corp,Pharmaceuticals,"$14M, Series Unknown",https://www.crunchbase.com/organization/revalesio,No
revelation biosciences inc,Biotechnology,"$9.6M, Post IPO equity",https://www.revbiosciences.com/,No
reviva pharmaceuticals holdings inc,Biotechnology,"$10M, IPO",https://finance.yahoo.com/quote/RVPH/press-releases/,No
rgenta therapeutics inc,Biotechnology,"$46M, Not Found",https://www.prnewswire.com/news-releases/rgenta-therapeutics-announces-strategic-alliance-with-gsk-to-develop-rna-targeted-small-molecule-splice-modulators-302321763.html,No
rich pharmaceuticals inc (inactive),Biotechnology,"$100K, Not Found",https://finance.yahoo.com/news/rich-pharmaceuticals-announces-collaboration-agreement-134500366.html,No
rigel pharmaceuticals inc,Biotechnology,"$16.5M, Grant",https://www.linkedin.com/company/rigel,No
rigenerand srl,Biotechnology,"$9.9M, Series Unknown",https://www.crunchbase.com/organization/rigenerand-srl,No
river 3 renal corp,Biotechnology,"$40M, Series A",https://www.baincapital.com/news/narrow-river-management-announces-formation-and-financing-two-new-companies-developing,No
river 3 renal corp (inactive),Biotechnology,"$10M, Series A",https://www.baincapital.com/news/narrow-river-management-announces-formation-and-financing-two-new-companies-developing,No
rivus pharmaceuticals inc,Biotechnology,"$57M, Series Unknown",https://www.crunchbase.com/organization/rivus-pharmaceuticals,No
rockwell medical inc,Pharmaceuticals,"$15M, Post IPO equity",https://www.linkedin.com/company/rockwell-medical,No
romark laboratories lc,Pharmaceuticals,"$10.7M, Debt Financing",https://www.linkedin.com/company/romark-laboratories-l-c-,No
rose research center llc,Pharmaceuticals,"$Not Found, Not Found",Not Found,No
rowpar pharmaceuticals inc,Pharmaceuticals,"$Not Found, Acquired",https://www.azbio.org/rowpar-pharmaceuticals-acquired-by-arcadia-consumer-healthcare,No
roxane laboratories inc,Pharmaceuticals,"$2.65B, Acquired",https://www.hikma.com/news/hikma-acquires-roxane-laboratories-transforming-its-position-in-the-us-generics-market/,No
rycarma therapeutics inc,Biotechnology,"$50M, Series B",https://endpts.com/exclusive-forbion-backed-cardio-biotech-rebrands-to-rycarma-with-phase-2-plans,No
sq innovation ag,Pharmaceuticals,"$10M, Series B",https://www.wlns.com/business/press-releases/cision/20251008NE92923/sq-innovation-ag-announces-the-appointment-of-two-new-board-members-and-successful-closing-of-series-b-financing-to-support-the-u-s-launch-of-lasix-onyu,No
surge therapeutics inc,Biotechnology,"$32M, Series B",https://www.linkedin.com/company/surge-therapeutics,No
sage therapeutics inc,Biotechnology,"$650M, Post IPO equity",https://www.linkedin.com/company/sage-therapeutics,No
sagimet biosciences inc,Biotechnology,"$112.5M, Post IPO equity",https://www.linkedin.com/company/3-v-biosciences,No
salarius pharmaceuticals inc,Biotechnology,"$16.1M, New Company Product Development",https://salariuspharma.com/,No
samumed pacific pty ltd,Biotechnology,"$438M, Series E",https://www.sandiegouniontribune.com/2018/08/06/samumed-raises-438-million-for-regenerative-therapies/,No
sanifit therapeutics sa,Biotechnology,"$231M, Acquired",https://www.fiercebiotech.com/biotech/sanifit-having-put-spain-s-biotech-scene-map-lands-231m-vifor-buyout-ahead-phase-3-data,No
saniona ab,Biotechnology,"$9M, Seed",https://www.linkedin.com/company/saniona,No
santhera pharmaceuticals holding ag,Pharmaceuticals,"$25.24M, Post-IPO Debt",https://ch.linkedin.com/company/santhera-pharmaceuticals-ltd,No
shanghai bozhiyan new drug technology co ltd,Pharmaceuticals,"$29.3M, Series C",https://tracxn.com/d/companies/shanghai-bocimed-pharmaceutical/__9jitQfzs-Nx7aQbiMcCPtU9gKpYxzfcU_wafzxnGwA4,No
shanghai guangsheng pharmaceutical co ltd,Pharmaceuticals,"$53.09M, Series C",https://www.globaldata.com/company-profile/guangdong-zhongsheng-pharmaceutical-co-ltd/deals/,No
shanghai high-tech bioengineering co ltd,Biotechnology,"$10M, Series B",https://www.bioengine-global.com/company-overview,No
shanghai huilun life science & technology co ltd,Pharmaceuticals,"$9.87M, Not Found",https://in.marketscreener.com/news/shanghai-huilun-life-sciences-technology-co-ltd-announced-that-it-has-received-cny-72-million-i-ce7d58deda88f02c,No
shanghai hutchison pharmaceuticals ltd,Pharmaceuticals,"$608M, Acquired",https://www.nasdaq.com/articles/hutchmed-announces-divestment-45-stake-shanghai-hutchison-pharmaceuticals-focus-innovative,No
shanghai jingfeng pharmaceutical co ltd,Pharmaceuticals,"$30M, Unattributed VC",https://www.cbinsights.com/company/shanghai-jingfeng-pharmaceutical-co,No
shanghai mengke pharmaceuticals inc,Pharmaceuticals,"$9.6M, Series A",https://www.biocentury.com/article/151871/micurx-deal,No
shanghai sinobioway sunterra biotechnology co ltd,Biotechnology,"$10M, Equity Investment",https://exumabio.com/news/f1-oncology-announces-development-milestone-and-10m-equity-investment/,No
shanghai zerun biotechnology co ltd,Biotechnology,"$13.1M, Not Found",https://en.walvax.com/news/148.html,No
shanton pharma co ltd,Biotechnology,"$31.2M, Series A+",https://www.shantonpharma.com/,No
shanton pharma holdings ltd,Biotechnology,"$31.2M, Series A+",https://www.shantonpharma.com/,No
shasqi inc,Biotechnology,"$10M, Not Found",https://www.linkedin.com/company/shasqi-inc-,No
shenzhen china resources gosun pharmaceuticals co ltd,Pharmaceuticals,"$10M, Not Found",Not Found,No
shenzhen forward pharmaceutical co ltd,Pharmaceuticals,"$7.75M, Series A+",https://www.forward-pharm.com/,No
shield therapeutics plc,Pharmaceuticals,"$6.1M, Post IPO equity",https://uk.linkedin.com/company/shield-therapeutics,No
shineway pharmaceutical group ltd,Pharmaceuticals,"$5B, Not Found",Not Found,No
shionogi &,Pharmaceuticals,"$375M, Grant",https://www.linkedin.com/company/shionogi-&-co.-ltd/,No
shouyao holding co ltd,Pharmaceuticals,"$36.28M, IPO",https://www.cbinsights.com/company/shouyao-holdings,No
sichuan kelun bio-tech pharmaceutical co ltd,Biotechnology,"$250M, Not Found",https://www.prnewswire.com/news-releases/kelun-biotech-announces-approximately-us250-million-placement-302475045.html,No
signpath pharma inc,Biotechnology,"$2.4M, Post IPO equity",https://www.linkedin.com/company/signpath-pharma-inc-,No
simmaron research inc,Biotechnology,"$4.5M, Not Found",https://www.simmaronresearch.com/,No
sinapis pharma inc,Biotechnology,"$1.6M, Seed",https://tracxn.com/d/companies/sinapis-pharma/__GcsiCfXBTdokIsEDfRt6QxfQ3SYAyBUoJL7guMzTxLA,No
sinew pharma inc,Biotechnology,"$10M, Seed",https://www.crunchbase.com/organization/sinew-pharma-inc,No
sinopharm group co ltd,Pharmaceuticals,"$1B, IPO",https://en.wikipedia.org/wiki/Sinopharm_Group,No
sinopharm shantou jinshi pharmaceutical co ltd,Pharmaceuticals,"$50.6M, Acquired",https://www.marketscreener.com/quote/stock/SHANGHAI-SHYNDEC-PHARMACE-9059391/news/Shanghai-Shyndec-Pharmaceutical-Co-Ltd-acquired-100-stake-in-Sinopharm-Shantou-Jinshi-Pharmaceutica-38070769/,No
sinsin pharmaceutical co ltd,Pharmaceuticals,"$10.9M, IPO",https://www.marketscreener.com/quote/stock/SINSIN-PHARMACEUTICAL-CO--64310127/company/,No
sionna therapeutics inc,Biotechnology,"$182M, Series C",https://www.linkedin.com/company/sionna-therapeutics,No
"sirion therapeutics, inc. (inactive)",Pharmaceuticals,"$71.5M, Series B",https://tracxn.com/d/companies/sirion-therapeutics/__-C2I-OADGt-zBZDB1G_PKO9dQ3-6YsEZP8jrnBme6PE,No
sironax ltd,Biotechnology,"$200M, Series B",https://www.crunchbase.com/organization/sironax,No
siteone therapeutics inc,Biotechnology,"$100M, Series C",https://www.biopharmadive.com/news/lilly-siteone-acquisition-pain-drug-non-opioid-deal/749012/,No
sitryx therapeutics ltd,Biotechnology,"$30M, Series A",https://uk.linkedin.com/company/sitryx-therapeutics-limited,No
skinject inc,Biotechnology,"$6M, Seed",https://www.razabokhari.com/press/skinject-an-innovator-in-skin-cancer-treatment-is-backed-by-us-healthcare-private-equity-and-institutional-investors-including-rbx-capital-lp-and-velocity-fund-partners,No
sling therapeutics inc,Biotechnology,"$35M, Series A",https://www.crunchbase.com/organization/sling-therapeutics,No
small pharma inc,Biotechnology,Acquired,https://www.biospace.com/cybin-completes-acquisition-of-small-pharma-inc-to-create-international-clinical-stage-leader-in-novel-psychedelic-therapeutics,No
small pharma ltd,Biotechnology,"$10M, Acquired",https://www.biospace.com/cybin-completes-acquisition-of-small-pharma-inc-to-create-international-clinical-stage-leader-in-novel-psychedelic-therapeutics,No
smart immune sas,Biotechnology,"$5M, Grant",https://www.crunchbase.com/organization/smart-immune,No
societal cdmo inc,Pharmaceuticals,"$130M, Acquired",https://www.contractpharma.com/breaking-news/corerx-to-acquire-societal-cdmo-in-130m-deal/,No
softox solutions as,Pharmaceuticals,"$7.5M, Series A",https://thehub.io/startups/softox-solutions-as,No
solasia pharma kk,Pharmaceuticals,"$500M, IPO",https://solasia.co.jp/en/,No
soleno therapeutics inc,Pharmaceuticals,"$200M, Post IPO equity",https://www.linkedin.com/company/soleno,No
solu therapeutics inc,Biotechnology,"$41M, Series A",https://synapse.patsnap.com/organization/0cea7172d91e9410a6c037afe428e177,No
sonalasense inc,Biotechnology,"$46M, Grant",https://www.fusfoundation.org/posts/arpa-h-designates-46-million-for-sonalasense-to-develop-ultrasound-activated-sonodynamic-treatments-for-blood-cancers-2/,No
sonire therapeutics inc,Biotechnology,"$4.8M, Series A",https://www.linkedin.com/company/sonire-therapeutics-inc/,No
sound pharmaceuticals inc,Pharmaceuticals,"$1.1M, Grant",https://www.linkedin.com/company/sound-pharmaceuticals-inc.,No
sparian biosciences inc,Biotechnology,"$60M, Grant",https://www.linkedin.com/company/sparian-biosciences,No
sparrow pharmaceuticals inc,Pharmaceuticals,"$95M, Series B",https://www.globenewswire.com/news-release/2025/09/24/3155451/0/en/Sparrow-Pharmaceuticals-Announces-95-Million-Series-B-Financing-to-Advance-Targeted-Therapy-for-Type-2-Diabetes.html,No
spectranetics corp,Biotechnology,"$2.2B, Acquired",https://www.philips.com/a-w/about/news/archive/standard/news/press/2017/20170809-philips-completes-acquisition-of-the-spectranetics-corporation.html,No
spectrumx holdings uk ltd,Biotechnology,"$6M, Pre-IPO",https://www.proactiveinvestors.com/companies/news/950846/spectrumx-advancing-full-service-infection-prevention-in-health-services-950846.html,No
spero therapeutics inc,Biotechnology,"$9M, Post IPO Equity",https://www.linkedin.com/company/spero-therapeutics,No
spinethera inc,Pharmaceuticals,"$5M, Grant",https://www.linkedin.com/company/spinethera,No
spinifex pharmaceuticals pty ltd (inactive),Biotechnology,"$45M, Series C",https://www.prnewswire.com/news-releases/spinifex-pharmaceuticals-raises-us45m-in-series-c-financing-254816981.html,No
springworks therapeutics inc,Biotechnology,"$275M, Post IPO equity",https://www.linkedin.com/company/springworks-therapeutics,No
spruce biosciences inc,Biotechnology,"$50M, Private Placement Financing",https://www.businesswire.com/news/home/20251008435141/en/Spruce-Biosciences-Announces-%2450.0-Million-Private-Placement-Financing,No
spybiotech ltd,Biotechnology,"$4.1M, Grant",https://www.gatesfoundation.org/about/committed-grants/2022/11/inv-042470,No
spyglass pharma inc,Pharmaceuticals,"$75M, Series D",https://www.ophthalmologytimes.com/view/spyglass-pharma-secures-75-million-series-d-financing-round,No
squarex llc,Pharmaceuticals,"$25K, Seed",https://tracxn.com/d/companies/squarex/__WrjDtueBk67_XE82bw5ehJF9dBeucOQKzDv6QzbUbcI,No
squarex pharmaceutical corp,Biotechnology,"$260K, Convertible Note - II",https://www.cbinsights.com/company/squarex-pharmaceutical,No
st george street capital ltd,Biotechnology,"$120M, Not Found",https://onenucleus.com/st-george-street-capital-agrees-deal-astrazeneca-drive-science-patients-need,No
stargazer pharmaceuticals inc,Pharmaceuticals,"$57M, Series A",https://novoholdings.dk/news/novo-ventures-incubated-rare-disease-company-stargazer-pharmaceuticals-enters-ph2-development-and-announces-57m-series-a-financing,No
stargazer pharmaceuticals inc (inactive),Pharmaceuticals,"$57M, Series A",https://www.retinaldegenerationfund.org/news/news-posts/stargazer-pharmaceuticals-inc-announces-57-million-series-a-financing-and-initiation-of-a-phase-2a-clinical-study-of-stg-001-in-stargardt-disease-patients/,No
stayble therapeutics ab,Pharmaceuticals,"$463K, Post IPO equity",https://www.crunchbase.com/organization/stayble-therapeutics,No
step pharma,Biotechnology,"$41.3M, Series B",https://www.crunchbase.com/organization/step-pharma,No
stratpharma ag,Pharmaceuticals,"$885,973, Horizon 2020",https://stratpharma.com/category/news/,No
strekin ag (inactive),Biotechnology,"$2.8M, Series A",https://www.startupticker.ch/en/news/strekin-s-development-candidate-obtains-eu-orphan-drug-designation,No
sucampo pharmaceuticals inc,Pharmaceuticals,"$1.2B, Acquired",https://www.mallinckrodt.com/about/news-and-media/news-detail/?id=8786,No
sucampo pharmaceuticals inc (inactive),Pharmaceuticals,"$1.2B, Acquired",https://www.pharmasalmanac.com/articles/mallinckrodt-expands-rare-disease-pipeline-with-sucampo-acquisition,No
sudo biosciences inc,Biotechnology,"$116M, Series B",https://www.tpg.com/news-and-insights/sudo-biosciences-raises-116m-series-b-financing-to-advance-potential-best-in-class-tyk2-therapeutics-programs-into-the-clinic,No
sun pharma advanced research company ltd,Biotechnology,"$10M, Not Found",https://medicine.washu.edu/news/sun-pharma-advanced-research-co-commits-10-million-drug-development/,No
sunflower pharmaceutical group co ltd,Pharmaceuticals,"$2M, SAFE Investment",https://www.businesswire.com/news/home/20240725394078/en/Sunflower-Therapeutics-Announces-SK-biosciences-2M-SAFE-Investment,No
sunovion pharmaceuticals inc,Pharmaceuticals,"$2.6B, Acquired",https://en.wikipedia.org/wiki/Sunovion,No
surmodics inc,Biotechnology,"$125M, Post IPO Debt",https://finance.yahoo.com/quote/SRDX/,No
sustained therapeutics inc,Biotechnology,"$100K, Seed",https://www.crunchbase.com/organization/sustained-therapeutics,No
Suzhou Amerigen Pharmaceuticals Co. Ltd.,Pharmaceuticals,"$35M, Series Unknown",https://www.linkedin.com/company/amerigen-pharmaceuticals-inc,No
suzhou genhouse pharmaceutical co ltd,Biotechnology,"$15.7M, Series B",https://bouncewatch.com/explore/startup/suzhou-genhouse-pharmaceutical-coltd,No
suzhou omni pharmaceutical co ltd,Pharmaceuticals,"$260M, Series C",https://omni-pharma.com/lang1-8,No
suzhou wangshan wangshui bio-pharmaceutical co ltd,Pharmaceuticals,"$20M, Angel Investment",https://www.itiger.com/news/1146477812,No
swiss parenterals pvt ltd,Pharmaceuticals,"$76.5M, Acquired",https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/eris-acquires-51-pc-stake-in-swiss-parenterals-for-rs-637-5-cr/articleshow/107665426.cms,No
sydnexis inc,Pharmaceuticals,"$Not Found, Not Found",Not Found,No
sylphar nv,Pharmaceuticals,"$290M, Acquired",https://www.karohealthcare.com/karo-pharma-acquires-sylphar-international-nv-for-eur-290m-and-intends-to-carry-out-a-rights-issue-of-approximately-eur-200-250m/,No
synact pharma ab,Biotechnology,"$1.84M, IPO",https://se.linkedin.com/company/synact-pharma,No
syndesi therapeutics sa,Biotechnology,"$1B, Acquired",https://www.pearceip.law/2022/03/01/abbvie-completes-its-acquisition-of-syndesi-therapeutics-sa/,No
synendos therapeutics ag,Biotechnology,"$27.8M, Series A",https://www.synendos.com/,No
synnovation therapeutics inc,Pharmaceuticals,"$102M, Series A",https://www.biospace.com/synnovation-therapeutics-launches-with-102-million-to-advance-clinical-stage-pipeline-of-precision-therapies-targeting-highly-validated-disease-pathways,No
synokem pharmaceuticals ltd,Pharmaceuticals,"$5.5B, Private Equity",https://www.synokempharma.com/,No
syqe medical ltd,Pharmaceuticals,"$83M, Acquired",https://www.forbes.com/sites/dariosabaghi/2023/07/20/philip-morris-to-acquire-israeli-cannabis-inhaler-company-syqe-medical-for-up-to-650-million/,No
t3d therapeutics inc,Pharmaceuticals,"$30M+, Series Unknown",https://www.ncbiotech.org/node/78586,No
task foundation npc,Pharmaceuticals,"$1.05M, Not Found",https://www.gatesfoundation.org/about/committed-grants/2017/03/opp1169595,No
tnf pharmaceuticals inc,Pharmaceuticals,"$7M, Private Placement",https://www.businesswire.com/news/home/20250904261260/en/TNF-Pharmaceuticals-Announces-Closing-of-%247-Million-Private-Placement,No
tolremo therapeutics ag,Biotechnology,"$39M, Series A",https://techparkbasel.ch/companies/tolremo-therapeutics-ag/,No
tract therapeutics inc,Biotechnology,"$15M, Series Unknown",https://www.crunchbase.com/organization/tract-therapeutics,No
trpharm ilac sanayi tic as,Pharmaceuticals,"$136M, Equity Offering",https://www.leadingmarketresearch.com/trpharm-ilac-sanayi-tic-as-pharmaceuticals-and-healthcare-deals-and-a,No
tablets (india) ltd,Pharmaceuticals,"$282K, Unattributed",https://tracxn.com/d/companies/tablets-india/__8Jxzrara7wakWC4MKAxyn-CYaVr-kmpajiMf8h2fu6o,No
tachyon therapeutics inc,Biotechnology,"$18.7M, Series A",https://www.biospace.com/tachyon-announces-financing-and-start-of-clinical-study-of-first-in-class-kdm4-inhibitor-for-advanced-cancers,No
targeted therapy technologies llc,Biotechnology,"$4.08M, Not Found",https://taggs.hhs.gov/Detail/RecipDetail?arg_EntityId=BFuqCjdDQlNTMcbi4oJx8w%3D%3D,No
taro pharmaceutical industries ltd,Pharmaceuticals,"$454M, Acquired",https://sunpharma.com/wp-content/uploads/2020/12/Sun-Pharma-to-acquire-Taro-Pharma-in-a-USD-454-million-deal.pdf,No
tarsier pharma ltd,Pharmaceuticals,"$2.4M, Grant",https://finder.startupnationcentral.org/company_page/tarsius-pharma,No
taurx pharmaceuticals ltd,Pharmaceuticals,"$890M, Not Found",https://uk.linkedin.com/company/taurx,No
taurx therapeutics ltd,Pharmaceuticals,"$890M, Not Found",https://uk.linkedin.com/company/taurx,No
tempero bio,Biotechnology,"$70M, Series B",https://www.prnewswire.com/news-releases/tempero-bio-secures-70-million-series-b-financing-to-advance-tmp-301-into-phase-2-trials-for-substance-use-disorders-302408403.html,No
tennor therapeutics ltd,Biotechnology,"$109M, Series E",https://tracxn.com/d/companies/tennor-therapeutics/__-0UBdfEdlO7v9IdvCSmHnYxuTnX9JwIYzfzgXvH23Eo,No
tenax therapeutics inc,Biotechnology,"$25M, Post IPO equity",https://www.linkedin.com/company/tenax-therapeutics,No
tetra bio-pharma inc,Biotechnology,"$6M, Post IPO Debt",https://ca.linkedin.com/company/tetra-bio-pharma,No
tetra therapeutics,Biotechnology,"$500M, Acquired",https://www.michiganbusiness.org/reports-data/success-stories/tetra-therapeutics/,No
tetralogic pharmaceuticals corp,Biotechnology,"$47M, Convertible Note",https://www.linkedin.com/company/tetralogic-pharmaceuticals,No
tetraphase pharmaceuticals inc,Biotechnology,"$4M, Grant",https://www.linkedin.com/company/tetraphase-pharmaceuticals,No
thar pharmaceuticals inc,Pharmaceuticals,"$12.36M, Acquired",https://www.cbinsights.com/company/thar-pharmaceuticals,No
the hospital for sick children,Biotechnology,"$1.5B, Not Found",https://en.wikipedia.org/wiki/The_Hospital_for_Sick_Children_(Toronto),No
the lundbeck foundation,Pharmaceuticals,"$2.6B, Acquired",https://en.wikipedia.org/wiki/Lundbeck,No
the therapeutic advances in childhood leukemia & lymphoma (tacl) consortium,Biotechnology,"$10M, Seed",https://pcrf-kids.org/2023/10/10/new-clinical-trial-seeks-to-lower-risks-expand-leukemia-treatment-options-for-children/,No
theracryf plc,Biotechnology,"$10M, Seed",https://theracryf.com/,No
theracos inc,Pharmaceuticals,"$120.86M, Convertible Note",https://www.cbinsights.com/company/theracos,No
theralase technologies inc,Pharmaceuticals,"$8M, IPO",https://ca.linkedin.com/company/theralase-technologies-inc-,No
therapeuticsmd inc,Pharmaceuticals,"$1.1M, Post IPO equity",https://www.linkedin.com/company/therapeuticsmd,No
theriva biologics sl,Biotechnology,"$7.5M, Post IPO equity",https://www.linkedin.com/company/theriva-biologics,No
theseus pharmaceuticals inc,Biotechnology,"$100M, IPO","https://pitchbook.com/profiles/company/464310-37#:~:text=Theseus%20Pharmaceuticals%20Inc%20is%20a,commercialization%20of%20transformative%20targeted%20therapies.",No
thetis pharmaceuticals llc,Pharmaceuticals,"$8.975M, Debt financing",https://www.businesswire.com/news/home/20250109823925/en/Thetis-Pharmaceuticals-Secures-an-Additional-%248.975-Million-in-Program-Related-Investment-Funds-from-the-Helmsley-Charitable-Trust-to-Advance-TP-317-an-Oral-BLT1-Agonist-into-a-Phase-1b-Trial-in-Ulcerative-Colitis-Patients,No
thiogenesis therapeutics corp,Biotechnology,"$3.06M, Seed",https://www.marketscreener.com/quote/stock/THIOGENESIS-THERAPEUTICS--136548345/,No
third harmonic bio inc,Biotechnology,"$185M, IPO",https://www.biopharmadive.com/news/third-harmonic-bio-dissolution-strategic-alternatives/745263/,No
thryv therapeutics inc,Biotechnology,"$15M, Series B",https://www.biospace.com/press-releases/thryv-therapeutics-to-share-recent-clinical-results-and-participate-in-upcoming-healthcare-investor-conferences,No
tianjin greenpine pharma co ltd,Pharmaceuticals,"$108M, Not Found",https://invest.teda.gov.cn/contents/1489/63470.html,No
tianjin xinyi suntech biomedical technology co ltd,Biotechnology,"$100M, Series B",https://www.tjsjkt.com/en/about.aspx,No
tibet rhodiola pharmaceutical holding co ltd,Pharmaceuticals,"$10M, IPO",https://dcfmodeling.com/blogs/history/600211ss-history-mission-ownership?srsltid=AfmBOooUQBuogMTQt1mDtEn9RYBG2FQ1_qYSwBIxTHG8Oq6Vw2tyypS-,No
tikomed ab,Biotechnology,"$8.6M, Series Unknown",https://tikomed.newswire.com/,No
timber pharmaceuticals inc,Pharmaceuticals,"$25M, Acquired",https://pcgadvisory.com/news/timber-pharmaceuticals-announces-merger-closing/,No
tioga pharmaceuticals inc,Pharmaceuticals,"$10M, Series B",https://www.linkedin.com/company/tioga-pharmaceuticals-inc-,No
tisento therapeutics inc,Biotechnology,"$81M, Series A",https://www.linkedin.com/company/tisentotx,No
titan pharmaceuticals inc,Pharmaceuticals,"$600K, Post IPO equity",https://www.linkedin.com/company/titan-pharmaceuticals,No
tiximed inc,Pharmaceuticals,"$2.65M, Seed",https://innovatealabama.org/stories/2025/07/where-discovery-meets-delivery-the-alabama-origin-story-of-tiximed/,No
tolero pharmaceuticals inc,Biotechnology,"$200M, Acquired",https://www.sumitomo-pharma.com/news/20161221-2.html,No
tolero pharmaceuticals inc (inactive),Pharmaceuticals,"$780M, Acquired",https://www.biospace.com/tolero-pharmaceuticals-to-be-acquired-for-up-to-780-million,No
tolerogenixx gmbh,Biotechnology,"$12.6M, Series A",https://www.labiotech.eu/trends-news/tolerogenixx-expands-trial-closes-financing/,No
topelia aust ltd,Biotechnology,"$25M, Series A",https://www.biospace.com/topelia-australia-launches-us-25m-series-a-call-for-covid-19-att-ziverdox,No
transcend therapeutics inc,Biotechnology,"$50M, Not Found",https://finance.yahoo.com/news/transcend-therapeutics-receives-breakthrough-therapy-120000110.html,No
transition therapeutics inc,Biotechnology,"$17M, Post IPO",https://tracxn.com/d/companies/transition-therapeutics/__bPQv9aF4ohU5ZJlUThTJEpUz1AJxihyyz2CGHCmE8do,No
"tranzyme pharma, inc. (formerly neokimia inc.) (inactive)",Biotechnology,"$20M, Not Found",https://www.fiercebiotech.com/biotech/press-release-tranzyme-pharma-closes-new-20-million-financing,No
treeway bv,Biotechnology,"$2.14M, Not Found",https://www.alzdiscovery.org/research-and-grants/portfolio-details/20720200,No
tremeau pharmaceuticals inc,Pharmaceuticals,"$110M, Private Equity",https://www.linkedin.com/company/tremeau-pharmaceuticals,No
trethera corp,Biotechnology,"$10.8M, Not Found",https://taggs.hhs.gov/Detail/RecipDetail?arg_EntityId=NmCCWxtCeZDQst3K7lIfWA%3D%3D,No
trevi therapeutics inc,Biotechnology,"$115.1M, IPO",https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-closing-of-115-million-underwritten-offering-and-full-exercise-by-underwriters-of-option-to-purchase-additional-shares-302474714.html,No
"triangle pharmaceuticals, inc. (inactive)",Pharmaceuticals,"$464M, Acquired",https://www.gilead.com/news/news-details/2002/gilead-sciences-to-acquire-triangle-pharmaceuticals-for-464-million,No
triastek inc,Pharmaceuticals,"$20.5M, Series C",https://www.crunchbase.com/organization/triastek,No
tricida inc,Pharmaceuticals,"$125M, Post IPO Debt",https://www.linkedin.com/company/tricida-inc-,No
trius therapeutics inc (inactive),Biotechnology,"$1.6B, Acquired",https://www.fiercebiotech.com/financials/cubist-splurges-on-trius-and-optimer-buyouts-to-spur-antibiotics-growth,No
tuhura biosciences inc,Biotechnology,"$5.3M, Post IPO equity",https://www.linkedin.com/company/tuhurabio,No
"tularik, inc. (inactive)",Biotechnology,"$1.3B, Acquired",https://investors.amgen.com/news-releases/news-release-details/amgen-acquire-tularik-13-billion,No
urcc ncorp research base,Biotechnology,"$2.5M, Early Stage Investigator Grants",https://prevention.cancer.gov/funding-and-grants/funded-grants/UG1CA189961,No
us worldmeds llc,Pharmaceuticals,"$55M, Acquired",https://www.prnewswire.com/news-releases/us-worldmeds-completes-acquisition-of-adaptimmunes-celltherapy-portfolio-ensures-continued-patient-access-to-tecelra-and-advances-development-of-lete-cel-302520986.html,No
ubix therapeutics inc,Biotechnology,"$17.7M, Series C",https://www.crunchbase.com/organization/ubix-therapeutics,No
umecrine cognition ab,Biotechnology,"$2.56M, Convertible Notes",https://www.crunchbase.com/organization/umecrine-cognition,No
umoja biopharma inc,Biotechnology,"$100M, Series C",https://www.biospace.com/employer/2387738/umoja-biopharma,No
unity biotechnology inc,Biotechnology,"$4.3M, Post IPO Debt",https://www.linkedin.com/company/unity-biotechnology,No
"genaissance pharmaceuticals, inc. (inactive)",Biotechnology,"$11M, Acquired",https://www.sec.gov/Archives/edgar/data/1110009/000104746905006537/a2152822z10-k.htm,No
modag gmbh,Biotechnology,"$12M, Not Found",https://www.izb-online.de/en/unternehmen/modag-gmbh/,No
modis therapeutics inc,Biotechnology,"$250M, Acquired",https://www.globenewswire.com/news-release/2019/08/26/1906376/35369/en/Zogenix-Announces-Acquisition-of-Modis-Therapeutics-Inc.html,No
modra pharmaceuticals bv,Pharmaceuticals,"$2.8M, Not Found",https://aglaia-oncology.com/news/modra-pharmaceuticals-expands-management-team-and-provides-corporate-update/,No
modulation therapeutics inc,Biotechnology,"$10M, Seed",https://www.linkedin.com/company/modulation-therapeutics,No
moleculin biotech inc,Biotechnology,"$5.9M, Post IPO equity",https://www.linkedin.com/company/moleculin-llc,No
molecure sa,Biotechnology,"$12.62M, IPO",https://pl.linkedin.com/company/molecure-sa,No
monta biosciences aps,Biotechnology,"$3.45M, Unknown",https://www.crunchbase.com/organization/monta-biosciences,No
sichuan nofit biopharmaceutical technology co ltd,Biotechnology,"$250M, Series B",https://www.prnewswire.com/news-releases/kelun-biotech-announces-approximately-us250-million-placement-302475045.html,No
morphic therapeutic inc,Biotechnology,"$647M, Acquired",https://www.businesswire.com/news/home/20250721005094/en/Omega-Funds-Closes-Oversubscribed-647-Million-Fund-VIII-to-Invest-in-Transformative-Life-Science-Companies,No
mothers pharm co ltd,Pharmaceuticals,"$5.3M, Not Found",https://uk.marketscreener.com/quote/stock/DAISHIN-SECURITIES-CO-LTD-6494628/news/Mother-s-Pharmaceutical-Co-Ltd-announced-that-it-expects-to-receive-KRW-7-billion-in-funding-from-45569128/,No
mothers pharmaceutical co ltd,Pharmaceuticals,"$5.3M, Not Found",https://uk.marketscreener.com/quote/stock/DAISHIN-SECURITIES-CO-LTD-6494628/news/Mother-s-Pharmaceutical-Co-Ltd-announced-that-it-expects-to-receive-KRW-7-billion-in-funding-from-45569128/,No
multidisciplinary association for psychedelic studies,Biotechnology,"$30M, Not Found",https://en.wikipedia.org/wiki/Multidisciplinary_Association_for_Psychedelic_Studies,No
mycomedica life sciences pbc,Biotechnology,"$60M, Series A",https://www.crunchbase.com/organization/mycomedica-life-sciences,No
mylan inc,Pharmaceuticals,"$147M, Settlement",https://en.wikipedia.org/wiki/Mylan,No
myokardia inc,Biotechnology,"$13.1B, Acquired",https://news.bms.com/news/details/2020/Bristol-Myers-Squibb-to-Acquire-MyoKardia-for-13.1-Billion-in-Cash/default.aspx,No
myovant sciences gmbh,Biotechnology,"$4.2B, Acquired",https://news.us.sumitomo-pharma.com/2023-03-10-Sumitovant-Biopharma-Completes-Acquisition-of-Myovant-Sciences,No
nls pharmaceutics ag,Biotechnology,"$6M, IPO",https://ch.linkedin.com/company/nls-pharmaceutics-ag,No
nmd pharma as,Biotechnology,"$155M, Series A",https://international.au.dk/collaboration/technology-transfer/spin-outs/nmd-pharma,No
nalagenetics pte ltd,Biotechnology,"$10M, Grant",https://www.crunchbase.com/organization/nalagenetics,No
nanjing haijing pharmaceutical co ltd,Pharmaceuticals,"$141M, Private Placement",https://news.futunn.com/en/post/62463338/20cm-price-limit-surge-micromed-completes-private-placement-haijing-pharmaceuticals,No
nanjing huanglong biotechnology co ltd,Biotechnology,"$90M, Not Found",https://www.marketscreener.com/quote/stock/XINJIANG-BAI-HUA-CUN-PHAR-9949882/news/Nanjing-Huanglong-Biotechnology-Co-Ltd-announced-that-it-expects-to-receive-CNY-90-million-in-fun-42619331/,No
nanjing huawe medicine technology development co ltd,Pharmaceuticals,"$1.9B, Acquired",https://www.marketscreener.com/quote/stock/XINJIANG-BAI-HUA-CUN-PHAR-9949882/news/Xinjiang-Bai-Hua-Cun-Co-Ltd-signed-an-agreement-to-acquire-Nanjing-Huawe-Medicine-Technology-Devel-38130061/,No
nanjing kangchuanji pharmaceutical technology co ltd,Pharmaceuticals,"$12.6M, Equity Round",https://www.marketscreener.com/quote/stock/ZHEJIANG-JIUZHOU-PHARMACE-21683496/news/Nan-Jing-Kang-Chuan-Ji-Pharmatech-Co-Ltd-announced-that-it-expects-to-receive-CNY-80-million-in-f-37829935/,No
nanjing meirui pharma co ltd,Pharmaceuticals,"$70M, Acquired",https://www.biospace.com/glaxosmithkline-buys-chinese-drugmaker-b-nanjing-meirui-pharma-b-for-70-million,No
nanjing norit pharmaceutical technology co ltd,Pharmaceuticals,"$10M, Seed",https://tracxn.com/d/companies/nanjing-norreite-pharmaceutical-technology/__j_QnG1lWscY26cZCEzl0h8ojylJbiSahObqzlcxAoNI,No
nanjing ruinian best pharmaceutical co ltd,Pharmaceuticals,"$100M, Acquired",https://ieg-banking.com/deals/imported-item-129,No
nanjing zenshine pharmaceuticals co ltd,Pharmaceuticals,"$13.7M, Series C",https://www.crunchbase.com/organization/zenshine,No
nano pharmasolutions inc,Pharmaceuticals,"$10M, Seed",https://www.crunchbase.com/organization/nano-pharmasolutions,No
narrows institute for biomedical research inc,Biotechnology,"$538,891, Not Found",https://taggs.hhs.gov/Detail/RecipDetail?arg_EntityId=tf%2F143NTos4J1YAfg1HonA%3D%3D,No
national institute for pharmaceutical research and development,Pharmaceuticals,"$400K, Not Found",https://en.wikipedia.org/wiki/National_Institute_for_Pharmaceutical_Research_and_Development,No
national institute for research in tuberculosis,Biotechnology,"$11M, Not Found",https://en.wikipedia.org/wiki/National_Institute_for_Research_in_Tuberculosis,No
naurex inc,Biotechnology,"$560M, Acquired",https://www.prnewswire.com/news-releases/allergan-to-acquire-naurex-300118764.html,No
nerre therapeutics ltd,Biotechnology,"$27.6M, Series B",https://uk.linkedin.com/company/nerre-therapeutics-ltd,No
neogene therapeutics inc,Biotechnology,"$110M, Series A",https://www.crunchbase.com/organization/neogene-therapeutics,No
neopharmed gentili spa,Pharmaceuticals,"$700M, Acquired",https://www.ardian.com/news-insights/video/empowering-family-businesses-ardian-buyout-approach-neopharmed-gentili,No
nephrogenex inc (inactive),Pharmaceuticals,"$4.3M, Series A",https://tracxn.com/d/companies/nephrogenex/__Y6_xm0iUuNUlwCcgWbi7y-N7sLhpuLACRuV6aGeGTWI,No
neuraltus pharmaceuticals inc (inactive),Biotechnology,"$43.1M, Series C",https://tracxn.com/d/companies/neuraltus/__wtZhj6JIj9_DoZnXWsP1jE_M66ZPjOubw-fW5jltmug,No
neurana pharmaceuticals inc (inactive),Pharmaceuticals,"$63.8M, Series A",https://tracxn.com/d/companies/neurana-pharmaceuticals/__Fg4A6D9mvCPcdxTIJ0qlUJ5XEg-gra5xWFUtf-uizL8,No
neurelis inc,Pharmaceuticals,"$114M, Series D",https://www.linkedin.com/company/neurelis-inc.,No
neurizon therapeutics ltd,Biotechnology,"$3.6M, Not Found",https://www.biospace.com/press-releases/pharmaust-affirms-corporate-strategy-with-name-change-to-neurizon-therapeutics,No
neuropharm inc,Pharmaceuticals,"$6.3M, Acquired",https://www.psychedelicfinance.com/articles/mydecine-innovations-group-completes-acquisition-of-neuropharm-inc,No
neurosense therapeutics ltd,Biotechnology,"$500,000, Private Placement",https://www.prnewswire.com/news-releases/neurosense-therapeutics-announces-500-000-private-placement-at-premium-to-market-price-302546560.html,No
neurotherapia inc,Biotechnology,"$12.3M, Series B",https://www.prnewswire.com/news-releases/neurotherapia-raises-12-3m-in-the-first-close-of-its-series-b-financing-302213518.html,No
neurotherpia inc,Biotechnology,"$12.3M, Series B",https://www.prnewswire.com/news-releases/neurotherapia-raises-12-3m-in-the-first-close-of-its-series-b-financing-302213518.html,No
neurotrauma sciences llc,Pharmaceuticals,"$10M, Seed",https://www.linkedin.com/company/neurotrauma-sciences-llc,No
neurovia inc (inactive),Biotechnology,"$14M, Series A",https://globalventuring.com/university/neurovia-journeys-to-14m-series-a/,No
neurocentrx pharma ltd,Biotechnology,"$10M, Seed",https://www.businesswire.com/news/home/20250923615281/en/Neurocentrx-Closes-Seed-Extension-Round-Including-Funding-from-the-Wellcome-Trust,No
neurogastrx inc,Pharmaceuticals,"$60M, Series B",https://pitchbook.com/profiles/company/135526-60,No
neurokine therapeutics,Biotechnology,"$4.83M, Grant",https://www.inknowvation.com/sbir/companies/neurokine-therapeutics-llc,No
neurolixis inc,Biotechnology,"$15K, Seed",https://www.crunchbase.com/organization/neurolixis-inc,No
neuropharm group plc (inactive),Pharmaceuticals,"$6.18M, Not Found",https://www.biospace.com/neuropharm-group-plc-to-mull-voluntary-liquidation-to-return-cash,No
neuropore therapies inc,Biotechnology,"$4.8M, Not Found",https://www.biospace.com/neuropore-therapies-awarded-4-8m-grant-from-the-michael-j-fox-foundation-for-parkinson-s-research-to-support-development-of-its-tlr2-program,No
neurotech international ltd,Biotechnology,"$10M, IPO",https://nextinvestors.com/company/asx-nti/,No
new river pharmaceuticals inc,Pharmaceuticals,"$2.6B, Acquired",https://sec.boardroomalpha.com/2007/QTR1/0000950103-07-000431/dp04772_sctoc.htm,No
newleos therapeutics inc,Biotechnology,"$93.5M, Series A",https://www.businesswire.com/news/home/20250213253174/en/Newleos-Therapeutics-Debuts-with-%2493.5-Million-Oversubscribed-Series-A-Financing-to-Transform-the-Treatment-of-Neuropsychiatric-Disorders-through-the-Advancement-of-Novel-Medicines,No
"niagen bioscience, inc.",Biotechnology,"$48M, Series C",https://en.wikipedia.org/wiki/Niagen_Bioscience,No
nicox research institute srl,Pharmaceuticals,"$3.2M, Post IPO equity",https://www.linkedin.com/company/nicox,No
nicox sa,Pharmaceuticals,"$3.2M, Post IPO Equity",https://www.linkedin.com/company/nicox,No
nido biosciences inc,Biotechnology,"$109M, Series B",https://www.fiercebiotech.com/biotech/new-neurological-disease-biotech-nido-unveils-109m-backing-eli-lilly,No
ningxia kangya pharmaceutical co ltd,Pharmaceuticals,"$10.39M, Series B",https://www.nxkangya.com/en/,No
nocion therapeutics inc,Biotechnology,"$62M, Series B",https://www.linkedin.com/company/nocion-therapeutics-inc,No
nodthera inc,Biotechnology,"$55M, Series B",https://pitchbook.com/profiles/company/163758-97,No
noema pharma ag,Biotechnology,"$147M, Series B",https://www.businesswire.com/news/home/20241211787741/en/Noema-Pharma-extends-Series-B-financing-round-closing-at-CHF-130-Million-%24147-Million,No
nohla therapeutics inc (inactive),Biotechnology,"$120M, Series B",https://tracxn.com/d/companies/nohla-therapeutics/__F7pLRBtCiZEQGn_2HwHUCSV_IPp-GTXoUCzzCsPDps8,No
nordisk rebalance a/s,Biotechnology,"$2.2M, Seed",https://se.linkedin.com/company/nordic-rebalance,No
north china pharmaceutical hebei huamin pharmaceutical co ltd,Pharmaceuticals,"$35.85M, Acquired",https://www.marketscreener.com/quote/stock/NORTH-CHINA-PHARMACEUTICA-6496323/news/North-China-Pharmaceutical-Company-Ltd-agreed-to-acquire-the-remaining-35-85-stake-in-NCPC-Hebei-Hu-46347447/,No
northsea therapeutics bv,Biotechnology,"$80M, Series B",https://www.crunchbase.com/organization/northsea-therapeutics,No
noucor health sa,Pharmaceuticals,"$Not Found, Not Found",Not Found,No
"novacea, inc. (inactive)",Biotechnology,"$88M-$92M, Acquired",https://www.biospace.com/novacea-inc-to-be-acquired-by-transcept-pharmaceuticals-inc,No
novalar pharmaceuticals inc (inactive),Pharmaceuticals,"$27M, Series C",https://www.biospace.com/b-novalar-pharmaceuticals-b-closes-27-million-series-c,No
novaliq gmbh,Pharmaceuticals,"$15M, Series Unknown",https://www.linkedin.com/company/novaliq,No
novan inc,Biotechnology,"$15M, Acquired",https://investor.ligand.com/news-and-events/press-releases/news-details/2023/Ligand-Offers-15-Million-To-Acquire-Assets-Of-Novan-Inc/default.aspx,No
novast holdings ltd,Pharmaceuticals,"$140M, Private Equity",https://www.bvcf.com/show.asp?id=91&nav=5,No
nupathe inc,Pharmaceuticals,"$Not Found, Acquired",https://www.sep.benfranklin.org/partner/nupathe/,No
nurx pharmaceuticals inc (inactive),Pharmaceuticals,"$22.5M, Series C",https://news.crunchbase.com/startups/telehealth-startup-nurx-raises-22-5m-series-c-extension/,No
nuance pharma (shanghai) co ltd,Pharmaceuticals,"$181M, Series D",https://www.nuancepharma.com/,No
nuance pharma ltd,Pharmaceuticals,"$181M, Series D",https://www.nuancepharma.com/,No
nura bio inc,Biotechnology,"$68M, Series A",https://www.biopharmadive.com/news/nura-bio-financing-sarm1-neurodegeneration-drug/727153/,No
nuvox pharma llc,Biotechnology,"$7.3M, Not Found",https://www.sbir.gov/portfolio/712096,No
nuvalent inc,Biotechnology,"$575M, Post IPO equity",https://www.linkedin.com/company/nuvalent-inc,No
nuvectis pharma inc,Biotechnology,"$15.5M, IPO",https://www.linkedin.com/company/nuvectis,No
omeicos therapeutics gmbh,Biotechnology,"$19.4M, Series C",https://www.linkedin.com/company/omeicos-therapeutics-gmbh,No
obseva sa,Biotechnology,"$500M, IPO",https://www.swissbiotech.org/listing/obseva-sa-started-trading-on-the-six-swiss-exchange/,No
occurx pty ltd,Biotechnology,"$30M, Acquired",https://certatherapeutics.com/certa-therapeutics-expands-gpr68-platform-through-acquisition-of-occurx/,No
ocuterra therapeutics inc,Biotechnology,"$40.2M, Series B",https://tracxn.com/d/companies/ocuterra-therapeutics/__NLp6hcJGoJxUNz62D6W-LzGVfN5mizADV0MqZjaVomE,No
ocugenix corp,Biotechnology,"$100K, Seed",https://tracxn.com/d/companies/ocugenix/__0shCy6suhFItWa1V-_lY4Bphb_8HQ7tfMwsoomZWvLA,No
ocular therapeutix inc,Biotechnology,"$475M, Post IPO equity",https://www.linkedin.com/company/ocular-therapeutix-inc,No
oculis sa,Biotechnology,"$160.3M, IPO",https://finance.yahoo.com/quote/OCS/,No
ocumension therapeutics co ltd,Pharmaceuticals,"$164.3M, IPO",https://www.crunchbase.com/organization/ocumension-therapeutics,No
ocuphire pharma inc,Biotechnology,"$915M, Seed",https://www.fightingblindness.org/news/the-rd-fund-announces-ocuphire-pharma-s-acquisition-of-opus-genetics-1366,No
olatec therapeutics llc,Biotechnology,"$40M, Series A",https://www.businesswire.com/news/home/20230223005975/en/Olatec-Therapeutics-Announces-the-Final-Closing-Led-by-Sanders-Morris-Harris-on-Its-%2440-Million-Series-A-Financing-Round,No
oncotartis inc,Biotechnology,"$6M, Series Unknown",https://www.linkedin.com/company/oncotartis-inc-,No
onconic therapeutics co ltd,Pharmaceuticals,"$34.9M, Series B",https://tracxn.com/d/companies/onconic-therapeutics/__Yxhn2F5qqSJvmr6vcVSQZ_we8OHlPQrswGcvkXEsUpA,No
onconova therapeutics inc,Biotechnology,"$21M, Post IPO equity",https://www.linkedin.com/company/onconova,No
oncorena ab,Pharmaceuticals,"$13.9M, Not Found",https://www.linkedin.com/company/oncorena-ab/,No
oncostellae sl,Biotechnology,"$10M, Series A",https://www.linkedin.com/company/oncostellae/,No
onyx pharmaceuticals inc,Biotechnology,"$20M, Series Unknown",https://www.linkedin.com/company/onyx-pharmaceuticals,No
ophirex inc,Biotechnology,"$37M, Series B",https://www.linkedin.com/company/ophirex,No
opiant pharmaceuticals inc,Pharmaceuticals,"$2M, Grant",https://www.linkedin.com/company/opiant-pharmaceuticals,No
opiant pharmaceuticals inc (inactive),Pharmaceuticals,"$145M, Acquired",https://www.vabio.org/indivior-completes-acquisition-of-opiant-pharmaceuticals-inc/,No
opna bio sa,Biotechnology,"$38M, Series A",https://www.crunchbase.com/organization/opna-bio,No
oppilan pharma ltd,Pharmaceuticals,"$4.25M, Unattributed",https://www.cbinsights.com/company/oppilan-pharma,No
optinose inc,Pharmaceuticals,"$55M, Post IPO equity",https://www.linkedin.com/company/optinose,No
optimus pharma pvt ltd,Pharmaceuticals,"$9.9M, Not Found",https://in.linkedin.com/company/optimus-pharma,No
orasis pharmaceuticals ltd,Pharmaceuticals,"$78M, Not Found",https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-completes-78-million-financing-to-support-commercial-launch-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-302269236.html,No
orbicular pharmaceutical technologies pvt ltd,Pharmaceuticals,"$20M, Private Equity",https://www.crunchbase.com/organization/orbicular-pharmaceutical-technologies,No
orcosa inc,Biotechnology,"$7.3M, Series Unknown",https://www.linkedin.com/company/orcosa-inc,No
orexa bv,Pharmaceuticals,"$940K, Series Unknown",https://www.crunchbase.com/organization/orexa,No
orexigen therapeutics inc,Pharmaceuticals,"$165M, Post IPO equity",https://www.linkedin.com/company/orexigen-therapeutics,No
orexigen therapeutics inc (inactive),Biotechnology,"$35M, Acquired",https://www.biopharmadive.com/news/orexigen-bankruptcy-asset-contrave-obesity/518914/,No
orfagen sas,Biotechnology,"$10.2M, Grant",https://www.orphagen.com/news/,No
organicell regenerative medicine inc,Biotechnology,"$5.5M, Not Found",https://www.accessnewswire.com/newsroom/en/biotechnology/organicell-regenerative-medicine-inc.-closes-5.5-million-funding-round-713696,No
orphazyme a/s,Pharmaceuticals,"$12.8M, Acquired",https://www.strategic-partners.dk/investorer/selskabsmeddelelser/orphazyme-as-under-in-court-restructuring-to-sell-substantially-all-of-its-assets-and-business-activities-to-kempharm-inc/,No
orphomed inc,Biotechnology,"$39M, Not Found",https://drug-dev.com/orphomed-secures-39-million/,No
oruka therapeutics inc,Biotechnology,"$180M, Post IPO equity",https://www.linkedin.com/company/oruka-therapeutics,No
oryzon genomics sa,Biotechnology,"$15.5M, Grant",https://www.crunchbase.com/organization/oryzon-genomics,No
ossium health inc,Biotechnology,"$130M, Not Found",https://www.linkedin.com/company/ossiumhealth,No
osteal therapeutics inc,Pharmaceuticals,"$50M, Series D",https://dallasinnovates.com/patented-osteal-therapeutics-treatment-system-for-joint-infections-and-more-north-texas-inventive-activity/,No
otonomy inc,Biotechnology,"$34.7M, IPO",https://www.linkedin.com/company/otonomy-inc,No
otonomy inc (inactive),Biotechnology,"$134.7M, IPO",https://www.sandiegouniontribune.com/2022/12/20/san-diego-biotech-that-studied-tinnitus-ear-diseases-is-closing-after-failing-to-find-a-buyer/,No
ovid therapeutics inc,Biotechnology,"$175M, Private Placement",https://www.cnn.com/markets/stocks/OVID,No
oxford cannabinoid technologies ltd,Pharmaceuticals,"$10M, Not Found",https://uk.linkedin.com/company/octavian-therapeutics,No
oxular ltd,Biotechnology,"$Not Found, Acquired",https://www.fiercebiotech.com/biotech/regeneron-acquires-uk-biotech-adding-oxulars-eye-disease-delivery-tech-portfolio,No
oyster point pharma inc,Pharmaceuticals,"$415M, Acquired","https://newsroom.viatris.com/2023-01-03-Viatris-Closes-Acquisitions-of-Oyster-Point-Pharma-and-Famy-Life-Sciences,-Establishing-New-Viatris-Eye-Care-Division",No
ozon medica,Pharmaceuticals,"$35M, Not Found",https://tadviser.com/index.php/Company:Ozon_Medica,No
paion ag,Pharmaceuticals,"$6.1M, Post IPO equity",https://www.linkedin.com/company/paion-ag,No
pari pharma gmbh,Pharmaceuticals,"$100M, Series D",https://www.linkedin.com/company/parigroup,No
pep-therapy sas,Biotechnology,"$10M, Seed",https://pep-therapy.com/,No
piqur therapeutics ag (inactive),Biotechnology,"$100M, Acquired",https://www.linkedin.com/pulse/swiss-rockets-ag-acquired-assets-intellectual-property-piqur-?trk=public_post_main-feed-card_feed-article-content,No
pacylex pharmaceuticals inc,Pharmaceuticals,"$1.4M, Grant",https://ca.linkedin.com/company/pacylex-pharma,No
palau pharma sa,Pharmaceuticals,"$10M, Private Equity",https://www.linkedin.com/company/palau-pharma,No
palladio biosciences inc,Biotechnology,"$28M, Series B",https://tracxn.com/d/companies/palladio-biosciences/__XNG16F1ZPQHW2TdpdNmx1rGK_D9XNUXKZu5E-jIFHXk,No
palobiofarma sl,Biotechnology,"$7M, Series A",https://medibiofarma.com/palobiofarma-and-medibiofarma-open-new-headquarters-in-the-ainbuilding-in-cordovilla-spain/,No
palvella therapeutics llc,Biotechnology,"$78.9M, Acquired",https://www.globenewswire.com/news-release/2024/12/13/2997010/0/en/Palvella-Therapeutics-Announces-Closing-of-Merger-with-Pieris-Pharmaceuticals-and-Concurrent-Private-Placement-of-78-9-Million.html,No
"palvella therapeutics, inc",Biotechnology,"$2.6M, Not Found",https://www.stocktitan.net/news/PVLA/u-s-food-and-drug-administration-awards-year-two-proceeds-from-uy95g7vt6r8f.html,No
panacea biotec ltd,Pharmaceuticals,"$35.65M, Not Found",https://www.screener.in/company/PANACEABIO/consolidated/,No
panoptes pharma gesmbh,Biotechnology,"$7.989M, Acquired",https://kiorapharma.com/eyegate-pharma-announces-transformative-acquisition-of-panoptes-pharma/,No
par pharmaceutical holdings inc,Pharmaceuticals,"$8.05B, Acquired",https://investor.endo.com/2015-09-28-Endo-Completes-Acquisition-of-Par-Pharmaceutical-and-Provides-Financial-Guidance,No
paratek pharmaceuticals inc,Pharmaceuticals,"$462M, Acquired",https://bflexion.com/news/paratek-pharmaceuticals-be-acquired-gurnet-point-capital-and-novo-holdings,No
pardes biosciences inc,Biotechnology,"$276M, IPO",https://www.foresitecapital.com/pardes-biosciences-legend/,No
park therapeutics inc,Pharmaceuticals,"$10M, Series A",https://www.bio.org/events/bio-investor-forum/sessions/751434,No
pasithea therapeutics corp,Biotechnology,"$6.3M, Post IPO equity",https://www.linkedin.com/company/pasitheacorp,No
patara pharma inc,Biotechnology,"$40.8M, Unattributed",https://www.cbinsights.com/company/patara-pharma,No
pathalys pharma inc,Pharmaceuticals,"$105M, Series B",https://www.prnewswire.com/news-releases/pathalys-pharma-secures-105-million-series-b-financing-302226093.html,No
pathios therapeutics ltd,Biotechnology,"$25M, Series B",https://www.crunchbase.com/organization/pathios-therapeutics,No
pearl therapeutics inc,Pharmaceuticals,"$115M, Acquired",https://www.astrazeneca.com/media-centre/press-releases/2013/astrazeneca-pearl-therapeutics-acquisition-28062013.html,No
university of sciences techniques and technologies of bamako-mali-bamako,Biotechnology,"$471,216, Not Found",https://www.gatesfoundation.org/about/committed-grants/2021/12/inv001983,No
urica therapeutics inc,Biotechnology,"$205M, Series A",https://drug-dev.com/fortress-biotech-urica-therapeutics-announce-crystalys-therapeutics-205-million-series-a-financing/,No
urigen pharmaceuticals inc,Pharmaceuticals,"$6.05M, Series A",https://tracxn.com/d/companies/urigen-pharmaceuticals/__li5o7YVy7_U-Stav3BGZgemNxcP6Dg1MgxCr2mT3S9Q,No
vbi vaccines inc,Biotechnology,"$2M, Post IPO equity",https://www.linkedin.com/company/vbi-vaccines-inc,No
vcn biosciences sl,Biotechnology,"$4.7M, Acquired",https://therivabio.com/press_releases/synthetic-biologics-completes-acquisition-of-vcn-biosciences/,No
vgi health technology limited,Biotechnology,"$2.5M, IPO",https://www.pittstreetresearch.com/vgi-health-technology,No
vgi health technology ltd,Biotechnology,"$2.5M, IPO",https://www.pittstreetresearch.com/vgi-health-technology,No
vyne therapeutics inc,Biotechnology,"$88.15M, Acquired",https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vyne/vyne-therapeutics,No
vaderis therapeutics ag,Biotechnology,"$18.1M, Series A",https://www.swissbiotech.org/listing/vaderis-therapeutics-ag/,No
valneva austria gmbh,Biotechnology,"$215M, Post IPO Debt",https://www.linkedin.com/company/valneva,No
vanda pharmaceuticals inc,Biotechnology,"$54M, Post IPO equity",https://www.linkedin.com/company/vanda-pharmaceuticals,No
vandria sa,Biotechnology,"$30.7M, Series A",https://hevolution.com/en/web/guest/w/hevolution-foundation-and-dolby-family-ventures-join-vandria-s-2nd-series-a-closing-bringing-the-total-round-to-30.7m-chf-28.3m-to-progress-the-mitophagy-inducer-vna-318-into-cns-clinical-development,No
vanquish oncology inc,Biotechnology,"$6.94M, Convertible Note",https://www.cbinsights.com/company/vanquish-oncology,No
vanquish oncology inc (inactive),Biotechnology,"$2.25M, Seed",https://vanquishoncology.com/company/,No
varmx bv,Biotechnology,"$68.5M, Series B",https://nl.linkedin.com/company/varmx,No
vasa therapeutics sp zoo,Biotechnology,"$2.3M, Not Found",https://www.newswise.com/articles/vasa-therapeutics-announces-upcoming-presentations-at-aha-scientific-sessions-2022,No
vector vitale inc,Pharmaceuticals,"$1.08M, Seed",https://tracxn.com/d/companies/vector-vitale/__lj5P5GgUcC0QeJlJiLCxj7Ek3e6nz0s1Fke3BJfevC0,No
vectura group plc,Pharmaceuticals,"$11.4M, Private Equity",https://uk.linkedin.com/company/vectura,No
vectus biosystems ltd,Biotechnology,"$5.1M, IPO",https://au.linkedin.com/company/vectus-biosystems,No
velpharm,Pharmaceuticals,"$30M, Not Found",https://globaltradealert.org/state-act/72065-russia-velpharm-secured-over-rub-3-billion-from-the-federal-and-moscow-governments,No
venatorx pharmaceuticals inc,Pharmaceuticals,"$42M, Series B",https://www.versantventures.com/portfolio/venatorx-pharmaceuticals,No
venturepharma inc,Pharmaceuticals,"$105M, Acquired",https://www.cvc.com/media/news/2012/2012-04-13-cvc-announces-investment-in-venturepharma-group-in-china/,No
ventyx biosciences inc,Biotechnology,"$27M, Post IPO equity",https://www.crunchbase.com/organization/ventyx-biosciences,No
veralox therapeutics inc,Biotechnology,"$24M, Series Unknown",https://www.linkedin.com/company/veralox-therapeutics,No
verona pharma plc,Biotechnology,"$10B, Acquired",https://www.merck.com/news/merck-to-acquire-verona-pharma-expanding-its-portfolio-to-include-ohtuvayre-ensifentrine-a-first-in-class-copd-maintenance-treatment-for-adults-and-expected-to-drive-growth-into-the-next-dec/,No
versantis ag,Biotechnology,"$16M, Series B",https://www.venturekick.ch/versantis,No
vittoria biotherapeutics inc,Biotechnology,"$25M, Series Unknown",https://www.globenewswire.com/news-release/2024/11/12/2978833/0/en/Vittoria-Biotherapeutics-Completes-25-Million-in-Private-Financing-to-Propel-Groundbreaking-Cell-Therapy-Candidates.html,No
vicuron pharmaceuticals llc,Pharmaceuticals,"$63.31M, Acquired",https://www.cbinsights.com/company/vicuron-pharmaceuticals,No
vidac pharma,Biotechnology,"$9M, Series A",https://il.linkedin.com/company/vidac-pharma,No
vion pharmaceuticals inc (inactive),Pharmaceuticals,"$2.37M, Not Found",https://www.inknowvation.com/sbir/companies/vion-pharmaceuticals-inc,No
"virios therapeutics, inc",Pharmaceuticals,"$30M, IPO",https://www.marketbeat.com/stocks/NASDAQ/VIRI/,No
virogenics inc,Biotechnology,"$4.5M, Not Found",https://www.salk.edu/news-release/salk-team-launches-phase-i-clinical-trial-for-alzheimers-therapy/,No
vistagen therapeutics inc,Biotechnology,"$63M, Not Found",https://finance.yahoo.com/news/vistagen-therapeutics-inc-vtgn-eyes-075144761.html,No
visufarma spa,Pharmaceuticals,"$56.3M, Acquired",https://www.ophthalmologytimes.com/view/lupin-signs-definitive-agreement-to-acquire-visufarma,No
visus therapeutics inc,Pharmaceuticals,"$20M, Not Found",https://www.biospace.com/employer/2388558/visus-therapeutics,No
viva vision biotech,Biotechnology,"$46M, Series E",https://tracxn.com/d/companies/vivavision-biotech/__vhlHcfhlvWnydjhdl_mANpsfThvEE-9H3qtHEX__iSY,No
vivoryon therapeutics nv,Biotechnology,"$5.1M, Private Placement",https://finance.yahoo.com/news/vivoryon-therapeutics-n-v-successfully-184800588.html,No
vivozon inc,Pharmaceuticals,"$34.2M, IPO",https://en.yna.co.kr/view/AEN20251013009300320,No
vogenx inc,Biotechnology,"$10M, Series A",https://www.crunchbase.com/organization/vogenx,No
wex pharmaceuticals inc,Pharmaceuticals,"$23M, Acquired",https://www.globenewswire.com/news-release/2024/10/07/2580000/0/en/Virios-Therapeutics-Inc-and-Wex-Pharmaceuticals-Inc-Announce-Business-Combination-to-Form-Dogwood-Therapeutics-Inc.html,No
wante pharmaceutical hainan co ltd,Pharmaceuticals,"$90M, Not Found",https://www.chemball.com/factory/q2eb2y/,No
warner chilcott company llc (inactive),Pharmaceuticals,"$8.5B, Acquired",https://www.prnewswire.com/news-releases/actavis-completes-warner-chilcott-acquisition-225944231.html,No
wayshine biopharma inc,Pharmaceuticals,"$2.5M, R01 Grant",https://www.linkedin.com/posts/bioseedin_raredisease-medical-clinicaltrials-activity-7119607502786236416-si5K,No
wecare probiotics co ltd,Biotechnology,"$10M, Series D",https://www.crunchbase.com/organization/wecare-probiotics,No
weifa asa,Pharmaceuticals,"$140M, Acquired",https://www.alpha.no/transactions?name=weifa-sold-to-aqualis,No
wenling chuangxin biomedical technology co ltd,Biotechnology,"$72.8M, Not Found",Not Found,No
west point jilin pharmaceutical technology development co ltd,Pharmaceuticals,"$10.2M, IPO",https://tracxn.com/d/companies/jilin-west-point-pharmaceutical-technology/__PRFoNg4XXxqwxa4BR5S82DDtC45iePX-U8__tKP6VuQ,No
whitehawk therapeutics inc,Biotechnology,"$100M, PIPE Financing",https://www.biospace.com/press-releases/aadi-bioscience-relaunches-as-whitehawk-therapeutics-marking-evolution-into-adc-company,No
wihuri research institute,Biotechnology,"$2M, Not Found",https://wihurinrahasto.fi/en/wihuri-research-institute/,No
winsantor inc,Biotechnology,"$1.2M, Seed",https://p2pmarketdata.com/companies/winsantor/,No
woke pharmaceuticals pty ltd,Pharmaceuticals,"$5M, Not Found",https://www.swinburne.edu.au/news/2023/01/Australias-biggest-research-trial-using-psychedelics-to-treat-depression-to-commence-in-2023/,No
woolsey pharmaceuticals inc,Pharmaceuticals,"$10M, Series B",https://www.prnewswire.com/news-releases/woolsey-pharmaceuticals-completes-b-round-extension-to-advance-its-als-program-302385983.html,No
wuhan langlai technology development co ltd,Pharmaceuticals,"$10M, Series A",https://www.createrna.com/en/news-activity/news-center/news/43.html,No
wuhan yinuo pharmaceutical co ltd,Pharmaceuticals,"$5.93M, Seed",https://tracxn.com/d/companies/yinuo-pharmaceutical/__t5sTGHvVlmrZlsi6dYzMf86eK8ME_Yt1NK21LDmaggo,No
xwpharma ltd,Biotechnology,"$17M, Series B",https://www.xwpharma.com/,No
xcovery holding co llc,Biotechnology,"$20M, Private Equity",https://www.crunchbase.com/organization/xcovery,No
xcovery holdings inc,Pharmaceuticals,"$20M, Private Equity",https://www.linkedin.com/company/xcovery,No
xenikos bv,Biotechnology,"$43M, Convertible Debt",https://www.veloxis.com/about/news/news-posts/veloxis-pharmaceuticals-announces-dosing-of-the-first-patient-by-partner-xenikos-in-the-global-phase-3-study-evaluating-t-guard-sup-sup/,No
xenoport inc,Pharmaceuticals,"$467M, Acquired",https://www.fiercebiotech.com/biotech/arbor-buys-out-struggling-horizant-developer-xenoport-for-467m,No
xeolas pharmaceuticals ltd,Pharmaceuticals,"$1.42M, Seed",https://tracxn.com/d/companies/xeolas-pharmaceuticals/__kBlCHywpG7F93tKCUvVE-qGbruB-qhvsNF5ShlJDptg,No
xspray pharma ab,Pharmaceuticals,"$9.2M, Post IPO Debt",https://www.linkedin.com/company/xspray-pharma-ab-publ-/,No
xuanzhu biological technology co ltd,Pharmaceuticals,"$96.1M, Series B",https://www.linkedin.com/company/xuanzhu-biopharmaceutical-ltd/,No
ym biosciences inc. (inactive),Biotechnology,"$510M, Acquired",https://www.contractpharma.com/breaking-news/gilead-to-acquire-ym-biosciences/,No
yaopharma co ltd,Pharmaceuticals,"$3.24M, Not Found",https://www.gatesfoundation.org/about/committed-grants/2022/11/inv-049561,No
yaqrit ltd,Biotechnology,"$2.8M, Grant",https://uk.linkedin.com/company/yaqrit-ltd,No
yas pharmaceutical co,Pharmaceuticals,"$45M, Not Found",https://www.alvotech.com/newsroom/yas-holding-invests-in-alvotech-and-agrees-on-a-strategic,No
yiviva inc,Biotechnology,"$10M, Series A",https://www.linkedin.com/company/yiviva,No
yourchoice therapeutics inc,Biotechnology,"$15M, Series A",https://www.biospace.com/press-releases/yourchoice-therapeutics-announces-nature-publication,No
z factor ltd,Pharmaceuticals,"$10M, Series A",https://www.cic.vc/company/z-factor/,No
zyus life sciences inc,Pharmaceuticals,"$2M, Private Placement",https://ca.linkedin.com/company/zyuslifesciences,No
zeno pharmaceuticals inc,Pharmaceuticals,"$15M, Unattributed",https://www.cbinsights.com/company/zeno-pharmaceuticals,No
zentiva ks,Pharmaceuticals,"$10M, Acquired",https://www.zentiva.com/,No
zhaoke ophthalmology ltd,Pharmaceuticals,"$145M, Series B",https://hk.linkedin.com/company/zhaoke-ophthalmology,No
zhaoke pharmaceutical guangzhou co ltd,Pharmaceuticals,"$145M, Series B",https://hk.linkedin.com/company/zhaoke-ophthalmology,No
zhejiang acea pharmaceutical co ltd,Pharmaceuticals,"$18M, Series A",https://tracxn.com/d/companies/acea-therapeutics/__oF3LZDNhW3ryKvUAbnVcC1krASimggAyqJujTG5rvmI,No
zhejiang qizheng pharmaceutical co ltd,Pharmaceuticals,"$2.74M, Not Found",https://www.marketscreener.com/quote/stock/ZHEJIANG-AUSUN-PHARMACEUT-42613223/news/Zhejiang-Qizheng-Pharmaceutical-Co-Ltd-announced-that-it-has-received-CNY-20-million-in-funding-f-43840124/,No
zhejiang zhongyi pharmaceutical co ltd,Pharmaceuticals,"$205.9M, Acquired",https://www.biospectrumasia.com/news/25/7412/china-resources-sanjiu-medical-to-acquire-zhejiang-zhongyi-pharmaceutical.html,No
zhuhai beihai biotech co ltd,Biotechnology,"$42.85M, Series C",https://www.cbinsights.com/company/beihai-biotech,No
zhuhai ebang pharmaceutical co ltd,Pharmaceuticals,"$374M, IPO",https://www.jdcapital.com/mobile/en/news/7B44513F-4C79-459D-B56C-3B41BE5E90DC,No
zhuhai essex bio-pharmaceutical co ltd,Pharmaceuticals,"$17M, Not Found",https://www.essex.com.cn/info-detail/i-204.html,No
zhuhai jianfu pharmaceutical co ltd,Pharmaceuticals,"$2.05M, Not Found",https://news.futunn.com/en/post/33143189/jianfan-biotech-300529-sz-plans-to-increase-the-capital-of,No
zogenix inc,Pharmaceuticals,"$230M, Acquired",https://www.linkedin.com/company/zogenix,No
zogenix inc (inactive),Biotechnology,"$1.9B, Acquired",https://www.prnewswire.com/news-releases/ucb-to-acquire-zogenix-301463511.html,No
zogenix international ltd,Pharmaceuticals,"$230M, IPO",https://www.linkedin.com/company/zogenix,No
zurex pharma inc,Pharmaceuticals,"$6.2M, Series A",https://www.vcnewsdaily.com/Zurex%20Pharma/venture-funding.php,No
zyversa therapeutics inc,Biotechnology,"$2M, Post IPO equity",https://www.stocktitan.net/news/ZVSA/,No
zymogenetics inc,Biotechnology,"$885M, Acquired",https://news.bms.com/news/details/2010/Bristol-Myers-Squibb-to-Acquire-ZymoGenetics/default.aspx,No
zymtech production as,Biotechnology,"$Not Found, Not Found",Not Found,No
zynerba pharmaceuticals inc,Biotechnology,"$60M, Acquired",https://www.prnewswire.com/news-releases/harmony-biosciences-completes-acquisition-of-zynerba-pharmaceuticals-and-expands-pipeline-301953012.html,No
exithera pharmaceuticals inc,Pharmaceuticals,"$15M, Acquired",https://finance.yahoo.com/news/cadrenal-therapeutics-acquires-exithera-factor-093632750.html,No
iqure pharma inc,Biotechnology,"$1.2M, Seed",https://synapse.patsnap.com/organization/5a48e07e9842147b7d06a61cf3c25080,No
iveena delivery systems inc,Biotechnology,"$3M, Series B-2",https://synapse.patsnap.com/organization/bd396a88f8ef5c19db19c860fde88885,No
invox belgium,Pharmaceuticals,"$22.7M, Acquired",https://be.linkedin.com/company/invox-belgium,No
ratiopharm gmbh,Pharmaceuticals,"$5B, Acquired",https://en.wikipedia.org/wiki/Ratiopharm,No
vtv therapeutics inc,Biotechnology,"$80M, PIPE",https://www.linkedin.com/company/vtv_therapeutics,No
cinclus pharma ag,Pharmaceuticals,"$24.14M, Not Found",https://www.trillimpact.com/portfolio-companies/cinclus-pharma,No
cinclus pharma holding ab,Pharmaceuticals,"$24.14M, Not Found",https://se.linkedin.com/company/cincluspharma,No
cingulate inc,Pharmaceuticals,"$4.3M, Not Found",https://www.linkedin.com/company/cingulateinc,No
cingulate therapeutics llc,Pharmaceuticals,"$3M, Grant",https://www.biospace.com/employer/549669/cingulate-therapeutics,No
cinphloro pharma llc,Pharmaceuticals,"$73M, Series B",https://www.ohiotechnews.com/stories/cinrx-pharma-announces-additional-73-million-financing,No
cisen pharmaceutical co ltd,Pharmaceuticals,"$851M, IPO",http://shandong.chinadaily.com.cn/jining/2022-01/29/c_649275.htm,No
city of hope,Biotechnology,"$5.4M, Grant",https://www.linkedin.com/company/city-of-hope,No
clarus therapeutics holdings inc,Pharmaceuticals,"$30M, Post IPO equity",https://www.linkedin.com/company/clarus-therapeutics,No
clear creek bio inc,Biotechnology,"$6.1M, Series Unknown",https://www.linkedin.com/company/clear-creek-bio,No
clearmind medicine inc,Biotechnology,"$10M, IPO",https://www.clearmindmedicine.com/,No
clearside biomedical inc,Biotechnology,"$15M, Post IPO equity",https://www.linkedin.com/company/clearside-biomedical-inc-,No
cleave therapeutics inc,Biotechnology,"$103M, Series B",https://tracxn.com/d/companies/cleave-therapeutics/__nDRL7oA4ADt6Q-uoh3NhVEJ52kW861LosD9qLVtpRR0,No
clementia pharmaceuticals inc,Pharmaceuticals,"$1.31B, Acquired",https://www.ipsen.com/press-releases/ipsen-to-acquire-clementia-pharmaceuticals-to-significantly-boost-rare-disease-portfolio/,No
clene nanomedicine inc,Pharmaceuticals,"$7.3M, Post IPO equity",https://synapse.patsnap.com/organization/586bdae41242e4685228af8f558ed7f0,No
clerkenwell health,Biotechnology,"$2.3M, Seed",https://uk.linkedin.com/company/clerkenwell-health,No
clinical research unit of nanoro,Biotechnology,"$0.5M, Not Found",https://www.gatesfoundation.org/about/committed-grants/2024/12/inv-082271,No
clovis oncology inc (inactive),Pharmaceuticals,"$70M, Acquired",https://www.biopharmadive.com/news/clovis-rubraca-sale-pharma-schweiz-bankruptcy/647111/,No
coave therapeutics,Biotechnology,"$39M, Series B",https://www.prnewswire.com/news-releases/coave-therapeutics-closes-eur33-million-39-million-series-b-financing-to-develop-its-gene-therapy-pipeline-and-next-generation-vectors-based-on-its-aav-ligand-conjugate-platform-868708634.html,No
cocrystal pharma inc,Biotechnology,"$13M, IPO",https://www.globenewswire.com/news-release/2025/09/15/3150405/0/en/Cocrystal-Pharma-Inc-Announces-Closing-of-Up-To-13-Million-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html,No
cognition therapeutics inc,Biotechnology,"$30M, IPO",https://finance.yahoo.com/news/cognition-therapeutics-closes-30-million-200000007.html,No
commave therapeutics sa,Pharmaceuticals,"$10.1M, Not Found",https://www.moneyhouse.ch/en/company/commave-therapeutics-sa-14271705431,No
compass pathways plc,Biotechnology,"$150M, Post IPO equity",https://uk.linkedin.com/company/compass-pathways,No
complexa inc,Biotechnology,"$78.9M, Series C",https://tracxn.com/d/companies/complexa/__K95h9q4af_DD-Ge2E9Ag9nNjoryqiaHN_v2VuzhIM0E,No
concentric analgesics inc,Biotechnology,"$20M, Convertible Note",https://www.linkedin.com/company/concentric-analgesics-inc-,No
concept medical inc,Biotechnology,"$60M, Series Unknown",https://www.crunchbase.com/organization/concept-medical,No
concert pharmaceuticals inc,Biotechnology,"$84M, IPO",https://www.flagshippioneering.com/companies/concert-pharmaceuticals,No
confo therapeutics,Biotechnology,"$60M, Series B",https://www.businesswire.com/news/home/20240725025121/en/Confo-Therapeutics-Announces-EUR-60M-Series-B-Financing-to-Advance-Pipeline-of-Novel-GPCR-Modulating-Therapies-into-Clinical-Development,No
confo therapeutics sa,Biotechnology,"$60M, Series B",https://www.vubtechtransfer.be/confo-therapeutics,No
constellation pharmaceuticals inc,Biotechnology,"$45M, Acquired",https://www.businesswire.com/news/home/20210602005571/en/MorphoSys-to-Acquire-Constellation-Pharmaceuticals,No
context therapeutics inc,Biotechnology,"$100M, Post IPO equity",https://www.linkedin.com/company/context-therapeutics,No
cormedix inc,Biotechnology,"$85M, Post IPO equity",https://www.linkedin.com/company/cormedix-inc-,No
"coria laboratories, ltd. (inactive)",Pharmaceuticals,"$95M, Acquired",https://www.contractpharma.com/breaking-news/valeant-to-acquire-coria-labs/,No
corium inc,Pharmaceuticals,"$400M, Acquired",https://www.prnewswire.com/news-releases/corium-pharma-solutions-inc-is-now-corium-innovations-inc-reflecting-commitment-to-specialty-contract-development-and-manufacturing-business-301842958.html,No
corium llc,Pharmaceuticals,"$Not Found, Acquired",https://www.linkedin.com/company/corium,No
correvio pharma corp,Pharmaceuticals,"$76M, Acquired",https://www.prnewswire.com/news-releases/advanz-pharma-to-acquire-correvio-301024562.html,No
cortendo ab,Biotechnology,"$27.5M, Private Placement",https://www.locustwalk.com/cortendo-ab-raises-up-to-27-5m-in-additional-private-placement-with-leading-u-s-and-eu-healthcare-investors/,No
crescent biopharma inc,Biotechnology,"$200M, Private Placement",https://www.biospace.com/press-releases/crescent-biopharma-completes-closing-of-merger-with-glycomimetics-and-previously-announced-private-placement-of-200-million,No
crinetics pharmaceuticals inc,Pharmaceuticals,"$500M, Post IPO equity",https://www.linkedin.com/company/crinetics-pharmaceuticals,No
cristal therapeutics bv,Pharmaceuticals,"$21.2M, Series B",https://tracxn.com/d/companies/cristal-therapeutics/__-5vcgGLoqXs7tlssUieYeehe1WAF07PP_MoMLmurWaI,No
crystal life sciences,Pharmaceuticals,"$15M, Funding Raised",https://tracxn.com/d/companies/crystal-life-science/__Ug3b98VZcPZEqaOKD4V2NeNe0YTg0Kv_NCsh02PTSz4,No
crystalys therapeutics inc,Biotechnology,"$205M, Series A",https://www.prnewswire.com/news-releases/crystalys-therapeutics-launches-with-205m-series-a-financing-to-transform-the-treatment-of-gout-302569747.html,No
cubist pharmaceuticals llc,Pharmaceuticals,"$700M, Acquired",https://www.merck.com/news/merck-to-acquire-cubist-pharmaceuticals-for-102-per-share-in-cash/,No
cullgen inc,Biotechnology,"$35M, Series C",https://www.contractpharma.com/breaking-news/pulmatrix-to-merge-with-cullgen/,No
curasen therapeutics inc,Biotechnology,"$5.8M, Not Found",https://www.alzdiscovery.org/research-and-grants/portfolio-details/21918113,No
curon biopharmaceutical (australia) co pty ltd,Biotechnology,"$700M, Acquired",https://www.biospectrumasia.com/news/48/24713/merck-buys-investigational-b-cell-depletion-therapy-from-chinese-startup-curon-biopharma-for-700-m.html,No
curon biopharmaceutical ltd,Biotechnology,"$700M, Acquired",https://www.biospace.com/business/merck-puts-up-potential-1-3b-to-acquire-curons-b-cell-depletion-therapy,No
currax holdings usa llc,Pharmaceuticals,"$75.6M, Acquired",https://www.curraxpharma.com/press-releases/currax-holdings-usa-llc-announces-launch-and-close-of-acquisition/,No
cutanea life sciences inc,Pharmaceuticals,"$900K, Seed",https://tracxn.com/d/companies/cutanea-life-sciences/__vJLITsYBPhnM7Snm2goE_E72HIQPBtTyPltsvkzPdRQ,No
cybin inc,Biotechnology,"$50M, Post IPO Debt",https://ca.linkedin.com/company/cybin,No
cybin therapeutics inc,Biotechnology,"$50M, Post IPO Debt",https://ca.linkedin.com/company/cybin,No
cyclacel pharmaceuticals inc,Biotechnology,"$3M, Series F",https://www.globenewswire.com/news-release/2025/06/20/3102932/10564/en/Cyclacel-Pharmaceuticals-Announces-3-Million-Private-Placement-Offering-of-Convertible-Preferred-Stock.html,No
cyclo therapeutics inc,Biotechnology,"$2.5M, Post IPO Debt",https://www.linkedin.com/company/cyclotherapeutics,No
cymabay therapeutics inc,Biotechnology,"$4.3B, Acquired",https://www.gilead.com/news/news-details/2024/gilead-sciences-expands-liver-portfolio-with-acquisition-of-cymabay-therapeutics,No
cyprium therapeutics inc,Biotechnology,"$4.1M, Grant",https://www.fortressbiotech.com/news-media/press-releases/detail/611/fortress-biotech-and-cyprium-therapeutics-announce-4-1,No
cyrano therapeutics inc,Pharmaceuticals,"$9M, Series B",https://www.crunchbase.com/organization/cyrano-therapeutics,No
cystetic medicines inc,Biotechnology,"$25M, Seed",https://medicine.illinois.edu/news/company-co-founded-by-carle-illinois-faculty-member-secures-25-million-to-advance-promising-new-cystic-fibrosis-treatment,No
cytoagents inc,Biotechnology,"$7.85M, Not Found",Not Found,No
cytokinetics inc,Biotechnology,"$450M, Financing Deal",https://en.wikipedia.org/wiki/Cytokinetics,No
cytosinlab therapeutics co ltd,Biotechnology,"$14M, Series A",https://www.linkedin.com/company/cytosinlab-therapeutics,No
das therapeutics inc,Pharmaceuticals,"$200K, Acquired",https://www.prnewswire.com/news-releases/gt-biopharma-announces-the-sale-of-its-fixed-dose-combination-tablet-gtb-004-for-myasthenia-gravis-chronic-autoimmune-disease-to-das-therapeutics-300923652.html,No
dice therapeutics inc,Biotechnology,"$574.2M, IPO",https://www.stocktitan.net/news/DICE/,No
durect corp,Biotechnology,"$15M, Post IPO equity",https://www.linkedin.com/company/durect-corporation,No
dusa pharmaceuticals inc,Pharmaceuticals,"$30M, Acquired",https://en.wikipedia.org/wiki/DUSA_Pharmaceuticals,No
dalian aosen pharmaceutical group co ltd,Pharmaceuticals,"$80M, Not Found",http://www.cphibiz.com/index.php?homepage=dlms,No
dalian fusheng natural medicine development co ltd,Pharmaceuticals,"$100K, Not Found",https://www.biospace.com/mmaap-foundation-announces-china-s-dalian-fusheng-pharmaceutical-company-co-ltd-makes-second-contribution-in-2019-to-fund-research-in-aging-and-immunity-sponsored-by-the-irma-and-paul-milstein-program,No
dantari inc,Biotechnology,"$47M, Series A",https://westlakebio.com/westlake-backed-dantari-launches-with-47-million-series-a/,No
dare bioscience inc,Biotechnology,"$48.95M, Grant",https://www.gatesfoundation.org/about/committed-grants/2021/06/inv026060,No
day one biopharmaceuticals holding co llc,Biotechnology,"$175M, Post IPO equity",https://www.linkedin.com/company/dayonebio,No
day one biopharmaceuticals inc,Biotechnology,"$175M, Post IPO equity",https://www.linkedin.com/company/dayonebio,No
de motu cordis pty ltd,Pharmaceuticals,"$10M, Series A",https://au.linkedin.com/company/demotucordis,No
defender pharmaceuticals inc,Pharmaceuticals,"$70M, Not Found",https://www.crunchbase.com/organization/defender-pharmaceuticals,No
delix therapeutics inc,Biotechnology,"$70M, Series A",https://en.wikipedia.org/wiki/Delix_Therapeutics,No
delpor inc,Biotechnology,"$5.7M, Not Found",https://www.kairosventures.com/delpor/,No
demerx inc,Biotechnology,"$1.7M, Not Applicable",https://finance.yahoo.com/news/demerx-awarded-1-7-million-114500503.html,No
dermbiont inc,Biotechnology,"$35.2M, Series B",https://www.linkedin.com/company/dermbiont,No
dermaliq therapeutics inc,Pharmaceuticals,"$10M, Series B",https://www.linkedin.com/company/dermaliq-therapeutics-inc,No
dermavant sciences inc,Biotechnology,"$160M, Acquired",https://www.linkedin.com/company/dermavant-sciences,No
dermira inc (inactive),Biotechnology,"$1.1B, Acquired",https://www.prnewswire.com/news-releases/lilly-announces-agreement-to-acquire-dermira-300984850.html,No
desano inc,Pharmaceuticals,"$10M, Series Unknown",https://www.linkedin.com/company/desano-pharmaceutical-co-ltd-,No
design therapeutics inc,Biotechnology,"$125M, Series B",https://www.linkedin.com/company/designtx,No
destiny pharma plc,Biotechnology,"$8.9M, Post IPO equity",https://uk.linkedin.com/company/destiny-pharma-ltd,No
deuteroncology nv,Biotechnology,"$6.1M, Series A",https://deuteroncology.com/,No
deutsches zentrum fur diabetesforschung ev,Biotechnology,"$36.4M, Not Found",https://de.wikipedia.org/wiki/Deutsches_Zentrum_f%C3%BCr_Diabetesforschung,No
"diobex, inc. (inactive)",Biotechnology,"$31.1M, Series B",https://tracxn.com/d/companies/diobex/__5ojuy2UkKz907KZzeGMByvoYuBSW3460zOqNpQ4zF1I,No
dialectic therapeutics inc,Biotechnology,"$17.4M, Seed",https://www.dtsciences.com/,No
dicot pharma ab,Pharmaceuticals,"$12.8M, Post IPO Equity",https://www.linkedin.com/company/dicot/,No
diffusion pharmaceuticals inc,Biotechnology,"$2.1M, Private Equity Round",https://en.wikipedia.org/wiki/Diffusion_Pharmaceuticals,No
dimerix ltd,Biotechnology,"$13.2M, Post IPO equity",https://synapse.patsnap.com/organization/f481122fa792f4c9cec8bda5806926a0,No
disarm therapeutics inc,Biotechnology,"$135M, Acquired",https://www.prnewswire.com/news-releases/lilly-announces-agreement-to-acquire-disarm-therapeutics-301153277.html,No
diurnal group ltd,Pharmaceuticals,"$483M, Acquired",https://www.fiercepharma.com/pharma/neurocrine-biosciences-doles-out-ps483-acquire-diurnal-group,No
diurnal group plc,Pharmaceuticals,"$48.3M, Acquired",https://www.ipgroupplc.com/news-and-events/portfolio-news/2022/2022-08-30,No
diurnal ltd,Pharmaceuticals,"$55M, Acquired",https://www.prnewswire.com/news-releases/diurnal-ltd-a-neurocrine-biosciences-company-presents-phase-3-extension-study-data-for-modified-release-hydrocortisone-in-patients-with-congenital-adrenal-hyperplasia-at-endo-2023-301849868.html,No
dongkoo bio & pharma co ltd,Pharmaceuticals,"$10.8M, Acquired",https://www.marketscreener.com/quote/stock/DONGKOO-BIO-PHARMA-CO-LTD-120974590/company/,No
douglas pharmaceuticals ltd,Pharmaceuticals,"$76.4K, Grant",https://nz.linkedin.com/company/douglas-pharmaceuticals,No
dova pharmaceuticals inc,Pharmaceuticals,"$29.00 per share, Acquired",https://www.globenewswire.com/search/organization/Dova%2520Pharmaceuticals%CE%B4%2520Inc%C2%A7,No
draig therapeutics ltd,Biotechnology,"$140M, Series A",https://www.pharmaceutical-technology.com/news/draig-funding-neuropsychiatric-disorder-therapies/,No
duke street bio ltd,Biotechnology,"$2.5M, Seed",https://www.crunchbase.com/organization/duke-street-bio,No
dupont danisco a/s,Biotechnology,"$6.3B, Acquired",https://www.prnewswire.com/news-releases/dupont-successfully-completes-tender-offer-for-danisco-121878368.html,No
eip pharma llc,Pharmaceuticals,"$21M, Grant",https://www.linkedin.com/company/eip-pharma-llc,No
eip pharma llc (inactive),Pharmaceuticals,"$21M, Grant",https://finance.yahoo.com/news/eip-pharma-diffusion-pharmaceuticals-announce-110000160.html,No
emulate therapeutics inc,Biotechnology,"$23.2M, Series A",https://tracxn.com/d/companies/emulate-therapeutics/__-gpiZAfLEyaeyqY6Zt6yXPEQqk9-PsptZ1OEdihu8KQ,No
ena respiratory pty ltd,Pharmaceuticals,"$33M, Not Found",https://brandoncapital.vc/portfolio/ena-respiratory/,No
epics therapeutics sa,Biotechnology,"$24.7M, Series A",https://tracxn.com/d/companies/epics-therapeutics/__mzJDIyknXkhNsKIXCb1X6QBbBmnt72EjsG64RDBaHH0,No
es therapeutics llc,Pharmaceuticals,"$5M, Acquired",https://www.globenewswire.com/news-release/2022/11/07/2549501/0/en/Avalo-Sells-Economic-Rights-to-Previously-Out-Licensed-Assets-for-5-Million.html,No
exact therapeutics as,Biotechnology,"$14M, IPO",https://live.euronext.com/en/ipo-showcase/exact-therapeutics,No
eagle pharmaceuticals inc,Pharmaceuticals,"$69M, Post IPO Debt",https://www.linkedin.com/company/eagle-pharmaceuticals-inc.,No
east coast institute for research inc,Biotechnology,"$3M, Private Equity",https://providenthp.com/expertise/east-coast-institute-for-research/,No
eclipse life sciences inc,Biotechnology,"$1.49M, Phase II",https://www.inknowvation.com/sbir/companies/eclipse-life-sciences-inc,No
ectin research ab,Pharmaceuticals,"$53.8K, Grant",https://www.linkedin.com/company/ectin-research/,No
edge therapeutics inc (inactive),Biotechnology,"$83.3M, IPO",https://www.biospace.com/edge-therapeutics-announces-closing-of-initial-public-offering-and-full-exercise-of-over-allotment-option,No
edgewise therapeutics inc,Biotechnology,"$594M, IPO",https://www.prnewswire.com/news-releases/edgewise-therapeutics-reports-second-quarter-2025-financial-results-and-recent-business-highlights-302523640.html,No
edgewood oncology inc,Biotechnology,"$20M, Series A",https://www.businesswire.com/news/home/20240325308786/en/Edgewood-Oncology-Emerges-From-Stealth-with-%2420-Million-in-Series-A-Financing-to-Advance-BTX-A51-in-Patients-with-Hematologic-Malignancies-and-Genetically-Defined-Solid-Tumors,No
egetis therapeutics ab,Pharmaceuticals,"$29.5M, Post IPO equity",https://www.crunchbase.com/organization/egetis-therapeutics-ab,No
eicosis llc,Biotechnology,"$15M, Grant",https://research.ucdavis.edu/eicosis-receives-15m-to-help-fund-human-clinical-trials-of-non-opioid-pain-therapy/,No
elastagen pty ltd,Biotechnology,"$95M, Acquired",https://www.biopharmadive.com/news/allergan-picks-up-australian-biotech-elastagen-in-95m-deal/516838/,No
elcelyx therapeutics inc,Pharmaceuticals,"$70M, Acquired",https://www.fiercebiotech.com/biotech/anji-pharma-secures-70m-series-b-for-phase-3-diabetes-asset-mid-stage-constipation,No
elicera therapeutics ab,Biotechnology,"$517,995, Grant",https://se.linkedin.com/company/elicera-therapeutics-ab,No
elicio therapeutics inc,Biotechnology,"$10M, Post IPO equity",https://www.linkedin.com/company/elicio-therapeutics-01,No
ellipses pharma ltd,Biotechnology,"$10M, Private Equity",https://uk.linkedin.com/company/ellipses-pharma,No
elmedix,Biotechnology,"$5M, Series A",https://pulse2.com/elmedix-up-to-%D1%945-million-for-series-a-following-strong-signals-in-pancreatic-cancer-patient-clinical-study/,No
eloxx pharmaceuticals inc,Biotechnology,"$2.0M, Post IPO equity",https://www.linkedin.com/company/eloxx-pharmaceuticals,No
elpida llc,Biotechnology,"$3.9M, Not Found",https://www.linkedin.com/company/elpidatx,No
elucida oncology inc,Biotechnology,"$75M, Series B",https://synapse.patsnap.com/article/elucida-oncology-closes-over-lack-of-funding-in-adc-pursuit,No
elysium health inc,Biotechnology,"$20M, Series B",https://en.wikipedia.org/wiki/Elysium_Health,No
elysium therapeutics inc,Biotechnology,"$16M, Not Found",https://www.linkedin.com/company/elysium-therapeutics-inc-,No
emalex biosciences inc,Biotechnology,"$250M, Series D",https://www.baincapital.com/news/emalex-biosciences-announces-250-million-financing-round-advance-investigational-new-drug,No
embera neurotherapeutics inc,Pharmaceuticals,"$17.1M, Series B",https://tracxn.com/d/companies/embera-neuro/__HYAOSJwSt5I9ifaaBpgjbai2hmXq0J_QsE4nEBqATKM,No
emeramed ltd,Pharmaceuticals,"$81.9K, Grant",https://www.linkedin.com/company/cti-science-inc.,No
emmaus life sciences inc,Pharmaceuticals,"$110K, Seed",https://www.linkedin.com/company/emmaus-life-sciences,No
emtora biosciences,Biotechnology,"$17M, Grant",https://www.cprit.texas.gov/grants-funded/grants/dp190069,No
enalare therapeutics inc,Pharmaceuticals,"$2.5M, Grant",https://www.biospace.com/press-releases/enalare-therapeutics-receives-second-component-of-a-national-institutes-of-health-nih-grant-award-to-fund-the-next-human-study-of-ena-001,No
enanta pharmaceuticals inc,Biotechnology,"$74.8M, Post IPO equity",https://www.linkedin.com/company/enanta-pharmaceuticals,No
encore pharmaceuticals inc,Pharmaceuticals,"$949,485, Not Found",https://www.sbir.gov/portfolio/156957,No
encube ethicals pvt ltd,Pharmaceuticals,"$65.5M, Series D",https://tracxn.com/d/companies/encube-ethicals/__Z75bPpcmPkjrlPaaUURsKZhG6RiQCG2ElBi5OXHl87w,No
endeavor biomedicines inc,Biotechnology,"$132.5M, Series C",https://www.biopharmadive.com/news/endeavor-john-hood-series-c-idiopathic-pulmonary-fibrosis-adc-her3/714060/,No
endocyte inc (inactive),Biotechnology,"$2.1B, Acquired",https://www.novartis.com/news/media-releases/novartis-announces-planned-acquisition-endocyte-expand-expertise-radiopharmaceuticals-and-build-commitment-transformational-therapeutic-platforms,No
enhancedbio usa inc,Biotechnology,"$4M, Seed",https://www.louisianacancercenter.org/news/nola-startup-advances-to-clinical-trials-of-breast-cancer-therapy,No
ensysce biosciences inc,Biotechnology,"$5.3M, Grant",https://www.linkedin.com/company/ensyscebio,No
entasis therapeutics holdings inc,Biotechnology,"$104.80M, Acquired",https://www.repair-impact-fund.com/investment/entasis-therapeutics/,No
enterprise therapeutics ltd,Pharmaceuticals,"$33.1M, Series B",https://www.news-medical.net/suppliers/Enterprise-Therapeutics-Ltd.aspx,No
enveric biosciences inc,Biotechnology,"$2.2M, Not Found",https://finance.yahoo.com/quote/ENVB/,No
enyo pharma sa,Biotechnology,"$34M, Series C",https://www.businesswire.com/news/home/20250612005046/en/ENYO-Pharma-Announces-Completion-of-Series-C-Financing-With-Vesalius-Biocapital-and-Continued-Progress-of-Its-ALPESTRIA-1-Clinical-Phase-2-Study-in-Alport-Syndrome-Patients,No
eolo pharma,Biotechnology,"$7M, Series A",https://labplus.uy/eolo-pharma-initiates-human-study-of-drug-against-obesity-and-type-2-diabetes/,No
epidestiny inc,Biotechnology,"$400M, Acquired",https://otm.uic.edu/news-stories/novo-nordisk-buys-blood-drug-licence-to-boost-anaemic-biopharma-business/,No
epigenetix inc,Biotechnology,"$167K, Grant",https://tracxn.com/d/companies/epigenetix/__uamY1SlASgdrMnH5Z4Xu1Lx_Vqpm7mzMJqu8tHuU49I,No
epion therapeutics inc,Biotechnology,"$18.5M, Convertible Note",https://www.newworldangels.com/news/nwa-invests-epion-therapeutics,No
epygenix therapeutics inc,Biotechnology,"$35M, Acquired",https://www.prnewswire.com/news-releases/harmony-biosciences-acquires-epygenix-therapeutics-inc-adding-late-stage-epilepsy-franchise-to-growing-pipeline-of-innovative-cns-assets-302131000.html,No
erydel spa,Biotechnology,"$6M, Acquired",https://iedat-project.eu/,No
escient pharmaceuticals inc,Pharmaceuticals,"$750M, Acquired",https://naspnet.org/incyte-completes-acquisition-of-escient-pharmaceuticals,No
esperas pharma inc,Pharmaceuticals,"$16.5M, Series B",https://www.cbinsights.com/company/esperas-pharma,No
esperion therapeutics inc,Pharmaceuticals,"$75M, IPO",https://finance.yahoo.com/quote/ESPR/,No
estetra sa,Pharmaceuticals,"$188.2M, Acquired",https://www.pharmaceutical-technology.com/news/bankrupt-mithra-cashes-in-on-remaining-assets-for-188-2m/,No
estetra sprl,Pharmaceuticals,"$188.2M, Acquired",https://www.gedeonrichter.com/en/news/240612,No
eterna therapeutics inc,Biotechnology,"$7.1M, Not Found",https://www.globenewswire.com/news-release/2025/03/25/3048736/0/en/Eterna-Therapeutics-Changes-Name-to-Ernexa-Therapeutics-to-Reflect-New-Strategic-Focus-on-Ovarian-Cancer-and-Autoimmune-Disease.html,No
eton pharmaceuticals inc,Pharmaceuticals,"$10.6M, Post IPO equity",https://www.linkedin.com/company/etonpharma,No
eupraxia pharmaceuticals inc,Biotechnology,"$80.5M, IPO",https://ca.linkedin.com/company/eupraxia-pharmaceuticals-inc-,No
european and developing countries clinical trials partnership,Pharmaceuticals,"$1.6B, Not Found",https://research-and-innovation.ec.europa.eu/research-area/health/edctp_en,No
evecxia therapeutics inc,Biotechnology,"$5M, Not Found",https://www.biospace.com/press-releases/evecxia-provides-financing-corporate-updates-including-plans-for-an-evx-101-proof-of-concept-phase-2-clinical-study-in-obsessive-compulsive-disorder-ocd-responding-inadequately-to-first-line-therapies,No
everfront biotech inc,Biotechnology,"$10M, IPO",https://www.renaissancecapital.com/IPO-Center/News/108502/Taiwanese-medical-device-developer-Everfront-Biotech-Holding-files-for-a-$1,No
evestra inc,Pharmaceuticals,"$3.3M, Not Found",https://evestra.com/,No
evoke pharma inc,Biotechnology,"$7.5M, Post IPO equity",https://evokepharma.com/,No
exeliom biosciences sas,Biotechnology,"$10M, Series A",https://fr.linkedin.com/company/exeliombio,No
exonate ltd,Biotechnology,"$1.9M, Series A",https://uk.linkedin.com/company/exonate-limited,No
expression therapeutics inc,Biotechnology,"$9.49M, Not Found",https://www.sbir.gov/portfolio/410642,No
eyed pharma sa,Pharmaceuticals,"$51M, Series Unknown",https://www.crunchbase.com/organization/eyed-pharma-sa,No
eyepoint pharmaceuticals inc,Biotechnology,"$215.9M, Post IPO equity",https://www.linkedin.com/company/eyepointpharmaceuticals,No
f2g ltd,Biotechnology,"$100M, Series H",https://www.crunchbase.com/organization/f2g,No
fda office of orphan products development,Pharmaceuticals,"$650,000 per year, Not Found",https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-25-020.html,No
fit-bioceuticals ltd,Pharmaceuticals,"$40M, Acquired",https://www.sparke.com.au/expertise/case-studies/sale-of-fit-bioceuticals-ltd-to-blackmores-ltd/,No
faculty of medicine thammasat university,Biotechnology,"$1.1M, Not Found",Not Found,No
farmak international,Pharmaceuticals,"$15M, Not Found",https://en.wikipedia.org/wiki/Farmak,No
farmalider sa,Pharmaceuticals,"$10M, Private Equity",https://www.cbinsights.com/company/farmalider-group,No
fertin pharma as,Pharmaceuticals,"$820M, Acquired",https://www.pmi.com/media-center/press-releases/press-details?newsId=24121,No
filament health corp,Pharmaceuticals,"$631.8K, Post IPO equity",https://ca.linkedin.com/company/filament-health,No
flare therapeutics inc,Biotechnology,"$123M, Series B",https://www.crunchbase.com/organization/flare-therapeutics,No
flatley discovery lab,Biotechnology,"$1.18M, Not Found",https://www.whoi.edu/press-room/news-release/whoi-teaming-with-flatley-discovery-lab-in-search-for-effective-treatments-for-cystic-fibrosis/,No
fochon pharmaceutical ltd,Pharmaceuticals,"$40M, License Agreement",https://www.fosunpharma.com/en/content/details165_7605.html,No
foghorn therapeutics inc,Biotechnology,"$110M, Post IPO equity",https://www.linkedin.com/company/foghorn-therapeutics,No
